[
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "1-(1-phenylcyclohexyl)-pyrrolidine",
    "guid": "c50f292e-c3ae-4269-b1d3-a5b9cfc67f9e",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "1-(1-phenylcyclohexyl)-pyrrolidine",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"PCPy\", \"PHP\", \"rolicyclidine\", \"pyrrolidine analog of phencyclidine\", \"1-(1-Phenylcyclohexyl)pyrrolidine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710968066, \"_nanoseconds\": 208000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "1-(5-fluoropentyl)-3-(1-naphthoyl)indole",
    "guid": "56d41c52-0bff-4e91-8a91-affd43366603",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "1-(5-fluoropentyl)-3-(1-naphthoyl)indole",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"AM2201\", \"AM-2201\", \"AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) \"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710967958, \"_nanoseconds\": 764000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole",
    "guid": "077962be-d445-499d-9743-545cbe047120",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"AM-694\", \"AM694\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710967911, \"_nanoseconds\": 213000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "1-[1-(2-thienyl)cyclohexyl]piperidine",
    "guid": "773864af-7bd8-4ca0-9ccf-4c4dcd8161e2",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "1-[1-(2-thienyl)cyclohexyl]piperidine",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"TPCP\", \"1-[1-(2-thienyl)-cyclohexyl]-piperidine\", \"TCP\", \"thiophene analog of phencyclidine\", \"2-thienylanalog of phencyclidine\", \"tenocyclidine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1712069029, \"_nanoseconds\": 192000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "1-[1-(2-thienyl)cyclohexyl]pyrrolidine",
    "guid": "b247bc5d-4672-446f-a9f2-5e92f289f1a3",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "1-[1-(2-thienyl)cyclohexyl]pyrrolidine",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"TCPy\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710967544, \"_nanoseconds\": 319000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "1-[2-(4-morpholinyl)ethyl]-3-(1-naphthoyl)indole",
    "guid": "fc92ccc9-afee-4718-bdbf-8bccce7d37f0",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "1-[2-(4-morpholinyl)ethyl]-3-(1-naphthoyl)indole",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"JWH-200\", \"JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1- naphthoyl)indole)\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710967452, \"_nanoseconds\": 71000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "1-androstenediol",
    "guid": "88678d34-2d8c-416d-a1cd-bef7b9e1a868",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "1-androstenediol",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}, {\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"3alpha,17beta-dihydroxy-5alpha-androst-1-ene\", \"3\u03b1,17\u03b2-dihydroxy-5\u03b1-androst-1-ene\", \"3\u03b2,17\u03b2-dihydroxy-5\u03b1-androst-1-ene\", \"3beta,17beta-dihydroxy-5alpha-androst-1-ene\", \"5\u03b1-androst-1-ene-3\u03b2,17\u03b2-diol\", \"5alpha-androst-1-ene-3beta,17beta-diol\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715689532, \"_nanoseconds\": 891000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "1-androstenedione",
    "guid": "71434dab-5b84-402a-a827-cf2ae17ea971",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "1-androstenedione",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}, {\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"5\u0251-androst-1-ene-3\u00df, 17\u00df-dione\", \"5alpha-androst-1-ene-3,17-dione\", \"5\u03b1-androst-1-ene-3,17-dione\", \"[5\u03b1]-androst-1-en-3,17-dione\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715689704, \"_nanoseconds\": 883000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S1: Anabolic Agents",
    "Name": "1-androsterone",
    "guid": "ee5e4249-b5e8-41e2-bdf1-f604f30307e4",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "1-androsterone",
    "Reasons": "[{\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"1-androstenolone\", \"(3beta,5alpha)-3-hydroxyandrost-1-en-17-one\", \"androst-1-en-17-one, 3-hydroxy-, (3beta,5alpha)-\", \"1-DHEA\", \"1-andro\", \"3\u03b2-hydroxy-5\u03b1-androst-1-ene-17-one\", \"1-androstene-3b-ol, 17-one\", \"5alpha-androst-1-en-17-one, 3beta-hydroxy-\", \"1 androstene-3b-ol,17-one undecanoate\", \"5\u03b1-androst-1-en-17-one, 3\u03b2-hydroxy-\", \"1 androstene-3b-ol, 17-one\", \"3beta-hydroxy-androst-1-en-17-one\", \"(3\u03b2,5\u03b1)-3-hydroxyandrost-1-en-17-one\", \"3beta-hydroxy-5alpha-androst-1-ene-17-one\", \"1-androstene-3bol,17-one decanoate\", \"androst-1-en-17-one, 3-hydroxy-, (3\u03b2,5\u03b1)-\", \"1 androstene-3b-ol,17-one caprylate\", \"3beta-hydroxy-5alpha-androst-1-en-17-one\", \"3\u03b2-hydroxy-androst-1-en-17-one\", \"3\u03b2-hydroxy-5\u03b1-androst-1-en-17-one\", \"1-epiandrosterone\", \"3alpha-hydroxy-5alpha-androst-1-ene-17-one\", \"1-androstene-3\u03b2-ol, 17-one\", \"1-androstene-3beta-ol, 17-one\", \"1-androsten-3b-ol-17-one\", \"3beta-hydroxy-5alpha-androsta-1-ene-17-one\", \"3b-hydroxy-androst-1-ene-17-one\", \"3\u03b2-hydroxy-5\u03b1-androsta-1-ene-17-one\", \"3\u03b1-hydroxy-5\u03b1-androst-1-ene-17-one\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738848862, \"_nanoseconds\": 507000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "1-butyl-3-(1-naphthoyl)indole",
    "guid": "05b347d2-beec-4527-801a-ac0b1a420323",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "1-butyl-3-(1-naphthoyl)indole",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"JWH-073\", \"JWH-073 (1-Butyl-3-(1-naphthoyl)indole)\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710966930, \"_nanoseconds\": 54000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "1-hexyl-3-(1-naphthoyl)indole",
    "guid": "f8b72b0e-547d-4054-b766-c37f831d8250",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "1-hexyl-3-(1-naphthoyl)indole",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"JWH-019\", \"JWH-019 (1-Hexyl-3-(1-naphthoyl)indole)\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710966884, \"_nanoseconds\": 318000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "1-pentyl-3-(1-naphthoyl)indole",
    "guid": "c7668250-8ffb-47c0-82e2-937c54264499",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "1-pentyl-3-(1-naphthoyl)indole",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"AM-678\", \"AM678\", \"JWH-018 (also known as AM678) (1-Pentyl-3-(1- naphthoyl)indole)\", \"JWH-018\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738849126, \"_nanoseconds\": 91000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "1-pentyl-3-(2-chlorophenylacetyl)indole",
    "guid": "ac39d73d-e6c9-4e68-acf4-d42ac7564c8b",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "1-pentyl-3-(2-chlorophenylacetyl)indole",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"2-(2-chlorophenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone\", \"JWH-203\", \"JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)indole)\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710966572, \"_nanoseconds\": 802000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "1-pentyl-3-(2-methoxyphenylacetyl)indole",
    "guid": "14747783-dcf1-4c38-b23f-072843b69aa4",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "1-pentyl-3-(2-methoxyphenylacetyl)indole",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"2-(2-methoxyphenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone\", \"JWH-250\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710966512, \"_nanoseconds\": 806000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "1-pentyl-3-(4-chloro-1-naphthoyl)indole",
    "guid": "11c39cb8-4264-437e-bed8-41c92746e756",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "1-pentyl-3-(4-chloro-1-naphthoyl)indole",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"JWH-398\", \"(4-chloronaphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone\", \"JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl)indole)\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710966463, \"_nanoseconds\": 702000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "1-pentyl-3-(4-methyl-1-naphthoyl)indole",
    "guid": "ebeb723a-ce80-4ec6-aa5c-247439b4614c",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "1-pentyl-3-(4-methyl-1-naphthoyl)indole",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"(4-methylnaphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone\", \"JWH-122\", \"JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole)\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710966415, \"_nanoseconds\": 557000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "1-pentyl-3-[1-(4-methoxynaphthoyl)]indole",
    "guid": "40c03c20-324f-4295-9bbe-a00bb0b8f555",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "1-pentyl-3-[1-(4-methoxynaphthoyl)]indole",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"1-pentyl-3-(4-methoxynaphthoyl)indole\", \"JWH-081\", \"(4-methoxynaphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone\", \"JWH-081 (1-Pentyl-3-(1-(4-methoxynaphthoyl)indole)\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710966356, \"_nanoseconds\": 102000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule II",
    "Name": "1-phenylcyclohexylamine",
    "guid": "44136b07-f7d9-4309-98c4-e64a893d5825",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "1-phenylcyclohexylamine",
    "Reasons": "[{\"reason_code\": 6004, \"reason\": \"DEA Controlled Substance List: Schedule  II\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"207f9e17-8a22-4523-8dd6-24d9d39b4c45\", \"link_title\": \"DEA Controlled Substance List: Schedule  II\", \"updated\": {\"_seconds\": 1712942744, \"_nanoseconds\": 783000000}}]",
    "other_names": "[\"1-phenylcyclohexan-1-amine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1712068662, \"_nanoseconds\": 176000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "1-testosterone",
    "guid": "65f9e27c-ee56-47a1-96db-4a57b3a4e0bd",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "1-testosterone",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}, {\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"\u03941-dihydrotestosterone\", \"delta1-dihydrotestosterone\", \"\u03941-dihydrotestosterone (17\u03b2-hydroxy-5\u03b1-androst-1-en3-one)\", \"17\u03b2-hydroxy-5\u03b1-androst-1-en-3-one\", \"1-testosterone acetate\", \"17beta-hydroxy-5alphaandrost-1-en-3-one\", \"1-Testo\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715693206, \"_nanoseconds\": 319000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "11-keto-testosterone",
    "guid": "0c1b0696-df4c-468c-8ee1-089a74c24d8b",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "11-keto-testosterone",
    "Reasons": "[{\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}, {\"reason_code\": 6014, \"reason\": \"DoDI 1010.16\", \"link\": \"https://www.esd.whs.mil/directives/issuances/dodi\", \"guid\": \"b757aa46-4729-4d4a-a32e-25ef0b04e5c3\", \"link_title\": \"Use or misuse prohibited under DoDI 1010.16\", \"updated\": {\"_seconds\": 1703683049, \"_nanoseconds\": 190000000}}]",
    "other_names": "[\"17\u03b2-Hydroxy-androst-4-en-3,11-one\", \"17beta-hydroxy-androst-4-en-3,11-one\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1722279530, \"_nanoseconds\": 775000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "11\u03b2-methyl-19-nortestosterone",
    "guid": "932e8a57-ac3a-4aaf-b158-0bcb160a5876",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "11\u03b2-methyl-19-nortestosterone",
    "Reasons": "[{\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"11beta-methyl-19-nortestosterone\", \"11beta-methylestr-4-en-17beta-ol-3-one\", \"11\u03b2-MNT\", \"11\u03b2-methylestr-4-en-17\u03b2-ol-3-one\", \"11beta-MNT\", \"11\u03b2-methyl-17\u03b2-hydroxy-estr-4-en-3-one\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1721919520, \"_nanoseconds\": 702000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "13\u03b2-ethyl-17\u03b2-hydroxygon-4-en-3-one",
    "guid": "81e1ddfe-ef11-4e96-982a-c638f71f350b",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "13\u03b2-ethyl-17\u03b2-hydroxygon-4-en-3-one",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}]",
    "other_names": "[\"18-methyl-19-nortestosterone\", \"13beta-ethyl-17beta-hydroxygon-4-en-3-one\", \"17beta-hydroxy-13-ethylgon-4-en-3-one\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1712758327, \"_nanoseconds\": 123000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: 17-dihydroexemestane\", \"url\": \"https://drugs.ncats.io/drug/U35ZNO9DJH\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S4: Hormone and Metabolic Modulators; Unapproved drug",
    "Name": "17-dihydroexemestane",
    "guid": "a5ea79cb-8a9a-4ddf-b950-2bed156bc064",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "17-dihydroexemestane",
    "Reasons": "[{\"reason_code\": 6012, \"reason\": \"WADA S4: Hormone and Metabolic Modulators\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"ac1ba347-6d44-4a17-829d-e589bf33bbdb\", \"link_title\": \"WADA Prohibited List S4: Hormone and Metabolic Modulators\", \"updated\": {\"_seconds\": 1703682875, \"_nanoseconds\": 162000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"17beta-dihydroxy exemestane\", \"17hydroxy 6methylene androsta 1,4 diene ,3one\", \"17beta-hydroxy exemestane\", \"DhExe cpd\", \"17\u03b2-hydroxy exemestane\", \"androsta-1,4-dien-3-one, 17-hydroxy-6-methylene-\", \"6-methylene-17-hydroxyandrosta-1,4-diene-3-one\", \"methylene boldenone\", \"17\u03b2-hydroxy exemestane\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738861821, \"_nanoseconds\": 781000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "17alpha-methyl-3alpha,17beta-dihydroxy-5alpha-androstane",
    "guid": "eb37074d-2553-4bc7-8f6d-7017f16ab55a",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "17alpha-methyl-3alpha,17beta-dihydroxy-5alpha-androstane",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}]",
    "other_names": "[\"17\u03b1-methyl-3\u03b1,17\u03b2-dihydroxy-5\u03b1-androstane\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1713795265, \"_nanoseconds\": 579000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "17alpha-methyl-3beta,17beta-dihydroxy-5alpha-androstane",
    "guid": "44493455-7fcd-4a7b-989c-4daf2159b688",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "17alpha-methyl-3beta,17beta-dihydroxy-5alpha-androstane",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}]",
    "other_names": "[\"17-methyl-5\u03b1-androstane-3\u03b2,17\u03b2-diol\", \"17-methyl-5alpha-androstane-3beta,17beta-diol\", \"17\u03b1-methyl-3\u03b2,17\u03b2-dihydroxy-5\u03b1-androstane\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1713896612, \"_nanoseconds\": 780000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "17alpha-methyl-3beta,17beta-dihydroxyandrost-4-ene",
    "guid": "08919dab-a435-4318-93bf-8f946438e760",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "17alpha-methyl-3beta,17beta-dihydroxyandrost-4-ene",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}]",
    "other_names": "[\"17-methyl-androst-4-ene-3beta,17beta-diol\", \"17-methyl-androst-4-ene-3\u03b2,17\u03b2-diol\", \"17-methylandrost-4-ene-3beta,17beta-diol\", \"17-methylandrost-4-ene-3\u03b2,17\u03b2-diol\", \"17\u03b1-methyl-3\u03b2,17\u03b2-dihydroxyandrost-4-ene\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710964763, \"_nanoseconds\": 480000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "17alpha-methyl-4-hydroxynandrolone",
    "guid": "bee6b6cc-92f1-4ef8-a522-617bf6cb79cb",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "17alpha-methyl-4-hydroxynandrolone",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}]",
    "other_names": "[\"17alpha-methyl-4-hydroxy-17beta-hydroxyestr-4-en-3-one\", \"4-hydroxy-19-normethyltestosterone\", \"17\u03b1-methyl-4-hydroxynandrolone\", \"estr-4-en-3-one, 4,17\u03b2-dihydroxy-17-methyl-\", \"17\u03b1-methyl-4-hydroxy-17\u03b2-hydroxyestr-4-en-3-one\", \"estr-4-en-3-one, 4,17beta-dihydroxy-17-methyl-\", \"17\u03b1-methyl-4-hydroxynandrolone (17\u03b1-methyl-4- hydroxy-17\u03b2-hydroxyestr-4-en-3-one)\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710964688, \"_nanoseconds\": 367000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "17alpha-methyl-5alpha-androstan-17beta-ol",
    "guid": "05f8920f-c3b6-4761-a504-1cb4ae6403d2",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "17alpha-methyl-5alpha-androstan-17beta-ol",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}, {\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"protodrol\", \"17-methyl-5alpha-androstan-17beta-ol\", \"17-methyl-5\u03b1-androstan-17\u03b2-ol\", \"17a-methyl-5a-androst-17b-ol\", \"17\u03b1-methyl-5\u03b1-androstan-17\u03b2-ol\", \"protobol\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1716928975, \"_nanoseconds\": 501000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "17alpha-methyl-androst-2-ene-3,17beta-diol",
    "guid": "aa8ee1d9-5281-44e2-afcc-71a411e074fe",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "17alpha-methyl-androst-2-ene-3,17beta-diol",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}]",
    "other_names": "[\"17\u03b1-methyl-androst-2-ene-3,17\u03b2-diol\", \"17a-methyl-androst-2-ene-3,17b-diol\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710964341, \"_nanoseconds\": 213000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "17alpha-methyl-androsta-1,4-diene-3,17beta-diol",
    "guid": "7ce95ff9-a6bc-4a0d-9ed1-a096adeaadb1",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "17alpha-methyl-androsta-1,4-diene-3,17beta-diol",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}]",
    "other_names": "[\"17a-methyl-1,4-androstadiene-3,17diol\", \"17alpha-methyl-1,4-androstadiene-3,17diol\", \"methyl-1,4AD\", \"17\u03b1-methyl-1,4-androstadiene-3,17diol\", \"M1,4ADD\", \"methyl-1,4 androstenediol\", \"17-methyl-1,4-androstadiene-3,17diol\", \"M-1 4ADD\", \"M1,4 ADD\", \"17\u03b1-methyl-androsta-1,4-diene-3,17\u03b2-diol\", \"M14ADD\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738861883, \"_nanoseconds\": 935000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "17alpha-methyl-androstan-3-hydroxyimine-17beta-ol",
    "guid": "66f5d986-0720-4459-b066-54be95fce75e",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "17alpha-methyl-androstan-3-hydroxyimine-17beta-ol",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}]",
    "other_names": "[\"17\u03b1-methyl-androstan-3-hydroxyimine-17\u03b2-ol\", \"17a-Methyl-androstan-3-hydroxyimine-17b-ol\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710963930, \"_nanoseconds\": 614000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "17beta-hydroxy-androstano[2,3-d]isoxazole",
    "guid": "47981a80-6c12-4d62-9862-f7d4522b648d",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "17beta-hydroxy-androstano[2,3-d]isoxazole",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}]",
    "other_names": "[\"17\u03b2-hydroxy-androstano[2,3-d]isoxazole\", \"17b-Hydroxy-androstano[2,3-d]isoxazole\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710963905, \"_nanoseconds\": 78000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "17beta-hydroxy-androstano[3,2-c]isoxazole",
    "guid": "a7718689-561d-4488-bcb6-37f6e6d8b4aa",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "17beta-hydroxy-androstano[3,2-c]isoxazole",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}]",
    "other_names": "[\"17\u03b2-hydroxy-androstano[3,2-c]isoxazole\", \"17b-Hydroxy-androstano[3,2-c]isoxazole\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710963877, \"_nanoseconds\": 589000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "18a-homo-3-hydroxy-estra-2,5(10)-dien-17-one",
    "guid": "d3601a2c-68b0-4972-9ee3-7bdbf6fae081",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "18a-homo-3-hydroxy-estra-2,5(10)-dien-17-one",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}]",
    "other_names": "[]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710963827, \"_nanoseconds\": 981000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "19-nor-4,9(10)-androstadienedione",
    "guid": "f06c1eaa-ca22-47bb-9ffe-33c39f5a2248",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "19-nor-4,9(10)-androstadienedione",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}, {\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"19-norandrosta-4,9(10)-diene-3,17-dione\", \"estra-4,9-dien-3,17-dione\", \"Trenbolin\", \"19-norandrosta-4,9-dien-3,17-dione\", \"19-norandrosta-4,9-diene-3,17-dione\", \"Trena\", \"4,9-esteadine-3,17-dione\", \"estra-4,9(10)-diene-3,17-dione\", \"methyldienedione\", \"dienedione\", \"19-nor-4,9(10)-androstadienedione (estra-4,9(10)- diene-3,17-dione)\", \"estra-4,9-diene-3,17-dione\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738862075, \"_nanoseconds\": 446000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "19-nor-5-androstenediol",
    "guid": "e5ed130d-9458-4b4d-8801-ae5c95133dfb",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "19-nor-5-androstenediol",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}]",
    "other_names": "[\"3alpha,17beta-dihydroxyestr-5-ene\", \"3\u03b1, 17\u03b2-dihydroxyestr-5-ene\", \"3\u03b2, 17\u03b2-dihydroxyestr-5-ene\", \"3beta,17beta-dihydroxyestr-5-\u00adene\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1714054628, \"_nanoseconds\": 337000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "19-nor-5-androstenedione",
    "guid": "35f93d41-5310-4e85-a444-8a39410fd211",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "19-nor-5-androstenedione",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}]",
    "other_names": "[\"19-norandrost-5-en-3,17-dione\", \"19-norandrost-5-ene-3,17-dione\", \"estr-5-en-3,17-dione\", \"estr-5-ene-3,17-dione\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1713972583, \"_nanoseconds\": 369000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: 19-norandrosterone\", \"url\": \"https://drugs.ncats.io/drug/5W4XKU708V\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S1: Anabolic agents; Unapproved drug",
    "Name": "19-norandrosterone",
    "guid": "3bc443c5-bab8-4564-b2a8-0544e543a3d6",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "19-norandrosterone",
    "Reasons": "[{\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"19-nor-androsterone\", \"5alpha-estran-3alpha-ol-17-one\", \"3\u03b1-hydroxy-5\u03b1-estran-17-one\", \"5\u03b1-estran-3\u03b1-ol-17-one\", \"3alpha-hydroxy-5alpha-estran-17-one\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738862377, \"_nanoseconds\": 389000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "2',5'-dimethoxyfentanyl",
    "guid": "6d50376e-c126-4750-bca9-4f49af619965",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "2',5'-dimethoxyfentanyl",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"N-(1-(2,5- dimethoxyphenethyl)piperidine-4-yl)-N-phenylpropionamide\", \"N-(1-(2,5-dimethoxyphenethyl)piperidin-4-yl)-N-phenylpropionamide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1711032059, \"_nanoseconds\": 330000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "2,5-dimethoxyamphetamine",
    "guid": "28588bb3-9173-43e0-ae79-0654ebd8e3fe",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "2,5-dimethoxyamphetamine",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"2,5-dimethoxy-alpha-methylphenethylamine\", \"2,5-dimethoxy-\u03b1-methylphenethylamine\", \"2,5-DMA\", \"DMA\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710962670, \"_nanoseconds\": 190000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one",
    "guid": "73677403-c80f-481f-a2d6-f7bc97d37b1b",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"2-(3-dethoxyphenyl)-2-(N-ethylamino)cyclohexanone\", \"2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone\", \"2-(3-methoxyphenyl)-2-(N-ethylamino)cyclohexanone\", \"2-(ethylamino)-2-(3-methoxyphenyl)-1-cyclohexanone\", \"2-(ethylamino)-2-(3-methoxyphenyl)cyclohexanone\", \"3-MeO-2-oxo-PCE\", \"cyclohexanone, 2-(ethylamino)-2-(3-methoxyphenyl)-\", \"methoxetamine\", \"Mexxy\", \"MXE\", \"2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one (methoxetamine)\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710963310, \"_nanoseconds\": 819000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S4: Hormone and Metabolic Modulators",
    "Name": "2-androstenol",
    "guid": "535793d2-5bab-4ca1-8925-11f3c7070db2",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "2-androstenol",
    "Reasons": "[{\"reason_code\": 6012, \"reason\": \"WADA S4: Hormone and Metabolic Modulators\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"ac1ba347-6d44-4a17-829d-e589bf33bbdb\", \"link_title\": \"WADA Prohibited List S4: Hormone and Metabolic Modulators\", \"updated\": {\"_seconds\": 1703682875, \"_nanoseconds\": 162000000}}]",
    "other_names": "[\"5alpha-androst-2-en-17-ol\", \"5\u03b1-androst-2-en-17-ol\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738862585, \"_nanoseconds\": 838000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S4: Hormone and Metabolic Modulators",
    "Name": "2-androstenone",
    "guid": "3fa5b7b5-4d2b-491f-95a4-385d71676686",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "2-androstenone",
    "Reasons": "[{\"reason_code\": 6012, \"reason\": \"WADA S4: Hormone and Metabolic Modulators\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"ac1ba347-6d44-4a17-829d-e589bf33bbdb\", \"link_title\": \"WADA Prohibited List S4: Hormone and Metabolic Modulators\", \"updated\": {\"_seconds\": 1703682875, \"_nanoseconds\": 162000000}}]",
    "other_names": "[\"delta-2\", \"2-androstene-17-one\", \"5\u03b1-androst-2-en-17-one\", \"5alpha-androst-2-en-17-one\", \"17-oxo-5\u03b1-androst-2-ene\", \"17-oxo-5alpha-androst-2-ene\", \"17-oxo-5a-androst-2-ene\", \"5 alpha androst-2-en- 17-one\", \"androst-2-en-17-one\", \"5 \u03b1 androst-2-en- 17-one\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738863718, \"_nanoseconds\": 677000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "25B-NBOMe",
    "guid": "b7144c2c-afda-4bee-a5a1-3a9e647067b2",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "25b-nbome",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine\", \"Cimbi-36\", \"2C-B-NBOMe\", \"2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25B-NBOMe)\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710962387, \"_nanoseconds\": 877000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "25C-NBOMe",
    "guid": "19bf1988-5f87-4223-aa3a-1f6cf2d962a6",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "25c-nbome",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine\", \"2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine\", \"2C-C-NBOMe\", \"Cimbi-82\", \"2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25C-NBOMe)\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710962310, \"_nanoseconds\": 211000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "25I-NBOMe",
    "guid": "9c2e59ac-3a48-414c-b3bb-cf04d5fbfc8e",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "25i-nbome",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"Cimbi-5\", \"2C-I-NBOMe\", \"2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine\", \"2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25I-NBOMe)\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710962207, \"_nanoseconds\": 261000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "2C-C",
    "guid": "8c22de36-dcc9-46d2-af1c-8366c42e4bfc",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "2c-c",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"2-(4-chloro-2,5-dimethoxyphenyl)ethanamine\", \"2-(4-chloro-2,5-dimethoxyphenyl) ethanamine\", \"2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C-C)\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710962079, \"_nanoseconds\": 5000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "2C-D",
    "guid": "10cc7a79-fa93-431e-9621-786f69e5253d",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "2c-d",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"2-(2,5-dimethoxy-4-methylphenyl) ethanamine\", \"2-(2,5-dimethoxy-4-methylphenyl)ethanamine\", \"2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C-D)\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710962033, \"_nanoseconds\": 904000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "2C-E",
    "guid": "f9f6f5fb-bda1-47da-99ae-cd9ae679d82e",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "2c-e",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"2,5-Dimethoxy-3,4-dimethylphenethylamine (2C-G)\", \"2-(2,5-dimethoxy-4-ethylphenyl) ethanamine\", \"2-(2,5-dimethoxy-4-ethylphenyl)ethanamine\", \"2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C-E)\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710961915, \"_nanoseconds\": 653000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "2C-H",
    "guid": "9474cc4f-d9a1-4f4a-b3f8-cd80d41f4a0d",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "2c-h",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"2-(2,5-dimethoxyphenyl)ethanamine\", \"2-(2,5-dimethoxyphenyl) ethanamine\", \"2-(2,5-Dimethoxyphenyl) ethanamine (2C-H)\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710957726, \"_nanoseconds\": 731000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "2C-I",
    "guid": "954c9ff2-c198-4437-b18e-9c34158fae93",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "2c-i",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"2-(4-iodo-2,5-dimethoxyphenyl)ethanamine\", \"2-(4-iodo-2,5-dimethoxyphenyl) ethanamine\", \"2-(4-iodo-2,5-dimethoxyphenyl) ethanamine (2C-I)\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710957690, \"_nanoseconds\": 651000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "2C-N",
    "guid": "c7e03f4c-d0a7-452b-9b8f-6a4a7784ecfd",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "2c-n",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"2-(2,5-dimethoxy-4-nitro-phenyl) ethanamine\", \"2-(2,5-dimethoxy-4-nitro-phenyl)ethanamine\", \"2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C-N)\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710957666, \"_nanoseconds\": 203000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "2C-P",
    "guid": "09bcfd23-8579-4b55-bf15-d41dad7871df",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "2c-p",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2-CP)\", \"2-(2,5-dimethoxy-4-(n)-propylphenyl)ethanamine\", \"2-(2,5-dimethoxy-4-(n)-propylphenyl) ethanamine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710957632, \"_nanoseconds\": 99000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "2C-T-2",
    "guid": "17612024-b418-4989-8453-6a595c43db01",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "2c-t-2",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"2-[4-(ethylthio)-2,5-dimethoxyphenyl] ethanamine\", \"2-[4-(ethylthio)-2,5-dimethoxyphenyl]ethanamine\", \"2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine (2C-T-2)\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710957601, \"_nanoseconds\": 699000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "2C-T-4",
    "guid": "c59d758d-8128-42fb-b948-31cdc485a267",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "2c-t-4",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"2,5-Dimethoxy-4-ethylthioamphetamine\", \"2-[4-(isopropylthio)-2,5-dimethoxyphenyl]ethanamine\", \"2,5-Dimethoxy-4-ethylthioamphetamine (Aleph-2)\", \"Aleph-2\", \"2-[4-(isopropylthio)-2,5-dimethoxyphenyl] ethanamine\", \"2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine (2C-T-4)\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710957571, \"_nanoseconds\": 387000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "2C-T-7",
    "guid": "d5b7b22d-0c94-41e1-8b05-1f26f6d37080",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "2c-t-7",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"2,5-dimethoxy-4(n)-propylthiophenethylamine\", \"2,5-dimethoxy-4-(n)-propylthiophenethylamine\", \"2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7)\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710957528, \"_nanoseconds\": 690000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "2alpha,17alpha-dimethyl-17beta-hydroxy-5beta-androstan-3-one",
    "guid": "9162a56b-306e-438f-9499-ba71b3fd0113",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "2alpha,17alpha-dimethyl-17beta-hydroxy-5beta-androstan-3-one",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}]",
    "other_names": "[\"2\u03b1,17\u03b1-dimethyl-17\u03b2-hydroxy-5\u03b2-androstan-3-one\", \"2a,17a-dimethyl-17b-hydroxy-5b-androstan-3-one\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710962136, \"_nanoseconds\": 125000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "2\u2032-fluoro ortho-fluorofentanyl",
    "guid": "7ca182f5-7845-4218-815f-4e290938045d",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "2\u2032-fluoro ortho-fluorofentanyl",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"2'-Fluoro ortho-fluorofentanyl (N-(1-(2- fluorophenethyl)piperidin-4-yl)-N-(2- fluorophenyl)propionamide; also known as 2'-fluoro 2- fluorofentanyl)\", \"N-(1-(2-fluorophenethyl)piperidin-4-yl)-N-(2-fluorophenyl)propionamide\", \"2\u2032-fluoro 2-fluorofentanyl\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738864218, \"_nanoseconds\": 477000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "3,4-dimethylmethcathinone",
    "guid": "e1b136b3-945b-4f6b-b81f-c8d8717188d0",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "3,4-dimethylmethcathinone",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"3,4-DMMC\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710957220, \"_nanoseconds\": 194000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "3-MMC",
    "guid": "9f0f5edf-ac7a-42f4-9634-20f80445fd2a",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "3-mmc",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"2-(methylamino)-1-(3-methylphenyl)propan-1-one\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709044672, \"_nanoseconds\": 194000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S4: Hormone and Metabolic Modulators",
    "Name": "3-androstenol",
    "guid": "1b1a560a-a88c-41c5-b4d8-7b1335d2d603",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "3-androstenol",
    "Reasons": "[{\"reason_code\": 6012, \"reason\": \"WADA S4: Hormone and Metabolic Modulators\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"ac1ba347-6d44-4a17-829d-e589bf33bbdb\", \"link_title\": \"WADA Prohibited List S4: Hormone and Metabolic Modulators\", \"updated\": {\"_seconds\": 1703682875, \"_nanoseconds\": 162000000}}]",
    "other_names": "[\"5\u03b1-androst-3-en-17-ol\", \"5alpha-androst-3-en-17-ol\", \"3-Androstenol (5\u0251-androst-3-en-17-ol)\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738864346, \"_nanoseconds\": 65000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S4: Hormone and Metabolic Modulators",
    "Name": "3-androstenone",
    "guid": "eaece171-f2b3-4208-a515-e14049d3d1ac",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "3-androstenone",
    "Reasons": "[{\"reason_code\": 6012, \"reason\": \"WADA S4: Hormone and Metabolic Modulators\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"ac1ba347-6d44-4a17-829d-e589bf33bbdb\", \"link_title\": \"WADA Prohibited List S4: Hormone and Metabolic Modulators\", \"updated\": {\"_seconds\": 1703682875, \"_nanoseconds\": 162000000}}]",
    "other_names": "[\"5\u03b1-androst-3-en-17-one\", \"5alpha-androst-3-en-17-one\", \"5a-androst-3-en-17-one\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738864411, \"_nanoseconds\": 763000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "3-fluoro-N-methylcathinone",
    "guid": "87a4a75f-e9bc-43f2-bcdc-5c73041e180c",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "3-fluoro-n-methylcathinone",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"3-FMC\", \"1-(3-fluorophenyl)-2-(methylamino)propan-1-one)\", \"3-Fluoro-N-methylcathinone (3-FMC)\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710957398, \"_nanoseconds\": 514000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "3-furanyl fentanyl",
    "guid": "f112cfe0-6f8a-4dee-b780-769c968ecd19",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "3-furanyl fentanyl",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-3-carboxamide\", \"N-(1-phenthylpiperidin-4-yl)-N-phenylfuran-3-carboxamide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709044584, \"_nanoseconds\": 658000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "3-methylethcathinone",
    "guid": "9c6d067c-34c8-4be0-a980-22597c7b90b0",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "3-methylethcathinone",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"3-MEC\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710957338, \"_nanoseconds\": 516000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "3-methylfentanyl",
    "guid": "542f45f7-54c2-4ce1-994b-cd66d46fc58b",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "3-methylfentanyl",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"3-MF\", \"mefentanyl\", \"China White\", \"N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710957313, \"_nanoseconds\": 763000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "3-methylthiofentanyl",
    "guid": "3f4f55f1-f2f0-4fdc-a5ac-7864f153b9c8",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "3-methylthiofentanyl",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"N-(3-methyl-1-(2-thienyl)ethyl-4-piperidinyl)-N-phenylpropanamide\", \"N-[3-methyl-1-(2-thienylethyl)-4-piperidinyl]-N-phenylpropanamide\", \"3-methyl-thiofentanyl\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710957264, \"_nanoseconds\": 683000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "3beta-hydroxy-estra-4,9,11-trien-17-one",
    "guid": "892c9730-3718-4390-b648-27ce0102c14a",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "3beta-hydroxy-estra-4,9,11-trien-17-one",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}]",
    "other_names": "[\"3\u03b2-hydroxy-estra-4,9,11-trien-17-one\", \"3b-hydroxy-estra-4,9,11-trien-17-one\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710957181, \"_nanoseconds\": 362000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "4'-chloro-alpha-PVP",
    "guid": "0870fad2-9333-48d3-8011-b98cc138de4b",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "4'-chloro-alpha-pvp",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"4'-chloro-\u03b1-pyrrolidinopentiophenone\", \"4-chloro-a-PVP\", \"4'-chloro-\u03b1-pyrrolidinovalerophenone\", \"4-chloro-\u03b1-PVP\", \"4'-chloro-alpha-pyrrolidinopentiophenone\", \"4'-chloro-alpha-pyrrolidinovalerophenone\", \"1-(4-chlorophenyl)-2-(pyrrolidin-1-yl)pentan-1-one\", \"4'-chloro-alpha-pyrrolidinovalerophenone (4-chloro-\u03b1PVP)\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710953987, \"_nanoseconds\": 38000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "4,4\u2032-Dimethylaminorex",
    "guid": "1ed86eaf-89bc-490b-88f5-ed72bddf0e07",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "4,4\u2032-dimethylaminorex",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"4,5-Dihydro-4-methyl-5-(4-methylphenyl)-2-oxazolamine\", \"4,4\u2032-DMAR\", \"4-methyl-5-(4-methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1712066569, \"_nanoseconds\": 825000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "4-(2-chlorophenyl)-2-ethyl-9-methyl-6H-thieno[3,2- F][1,2,4]triazolo[4,3-A][1,4]diazepine",
    "guid": "83f35b3a-5879-44a6-9aba-98f4f5ed1df0",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "4-(2-chlorophenyl)-2-ethyl-9-methyl-6h-thieno[3,2- f][1,2,4]triazolo[4,3-a][1,4]diazepine",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"etizolam\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710957111, \"_nanoseconds\": 419000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "4-MEAP",
    "guid": "92c590c3-9149-43ae-936f-646f95a45f1b",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "4-meap",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"4-methyl-alpha-ethylaminopentiophenone\", \"4-methyl-\u03b1-ethylaminopentiophenone\", \"2-(ethylamino)-1-(4-methylphenyl)pentan-1-one\", \"4-methyl-alpha-ethylaminopentiophenone (4-MEAP)\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710955223, \"_nanoseconds\": 239000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "4-MePPP",
    "guid": "18d46221-c4f1-42d1-bf20-1b67b6f179ac",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "4-meppp",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"4-methyl-alphapyrrolidinopropiophenone\", \"1-(4-methylphenyl)-2-(pyrrolidin-1-yl)-propan-1-one)\", \"4-methyl-alpha-pyrrolidinopropiophenone\", \"4-methyl-\u03b1-pyrrolidinopropiophenone\", \"4-Methyl-alphapyrrolidinopropiophenone (4-MePPP)\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710955176, \"_nanoseconds\": 855000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"DoDI 1010.04 Problematic Substance Use by DoD Personnel\", \"url\": \"https://www.esd.whs.mil/Directives/issuances/dodi\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "4-OH-DiPT",
    "guid": "12151546-5d51-4b9b-b86e-2345e1f6d5cf",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "4-oh-dipt",
    "Reasons": "[{\"reason_code\": 6021, \"reason\": \"Other reason\", \"link\": null, \"guid\": \"9bdb33d0-1759-4198-8056-bc40e52a3afd\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683326, \"_nanoseconds\": 656000000}}]",
    "other_names": "[\"4-hydroxy-N,N-diisopropyltryptamine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1712170148, \"_nanoseconds\": 246000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: 4-androstene-3,6,17-trione\", \"url\": \"https://drugs.ncats.io/drug/L8L0381OBP\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S4: Hormone and Metabolic Modulators",
    "Name": "4-androstene-3,6,17 trione",
    "guid": "fe564a0f-85da-414c-8241-41bf423fabf1",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "4-androstene-3,6,17 trione",
    "Reasons": "[{\"reason_code\": 6012, \"reason\": \"WADA S4: Hormone and Metabolic Modulators\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"ac1ba347-6d44-4a17-829d-e589bf33bbdb\", \"link_title\": \"WADA Prohibited List S4: Hormone and Metabolic Modulators\", \"updated\": {\"_seconds\": 1703682875, \"_nanoseconds\": 162000000}}]",
    "other_names": "[\"6-oxo-androstenedione\", \"androst-4-ene-3,6,17-trione\", \"4-AT\", \"4-Androstene-3,6,17-trione\", \"4-etioallocholen-3,6,17-trione\", \"4-androsten-3,6,17-trione\", \"6-oxo\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738864699, \"_nanoseconds\": 690000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "4-androstenediol",
    "guid": "56307d1b-64f7-4e6c-9dbb-e1b8e07f9adc",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "4-androstenediol",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}, {\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"androst-4-ene-3\u03b2,17\u03b2-diol\", \"3\u03b2,17\u03b2-dihydroxy-androst-4-ene\", \"3beta,17beta-dihydroxy-androst-4-ene\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715693804, \"_nanoseconds\": 328000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule II",
    "Name": "4-anilino-N-phenethylpiperidine",
    "guid": "e25a2850-b3ed-4876-9572-12316773df1e",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "4-anilino-n-phenethylpiperidine",
    "Reasons": "[{\"reason_code\": 6004, \"reason\": \"DEA Controlled Substance List: Schedule  II\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"207f9e17-8a22-4523-8dd6-24d9d39b4c45\", \"link_title\": \"DEA Controlled Substance List: Schedule  II\", \"updated\": {\"_seconds\": 1712942744, \"_nanoseconds\": 783000000}}]",
    "other_names": "[\"4-anilino-N-phenethyl-4-piperidine\", \"N-phenyl-1-(2-phenylethyl)piperidin-4-amine\", \"1-phenethyl-N-phenylpiperidin-4-amine\", \"despropionylfentanyl\", \"4-Anilino-N-phenethyl-4-piperidine (ANPP)\", \"despropionyl fentanyl\", \"ANPP\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738864827, \"_nanoseconds\": 543000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "4-bromo-2,5-dimethoxyphenethylamine",
    "guid": "bcbe6cd6-c275-4447-877a-8b5b56704288",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "4-bromo-2,5-dimethoxyphenethylamine",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"alpha-desmethyl DOB\", \"Nexus\", \"2C-B\", \"2-(4-bromo-2,5-dimethoxyphenyl)ethylamine\", \"4-bromo-2,5-dimethoxyphenethylamine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1711995958, \"_nanoseconds\": 522000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "4-fluoro-N-methylcathinone",
    "guid": "d23ab358-6a21-45eb-ad48-6cdfc732ee2d",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "4-fluoro-n-methylcathinone",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"1-(4-fluorophenyl)-2-(methylamino)propan-1-one)\", \"flephedrone\", \"2-FMC\", \"4-FMC\", \"4-Fluoro-N-methylcathinone (4-FMC)\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710956777, \"_nanoseconds\": 83000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "4-fluoroisobutyryl fentanyl",
    "guid": "31cd6b25-7d1d-44bf-93d4-7b7b2dd2a10c",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "4-fluoroisobutyryl fentanyl",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"p-fluoroisobutyrfentanyl\", \"N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide\", \"para-fluoroisobutyryl fentanyl\", \"P-FIBF\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710956178, \"_nanoseconds\": 938000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: 4-fluoromethylphenidate\", \"url\": \"https://drugs.ncats.io/drug/TN2LV2C0X9\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Unapproved drug",
    "Name": "4-fluoromethylphenidate",
    "guid": "9689fc6e-6585-4965-9d62-8d9db84dfd9b",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "4-fluoromethylphenidate",
    "Reasons": "[{\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"(\u00b1)-threo-4-fluoromethylphenidate\", \"4-FMPH\", \"4F-MPH\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738864960, \"_nanoseconds\": 197000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "4-hydroxytestosterone",
    "guid": "0d6d0ba6-6a3a-48d7-bfe3-75c1dcded316",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "4-hydroxytestosterone",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}, {\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"4,17\u03b2-dihydroxyandrost-4-en-3-one\", \"4-hydroxytestosterone (4,17\u03b2-dihydroxyandrost-4-en-3- one)\", \"4,17beta-dihydroxy-androst-4-en-3-one\", \"4,17beta-dihydroxyandrost-4-en-3-one\", \"4,17\u03b2-dihydroxy-androst-4-en-3-one\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715693939, \"_nanoseconds\": 824000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "4-methoxyamphetamine",
    "guid": "df177b8f-5627-4b53-95a5-7e8dde6450cb",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "4-methoxyamphetamine",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"4-methoxy-\u03b1-methylphenethylamine\", \"PMA\", \"p-methoxyamphetamine\", \"1-(4-methoxyphenyl)propan-2-amine\", \"paramethoxyamphetamine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710955110, \"_nanoseconds\": 326000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "4-methyl-N-ethylcathinone",
    "guid": "f9c92fb5-cf03-47c2-8860-c08d0f498492",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "4-methyl-n-ethylcathinone",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"4-MEC\", \"2-(ethylamino)-1-(4-methylphenyl)-1-propanone\", \"4-EMC\", \"EMC\", \"4-ethylmethcathinone\", \"4-methylethcathinone\", \"2-(ethylamino)-1-(4-methylphenyl)propan-1-one\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710954881, \"_nanoseconds\": 253000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "4-methylaminorex, cis-(+/-)-",
    "guid": "a2819b06-1959-472e-a9a7-208b2f5f365d",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "4-methylaminorex, cis-(+/-)-",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"U4Euh\", \"4-methylaminorex (cis isomer)\", \"(\u00b1)cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine\", \"(\u00b1)cis-4-methylaminorex\", \"McN-422\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738865443, \"_nanoseconds\": 326000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: 4-methylamphetamine\", \"url\": \"https://drugs.ncats.io/drug/9E273KL7HS\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule II",
    "Name": "4-methylamphetamine",
    "guid": "0ffa23de-207c-4d6b-8f79-7af347ddea88",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "4-methylamphetamine",
    "Reasons": "[{\"reason_code\": 6014, \"reason\": \"DoDI 1010.16\", \"link\": \"https://www.esd.whs.mil/directives/issuances/dodi\", \"guid\": \"b757aa46-4729-4d4a-a32e-25ef0b04e5c3\", \"link_title\": \"Use or misuse prohibited under DoDI 1010.16\", \"updated\": {\"_seconds\": 1703683049, \"_nanoseconds\": 190000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"4-MA\", \"p-methylamphetamine\", \"p-methylamfetamine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715355420, \"_nanoseconds\": 82000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "4-methylbuphedrone",
    "guid": "e5d76145-cb10-45c4-9276-58091157292c",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "4-methylbuphedrone",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"4-MeMABP\", \"4-MeBP\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710954159, \"_nanoseconds\": 792000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "4F-MDMB-BINACA",
    "guid": "78e00c2a-5426-40a3-9318-df8f8c0a8379",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "4f-mdmb-binaca",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"methyl 2-(1-(4-fluorobutyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate)\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738865633, \"_nanoseconds\": 611000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "4F-MDMB-BUTICA",
    "guid": "616ab105-b1b8-4ce6-9979-8a2c8fbc64d8",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "4f-mdmb-butica",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"4fluoro-MDMB-BUTICA\", \"methyl 2-[[1-(4-fluorobutyl)indole-3-carbonyl]amino]-3,3-dimethyl-butanoate\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709044695, \"_nanoseconds\": 322000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "4\u2032-methyl acetyl fentanyl",
    "guid": "bf7b0985-d29f-4e25-838b-0c95771d7d36",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "4\u2032-methyl acetyl fentanyl",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"N-(1-(4-methylphenethyl)piperidin-4-yl)-N-phenylacetamide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738865542, \"_nanoseconds\": 977000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "5-(1,1-dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol",
    "guid": "02bf2ea6-86c7-4710-996e-b51d09cd34b8",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "5-(1,1-dimethylheptyl)-2-[(1r,3s)-3-hydroxycyclohexyl]-phenol",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"CP-47,497\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710953790, \"_nanoseconds\": 322000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "5-(1,1-dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol",
    "guid": "a027329c-1cd4-4c35-9014-89864e757812",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "5-(1,1-dimethyloctyl)-2-[(1r,3s)-3-hydroxycyclohexyl]-phenol",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"CP-47,497 C8-homolog\", \"cannabicyclohexanol\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710953750, \"_nanoseconds\": 762000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"DoDI 1010.04 Problematic Substance Use by DoD Personnel\", \"url\": \"https://www.esd.whs.mil/Directives/issuances/dodi\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "5-MeO-AMT",
    "guid": "031112a0-e038-4131-8872-e7b5795a7fbc",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "5-meo-amt",
    "Reasons": "[{\"reason_code\": 6021, \"reason\": \"Other reason\", \"link\": null, \"guid\": \"9bdb33d0-1759-4198-8056-bc40e52a3afd\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683326, \"_nanoseconds\": 656000000}}]",
    "other_names": "[\"5-methoxy-alpha-methyltryptamine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1712170080, \"_nanoseconds\": 894000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"DoDI 1010.04 Problematic Substance Use by DoD Personnel\", \"url\": \"https://www.esd.whs.mil/Directives/issuances/dodi\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "5-MeO-DET",
    "guid": "2ea86042-b5df-47cb-9fdf-d9a75bdab9fe",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "5-meo-det",
    "Reasons": "[{\"reason_code\": 6021, \"reason\": \"Other reason\", \"link\": null, \"guid\": \"9bdb33d0-1759-4198-8056-bc40e52a3afd\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683326, \"_nanoseconds\": 656000000}}]",
    "other_names": "[\"5-methoxy-N,N-diethyltryptamine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1712169998, \"_nanoseconds\": 838000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "5-MeO-DIPT",
    "guid": "572b8c84-a03b-4020-b96d-34f9a4b4dd25",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "5-meo-dipt",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"Foxy methoxy\", \"FOXY\", \"5-methoxy-N,N-dipropyltryptamine\", \"5-MeO-DPT\", \"5-methoxy-N,N-diisopropyltryptamine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710953324, \"_nanoseconds\": 22000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "5-MeO-DMT",
    "guid": "0a3be3e6-0a45-4195-92f9-0e1c373c9097",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "5-meo-dmt",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"methylbufotenine\", \"5-methoxy-N,N-dimethyltryptamine\", \"5-methoxy-3-[2-(dimethylamino)ethyl]indole\", \"4-methoxy-N,N-dimethyltryptamine\", \"4-MeO-DMT\", \"methoxybufotenin\", \"O-methylbufotenine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1712064993, \"_nanoseconds\": 889000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"DoDI 1010.04 Problematic Substance Use by DoD Personnel\", \"url\": \" https://www.esd.whs.mil/Directives/issuances/dodi\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "5-MeO-MiPT",
    "guid": "1c210870-4dbb-434d-98fc-015fe32b86a4",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "5-meo-mipt",
    "Reasons": "[{\"reason_code\": 6021, \"reason\": \"Other reason\", \"link\": null, \"guid\": \"9bdb33d0-1759-4198-8056-bc40e52a3afd\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683326, \"_nanoseconds\": 656000000}}]",
    "other_names": "[\"5-methoxy-N-methyl-N-isopropyltryptamine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1712170240, \"_nanoseconds\": 238000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"FDA Warning Letter: Does not meet the definition of a dietary ingredient\", \"url\": \"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/steel-supplements-inc-622405-05042022\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "FDA Warning Letter: Does not meet the definition of a dietary ingredient",
    "Name": "5-alpha-hydroxy-laxogenin",
    "guid": "2f363e26-b3d8-4283-b8fa-eb47975c0f00",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "5-alpha-hydroxy-laxogenin",
    "Reasons": "[{\"reason_code\": 6019, \"reason\": \"FDA Warning Letter\", \"link\": null, \"guid\": \"1cd0ab89-14ce-43c2-a804-e4b29b8780fe\", \"link_title\": null, \"updated\": {\"_seconds\": 1711571477, \"_nanoseconds\": 43000000}}]",
    "other_names": "[\"Biobras 16\", \"BB-16\", \"spirostan-6-one, 3,5-dihydroxy-, (3b,5a,25R)-\", \"25-R-spirostan-5a-diol-6-one-3-one\", \"25R,5\u03b1-spirostan-3\u03b2,5-diol-6-one\", \"25R spirostan-5a-diol-6-one-3-one decanoate\", \"5a-hydroxylaxogenin\", \"(25R)-3beta,5alpha-dihydroxyspirostan-6-one\", \"spirostan-6-one, 3,5-dihydroxy-, (3beta,5alpha,25R)-\", \"Di-31\", \"25R spirostan-5a-diol-6-one-3-one undecanoate\", \"spirostan-6-one, 3,5-dihydroxy-, (3\u03b2,5\u03b1,25R)-\", \"5a-hydroxy-laxogenin\", \"5a-hydroxyl-laxogenin acetate\", \"(25R)-3\u03b2,5\u03b1-dihydroxyspirostan-6-one\", \"25R,5alpha-spirostan-3beta,5-diol-6-one\", \"brassinosteroid BB 16\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738865780, \"_nanoseconds\": 803000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "5-androstenedione",
    "guid": "4a7abba9-d2cb-42f1-8cfa-50b9d00c1dd2",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "5-androstenedione",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}, {\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"androst-5-en-3,17-dione\", \"androst-5-ene-3,17-dione\", \"5-androsten-3,17-dione\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1716911031, \"_nanoseconds\": 765000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "5-fluoro-PB-22",
    "guid": "082e470f-5c92-4ffa-8e47-021618cd039b",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "5-fluoro-pb-22",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"1-(5-fluoropentyl)-1H-indole-3-carboxylic acid 8-quinolinyl ester\", \"5F-PB-22\", \"quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710953564, \"_nanoseconds\": 981000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "5-fluoro-UR-144",
    "guid": "5a44fa23-ca0a-4c5e-9f52-94fe1f600caf",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "5-fluoro-ur-144",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"[1-(5-fluoro-pentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone\", \"XLR-11\", \"XLR11\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710953519, \"_nanoseconds\": 708000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "5F-AB-PINACA",
    "guid": "8fd8dc6e-b911-4c88-b8b1-abe942b41cdb",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "5f-ab-pinaca",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"5-fluoro-AB-PINACA\", \"N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710952018, \"_nanoseconds\": 964000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "5F-ADB",
    "guid": "b602b55f-4a9b-4df7-89e1-3fb6175d0c33",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "5f-adb",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"5F-EMB-PINACA\", \"methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate\", \"5F-MDMB-PINACA\", \"5-fluoro-ADB\", \"5F-AEB\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710951949, \"_nanoseconds\": 35000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "5F-AMB",
    "guid": "e4d07572-656c-414c-b929-c062191cd4c6",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "5f-amb",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate\", \"5-fluoro-AMB\", \"5-fluoro-AMP\", \"2-(1-(5-Fluoropentyl)-1H-indazole-3-ylcarbonylamino)-3-methylbutanoic acid methyl ester\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1712064674, \"_nanoseconds\": 569000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "5F-APINACA",
    "guid": "0b662bf5-c9dd-4477-be7a-112b718953b1",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "5f-apinaca",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide\", \"5F-AKB48 \"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710871433, \"_nanoseconds\": 761000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "5F-CUMYL-P7AICA",
    "guid": "ef321efa-547d-4e2e-8461-981ae76d522f",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "5f-cumyl-p7aica",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710951462, \"_nanoseconds\": 267000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "5F-CUMYL-PINACA",
    "guid": "ac4a097d-6ce4-4701-b3e3-bb0fc02ababa",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "5f-cumyl-pinaca",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide\", \"SGT-25\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710951338, \"_nanoseconds\": 13000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "5F-EDMB-PICA",
    "guid": "6a30e475-45d6-406c-8423-4b0855460f5d",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "5f-edmb-pica",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"5fluoro-EDMB-PICA\", \"ethyl 2-[[1-(5-fluoropentyl)indole-3-carbonyl]amino]-3,3-dimethyl-butanoate\", \"ethyl 2-[[1-(5-fluorophentyl)indole-3-carbonyl]amino]-3,3-dimethyl-butanoate\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1711032373, \"_nanoseconds\": 332000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "5F-EDMB-PINACA",
    "guid": "44769116-2fe1-43e3-ba40-852d4c7e0cc8",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "5f-edmb-pinaca",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710951288, \"_nanoseconds\": 20000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "5F-MDMB-PICA",
    "guid": "cb106ad2-5aa0-4f7b-9a53-9d1fd2bd1fdb",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "5f-mdmb-pica",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"5-fluoro-EMB-PICA\", \"5F-MDMB-2201\", \"5FMDMB-PICA\", \"5F-EMB-PICA\", \"methyl 2-(1-(5-fluoropentyl)-1Hindole-3-carboxamido)-3,3-dimethylbutanoate\", \"methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710951207, \"_nanoseconds\": 373000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "5alpha-androstan-3,6,17-trione",
    "guid": "f6917230-a85e-466b-8ffe-25f6513525bf",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "5alpha-androstan-3,6,17-trione",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}]",
    "other_names": "[\"5alpha-androstane-3,6,17-trione\", \"5\u03b1-androstane-3,6,17-trione\", \"5\u03b1-androstan-3,6,17-trione\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710952085, \"_nanoseconds\": 861000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "6-(2-chlorophenyl)-1-methyl-8-nitro-4H-benzo[F][1,2,4]triazolo[4,3-A][1,4]diazepine",
    "guid": "8e832431-266f-4b3b-88f2-b3ddda8d2d48",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "6-(2-chlorophenyl)-1-methyl-8-nitro-4h-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"clonazolam\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710951109, \"_nanoseconds\": 5000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "6-bromo-androsta-1,4-diene-3,17-dione",
    "guid": "3fc08a54-2e3c-446a-b7d4-154140d39885",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "6-bromo-androsta-1,4-diene-3,17-dione",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}, {\"reason_code\": 6012, \"reason\": \"WADA S4: Hormone and Metabolic Modulators\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"ac1ba347-6d44-4a17-829d-e589bf33bbdb\", \"link_title\": \"WADA Prohibited List S4: Hormone and Metabolic Modulators\", \"updated\": {\"_seconds\": 1703682875, \"_nanoseconds\": 162000000}}]",
    "other_names": "[\"6-bromoandrosta-1,4-diene-3,17-dione\", \"6-bromo boldione\", \"6-bromo-androstan-1,4-diene-3,17-dione\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1721836597, \"_nanoseconds\": 524000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "6-bromo-androstan-3,17-dione",
    "guid": "b7f7f4a5-ddb3-4324-b531-eb3a7d3705f8",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "6-bromo-androstan-3,17-dione",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}, {\"reason_code\": 6012, \"reason\": \"WADA S4: Hormone and Metabolic Modulators\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"ac1ba347-6d44-4a17-829d-e589bf33bbdb\", \"link_title\": \"WADA Prohibited List S4: Hormone and Metabolic Modulators\", \"updated\": {\"_seconds\": 1703682875, \"_nanoseconds\": 162000000}}]",
    "other_names": "[]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1720810364, \"_nanoseconds\": 897000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Use or misuse prohibited under DoDI 1010.16 (opioids)",
    "Name": "6-monoacetylmorphine",
    "guid": "86bb794f-cbde-4c71-bbf7-a29e8268cc4d",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "6-monoacetylmorphine",
    "Reasons": "[{\"reason_code\": 6014, \"reason\": \"DoDI 1010.16\", \"link\": \"https://www.esd.whs.mil/directives/issuances/dodi\", \"guid\": \"b757aa46-4729-4d4a-a32e-25ef0b04e5c3\", \"link_title\": \"Use or misuse prohibited under DoDI 1010.16\", \"updated\": {\"_seconds\": 1703683049, \"_nanoseconds\": 190000000}}]",
    "other_names": "[\"6-MAM\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710882664, \"_nanoseconds\": 41000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "6alpha-methyl-androst-4-ene-3,17-dione",
    "guid": "019b04e4-6151-4c77-807b-b571318a2cad",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "6alpha-methyl-androst-4-ene-3,17-dione",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}]",
    "other_names": "[\"6\u03b1-methylandrostenedione\", \"6alpha-methylandrostenedione\", \"6\u03b1-methyl-androst-4-ene-3,17-dione\", \"6\u03b1-methyl-androst-4-en-3,17-dione\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1721308514, \"_nanoseconds\": 365000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "7-chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro- 2H-benzo[E][1,4]diazepin-2-one",
    "guid": "5269e7bc-ad10-491c-bee0-bfb032dd57bf",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "7-chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro- 2h-benzo[e][1,4]diazepin-2-one",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"diclazepam\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710882329, \"_nanoseconds\": 154000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Ipriflavone\", \"url\": \"https://drugs.ncats.io/drug/80BJ7WN25Z\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Unapproved drug",
    "Name": "7-isopropoxyisoflavone",
    "guid": "ab3a8675-be1d-472a-aae2-b909ca707d8f",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "7-isopropoxyisoflavone",
    "Reasons": "[{\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"7-isopropoxy-3-phenyl-4H-chromen-4-one\", \"Ipriflavone\", \"Osten\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1751305790, \"_nanoseconds\": 839000000}",
    "label_terms": "[\"7-isopropoxyflavone\"]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"DoDI 6130.06 Use of Dietary Supplements in the DoD\", \"url\": \"https://www.esd.whs.mil/Directives/issuances/dodi\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "7-keto DHEA",
    "guid": "4647d7f3-10d4-4ad8-8246-6a3f562929aa",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "7-keto dhea",
    "Reasons": "[{\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}, {\"reason_code\": 6017, \"reason\": \"Military policy\", \"link\": null, \"guid\": \"96435789-439c-44d4-83cf-1d10a25ab7b5\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683268, \"_nanoseconds\": 216000000}}]",
    "other_names": "[\"7-keto-DHEA\", \"3beta-hydroxyandrost-5-ene-7,17-dione\", \"7-oxodehydroepiandrosterone\", \"7-Ketodehydroepiandrosterone\", \"3\u03b2-hydroxyandrost-5-ene-7,17-dione\", \"7-oxo-DHEA\", \"7-keto-dehydroepiandrosterone\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1763061720, \"_nanoseconds\": 558000000}",
    "label_terms": "[]",
    "linked_ingredients": "[]",
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S1: Anabolic Agents",
    "Name": "7alpha-hydroxy-DHEA",
    "guid": "a435477a-7e14-4aed-b642-32ff72b9ccf1",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "7alpha-hydroxy-dhea",
    "Reasons": "[{\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"7\u03b1-OH-DHEA\", \"7alpha-hydroxydehydroepiandrosterone\", \"7\u03b1-hydroxy-DHEA (C.S.)\", \"7-hydroxy DHEA\", \"7\u03b1-hydroxydehydroepiandrosterone\", \"7-hydroxydehydroepiandrosterone\", \"3\u03b2,7\u03b1-dihydroxy-5-androsten-17-one\", \"7-hydroxy-DHEA\", \"7alpha-OH-DHEA\", \"7a-hydroxy-dehydroepiandrosterone\", \"3beta,7alpha-dihydroxy-5-androsten-17-one\", \"7\u03b1-hydroxy-DHEA\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738866516, \"_nanoseconds\": 431000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S1: Anabolic Agents",
    "Name": "7beta-hydroxy-DHEA",
    "guid": "ebf474d3-db41-44ee-8c63-70d57701c266",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "7beta-hydroxy-dhea",
    "Reasons": "[{\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"7b-hydroxydehydroepiandrosterone\", \"7\u03b2-hydroxy-DHEA\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738866712, \"_nanoseconds\": 617000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "8-bromo-6-(2-fluorophenyl)-1-methyl-4H-benzo[F][1,2,4]trazolo[4,3-A][1,4]diazepine",
    "guid": "e0506719-eb35-4247-a240-96ff16d8fef7",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "8-bromo-6-(2-fluorophenyl)-1-methyl-4h-benzo[f][1,2,4]trazolo[4,3-a][1,4]diazepine",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"flubromazolam\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710880965, \"_nanoseconds\": 567000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "8-chloro-6-(2-fluorophenyl)-1-methyl-4H-benzo[F][1,2,4]triazolo[4,3-A][1,4]diazepine",
    "guid": "f3c5fb36-d40d-49e6-b0cf-c0f8ffb0db6f",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "8-chloro-6-(2-fluorophenyl)-1-methyl-4h-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"flualprazolam\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710880878, \"_nanoseconds\": 134000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: 9-hydroxyfluorene\", \"url\": \"https://drugs.ncats.io/drug/BV0Q72R613\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Unapproved drug",
    "Name": "9-hydroxyfluorene",
    "guid": "bc21cb91-5c30-456b-a3d7-44cfff459f4a",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "9-hydroxyfluorene",
    "Reasons": "[{\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"9-fluorenol\", \"hydrafinil\", \"fluoren-9-ol\", \"9 fluorenol\", \"fluorenol\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1762180026, \"_nanoseconds\": 303000000}",
    "label_terms": "[\"hydrafinil9 hydroxyfluorene\"]",
    "linked_ingredients": "[]",
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "AB-CHMINACA",
    "guid": "2656c934-c780-48ce-a172-4e0c4ce741fe",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "ab-chminaca",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710880076, \"_nanoseconds\": 607000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "AB-FUBINACA",
    "guid": "147c2e7d-f488-4460-ae8c-a07a2845bb86",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "ab-fubinaca",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710880014, \"_nanoseconds\": 349000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "AB-PINACA",
    "guid": "b0ba5115-faaa-4d33-a7b7-f4a8b0988b63",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "ab-pinaca",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710878770, \"_nanoseconds\": 908000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"FDA warns against using SARMs in body-building products\", \"url\": \"https://www.fda.gov/news-events/fda-brief/fda-brief-fda-warns-against-using-sarms-body-building-products\"}, {\"title\": \"NIH NCATS Inxight Drugs entry: AC-262536\", \"url\": \"https://drugs.ncats.io/drug/U8VS41J5O6\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S1: Anabolic Agents; Unapproved drug; FDA statement: SARMs",
    "Name": "AC-262536",
    "guid": "26ce4b2c-b21b-4244-be4d-b1eeb03e1475",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "ac-262536",
    "Reasons": "[{\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}, {\"reason_code\": 6018, \"reason\": \"FDA Statement\", \"link\": \"\", \"guid\": \"3cd17124-6ebc-4828-9edb-c20a81755502\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1711715334, \"_nanoseconds\": 457000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"AC-262,536\", \"4-(3-endo-hydroxy-8-azabicyclo(3.2.1)oct-8-yl)naphthalene-1-carbonitrile\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738867231, \"_nanoseconds\": 923000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Ramatercept\", \"url\": \"https://drugs.ncats.io/drug/42HQC6QLEK\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S4: Hormone and Metabolic Modulators; Unapproved drug",
    "Name": "ACE-031",
    "guid": "17d3d8b4-2314-4d8a-8665-81c973bb3d28",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "ace-031",
    "Reasons": "[{\"reason_code\": 6012, \"reason\": \"WADA S4: Hormone and Metabolic Modulators\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"ac1ba347-6d44-4a17-829d-e589bf33bbdb\", \"link_title\": \"WADA Prohibited List S4: Hormone and Metabolic Modulators\", \"updated\": {\"_seconds\": 1703682875, \"_nanoseconds\": 162000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"Ramatercept\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738867389, \"_nanoseconds\": 673000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"CAS Common Chemistry entry: 2-Chloro-4-(3-hydroxy-3-methyl-8-azabicyclo[3.2.1]oct-8-yl)-3-methylbenzonitrile\", \"url\": \"https://commonchemistry.cas.org/detail?cas_rn=1048998-11-3\"}, {\"title\": \"FDA warns against using SARMs in body-building products\", \"url\": \"https://www.fda.gov/news-events/fda-brief/fda-brief-fda-warns-against-using-sarms-body-building-products\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S1: Anabolic AgentsUnapproved drugFDA statement: SARMs",
    "Name": "ACP-105",
    "guid": "bf8f507f-36b2-4796-9444-4582af2e4b49",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "acp-105",
    "Reasons": "[{\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}, {\"reason_code\": 6018, \"reason\": \"FDA Statement\", \"link\": \"\", \"guid\": \"3cd17124-6ebc-4828-9edb-c20a81755502\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1711715334, \"_nanoseconds\": 457000000}}]",
    "other_names": "[\"2-chloro-4-[(1R,5S)-3-hydroxy-3-methyl-8-azabicyclo[3.2.1]octan-8-yl]-3-methylbenzonitrile\", \"2-chloro-4-[(1R,5R)-3-hydroxy-3-methyl-8-azabicyclo[3.2.1] octan-8-yl]-3-methylbenzonitrile\", \"Acadibol\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738867990, \"_nanoseconds\": 271000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "ADB-4en-PINACA",
    "guid": "95912e36-35be-446f-95c2-ef1312ada649",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "adb-4en-pinaca",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(pent-4-en-1-yl)-1H-indazole-3-carboxamide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709044737, \"_nanoseconds\": 370000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "ADB-BUTINACA",
    "guid": "87e9b6b3-10d7-4c20-ad76-0e62bda16741",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "adb-butinaca",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-butyl-1H-indazole-3-carboxamide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709044764, \"_nanoseconds\": 410000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "ADB-FUBINACA",
    "guid": "d4bd44f0-2661-4812-a449-5159b5ac9d54",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "adb-fubinaca",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710871342, \"_nanoseconds\": 601000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "ADB-PINACA",
    "guid": "f0678968-4ea6-4998-af80-734c443d7950",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "adb-pinaca",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710879857, \"_nanoseconds\": 253000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "AH-7921",
    "guid": "656961af-175f-4c7c-b558-494c8af5b93e",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "ah-7921",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710870828, \"_nanoseconds\": 633000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: AICAR\", \"url\": \"https://drugs.ncats.io/drug/F0X88YW0YK\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S4: Hormone and Metabolic ModulatorsUnapproved drug",
    "Name": "AICAR",
    "guid": "c7a156f9-5b1a-4df6-888a-8ad4ab8bf2f8",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "aicar",
    "Reasons": "[{\"reason_code\": 6012, \"reason\": \"WADA S4: Hormone and Metabolic Modulators\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"ac1ba347-6d44-4a17-829d-e589bf33bbdb\", \"link_title\": \"WADA Prohibited List S4: Hormone and Metabolic Modulators\", \"updated\": {\"_seconds\": 1703682875, \"_nanoseconds\": 162000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"AICAriboside 5'-monophosphate\", \"NSC 292227\", \"5'-phosphoribosyl-5-amino-4-imidazolecarboxamide\", \"aminoimidazole carboxamide ribonucleotide\", \"5-amino-4-imidazole carboxamide ribonucleotide\", \"5-amino-4-imidazolecarboxamide ribonucleoside 5'-monophosphate\", \"adenosine monophosphate activated protein kinase activator 5-amino-4-imidazolecarboxyamide ribonucleoside\", \"Z-nucleotide\", \"4-carboxy-5-aminoimidazole ribotide\", \"5-amino-4-imidazolecarboxamide ribofuranoside 5'-monophosphate\", \"5-amino-1-\u03b2-D-ribofuranosylimidazole-4-carboxamide monophosphate\", \"ZMP\", \"AICA ribonucleotide, (D-ribofuranosyl)-isomer\", \"AICA ribonucleotide\", \"5-amino-1-beta-D-ribofuranosylimidazole-4-carboxamide monophosphate\", \"NSC 283955\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738868877, \"_nanoseconds\": 191000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "AMB-FUBINACA",
    "guid": "e4ae889c-3dee-4945-a7b6-19e65b881534",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "amb-fubinaca",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3-methylbutanoate\", \"FUB-AMB\", \"MMB-FUBINACA\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710868670, \"_nanoseconds\": 119000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "AOD-9604",
    "guid": "41b73a7f-f247-44ae-88c1-2047cd86aa1d",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "aod-9604",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}, {\"reason_code\": 6014, \"reason\": \"DoDI 1010.16\", \"link\": \"https://www.esd.whs.mil/directives/issuances/dodi\", \"guid\": \"b757aa46-4729-4d4a-a32e-25ef0b04e5c3\", \"link_title\": \"Use or misuse prohibited under DoDI 1010.16\", \"updated\": {\"_seconds\": 1703683049, \"_nanoseconds\": 190000000}}]",
    "other_names": "[\"AOD 9604\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1722430169, \"_nanoseconds\": 894000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "APINACA",
    "guid": "a7f6eeaa-8d45-4c25-8347-8c1b24dcc568",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "apinaca",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide\", \"AKB48\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710783720, \"_nanoseconds\": 874000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"FDA: Acacia rigidula in Dietary Supplements\", \"url\": \"https://www.fda.gov/food/dietary-supplement-products-ingredients/acacia-rigidula-dietary-supplements\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "FDA statement: New dietary ingredient lacking evidence for safe use",
    "Name": "Acacia rigidula",
    "guid": "e6f7f717-25e0-49d6-8adb-610c6e3e6593",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "acacia rigidula",
    "Reasons": "[{\"reason_code\": 6018, \"reason\": \"FDA Statement\", \"link\": \"\", \"guid\": \"3cd17124-6ebc-4828-9edb-c20a81755502\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1711715334, \"_nanoseconds\": 457000000}}]",
    "other_names": "[\"Chaparro prieto\", \"Acaciopsis rigidula\", \"blackbrush acacia\", \"Acacia rigidula extract (98%)\", \"Vachellia rigidula\", \"Acacia rigidula extract\", \"A. rigidula\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710878216, \"_nanoseconds\": 92000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Aconitine\", \"url\": \"https://drugs.ncats.io/drug/X8YN71D5WC\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Potentially fatal poisonous plant",
    "Name": "Aconitum",
    "guid": "ee46c098-ae99-4766-8588-f293296df350",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "aconitum",
    "Reasons": "[{\"reason_code\": 6021, \"reason\": \"Other reason\", \"link\": null, \"guid\": \"9bdb33d0-1759-4198-8056-bc40e52a3afd\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683326, \"_nanoseconds\": 656000000}}]",
    "other_names": "[\"aconite root\", \"queen of poisons\", \"mousebane\", \"leopard's bane\", \"wolfsbane\", \"monkshood\", \"women's bane\", \"Aconitum carmichaelii\", \"blue rocket\", \"Aconitum japonicum\", \"aconit\", \"Aconitum kusnezoffii\", \"aconite\", \"Aconitum napellus\", \"aconite extract\", \"devil's helmet\", \"Aconitum squamosa\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710875690, \"_nanoseconds\": 938000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"DoDI 1010.04 Problematic Substance Use by DoD Personnel and DoDI 6130.06 Use of Dietary Supplements in the DoD\", \"url\": \"https://www.esd.whs.mil/Directives/issuances/dodi\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "Amanita muscaria",
    "guid": "94465217-c2de-4d83-ad45-3bf98cbca29d",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "amanita muscaria",
    "Reasons": "[{\"reason_code\": 6017, \"reason\": \"Military policy\", \"link\": null, \"guid\": \"96435789-439c-44d4-83cf-1d10a25ab7b5\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683268, \"_nanoseconds\": 216000000}}]",
    "other_names": "[\"fly agaric mushroom\", \"ibotenic acid\", \"muscarine\", \"muscimol\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1750959961, \"_nanoseconds\": 152000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"DoDI 1010.04 Problematic Substance Use by DoD Personnel and DoDI 6130.06 Use of Dietary Supplements in the DoD\", \"url\": \"https://www.esd.whs.mil/Directives/issuances/dodi\"}]",
    "SourceOf": "arecoline",
    "More_info_URL": "",
    "Reason": "Per DoDI 1010.04 and DoDI 6130.06",
    "Name": "Areca catechu nut",
    "guid": "38a7798d-cc11-44b9-9e26-6faf68abb02f",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "areca catechu nut",
    "Reasons": "[{\"reason_code\": 6017, \"reason\": \"Military policy\", \"link\": null, \"guid\": \"96435789-439c-44d4-83cf-1d10a25ab7b5\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683268, \"_nanoseconds\": 216000000}}]",
    "other_names": "[\"areca nut\", \"betel nut\", \"Areca catechu extract\", \"arecoline\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1749059111, \"_nanoseconds\": 625000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"FDA: BMPEA in Dietary Supplements\", \"url\": \"https://www.fda.gov/food/dietary-supplement-products-ingredients/bmpea-dietary-supplements\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "FDA statement: Synthetic substance that currently does not meet the definition of a dietary ingredient",
    "Name": "BMPEA",
    "guid": "6196d4cc-7173-48f8-8a90-e17c7387ee14",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "bmpea",
    "Reasons": "[{\"reason_code\": 6018, \"reason\": \"FDA Statement\", \"link\": \"\", \"guid\": \"3cd17124-6ebc-4828-9edb-c20a81755502\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1711715334, \"_nanoseconds\": 457000000}}]",
    "other_names": "[\"beta-phenylpropylamine\", \"B-Methylphenethylamine\", \"\u00df-MePEA\", \"1-propanamine, 2-phenyl-\", \"R-beta methylphenylethylamine\", \"beta-methylbenzeneethanamine\", \"2-phenylpropylamine\", \"R-beta-methylphenethylamine\", \"2-phenyl-1-propanamine, 2-phenylpropan-1-amine\", \"beta-Me-PEA\", \"beta-methylphenethylamine\", \"R-beta-methylphenethylamine HCl\", \"\u03b2-methylphenylethylamine\", \"\u00df-methylphenethylamine\", \"beta-methylphenylethylamine\", \"alpha-benzylethylamine\", \"\u03b2-phenylpropylamine\", \"2-phenylpropan-1-amine\", \"(R)-(+)-N-benzyl-\u03b1-phenethylamine\", \"2- phenyl-1-propanamine\", \"beta-MePEA\", \"1-amino-2-phenylpropane\", \"methylphenylethylamine\", \"methylbenzeneethanamine\", \"propylamine, 2-phenyl-\", \"4-methylphenylethylamine\", \"\u03b2-methylbenzeneethanamine\", \"1-phenyl-1-methyl-2-aminoethane\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738938772, \"_nanoseconds\": 562000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: BMS-564929\", \"url\": \"https://drugs.ncats.io/drug/9BLW27W4X7\"}, {\"title\": \"FDA warns against using SARMs in body-building products\", \"url\": \"https://www.fda.gov/news-events/fda-brief/fda-brief-fda-warns-against-using-sarms-body-building-products\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S1: Anabolic Agents; Unapproved drug; FDA statement: SARMs",
    "Name": "BMS-564929",
    "guid": "5482ee90-0035-4f13-8538-8bd3b90ada03",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "bms-564929",
    "Reasons": "[{\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}, {\"reason_code\": 6018, \"reason\": \"FDA Statement\", \"link\": \"\", \"guid\": \"3cd17124-6ebc-4828-9edb-c20a81755502\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1711715334, \"_nanoseconds\": 457000000}}]",
    "other_names": "[\"BMS-564,929\", \"benzonitrile, 2-chloro-3-methyl-4-((7R,7AS)-tetrahydro-7-hydroxy-1,3-dioxo-1H-pyrrolo(1,2-C)imidazol-2(3H)-yl)-\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738938949, \"_nanoseconds\": 594000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: BPC-157\", \"url\": \"https://drugs.ncats.io/drug/8ED8NXK95P\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S0: Non-approved Substances; Unapproved drug",
    "Name": "BPC-157",
    "guid": "47c306c6-f222-40f5-9c81-76c00a281333",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "bpc-157",
    "Reasons": "[{\"reason_code\": 6008, \"reason\": \"WADA S0: Non-approved Substances\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"f321f8bd-47c9-42f3-bea6-f36eafa02ecf\", \"link_title\": \"WADA Prohibited List S0: Non-approved Substances\", \"updated\": {\"_seconds\": 1703682727, \"_nanoseconds\": 352000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"Bepecin\", \"PL-14736\", \"body protection compound\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1748886816, \"_nanoseconds\": 36000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: CJC-1293\", \"url\": \"https://drugs.ncats.io/drug/ZZM61DP6TS\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S2: Hormones; Unapproved drug",
    "Name": "CJC-1293",
    "guid": "cdec865c-6da2-4c11-b139-7e4912870dae",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "cjc-1293",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710447073, \"_nanoseconds\": 621000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: CJC-1295\", \"url\": \"https://drugs.ncats.io/drug/62RC32V9N7\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S2: Peptide Hormones, Growth Factors, etc.Unapproved drug",
    "Name": "CJC-1295",
    "guid": "ecd3a1cc-18ba-4732-bd30-92ea46ee9306",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "cjc-1295",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"DAC-GRF\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738945342, \"_nanoseconds\": 48000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S2: Hormones (EPO mimetic); Unapproved drug",
    "Name": "CNTO-530",
    "guid": "5a218e27-afbe-49dc-927b-7ff954d8012f",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "cnto-530",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738945994, \"_nanoseconds\": 981000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "CP-47,497",
    "guid": "2dacd60e-fb15-4125-860a-abddc3b8ac0f",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "cp-47,497",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol\", \"5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol\", \"CP-47,497 C8 Homologue\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710441375, \"_nanoseconds\": 493000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "CUMYL-4CN-BINACA",
    "guid": "13597911-4afd-4450-8790-52cb14ddc6e2",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "cumyl-4cn-binaca",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"4-cyano-CUMYL-BUTINACA\", \"1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide\", \"4-CN-CUMYL BINACA\", \"SGT-78\", \"4-CN-CUMYL-BUTINACA\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710440911, \"_nanoseconds\": 491000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "CUMYL-PEGACLONE",
    "guid": "7b4ce6ff-f439-4df5-a998-c4baec85f16e",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "cumyl-pegaclone",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"5-pentyl-2-(2-phenylpropan-2-yl)pyrido[4,3-B]indole-1-one\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709044851, \"_nanoseconds\": 977000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"DoDI 1010.04 Problematic Substance Use by DoD Personnel and DoDI 6130.06 Use of Dietary Supplements in the DoD\", \"url\": \"https://www.esd.whs.mil/Directives/issuances/dodi\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "Catha edulis",
    "guid": "39d501e0-1406-4a9b-8310-6c052a7eb233",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "catha edulis",
    "Reasons": "[{\"reason_code\": 6017, \"reason\": \"Military policy\", \"link\": null, \"guid\": \"96435789-439c-44d4-83cf-1d10a25ab7b5\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683268, \"_nanoseconds\": 216000000}}]",
    "other_names": "[\"khat\", \"Abyssinian tea\", \"Graba\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1762178086, \"_nanoseconds\": 700000000}",
    "label_terms": "[]",
    "linked_ingredients": "[{\"guid\": \"b2d9a08e-155d-40b7-b50f-c3db61ddfec9\", \"Name\": \"cathine\"}, {\"guid\": \"99066ef9-1476-44dc-9a43-415f0bffb2bb\", \"Name\": \"cathinone\"}, {\"guid\": \"eaddaa9e-ff30-4ce2-8419-794b481a8267\", \"Name\": \"ephedrine alkaloids\"}]",
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"FDA: DMAA in Dietary Supplements\", \"url\": \"https://www.fda.gov/food/dietary-supplement-products-ingredients/dmaa-products-marketed-dietary-supplements\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "FDA statement: Synthetic substance that currently does not meet the definition of a dietary ingredient",
    "Name": "DMAA (1,3)",
    "guid": "d0ce4d51-06f8-4541-8c2d-111aa3465241",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "dmaa (1,3)",
    "Reasons": "[{\"reason_code\": 6018, \"reason\": \"FDA Statement\", \"link\": \"\", \"guid\": \"3cd17124-6ebc-4828-9edb-c20a81755502\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1711715334, \"_nanoseconds\": 457000000}}]",
    "other_names": "[\"1,3-DMAA\", \"dimethylpentylamine\", \"Floradrene\", \"1,3-dimethylpentylamine\", \"methylhexanamine\", \"Forthan\", \"1,3-dimethylamylamine\", \"4-methyl-2-hexanamine\", \"2-amino-4-methylhexane\", \"methylhexaneamine\", \"dimethylamylamine\", \"2-hexanamine,4-methyl-(9Cl)\", \"DMP\", \"Forthane\", \"Geranamine\", \"4-methyl-2-hexylamine\", \"DMAA\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738949674, \"_nanoseconds\": 211000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"FDA Warning Letter\", \"url\": \"https://www.fda.gov/drugs/medication-health-fraud/govvi-wow-contains-hidden-ingredients\"}, {\"title\": \"FDA Warning Letter\", \"url\": \"https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/hi-tech-pharmaceuticals-issues-voluntary-recall-lipodrene-w25mg-ephedra-extract-dietary-supplement\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "DMAA (1,4)",
    "guid": "b67f6eb7-a90f-49b5-ae42-27dee91fcd96",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "dmaa (1,4)",
    "Reasons": "[{\"reason_code\": 6019, \"reason\": \"FDA Warning Letter\", \"link\": null, \"guid\": \"1cd0ab89-14ce-43c2-a804-e4b29b8780fe\", \"link_title\": null, \"updated\": {\"_seconds\": 1711571477, \"_nanoseconds\": 43000000}}]",
    "other_names": "[\"5-methyl-2-hexylamine\", \"5-methylhexan-2-amine\", \"1,4 dimethylamylamine\", \"1,4-DMAA\", \"DMPA\", \"1,4 dimethylpentylamine\", \"2-amino-5-methylhexane\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738949769, \"_nanoseconds\": 407000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"FDA: DMBA in Dietary Supplements\", \"url\": \"https://www.fda.gov/food/dietary-supplement-products-ingredients/dmba-dietary-supplements\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "FDA statement: New dietary ingredient lacking evidence for safe use",
    "Name": "DMBA",
    "guid": "cf1a2bc7-1a39-47c4-acfd-ee0e5b1b5382",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "dmba",
    "Reasons": "[{\"reason_code\": 6018, \"reason\": \"FDA Statement\", \"link\": \"\", \"guid\": \"3cd17124-6ebc-4828-9edb-c20a81755502\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1711715334, \"_nanoseconds\": 457000000}}]",
    "other_names": "[\"1,3-DMBA\", \"1,3-dimethylbutanamine\", \"4-methyl-2-pentanamine\", \"4-amino-2-methylpentane citrate\", \"4-amino-2-pentanamine\", \"1,3-dimethylbutylamine\", \"2-amino-4-methylpentane\", \"AMP citrate\", \"methylpentane citrate (HCl)\", \"Amperall\", \"AMP\", \"4-methyl-2-aminopentane\", \"Pentergy\", \"4-methyl-2-pentanamine citrate\", \"4-amino-2-methylpentane\", \"2-amino-4-methylpentane citrate\", \"4-methylpentan-2-amine\", \"4-AMP citrate\", \"4-AMP\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715357248, \"_nanoseconds\": 355000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"FDA: DMHA in Dietary Supplements\", \"url\": \"https://www.fda.gov/food/dietary-supplement-products-ingredients/dmha-dietary-supplements\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "FDA statement: New dietary ingredient lacking evidence for safe use",
    "Name": "DMHA",
    "guid": "a852add0-13b0-4609-8539-a2104171a9ee",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "dmha",
    "Reasons": "[{\"reason_code\": 6018, \"reason\": \"FDA Statement\", \"link\": \"\", \"guid\": \"3cd17124-6ebc-4828-9edb-c20a81755502\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1711715334, \"_nanoseconds\": 457000000}}]",
    "other_names": "[\"Vaporpac\", \"1,5-DMHA\", \"2-isooctyl amine\", \"2-aminoisoheptane HCl (DMHA)\", \"6-methyl-2-heptylamine\", \"2-aminoisoheptane\", \"2-aminoisoheptane hydrochloride\", \"Amidrine\", \"Isoctaminum\", \"2-amino-6-methylheptane\", \"2-amino-5-methylheptane\", \"2-amino-6-methylheptane(DMHA)\", \"2-aminoisoheptane HCl\", \"2-metil-6-amino-eptano\", \"2-aminoisoheptane (DMHA)\", \"6-amino-2-methylheptane\", \"2-heptylamine, 6-methyl-\", \"1,5-dimethylhexylamine\", \"6-methyl-2-heptanamine, 6-methyl-2-heptylamine\", \"octodrine\", \"dimethylhexylamine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715368478, \"_nanoseconds\": 894000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "DOB",
    "guid": "cfab9956-aa08-403a-b4bc-aa06d85da005",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "dob",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"4-bromo-2,5-dimethoxyamphetamine\", \"4-bromo-DMA\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710426925, \"_nanoseconds\": 113000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "DOC",
    "guid": "8a38d69b-3764-4f01-8ece-f374d8211b96",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "doc",
    "Reasons": "[{\"reason_code\": 6014, \"reason\": \"DoDI 1010.16\", \"link\": \"https://www.esd.whs.mil/directives/issuances/dodi\", \"guid\": \"b757aa46-4729-4d4a-a32e-25ef0b04e5c3\", \"link_title\": \"Use or misuse prohibited under DoDI 1010.16\", \"updated\": {\"_seconds\": 1703683049, \"_nanoseconds\": 190000000}}]",
    "other_names": "[\"2,5-dimethoxy-4-chloroamphetamine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1712169253, \"_nanoseconds\": 884000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "DOET",
    "guid": "e346656e-6f1a-4769-980c-32259f3fc127",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "doet",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"2,5-dimethoxy-4-ethylamphetamine\", \"2,5-dimethoxy-4-ethylamphet-amine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710426708, \"_nanoseconds\": 322000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "DOI",
    "guid": "32c603d1-2346-48f8-92f5-ba3bcb5fdf1a",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "doi",
    "Reasons": "[{\"reason_code\": 6014, \"reason\": \"DoDI 1010.16\", \"link\": \"https://www.esd.whs.mil/directives/issuances/dodi\", \"guid\": \"b757aa46-4729-4d4a-a32e-25ef0b04e5c3\", \"link_title\": \"Use or misuse prohibited under DoDI 1010.16\", \"updated\": {\"_seconds\": 1703683049, \"_nanoseconds\": 190000000}}]",
    "other_names": "[\"2,5-dimethoxy-4-iodoamphetamine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1712169148, \"_nanoseconds\": 876000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "DOM",
    "guid": "5a94586a-a5a9-40fc-8e1b-36704a3b36ad",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "dom",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"STP\", \"4-methyl-2,5-dimethoxy-\u03b1-methylphenethylamine\", \"2C-G\", \"4-methyl-2,5-dimethoxy-amphetamine\", \"2,5-Dimethoxy-3,4-dimethylphenethylamine\", \"4-methyl-2,5-dimethoxyamphetamine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710426486, \"_nanoseconds\": 171000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "Desidustat",
    "guid": "e1ca55cf-9bd8-418b-b680-36ce20966fd1",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "desidustat",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}, {\"reason_code\": 6014, \"reason\": \"DoDI 1010.16\", \"link\": \"https://www.esd.whs.mil/directives/issuances/dodi\", \"guid\": \"b757aa46-4729-4d4a-a32e-25ef0b04e5c3\", \"link_title\": \"Use or misuse prohibited under DoDI 1010.16\", \"updated\": {\"_seconds\": 1703683049, \"_nanoseconds\": 190000000}}]",
    "other_names": "[\"ZYAN1\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1722279406, \"_nanoseconds\": 364000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"DoDI 1010.04 Problematic Substance Use by DoD Personnel \", \"url\": \"https://www.esd.whs.mil/Directives/issuances/dodi\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "DiPT",
    "guid": "ed991569-9a37-495e-80ad-964e447c06db",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "dipt",
    "Reasons": "[{\"reason_code\": 6021, \"reason\": \"Other reason\", \"link\": null, \"guid\": \"9bdb33d0-1759-4198-8056-bc40e52a3afd\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683326, \"_nanoseconds\": 656000000}}]",
    "other_names": "[\"N,N-diisopropyltryptamine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1712169868, \"_nanoseconds\": 663000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "Enarodustat",
    "guid": "8701325e-0c3c-4f00-8d09-7c3bec16928e",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "enarodustat",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}, {\"reason_code\": 6014, \"reason\": \"DoDI 1010.16\", \"link\": \"https://www.esd.whs.mil/directives/issuances/dodi\", \"guid\": \"b757aa46-4729-4d4a-a32e-25ef0b04e5c3\", \"link_title\": \"Use or misuse prohibited under DoDI 1010.16\", \"updated\": {\"_seconds\": 1703683049, \"_nanoseconds\": 190000000}}]",
    "other_names": "[\"JTZ-951\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1722279395, \"_nanoseconds\": 195000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "FG-2216",
    "guid": "9feef841-4d7d-4011-87df-b636b82fb68d",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "fg-2216",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}, {\"reason_code\": 6014, \"reason\": \"DoDI 1010.16\", \"link\": \"https://www.esd.whs.mil/directives/issuances/dodi\", \"guid\": \"b757aa46-4729-4d4a-a32e-25ef0b04e5c3\", \"link_title\": \"Use or misuse prohibited under DoDI 1010.16\", \"updated\": {\"_seconds\": 1703683049, \"_nanoseconds\": 190000000}}]",
    "other_names": "[]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1722279657, \"_nanoseconds\": 264000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "FP-3",
    "guid": "319fce1c-31cb-4463-b78c-0dd91bddbfa9",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "fp-3",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}]",
    "other_names": "[\"Pentobarbital & noncontrolled active ingred\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710260293, \"_nanoseconds\": 581000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "FUB-144",
    "guid": "d24cec6d-0aba-462f-a69e-fe19fca02532",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "fub-144",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"[1-[(4-Fluorophenyl)methyl]-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone\", \"FUB-UR-144\", \"(1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl) methanone\", \"Methanone, [1-[(4-fluorophenyl)methyl]-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)-\", \"(1-(4-Fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738953745, \"_nanoseconds\": 689000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "FUB-APINACA",
    "guid": "436e614c-b07d-4aec-a2cf-a60aea376163",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "fub-apinaca",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"AKB48 N-(4-FLUOROBENZYL)\", \"FUB-AKB48\", \"N-(adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamid\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710174985, \"_nanoseconds\": 522000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Growth hormone-releasing peptide 1\", \"url\": \"https://drugs.ncats.io/drug/39EVI31P0W\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S2: HormonesUnapproved drug",
    "Name": "GHRP-1",
    "guid": "d6082aef-5971-4494-890f-4076e106d092",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "ghrp-1",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"growth hormone-releasing peptide 1\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738954510, \"_nanoseconds\": 106000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Hexapeptide-2\", \"url\": \"https://drugs.ncats.io/drug/4H7N4I6X6A\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S2: HormonesUnapproved drug",
    "Name": "GHRP-6",
    "guid": "2101bf2a-57cd-4f97-8ff2-de7ecc45ab1b",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "ghrp-6",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"hexapeptide-2\", \"growth hormone-releasing peptide hexapeptide\", \"growth hormone-releasing peptide 6\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710173278, \"_nanoseconds\": 628000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "GSK2881078",
    "guid": "3246eef7-6eb2-4ba4-82df-d025569be907",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "gsk2881078",
    "Reasons": "[{\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}, {\"reason_code\": 6014, \"reason\": \"DoDI 1010.16\", \"link\": \"https://www.esd.whs.mil/directives/issuances/dodi\", \"guid\": \"b757aa46-4729-4d4a-a32e-25ef0b04e5c3\", \"link_title\": \"Use or misuse prohibited under DoDI 1010.16\", \"updated\": {\"_seconds\": 1703683049, \"_nanoseconds\": 190000000}}]",
    "other_names": "[\"SARM GSK2881078\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1722279339, \"_nanoseconds\": 121000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S4: Hormone and Metabolic ModulatorsUnapproved drug",
    "Name": "GW-0742",
    "guid": "8c239371-c374-4dca-acee-b1504631de9a",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "gw-0742",
    "Reasons": "[{\"reason_code\": 6012, \"reason\": \"WADA S4: Hormone and Metabolic Modulators\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"ac1ba347-6d44-4a17-829d-e589bf33bbdb\", \"link_title\": \"WADA Prohibited List S4: Hormone and Metabolic Modulators\", \"updated\": {\"_seconds\": 1703682875, \"_nanoseconds\": 162000000}}]",
    "other_names": "[\"GW 0742X\", \"GW610742\", \"{4-[({2-[3-fluoro-4-(trifluoromethyl)phenyl]-4-methyl-1,3-thiazol-5-Yl}methyl)sulfanyl]-2-methylphenoxy}acetic acid\", \"2-[4-[[[2-[3-fluoro-4-(trifluoromethyl)phenyl]-4-methyl-5-thiazolyl]methyl]thio]-2-methylphenoxy]acetic acid\", \"GW0742\", \"[4-[[[2-[3-fluoro-4-(trifluoromethyl)phenyl]-4-methyl-5-thiazolyl]methyl]thio]-2-methylphenoxy]acetic acid\", \"GW0742\", \"GW\u03b4 0742\", \"GW-0742X\", \"GWdelta 0742\", \"2-[4-[[2-[3-fluoro-4-(trifluoromethyl)phenyl]-4-methyl-1,3-thiazol-5-yl]methylsulfanyl]-2-methylphenoxy]acetic acid\", \"GW-610742\", \"[4-[[[2-[3-fluoro-4-(trifluoromethyl)phenyl]-4-methyl-5-thiazolyl]methyl]thio]-2-methyl phenoxy]-acetic acid\", \"2-(4-(((2-(3-fluoro-4-(trifluoromethyl)phenyl)-4-methylthiazol-5-yl)methyl)thio)-2-methylphenoxy)acetic acid\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738955008, \"_nanoseconds\": 220000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S4: Hormone and Metabolic ModulatorsUnapproved drug",
    "Name": "GW-501516",
    "guid": "5008bb4b-b944-428b-8685-b516f7b6df31",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "gw-501516",
    "Reasons": "[{\"reason_code\": 6012, \"reason\": \"WADA S4: Hormone and Metabolic Modulators\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"ac1ba347-6d44-4a17-829d-e589bf33bbdb\", \"link_title\": \"WADA Prohibited List S4: Hormone and Metabolic Modulators\", \"updated\": {\"_seconds\": 1703682875, \"_nanoseconds\": 162000000}}]",
    "other_names": "[\"GSK-516\", \"GW501516\", \"2-[2-methyl-4-[[4-methyl-2-[4-(trifluoromethyl)phenyl]- 1,3-thiazol-5-yl]methylsulfanyl]phenoxy]acetic acid\", \"Endurobol\", \"GW-1516\", \"2-(2-methyl- 4-((4-methyl-2-(4-(trifluoromethyl)phenyl)thiazol-5-yl)methylthio)phenoxy) acetic acid\", \"Cardarine\", \"{4-[({4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol- 5-yl} methyl)sulfanyl]-2-methylphenoxy}acetic acid\", \"GW1516\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738955165, \"_nanoseconds\": 731000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Chorionic gonadotropin\", \"url\": \"https://drugs.ncats.io/drug/20ED16GHEB\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S2: Peptide Hormones, Growth Factors, etc.Prescription drug",
    "Name": "HCG",
    "guid": "ccfbe3c7-7950-4c7d-a898-09684f8ed93e",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "hcg",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}, {\"reason_code\": 6016, \"reason\": \"Prescription drug\", \"link\": null, \"guid\": \"becae72e-580f-4d8d-8665-c0c4b1dc1381\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683249, \"_nanoseconds\": 70000000}}]",
    "other_names": "[\"chorionic gonadotropin\", \"hCG\", \"human chorionic gonadotropin\", \"chorionic gonadotrophin\", \"chorionic gonadotrophin (CG)\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738956224, \"_nanoseconds\": 449000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Somatropin\", \"url\": \"https://drugs.ncats.io/drug/NQX9KB6PCL\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S2: Peptide Hormones, Growth Factors, etc.Prescription drug",
    "Name": "HGH",
    "guid": "60ed20c4-afda-4e14-a384-38c567b276b5",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "hgh",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}, {\"reason_code\": 6016, \"reason\": \"Prescription drug\", \"link\": null, \"guid\": \"becae72e-580f-4d8d-8665-c0c4b1dc1381\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683249, \"_nanoseconds\": 70000000}}]",
    "other_names": "[\"Humatrope\", \"somatotropin recombinant\", \"Accretropin\", \"Valtropin\", \"Norditropin Flexpro\", \"Norditropin Simplexx\", \"Omnitrope\", \"Nutropin AQ\", \"Norditropin nordiflex\", \"Zomacton\", \"Nutropin Depot\", \"Serostim\", \"Genotonorm\", \"Norditropin\", \"hGH 176-191\", \"somatotropin (human)\", \"r-hGH\", \"Zarbtive\", \"human growth hormone\", \"Serostim LQ\", \"Saizen\", \"recombinant human growth hormone\", \"Nordotropin\", \"Zorbtive\", \"somatropin\", \"Genotropin\", \"Nutropin AQ Pen\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1761913606, \"_nanoseconds\": 226000000}",
    "label_terms": "[]",
    "linked_ingredients": "[]",
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Mecasermin\", \"url\": \"https://drugs.ncats.io/drug/7GR9I2683O\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S2: Peptide Hormones, Growth Factors, etc.Prescription drug",
    "Name": "IGF",
    "guid": "2448390d-37cf-409f-a5ba-03e570b816f1",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "igf",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}, {\"reason_code\": 6016, \"reason\": \"Prescription drug\", \"link\": null, \"guid\": \"becae72e-580f-4d8d-8665-c0c4b1dc1381\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683249, \"_nanoseconds\": 70000000}}]",
    "other_names": "[\"recombinant human insulin-like growth factor-1\", \"Somatomedin C\", \"Mecasermin\", \"IGF-1\", \"insulin-like growth factor 1\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1761926845, \"_nanoseconds\": 484000000}",
    "label_terms": "[]",
    "linked_ingredients": "[]",
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S2: HormonesUnapproved drug",
    "Name": "IOX2",
    "guid": "aec2174a-ec9d-4231-9f97-8c07a9493fc8",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "iox2",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}]",
    "other_names": "[\"JICL38\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709910976, \"_nanoseconds\": 182000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "IOX4",
    "guid": "ff883915-6916-4744-8523-0b7b97d6bf48",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "iox4",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}, {\"reason_code\": 6014, \"reason\": \"DoDI 1010.16\", \"link\": \"https://www.esd.whs.mil/directives/issuances/dodi\", \"guid\": \"b757aa46-4729-4d4a-a32e-25ef0b04e5c3\", \"link_title\": \"Use or misuse prohibited under DoDI 1010.16\", \"updated\": {\"_seconds\": 1703683049, \"_nanoseconds\": 190000000}}]",
    "other_names": "[]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1722279651, \"_nanoseconds\": 31000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry:JNJ-28330835\", \"url\": \"https://drugs.ncats.io/drug/544SF265DA\"}, {\"title\": \"FDA warns against using SARMs in body-building products\", \"url\": \"https://www.fda.gov/news-events/fda-brief/fda-brief-fda-warns-against-using-sarms-body-building-products\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S1: AnabolicUnapproved drugFDA statement: SARMs",
    "Name": "JNJ-28330835",
    "guid": "15b12082-c92f-4e2e-b6fb-d8b929d86700",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "jnj-28330835",
    "Reasons": "[{\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}, {\"reason_code\": 6018, \"reason\": \"FDA Statement\", \"link\": \"\", \"guid\": \"3cd17124-6ebc-4828-9edb-c20a81755502\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1711715334, \"_nanoseconds\": 457000000}}]",
    "other_names": "[\"(3 S)-3-methyl-5-trifluoromethyl-3,4-dihydro-2H-pyrazole-3-carboxylic acid N-(4-cyano-3-trifluoromethylphenyl)amide)\", \"(S)-3-methyl-5-trifluoromethyl-3,4-dihydro-2H-pyrazole-3-carboxylic acid N-(4-cyano-3-trifluoromethylphenyl)amide)\", \"JNJ 28330835\", \"1H-pyrazole-5-carboxamide, N-(4-cyano-3-(trifluoromethyl)phenyl)-4,5-dihydro-5-methyl-3-(trifluoromethyl)-, (5S)-\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709840995, \"_nanoseconds\": 452000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "JNJ-42041935",
    "guid": "9c4cfdae-320c-4ffd-bc10-625739e46a41",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "jnj-42041935",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}, {\"reason_code\": 6014, \"reason\": \"DoDI 1010.16\", \"link\": \"https://www.esd.whs.mil/directives/issuances/dodi\", \"guid\": \"b757aa46-4729-4d4a-a32e-25ef0b04e5c3\", \"link_title\": \"Use or misuse prohibited under DoDI 1010.16\", \"updated\": {\"_seconds\": 1703683049, \"_nanoseconds\": 190000000}}]",
    "other_names": "[]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1722279647, \"_nanoseconds\": 992000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S2: Peptide Hormones, Growth Factors, etc.",
    "Name": "K-11706",
    "guid": "80af2657-e616-4bac-b26b-018f3a1e4daf",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "k-11706",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}]",
    "other_names": "[]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709840782, \"_nanoseconds\": 545000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: LGD-2226\", \"url\": \"https://drugs.ncats.io/drug/RI376RM5MT\"}, {\"title\": \"FDA warns against using SARMs in body-building products\", \"url\": \"https://www.fda.gov/news-events/fda-brief/fda-brief-fda-warns-against-using-sarms-body-building-products\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S1: Anabolic AgentsUnapproved drugFDA statement: SARMs",
    "Name": "LGD-2226",
    "guid": "f8ac0603-0b83-4746-aed2-68ef75538f22",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "lgd-2226",
    "Reasons": "[{\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}, {\"reason_code\": 6018, \"reason\": \"FDA Statement\", \"link\": \"\", \"guid\": \"3cd17124-6ebc-4828-9edb-c20a81755502\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1711715334, \"_nanoseconds\": 457000000}}]",
    "other_names": "[\"LGD2226\", \"6-(bis-(2,2,2-trifluoroethyl)amino)-4-trifluoromethyl-1H-quinolin-2-one\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709838302, \"_nanoseconds\": 554000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: LGD-3303\", \"url\": \"https://drugs.ncats.io/drug/7N4E1X2RJM\"}, {\"title\": \"FDA warns against using SARMs in body-building products\", \"url\": \"https://www.fda.gov/news-events/fda-brief/fda-brief-fda-warns-against-using-sarms-body-building-products\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S1: Anabolic AgentsUnapproved drugFDA statement: SARMs",
    "Name": "LGD-3303",
    "guid": "a05db0d7-90a1-4e9a-bd13-64a34f3e34bf",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "lgd-3303",
    "Reasons": "[{\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}, {\"reason_code\": 6018, \"reason\": \"FDA Statement\", \"link\": \"\", \"guid\": \"3cd17124-6ebc-4828-9edb-c20a81755502\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1711715334, \"_nanoseconds\": 457000000}}]",
    "other_names": "[\"LGD 3033\", \"LGD3033\", \"LGD-3033\", \"7H-pyrrolo(3,2-F)quinolin-7-one, 9-chloro-2-ethyl-3,6-dihydro-1-methyl-3-(2,2,2-trifluoroethyl)-\", \"LGD3303\", \"9-chloro-2-ethyl-1-methyl-3-(2,2,2-trifluoroethyl)-3H-pyrrolo[3,2-f]quinolin-7(6H)-one\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1713536106, \"_nanoseconds\": 923000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: VK-5211\", \"url\": \"https://drugs.ncats.io/drug/1EJT54415A\"}, {\"title\": \"FDA warns against using SARMs in body-building products\", \"url\": \"https://www.fda.gov/news-events/fda-brief/fda-brief-fda-warns-against-using-sarms-body-building-products\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S1: Anabolic AgentsUnapproved drugFDA statement: SARMs",
    "Name": "LGD-4033",
    "guid": "16ca3215-e10f-4609-bf56-f5ea39a0383a",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "lgd-4033",
    "Reasons": "[{\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}, {\"reason_code\": 6018, \"reason\": \"FDA Statement\", \"link\": \"\", \"guid\": \"3cd17124-6ebc-4828-9edb-c20a81755502\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1711715334, \"_nanoseconds\": 457000000}}]",
    "other_names": "[\"VK5211\", \"anabolicum\", \"LGD4033\", \"VK-5211\", \"4-((R)-2-((R)-2,2,2-Trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-(trifluoromethyl)benzonitrile\", \"4-[(2R)-w-[(1R)-2,2,2-trifluoro-1-hydroxyethyl]pyrrolidin-1-yl]-2-(trifluoromethyl)benzonitrile\", \"Ligandrol\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1720807170, \"_nanoseconds\": 141000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "MAB-CHMINACA",
    "guid": "86f136be-ae09-4f3a-8c6e-5e85289180b0",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "mab-chminaca",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"ADB-CHMINACA\", \"N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709834680, \"_nanoseconds\": 213000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "MDA",
    "guid": "a2b25dc1-77ae-4697-9424-9a29d935d766",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "mda",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"N-hydroxy-3,4-methylenedioxyamphetamine\", \"Love Drug\", \"tenamfetamine\", \"methylenedioxyamphetamine\", \"3,4-methylenedioxy amphetamine\", \"N-hydroxy MDA\", \"3,4-methylenedioxyamphetamine\", \"N-hydroxy-alpha-methyl-3,4(methylenedioxy)phenethylamine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715370785, \"_nanoseconds\": 22000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "MDEA",
    "guid": "f48c3eee-0ed5-489d-9d53-6997e3220a8b",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "mdea",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"MDMB\", \"3,4-methylenedioxy-N-ethylamphetamine\", \"MDE\", \"N-ethyl MDA\", \"N-ethyl-alpha-methyl-3,4(methylenedioxy)phenethylamine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709834008, \"_nanoseconds\": 349000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "MDMA",
    "guid": "52f32536-a61a-48fb-9eee-d196bf8fb995",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "mdma",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"Ectasy\", \"3,4-methylenedioxymethamphetamine\", \"XTC\", \"methylenedioxymethamphetamine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715368044, \"_nanoseconds\": 859000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "MDMB-4en-PINACA",
    "guid": "01678059-d0e0-4b6b-b3d5-ac70dd43cdfc",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "mdmb-4en-pinaca",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"methyl 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1H-indazole-3-carboxamido)butanoate\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709044902, \"_nanoseconds\": 365000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "MDMB-CHMICA",
    "guid": "9766a250-e388-4e44-a933-192cafe2fb5f",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "mdmb-chmica",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate\", \"MMB-CHMINACA\", \"MDMB\u2013CHMICA\", \"MMB\u2013CHMINACA\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709833691, \"_nanoseconds\": 421000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "MDMB-FUBINACA",
    "guid": "f3b29000-b090-4b81-b02f-4d2b2d3f158a",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "mdmb-fubinaca",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate\", \"MDMB\u2013FUBINACA\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709833519, \"_nanoseconds\": 416000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "MDPV",
    "guid": "f0ded596-0e1b-4e46-adc5-954af853c458",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "mdpv",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"3,4-methylenedioxypyrovalerone\", \"1-(1,3-benzodioxol-4-yl)-2-(pyrrolidin-1-yl)pentan-1-one (2,3-methylenedioxy pyrovalerone)\", \"1-(1,3-benzodioxol-5-yl)-2-(cyclohexylamino)propan-1-one(n-cyclohexylmethylone)\", \"3,4-methylenedioxy-\u03b1-cyclohexylaminopropiophenone \"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1712071734, \"_nanoseconds\": 349000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Ibutamoren mesylate\", \"url\": \"https://drugs.ncats.io/drug/R90JB6QJ2B\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S2: Peptide Hormones, Growth Factors, etc.Unapproved drug",
    "Name": "MK-677",
    "guid": "a70eac9d-8cb8-413b-aa10-1ec5a09f8c97",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "mk-677",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"MK 0677\", \"Nutrobal\", \"2-amino-N-((R)-2-(benzyloxy)-1-((1-(methylsulfonyl)spiro(indoline-3,4'-piperidin)-1'-yl)carbonyl)ethyl)-2-methyl-propionamide monomethanesulfonate\", \"ibutamoren mesilate\", \"ibutamoren mesylate\", \"ibutamoren\", \"Crescendo\", \"MK 677\", \"2-amino-N-((R)-2-(benzyloxy)-1-((1-(methylsulfonyl)spiro(indoline-3,4'-piperidin)-1'-yl)carbonyl)ethyl)-2-methylpropionamide monomethanesulfonate\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709315851, \"_nanoseconds\": 565000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "MMB-CHMICA",
    "guid": "7ae06745-dabb-4ada-b219-f1f810665ae2",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "mmb-chmica",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutanoate\", \"AMB-CHMICA\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709315740, \"_nanoseconds\": 765000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "MMB-FUBICA",
    "guid": "1d8ddc9c-2069-4b31-a261-c794e467a7d7",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "mmb-fubica",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"methyl 2-(1-(4-fluorobenzyl)-1H-indole-3-carboxamido)-3-methyl butanoate\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709046684, \"_nanoseconds\": 565000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "MMDA",
    "guid": "20fd58c2-71be-41c9-83e2-49c75c59212f",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "mmda",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"5-methoxy-3,4-methylenedioxy-amphetamine\", \"5-methoxy-3,4-methylenedioxyamphetamine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709315684, \"_nanoseconds\": 877000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "MPHP",
    "guid": "08200d04-9b30-466b-9883-0f6a0d2d1829",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "mphp",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"4'-methyl-alpha-pyrrolidinohexiophenone\", \"1-(4-methylphenyl)-2-(pyrrolidin-1-yl)hexan-1-one\", \"4'-methyl-alpha-pyrrolidinohexanophenone\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709314922, \"_nanoseconds\": 525000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "MPPP",
    "guid": "752f02eb-67c6-4c42-aa5f-be3f23d5abe3",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "mppp",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"1-methyl-4-phenyl-4-propionoxypiperidine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709314870, \"_nanoseconds\": 805000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "MT-45",
    "guid": "ab3894f1-e4d9-4a98-9bc0-90ba47ea8c53",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "mt-45",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"1-cyclohexyl-4-(1,2-diphenylethyl)piperazine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709314838, \"_nanoseconds\": 165000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "N,N-dimethylamphetamine",
    "guid": "c0d33a0d-2a7c-405f-982b-42db9d39751c",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "n,n-dimethylamphetamine",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"N,N-alpha-trimethylphenethylamine\", \"dimethylamphetamine\", \"dimetamfetamine\", \"N,N-alpha-trimethyl-benzeneethanamine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715362113, \"_nanoseconds\": 257000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"Toxic volatile industrial chemical\", \"url\": \"https://www.cdc.gov/niosh/docs/88-103/default.html\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Industrial chemical",
    "Name": "N,N-dimethylethylamine",
    "guid": "3888e51c-5f4b-4131-9c17-00400f2ddd55",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "n,n-dimethylethylamine",
    "Reasons": "[{\"reason_code\": 6021, \"reason\": \"Other reason\", \"link\": null, \"guid\": \"9bdb33d0-1759-4198-8056-bc40e52a3afd\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683326, \"_nanoseconds\": 656000000}}]",
    "other_names": "[\"1,3-dimethylethylamine\", \"dimethylethylamine\", \"DMEA\", \"ethanamine, N,N-dimethyl-\", \"ethylamine, N,N-dimethyl-\", \"ethyldimethylamine\", \"methanamine, N-ethyl-N-methyl-\", \"N-ethyldimethylamine\", \"N,N-dimethylaminoethane\", \"N,N-dimethylethanamine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709312735, \"_nanoseconds\": 788000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "N-benzylpiperazine",
    "guid": "1834d61d-8e89-4022-878a-e1a492a2334c",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "n-benzylpiperazine",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"1-benzylpiperazine tartrate\", \"1-benzylpiperazine dihydrochloride\", \"benzylpiperazine\", \"BZP\", \"1-benzylpiperazine fumarate\", \"1-benzylpiperazine\", \"4-benzylpiperazine\", \"1-benzylpiperazine hydrochloride\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715354318, \"_nanoseconds\": 105000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "N-ethyl-1-phenylcyclohexylamine",
    "guid": "15559c5c-0a64-4ca3-a623-eb967cba4e91",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "n-ethyl-1-phenylcyclohexylamine",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"PCE\", \"(1-phenylcyclohexyl)ethylamine\", \"cyclohexamine\", \"N-(1-phenylcyclohexyl)ethylamine\", \"ethylamine analog of phencyclidine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709314670, \"_nanoseconds\": 5000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "N-ethyl-3-piperidyl benzilate",
    "guid": "566dfc9f-2596-432b-812d-694bac57ad0d",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "n-ethyl-3-piperidyl benzilate",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"JB 323\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709314507, \"_nanoseconds\": 964000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "N-ethyl-N-methylcathinone",
    "guid": "df32b608-80bd-4cfc-93bd-bf923884bd0b",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "n-ethyl-n-methylcathinone",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709314476, \"_nanoseconds\": 460000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "N-ethylamphetamine",
    "guid": "361c7a5c-dcc5-4b26-846a-0a050705ff0a",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "n-ethylamphetamine",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"ethylamphetamine\", \"etilamfetamine\", \"NEA\", \"Adiparthrol\", \"Apetinil\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715362716, \"_nanoseconds\": 957000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "N-ethylbuphedrone",
    "guid": "ba3e0f4e-dfd0-4197-a91a-5fab1c54a5fb",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "n-ethylbuphedrone",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"NEB\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709313924, \"_nanoseconds\": 31000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "N-ethylhexedrone",
    "guid": "ba23bf5a-c0fc-4668-bf74-810d11eb8896",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "n-ethylhexedrone",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"2-(ethylamino)-1-phenylhexan-1-one\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709313830, \"_nanoseconds\": 84000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "N-ethylpentylone",
    "guid": "cf3d4fcc-da2f-48ea-81e1-f5291ce0a092",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "n-ethylpentylone",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"\u03b2k-ethyl-K\", \"\u03b2-keto-ethylbenzodioxolylpentanamine\", \"\u03b2k-EBDP\", \"ephylone\", \"1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-pentan-1-one\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709313785, \"_nanoseconds\": 740000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "N-methyl-3-piperidyl benzilate",
    "guid": "4757cdcf-1021-4bbb-9aff-06749d992741",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "n-methyl-3-piperidyl benzilate",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"JB 336\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709313177, \"_nanoseconds\": 134000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"FDA Warning Letter\", \"url\": \"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/carbon-fire-llc-664700-03012024 \"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "N-methyltyramine",
    "guid": "3a7ab55f-07bf-4a89-878c-6178c6d640c6",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "n-methyltyramine",
    "Reasons": "[{\"reason_code\": 6019, \"reason\": \"FDA Warning Letter\", \"link\": null, \"guid\": \"1cd0ab89-14ce-43c2-a804-e4b29b8780fe\", \"link_title\": null, \"updated\": {\"_seconds\": 1711571477, \"_nanoseconds\": 43000000}}]",
    "other_names": "[\"p-(2-(Methylamino)ethyl)phenol\", \"methyl tyramine\", \"NMT\", \"p-(2-methylaminoethyl)phenol\", \"4-[2-(methylamino)ethyl]phenol\", \"N-methyl L-tyramine\", \"methyl-4-tyramine\", \"N methyl tyramine\", \"N-Methyl-p-tyramine\", \"N-methyl tyramine\", \"N-Methyl-tyramine\", \"4-(methylamino)ethyl)phenol\", \"4-hydroxy-N-methylphenethylamine\", \"N-methyltyramine HCl\", \"p-(2-Methylaminoethyl)-phenol\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1741806889, \"_nanoseconds\": 643000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "N-pyrrolidino etonitazene",
    "guid": "b8c3dd76-9a46-4362-8e74-814fed15aa06",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "n-pyrrolidino etonitazene",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"(2-(4-ethoxybenzyl)-5-nitro-1-(2- (pyrrolidin-1-yl)ethyl)-1H-benzimidazole)\", \"2-(4-ethoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)1Hbenzimidazone\", \"2-[(4-ethoxyphenyl)methyl]-5-nitro-1-(2-pyrrolidin-1-ylethyl)benzimidazole\", \"etonitazepyne \", \"2-(4-ethoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzo(d)imidazole\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709313140, \"_nanoseconds\": 260000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "NM2201",
    "guid": "f1c642d6-59f2-4b13-b892-6d9c89e21fc2",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "nm2201",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate\", \"CBL2201\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709311636, \"_nanoseconds\": 491000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"DoDI 1010.04 Problematic Substance Use by DoD Personnel and DoDI 6130.06 Use of Dietary Supplements in the DoD\", \"url\": \"https://www.esd.whs.mil/Directives/issuances/dodi\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Per DoDI 1010.04 and DoDI 6130.06",
    "Name": "Nymphaea caerulea",
    "guid": "c5d44319-23fc-4c70-a917-ba708bc5d142",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "nymphaea caerulea",
    "Reasons": "[{\"reason_code\": 6017, \"reason\": \"Military policy\", \"link\": null, \"guid\": \"96435789-439c-44d4-83cf-1d10a25ab7b5\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683268, \"_nanoseconds\": 216000000}}]",
    "other_names": "[\"blue lotus\", \"blue lotus (Nymphaea caerulea)\", \"Egyptian water lily\", \"nuciferine\", \"apomorphine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1749059218, \"_nanoseconds\": 307000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule II",
    "Name": "PCC",
    "guid": "3ecb8911-62ed-4beb-b99c-fa9bf1d1e4b0",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "pcc",
    "Reasons": "[{\"reason_code\": 6004, \"reason\": \"DEA Controlled Substance List: Schedule  II\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"207f9e17-8a22-4523-8dd6-24d9d39b4c45\", \"link_title\": \"DEA Controlled Substance List: Schedule  II\", \"updated\": {\"_seconds\": 1712942744, \"_nanoseconds\": 783000000}}]",
    "other_names": "[\"1-piperidinocyclohexanecarbonitrile\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709142856, \"_nanoseconds\": 876000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "PEPAP",
    "guid": "98cd0169-1121-495b-9b0f-50773484bfcb",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "pepap",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"1-(2-phenylethyl)-4-phenyl-4-acetoxypiperidine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709141764, \"_nanoseconds\": 903000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "PV8",
    "guid": "1c365b68-12d2-43e9-b673-88ebe28ecf60",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "pv8",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"alpha-pyrrolidinoheptaphenone\", \"1-phenyl-2-(pyrrolidin-1-yl)heptan-1-one\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709053644, \"_nanoseconds\": 822000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"DoDI 1010.04 Problematic Substance Use by DoD Personnel and DoDI 6130.06 Use of Dietary Supplements in the DoD\", \"url\": \"https://www.esd.whs.mil/Directives/issuances/dodi\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "Piper methysticum",
    "guid": "8bb8e1bf-24fb-40a3-a2fc-656944e8b494",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "piper methysticum",
    "Reasons": "[{\"reason_code\": 6017, \"reason\": \"Military policy\", \"link\": null, \"guid\": \"96435789-439c-44d4-83cf-1d10a25ab7b5\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683268, \"_nanoseconds\": 216000000}}]",
    "other_names": "[\"kava kava\", \"kava\", \"kavain\", \"kawain\", \"kavalactone\", \"kavalactones\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1749059330, \"_nanoseconds\": 729000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "QUPIC",
    "guid": "cb3d47d0-1d81-420e-9748-66eebebf8345",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "qupic",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"PB-22\", \"quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709041493, \"_nanoseconds\": 230000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "R3-IGF-1",
    "guid": "265e787a-e6d0-406b-b060-29cb4bdba031",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "r3-igf-1",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}, {\"reason_code\": 6014, \"reason\": \"DoDI 1010.16\", \"link\": \"https://www.esd.whs.mil/directives/issuances/dodi\", \"guid\": \"b757aa46-4729-4d4a-a32e-25ef0b04e5c3\", \"link_title\": \"Use or misuse prohibited under DoDI 1010.16\", \"updated\": {\"_seconds\": 1703683049, \"_nanoseconds\": 190000000}}]",
    "other_names": "[]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1722279641, \"_nanoseconds\": 903000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"FDA warns against using SARMs in body-building products\", \"url\": \"https://www.fda.gov/news-events/fda-brief/fda-brief-fda-warns-against-using-sarms-body-building-products\"}, {\"title\": \"FDA Information on Select Dietary Supplement Ingredients and Other Substances\", \"url\": \"https://www.fda.gov/food/dietary-supplements/information-select-dietary-supplement-ingredients-and-other-substances\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S1: Anabolic AgentsUnapproved drugFDA statement: SARMs",
    "Name": "RAD-150",
    "guid": "9addb2be-9141-4926-98e8-68166ce6ef9e",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "rad-150",
    "Reasons": "[{\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}, {\"reason_code\": 6018, \"reason\": \"FDA Statement\", \"link\": \"\", \"guid\": \"3cd17124-6ebc-4828-9edb-c20a81755502\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1711715334, \"_nanoseconds\": 457000000}}]",
    "other_names": "[\"teptadrol\", \"(2S,3R)-3-[(4-cyanophenyl)-1,3,4- oxadiazol-2-yl]-3-[(2-methyl- 3- chloro-4- cyanophenyl)amino]-2- propyl alcohol\", \"2-[5-chloropentyl(methyl)amino]-N-(2,6-dimethylphenyl)acetamide\", \"TLB-150 benzoate\", \"N-(5-chloropentyl)-N-methylaminoaceto-2,6-xylidide\", \"benzoate (2S,3R)-3-[(4-cyanophenyl)-1,3,4,oxadiazol-2-yl]-3-[(2- methyl-3-chloro-4-cyanphenyl)amino]-2-propyl alcohol benzoate\", \"2-((5-chloropentyl)methylamino)-N-(2,6-dimethylphenyl)acetamide\", \"TLB-150\", \"(2S,3R)-3-[(4-cyanophenyl)-1,3,4-oxadiazol-2-yl]-3-[(2- methyl-3-chloro-4-cyanphenyl)amino]-2-propyl alcohol benzoate\", \"(2S,3R)-3-[(cyanophenyl)-1,3,4-oxadiazoll-2-yl]-3-[(2-methyl-3-chloro-4-cyanphenyl)amino]-2-propyl alcohol benzoate\", \"RAD 150\", \"RAD-150 SARM powder\", \"RAD 150 (TLB 150) SARM\", \"sustalone\", \"RAD150+TLB150 benzoate liquid\", \"RAD-140 ester\", \"RAD150\", \"TLB 150\", \"RAD-150 (TLB-150)\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709742249, \"_nanoseconds\": 155000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "S-107",
    "guid": "baab85bb-ca1e-406d-842a-a0f5ba15a8b9",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "s-107",
    "Reasons": "[{\"reason_code\": 6008, \"reason\": \"WADA S0: Non-approved Substances\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"f321f8bd-47c9-42f3-bea6-f36eafa02ecf\", \"link_title\": \"WADA Prohibited List S0: Non-approved Substances\", \"updated\": {\"_seconds\": 1703682727, \"_nanoseconds\": 352000000}}]",
    "other_names": "[]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1735580180, \"_nanoseconds\": 396000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: S-23\", \"url\": \"https://drugs.ncats.io/drug/XDK89456WM\"}, {\"title\": \"FDA warns against using SARMs in body-building products\", \"url\": \"https://www.fda.gov/news-events/fda-brief/fda-brief-fda-warns-against-using-sarms-body-building-products\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S1: Anabolic AgentsUnapproved drugFDA statement: SARMs",
    "Name": "S-23",
    "guid": "2467e4f8-48d8-4c97-ad07-726a2d8ee6dc",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "s-23",
    "Reasons": "[{\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}, {\"reason_code\": 6018, \"reason\": \"FDA Statement\", \"link\": \"\", \"guid\": \"3cd17124-6ebc-4828-9edb-c20a81755502\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1711715334, \"_nanoseconds\": 457000000}}]",
    "other_names": "[\"(S)-N-(4-cyano-3-trifluoromethyl-phenyl)-3-(3-fluoro, 4-chlorophenoxy)-2-hydroxy-2-methyl-propanamide\", \"3-(4-cyanophenoxy)-N-(4-cyano-3-trifluoromethylphenyl)-2-hydroxy-2-methylpropionamide\", \"S23\", \"S 23\", \"propanamide, 3-(4-chloro-3-fluorophenoxy)-N-(4-cyano-3-(trifluoromethyl)phenyl)-2-hydroxy-2-methyl-, (2S)-\", \"1-phenyl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline hydrochloride, (+-)-isomer\", \"6,7-dimethoxy-4-phenyl-1,2,3,4-tetrahydroisoquinoline\", \"1-phenyl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline\", \"1-phenyl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline hydrochloride\", \"(S)-N-(4-cyano-3-fluoro, 4-chlorophenoxy)-2-hydroxy-2-methyl-propanamide\", \"(2S)-3-(4-Chloro-3-fluorophenoxy)-N-(4-cyano-3-(trifluoromethyl)phenyl)-2-hydroxy-2-methylpropanamide\", \"CCTH-methylpropionamide\", \"(2S)-N-(4-cyano-3-trifluoromethylphenyl)-3-(3-fluoro-4-chlorophenoxy)-2-hydroxy-2-methyl-propanamide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1721052321, \"_nanoseconds\": 625000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: S-40503\", \"url\": \"https://drugs.ncats.io/drug/TBF49WHM83\"}, {\"title\": \"FDA warns against using SARMs in body-building products\", \"url\": \"https://www.fda.gov/news-events/fda-brief/fda-brief-fda-warns-against-using-sarms-body-building-products\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S1: Anabolic AgentsUnapproved drugFDA statement: SARMs",
    "Name": "S-40503",
    "guid": "933ee4b1-6a10-4688-a5e0-dc001ac1ed5a",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "s-40503",
    "Reasons": "[{\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}, {\"reason_code\": 6018, \"reason\": \"FDA Statement\", \"link\": \"\", \"guid\": \"3cd17124-6ebc-4828-9edb-c20a81755502\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1711715334, \"_nanoseconds\": 457000000}}]",
    "other_names": "[\"2-(4-(dimethylamino)-6-nitro-1,2,3,4-tetrahydroquinolin-2-YL)-2-methylpropan-1-ol\", \"2-quinolineethanol, 4-(dimethylamino)-1,2,3,4-tetrahydro-\u03b2,\u03b2-dimethyl-6-nitro-\", \"2-quinolineethanol, 4-(dimethylamino)-1,2,3,4-tetrahydro-beta,beta-dimethyl-6-nitro-\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709742023, \"_nanoseconds\": 42000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "S48168 (ARM210)",
    "guid": "b673c083-3910-4bfd-b704-6f89e9ef61ef",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "s48168 (arm210)",
    "Reasons": "[{\"reason_code\": 6008, \"reason\": \"WADA S0: Non-approved Substances\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"f321f8bd-47c9-42f3-bea6-f36eafa02ecf\", \"link_title\": \"WADA Prohibited List S0: Non-approved Substances\", \"updated\": {\"_seconds\": 1703682727, \"_nanoseconds\": 352000000}}]",
    "other_names": "[]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1735580170, \"_nanoseconds\": 684000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "S519",
    "guid": "3558b525-4af5-484f-a6d9-237a89ac61b7",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "s519",
    "Reasons": "[{\"reason_code\": 6012, \"reason\": \"WADA S4: Hormone and Metabolic Modulators\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"ac1ba347-6d44-4a17-829d-e589bf33bbdb\", \"link_title\": \"WADA Prohibited List S4: Hormone and Metabolic Modulators\", \"updated\": {\"_seconds\": 1703682875, \"_nanoseconds\": 162000000}}]",
    "other_names": "[]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1735580226, \"_nanoseconds\": 926000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "S597",
    "guid": "a3474883-b43e-4134-8ac7-a38e5581fa6b",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "s597",
    "Reasons": "[{\"reason_code\": 6012, \"reason\": \"WADA S4: Hormone and Metabolic Modulators\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"ac1ba347-6d44-4a17-829d-e589bf33bbdb\", \"link_title\": \"WADA Prohibited List S4: Hormone and Metabolic Modulators\", \"updated\": {\"_seconds\": 1703682875, \"_nanoseconds\": 162000000}}]",
    "other_names": "[]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1735580206, \"_nanoseconds\": 818000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"FDA warns against using SARMs in body-building products\", \"url\": \"https://www.fda.gov/news-events/fda-brief/fda-brief-fda-warns-against-using-sarms-body-building-products\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S1: Anabolic AgentsUnapproved drugFDA statement: SARMs",
    "Name": "SARM",
    "guid": "88c1874f-4d72-44ac-9dec-c275fc406e5d",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "sarm",
    "Reasons": "[{\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}, {\"reason_code\": 6018, \"reason\": \"FDA Statement\", \"link\": \"\", \"guid\": \"3cd17124-6ebc-4828-9edb-c20a81755502\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1711715334, \"_nanoseconds\": 457000000}}]",
    "other_names": "[\"selective androgen receptor modulator\", \"SARMs\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709041978, \"_nanoseconds\": 472000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "SARM S1",
    "guid": "fe62889a-d9f2-40e3-b6e1-a82729f24f5d",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "sarm s1",
    "Reasons": "[{\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}, {\"reason_code\": 6014, \"reason\": \"DoDI 1010.16\", \"link\": \"https://www.esd.whs.mil/directives/issuances/dodi\", \"guid\": \"b757aa46-4729-4d4a-a32e-25ef0b04e5c3\", \"link_title\": \"Use or misuse prohibited under DoDI 1010.16\", \"updated\": {\"_seconds\": 1703683049, \"_nanoseconds\": 190000000}}]",
    "other_names": "[]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1722279662, \"_nanoseconds\": 880000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "SARM S9",
    "guid": "0cbb7dbe-3856-4859-8f0b-98bc150a228b",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "sarm s9",
    "Reasons": "[{\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}, {\"reason_code\": 6014, \"reason\": \"DoDI 1010.16\", \"link\": \"https://www.esd.whs.mil/directives/issuances/dodi\", \"guid\": \"b757aa46-4729-4d4a-a32e-25ef0b04e5c3\", \"link_title\": \"Use or misuse prohibited under DoDI 1010.16\", \"updated\": {\"_seconds\": 1703683049, \"_nanoseconds\": 190000000}}]",
    "other_names": "[]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1722279668, \"_nanoseconds\": 328000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "SR-18",
    "guid": "5aface34-5135-474f-a649-47d8ae3c2141",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "sr-18",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"1-cyclohexylethyl-3-(2-methoxyphenylacetyl)indole\", \"1-(2-cyclohexylethyl)-3-(2-methoxyphenylacetyl)indole\", \"RCS-8\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709042403, \"_nanoseconds\": 775000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "SR-19",
    "guid": "cc4ca9d8-9505-4980-84fa-113a6a8b4042",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "sr-19",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"RCS-4\", \"1-pentyl-3-[(4-methoxy)-benzoyl]indole\", \"1-pentyl-3-(4-methoxybenzoyl)indole\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709042411, \"_nanoseconds\": 64000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: SR-9006\", \"url\": \"https://drugs.ncats.io/drug/X5DCA09N30\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S4: Hormone and Metabolic Modulators",
    "Name": "SR-9009",
    "guid": "35693560-6d54-4602-90a1-7c32c5b0dcd8",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "sr-9009",
    "Reasons": "[{\"reason_code\": 6012, \"reason\": \"WADA S4: Hormone and Metabolic Modulators\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"ac1ba347-6d44-4a17-829d-e589bf33bbdb\", \"link_title\": \"WADA Prohibited List S4: Hormone and Metabolic Modulators\", \"updated\": {\"_seconds\": 1703682875, \"_nanoseconds\": 162000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"Stenabolic\", \"SR9009\", \"ethyl 3-[[(4-chlorophenyl)methyl-[(5-nitrothiophen-2-yl)methyl]amino]methyl]pyrrolidine-1-carboxylate\", \"1-pyrrolidinecarboxylic acid, 3-((((4-chlorophenyl)methyl)((5-nitro-2-thienyl)methyl)amino)methyl)-, ethyl ester\", \"SR 9009\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709042423, \"_nanoseconds\": 680000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: SR-9011\", \"url\": \"https://drugs.ncats.io/drug/VYI79FLZ6W\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S4: Hormone and Metabolic ModulatorsUnapproved drug",
    "Name": "SR-9011",
    "guid": "b555a47d-3c21-495d-a128-c4a3c5f66f56",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "sr-9011",
    "Reasons": "[{\"reason_code\": 6012, \"reason\": \"WADA S4: Hormone and Metabolic Modulators\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"ac1ba347-6d44-4a17-829d-e589bf33bbdb\", \"link_title\": \"WADA Prohibited List S4: Hormone and Metabolic Modulators\", \"updated\": {\"_seconds\": 1703682875, \"_nanoseconds\": 162000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"1-pyrrolidinecarboxamide, 3-((((4-chlorophenyl)methyl)((5-nitro-2-thienyl)methyl)amino)methyl)-n-pentyl-\", \"3-[[(4-chlorophenyl)methyl-[(5-nitrothiophen-2-yl)methyl]amino]methyl]-N-pentylpyrrolidine-1-carboxamide\", \"SR9011\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709042437, \"_nanoseconds\": 736000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"Salvia and drug testing\", \"url\": \"https://www.opss.org/article/salvia-and-drug-testing\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Military policy",
    "Name": "Salvia divinorum",
    "guid": "4ebaeda5-5400-4372-9428-13fd8e109130",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "salvia divinorum",
    "Reasons": "[{\"reason_code\": 6017, \"reason\": \"Military policy\", \"link\": null, \"guid\": \"96435789-439c-44d4-83cf-1d10a25ab7b5\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683268, \"_nanoseconds\": 216000000}}]",
    "other_names": "[\"Divine Mexican Mint\", \"Pipiltzintzintli\", \"divinorin A\", \"salvinorin A\", \"Leaves of the Virgin Shepherdess\", \"Herb-of-the-Virgin\", \"Sally D\", \"Ska Pastora\", \"salvia\", \"Diviner\u2019s Sage\", \"divinorin\", \"Ska Maria pastora\", \"Yerba Maria\", \"Yerba de Maria\", \"Magic Mint\", \"Diviner\u2019s Mint\", \"Sage of the Seers\", \"Herb of Mary\", \"Ska Maria\", \"Sally-D\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709041932, \"_nanoseconds\": 463000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: TB-500\", \"url\": \"https://drugs.ncats.io/drug/QHK6Z47GTG\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S2: Peptide Hormones - Growth Factors - etc.; Unapproved drug",
    "Name": "TB-500",
    "guid": "757d9e27-1685-4de8-bc6a-20be8697d8cd",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "tb-500",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"Ac-LKKTETQ\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1761937201, \"_nanoseconds\": 991000000}",
    "label_terms": "[]",
    "linked_ingredients": "[]",
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "THJ-2201",
    "guid": "f4ef7058-b116-4698-9d6f-5aa4ec053b2a",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "thj-2201",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"[1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709044047, \"_nanoseconds\": 170000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "TMA",
    "guid": "e01e07e4-8fac-44e3-9630-527704700cd5",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "tma",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"3,4,5-trimethoxyamphetamine\", \"3,4,5-trimethoxy amphetamine\", \"2,4,5-trimethoxyamphetamine\", \"TMA-6\", \"escaline\", \"2,4,6-trimethoxyamphetamine\", \"TMA-5\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709047281, \"_nanoseconds\": 333000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "U-47700",
    "guid": "eb7f0456-a88c-4da7-9fdf-7f531ca86624",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "u-47700",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709048217, \"_nanoseconds\": 404000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "UR-144",
    "guid": "f6f1a9f4-9239-4631-abd6-36a15533585b",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "ur-144",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"(1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709048316, \"_nanoseconds\": 485000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: YK-11\", \"url\": \"https://drugs.ncats.io/drug/Z9748J6B0R\"}, {\"title\": \"FDA warns against using SARMs in body-building products\", \"url\": \"https://www.fda.gov/news-events/fda-brief/fda-brief-fda-warns-against-using-sarms-body-building-products\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S1: Anabolic AgentsUnapproved drugFDA statement: SARMs",
    "Name": "YK-11",
    "guid": "abf7848f-3428-4117-a0b8-5a4c578d4a3f",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "yk-11",
    "Reasons": "[{\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}, {\"reason_code\": 6018, \"reason\": \"FDA Statement\", \"link\": \"\", \"guid\": \"3cd17124-6ebc-4828-9edb-c20a81755502\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1711715334, \"_nanoseconds\": 457000000}}]",
    "other_names": "[\"YK-11-OA\", \"19-norpregna-4,20-diene-21-carboxylic acid, 17,20-((1-methoxyethylidene)bis(oxy))-3-oxo-, methyl ester, (17alpha,20E)-\", \"methyl(2E)-2-[(8R,9S,10R,13S,14S,17R)-2\u2019-methoxy-2\u2019,13-dimethyl-3-0x0spiro[1,2,6.7,8,9,10,11,12,14,15,16-dodecahydroyclopenta[\", \"19-norpregna-4,20-diene-21-carboxylic acid, 17,20-((1-methoxyethylidene)bis(oxy))-3-oxo-, methyl ester, (17\u03b1,20E)-\", \"YK-500\", \"(17-\u03b1,20E)-17,20-[(1-methoxyethylidene)bis(oxy)]-3- oxo-19-norpregna-4,20-diene-21-carboxylic acid methyl ester)\", \"17\u03b1,20E)-17,20-[(1-methoxyethylidene)bis(oxy)]-3-oxo-19-norpregna-4,20-diene- 21-carboxylic acid methyl ester\", \"YK11 cpd\", \"(17a,20E)-17,20-[(1-Methoxyethylidene)bis(oxy)]-3-oxo-19-norpregna-4,20-diene-21-carboxylic acid methyl ester\", \"YK11\", \"YK 11\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1720807865, \"_nanoseconds\": 909000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "[3,2-c]-furazan-5alpha-androstan-17beta-ol",
    "guid": "06383997-c88c-42e0-bb75-aff445e0cff4",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "[3,2-c]-furazan-5alpha-androstan-17beta-ol",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}]",
    "other_names": "[\"[3,2-c]-furazan-5\u03b1-androstan-17\u03b2-ol\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710968294, \"_nanoseconds\": 223000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "[3,2-c]pyrazole-androst-4-en-17beta-ol",
    "guid": "eda47c02-aedd-4a86-b398-0969028c9c48",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "[3,2-c]pyrazole-androst-4-en-17beta-ol",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}]",
    "other_names": "[\"[3,2-c]pyrazole-androst-4-en-17\u03b2-ol\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710968122, \"_nanoseconds\": 535000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Acetazolamide\", \"url\": \"https://drugs.ncats.io/drug/O3FX965V0I\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "acetazolamide",
    "guid": "fad0d880-8be3-4892-ab21-0be9a6fb1f92",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "acetazolamide",
    "Reasons": "[{\"reason_code\": 6013, \"reason\": \"WADA S5: Diuretics and Masking Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b1ad44e4-cef0-4ae2-99fb-19e28540f282\", \"link_title\": \"WADA Prohibited List S5: Diuretics and Masking Agents\", \"updated\": {\"_seconds\": 1703682941, \"_nanoseconds\": 864000000}}, {\"reason_code\": 6016, \"reason\": \"Prescription drug\", \"link\": null, \"guid\": \"becae72e-580f-4d8d-8665-c0c4b1dc1381\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683249, \"_nanoseconds\": 70000000}}]",
    "other_names": "[\"acetazolamide sodium\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738867697, \"_nanoseconds\": 504000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "acetorphine",
    "guid": "38ea2027-bfd7-4acd-a402-ea8a222d0f79",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "acetorphine",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"7alpha-etorphine 3-acetate\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710877993, \"_nanoseconds\": 972000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "acetyl fentanyl",
    "guid": "76f65f10-653b-4df5-999d-9bf7fdfee5cd",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "acetyl fentanyl",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide\", \"acetylfentanyl\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710877902, \"_nanoseconds\": 124000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "acetyl-alpha-methylfentanyl",
    "guid": "ce65fd7c-3da8-4b31-971e-dcf6bd80904c",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "acetyl-alpha-methylfentanyl",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"acetyl-\u03b1-methylfentanyl\", \"alphamethylacetylfentanyl\", \"N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710876121, \"_nanoseconds\": 386000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "acetyldihydrocodeine",
    "guid": "66286a2c-c7ad-472d-a50f-cfcd9c129278",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "acetyldihydrocodeine",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"dihydrothebacone\", \"dihydrocodeine 6-acetate\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710875994, \"_nanoseconds\": 962000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "acetylmethadol",
    "guid": "c885ab78-08df-43e6-9230-63dd348e6889",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "acetylmethadol",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"acemethadone\", \"methadyl acetate\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710875912, \"_nanoseconds\": 458000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"url\": \"https://www.esd.whs.mil/Directives/issuances/dodi\", \"title\": \"DoDI 1010.04 Problematic Substance Use by DoD Personnel and DoDI 6130.06 Use of Dietary Supplements in the DoD\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "acetylpsilocin",
    "guid": "df9d9f0b-bc79-4c58-b720-bd8391381edc",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "acetylpsilocin",
    "Reasons": "[{\"reason_code\": 6017, \"reason\": \"Military policy\", \"link\": null, \"guid\": \"96435789-439c-44d4-83cf-1d10a25ab7b5\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683268, \"_nanoseconds\": 216000000}}]",
    "other_names": "[\"O-acetylpsilocin \", \"4-AcO-DMT\", \"psilacetin\", \"4-acetoxy-N,N-dimethyltryptamine\", \"4-acetoxy-DMT\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1745948130, \"_nanoseconds\": 576000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Aconitine\", \"url\": \"https://drugs.ncats.io/drug/X8YN71D5WC\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Unapproved drug; Extract of a poisonous plant - potentially fatal",
    "Name": "aconitine",
    "guid": "eed16a4e-b7a7-48a9-b4eb-ba2de319f40f",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "aconitine",
    "Reasons": "[{\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"acetylbenzoylaconine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738867879, \"_nanoseconds\": 751000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "acryl fentanyl",
    "guid": "518a7ad7-7153-4850-b7b2-2cbc55d4c2e0",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "acryl fentanyl",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"acryloylfentanyl\", \"acrylfentanyl\", \"N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710875061, \"_nanoseconds\": 667000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: AB-001\", \"url\": \"https://drugs.ncats.io/drug/H657DIA015\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Use or misuse prohibited under DoDI 1010.16 (synthetic cannabinoids); Unapproved drug",
    "Name": "adamantoyl",
    "guid": "9c18a4d5-3269-42e1-b263-215c6b540f2a",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "adamantoyl",
    "Reasons": "[{\"reason_code\": 6014, \"reason\": \"DoDI 1010.16\", \"link\": \"https://www.esd.whs.mil/directives/issuances/dodi\", \"guid\": \"b757aa46-4729-4d4a-a32e-25ef0b04e5c3\", \"link_title\": \"Use or misuse prohibited under DoDI 1010.16\", \"updated\": {\"_seconds\": 1703683049, \"_nanoseconds\": 190000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"1-pentyl-3-(1-adamantoyle)indole\", \"AB-001\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738868277, \"_nanoseconds\": 785000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Adrafinil\", \"url\": \"https://drugs.ncats.io/drug/BI81Z4542G\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Unapproved drug",
    "Name": "adrafinil",
    "guid": "0bcf6dbf-70e7-4723-9f34-223c09a7a889",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "adrafinil",
    "Reasons": "[{\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"2-((diphenylmethyl)sulfinyl)-N-hydroxyacetamide\", \"Olmifon\", \"adrafinilum\", \"benzhydrylsulfinylacetohydroxamic acid\", \"adrafinyl\", \"2-(benzhydrylsulfinyl)acetohydroxamic acid\", \"Noofon\", \"CRL 40028\", \"acetohydroxamic acid, 2-((diphenylmethyl)sulfinyl)-\", \"2-((diphenylmethyl)sulfinyl)acetohydroxamsaeure\", \"2-((diphenylmethyl)sulfinyl)acetohydroxamic acid\", \"CRL-40028\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715353646, \"_nanoseconds\": 760000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Adrenosterone\", \"url\": \"https://drugs.ncats.io/drug/AE4E9102GY\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S1: Anabolic AgentsUnapproved drug",
    "Name": "adrenosterone",
    "guid": "4edcc5e7-862d-4b81-a878-7ffdb7831090",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "adrenosterone",
    "Reasons": "[{\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"androst-4-ene-3,11,17-trione\", \"11-oxoandrostenedione\", \"11-ketoandrostenedione\", \"11-keto-androstenedione\", \"androst-4-ene-3, 11, 17-trione\", \"Androst-4-ene-3,11,17- trione\", \"11-oxy-4-androstenedione\", \"4-androst-3,11,17-trione\", \"andrenosterone\", \"11-OXO\", \"4-androstene-3,11,17-trione\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738871512, \"_nanoseconds\": 311000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"FDA warning letter: New dietary ingredient lacking evidence for safe use; associated adverse events reported\", \"url\": \"http://nemsn.org/sites/default/files/PDFs/2-USPlabs-warning%20letter-FDA.pdf\"}, {\"title\": \"NIH NCATS Inxight Drugs entry: Aegeline\", \"url\": \"https://drugs.ncats.io/drug/60T59LN3SG\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "FDA warning letter: New dietary ingredient lacking evidence for safe use; associated adverse events reported",
    "Name": "aegeline",
    "guid": "0c4a35d7-a541-4fc2-8c5a-4642176f3b69",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "aegeline",
    "Reasons": "[{\"reason_code\": 6019, \"reason\": \"FDA Warning Letter\", \"link\": null, \"guid\": \"1cd0ab89-14ce-43c2-a804-e4b29b8780fe\", \"link_title\": null, \"updated\": {\"_seconds\": 1711571477, \"_nanoseconds\": 43000000}}]",
    "other_names": "[\"aegelin\", \"N-2-hydroxy-2(4-methoxyphenyl) ethyl-3-phenyl-2-propenamide\", \"egeline\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738868732, \"_nanoseconds\": 4000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S2: Peptide Hormones, Growth Factors, etc.",
    "Name": "alexamorelin",
    "guid": "7b14f51c-0753-4580-a392-654f8da36df0",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "alexamorelin",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}]",
    "other_names": "[]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738869106, \"_nanoseconds\": 741000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "alfaxalone",
    "guid": "ba65dcdb-bf9a-478a-a9f7-322fb4ffb92c",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "alfaxalone",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"5alpha-pregnan-3alpha-ol-11,20-dione\", \"Alfaxan\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710870303, \"_nanoseconds\": 401000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule II",
    "Name": "alfentanil",
    "guid": "1c528829-1fbc-4c66-a9a9-9d3a964ee735",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "alfentanil",
    "Reasons": "[{\"reason_code\": 6004, \"reason\": \"DEA Controlled Substance List: Schedule  II\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"207f9e17-8a22-4523-8dd6-24d9d39b4c45\", \"link_title\": \"DEA Controlled Substance List: Schedule  II\", \"updated\": {\"_seconds\": 1712942744, \"_nanoseconds\": 783000000}}]",
    "other_names": "[\"alfentanyl\", \"Alfenta\", \"N-(1-(2-(4-ethyl-5-oxo-2-tetrazolin-1-yl)ethyl)-4-(methoxymethyl)-4-piperidyl)propionanilide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710870269, \"_nanoseconds\": 193000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "allylprodine",
    "guid": "7fb59894-d537-469d-831a-e8530cf5af1c",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "allylprodine",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"alperidine\", \"4-piperidinol, 1-methyl-4-phenyl-3-(2-propenyl)-, propanoate (ester)\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710870232, \"_nanoseconds\": 777000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "alpha'-methyl butyryl fentanyl",
    "guid": "d10fc6fc-9e92-41ed-b3ed-7abb05cb7e42",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "alpha'-methyl butyryl fentanyl",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"2-methyl-N-(1\u00adphenethylpiperidin-4-yl)-N-phenylbutanamide\", \"\u03b1'-methyl butyryl fentanyl\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709044824, \"_nanoseconds\": 265000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "alpha-PHP",
    "guid": "052cd93c-e27b-4762-81c1-6be1925032f0",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "alpha-php",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"alpha-pyrrolidinohexiophenone\", \"\u03b1-PHP\", \"alpha-pyrrolidinohexanophenone\", \"1-phenyl-2-(pyrrolidin-1-yl)hexan-1-one\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710869967, \"_nanoseconds\": 824000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "alpha-PiHP",
    "guid": "1275360f-f354-4c45-9f0d-c9b2084aa836",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "alpha-pihp",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"4-methyl-1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one\", \"\u03b1-PiHP\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709044786, \"_nanoseconds\": 730000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "alpha-ethyltryptamine",
    "guid": "aacf4ee3-5860-4836-a390-d1e045d3351f",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "alpha-ethyltryptamine",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"ET\", \"etryptamine\", \"Trip\", \"\u03b1-ethyltryptamine\", \"Monase\", \"3-(2-aminobutyl) indole\", \"AET\", \"\u03b1-ethyl-1H-indole-3-ethanamine\", \"\u03b1-ET\", \"3-indolylbutylamine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710870196, \"_nanoseconds\": 866000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "alpha-methylfentanyl",
    "guid": "e0141232-db4f-4b39-b727-ef52347c5595",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "alpha-methylfentanyl",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl]propionanilide\", \"\u03b1-methylfentanyl\", \"1-(1-methyl-2-phenylethyl)-4-(N-propanilido)piperidine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710870107, \"_nanoseconds\": 489000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "alpha-methylthiofentanyl",
    "guid": "c5a8c459-8e66-4bea-a955-236b65ea8fd6",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "alpha-methylthiofentanyl",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide\", \"\u03b1-methylthiofentanyl\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710870071, \"_nanoseconds\": 704000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "alpha-methyltryptamine",
    "guid": "7e67dd45-6966-45ab-ade7-d7a6432dcf7e",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "alpha-methyltryptamine",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"3-(2-aminopropyl)indole\", \"AMT\", \"N-methyltryptamine\", \"Indopan\", \"\u03b1-methyltryptamine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710870030, \"_nanoseconds\": 760000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "alpha-pyrrolidinobutiophenone",
    "guid": "985d92b8-f354-41ed-8d3e-61733f605c0f",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "alpha-pyrrolidinobutiophenone",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"alpha-PBP\", \"\u03b1-PBP\", \"1-phenyl-2-(pyrrolidin-1-yl)butan-1-one\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710869878, \"_nanoseconds\": 303000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "alpha-pyrrolidinopentiophenone",
    "guid": "be374c8f-d773-4d77-a842-c36d8ab04d0f",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "alpha-pyrrolidinopentiophenone",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"flakka\", \"\u03b1-pyrrolidinovalerophenone\", \"1-phenyl-2- (pyrrolidin-1-yl)pentan-1-one\", \"1-phenyl-2-(piperidin-1-yl)butan-1-one)\", \"\u03b1-PVP\", \"1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one\", \"alpha-PVP\", \"4-MePBP\", \"4-methyl-\u03b1-pyrrolidinobutiophenone\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715361942, \"_nanoseconds\": 736000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "alphacetylmethadol",
    "guid": "041a7c8a-5d1b-471a-b64c-8fb8771a305e",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "alphacetylmethadol",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"alphacemethadone\", \"alpha-3-acetoxy-6-dimethylamino-4,4-diphenylheptane\", \"alphacetylmathadol\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710869143, \"_nanoseconds\": 391000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "alphameprodine",
    "guid": "af0cd3f8-1829-42e8-b4f4-11d7b7848368",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "alphameprodine",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"3alpha-ethyl-1-methyl-4-phenyl-4alpha-piperidyl propionat\", \"3\u03b1-ethyl-1-methyl-4-phenyl-4\u03b1-piperidyl propionat\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710868876, \"_nanoseconds\": 551000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "alphamethadol",
    "guid": "dcf7add1-aaf9-49b3-bd46-f6be3f2c8ceb",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "alphamethadol",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"alpha-methadol\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710868816, \"_nanoseconds\": 543000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule II",
    "Name": "alphaprodine",
    "guid": "221325f3-05c1-43d4-b405-7e63d4d80e1d",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "alphaprodine",
    "Reasons": "[{\"reason_code\": 6004, \"reason\": \"DEA Controlled Substance List: Schedule  II\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"207f9e17-8a22-4523-8dd6-24d9d39b4c45\", \"link_title\": \"DEA Controlled Substance List: Schedule  II\", \"updated\": {\"_seconds\": 1712942744, \"_nanoseconds\": 783000000}}]",
    "other_names": "[\"prodine\", \"1,3-dimethyl-4-phenyl-4-propionoxypiperidine\", \"Nisentil\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710868776, \"_nanoseconds\": 399000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "alprazolam",
    "guid": "908cfae4-09b0-472f-8d96-a7b29bb65e2c",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "alprazolam",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"\u03b1-hydroxy-alprazolam\", \"Xanax\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710868736, \"_nanoseconds\": 494000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Amfetaminil\", \"url\": \"https://drugs.ncats.io/drug/0XU0V77JVE\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Use or misuse prohibited under DoDI 1010.16; Unapproved drug",
    "Name": "amfetaminil",
    "guid": "36e91d21-855e-4441-93e3-204caf8d2b00",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "amfetaminil",
    "Reasons": "[{\"reason_code\": 6014, \"reason\": \"DoDI 1010.16\", \"link\": \"https://www.esd.whs.mil/directives/issuances/dodi\", \"guid\": \"b757aa46-4729-4d4a-a32e-25ef0b04e5c3\", \"link_title\": \"Use or misuse prohibited under DoDI 1010.16\", \"updated\": {\"_seconds\": 1703683049, \"_nanoseconds\": 190000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"amphetaminil\", \"AN-1\", \"N-cyanobenzylamphetamine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715353937, \"_nanoseconds\": 369000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Amiloride\", \"url\": \"https://drugs.ncats.io/drug/7DZO8EB0Z3\"}, {\"title\": \"National Drug Code Directory: Amiloride\", \"url\": \"https://www.accessdata.fda.gov/scripts/cder/ndc/index.cfm\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S5: Diuretics and Masking Agents; Prescription drug",
    "Name": "amiloride",
    "guid": "66dc834b-dce1-4d5c-87f2-41ce65cea2f1",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "amiloride",
    "Reasons": "[{\"reason_code\": 6013, \"reason\": \"WADA S5: Diuretics and Masking Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b1ad44e4-cef0-4ae2-99fb-19e28540f282\", \"link_title\": \"WADA Prohibited List S5: Diuretics and Masking Agents\", \"updated\": {\"_seconds\": 1703682941, \"_nanoseconds\": 864000000}}, {\"reason_code\": 6016, \"reason\": \"Prescription drug\", \"link\": null, \"guid\": \"becae72e-580f-4d8d-8665-c0c4b1dc1381\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683249, \"_nanoseconds\": 70000000}}]",
    "other_names": "[\"Midamor\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738869700, \"_nanoseconds\": 496000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "amineptine",
    "guid": "835735ba-2bd1-4f1f-9af2-6646613c8d3d",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "amineptine",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"(7-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid)\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710868211, \"_nanoseconds\": 511000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Aminoglutethimide\", \"url\": \"https://drugs.ncats.io/drug/0O54ZQ14I9\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S4: Hormone and Metabolic Modulators; Unapproved drug",
    "Name": "aminoglutethimide",
    "guid": "6afbd86e-8364-4b54-899c-79281805c07f",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "aminoglutethimide",
    "Reasons": "[{\"reason_code\": 6012, \"reason\": \"WADA S4: Hormone and Metabolic Modulators\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"ac1ba347-6d44-4a17-829d-e589bf33bbdb\", \"link_title\": \"WADA Prohibited List S4: Hormone and Metabolic Modulators\", \"updated\": {\"_seconds\": 1703682875, \"_nanoseconds\": 162000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"3-(4-Aminophenyl)-3-ethylpiperidine-2,6-dione\", \"Cytadren\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738869890, \"_nanoseconds\": 750000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "aminorex",
    "guid": "5f80c914-68a3-4ecf-9523-dad6b22ef5ca",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "aminorex",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"4,5-dihydro-5-phenly-2-oxazolamine\", \"aminoxaphen\", \"2-amino-5-phenyl-2-oxazoline\", \"Apiquel\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710868113, \"_nanoseconds\": 95000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Amiphenazole\", \"url\": \"https://drugs.ncats.io/drug/7ZJ8PWY0XD\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Unapproved drug",
    "Name": "amiphenazole",
    "guid": "ee08db3c-9513-424e-bea8-0c36e5c273c1",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "amiphenazole",
    "Reasons": "[{\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"Phenamizol\", \"Phenamizole\", \"amiphenazole monohydrochloride\", \"Fenamizol\", \"Daptazile\", \"Daftazol\", \"Daptazole\", \"amiphenazolum\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715354218, \"_nanoseconds\": 105000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule II & III",
    "Name": "amobarbital",
    "guid": "46766657-e945-4fe3-8b81-982bd205c789",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "amobarbital",
    "Reasons": "[{\"reason_code\": 6004, \"reason\": \"DEA Controlled Substance List: Schedule  II\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"207f9e17-8a22-4523-8dd6-24d9d39b4c45\", \"link_title\": \"DEA Controlled Substance List: Schedule  II\", \"updated\": {\"_seconds\": 1712942744, \"_nanoseconds\": 783000000}}, {\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}]",
    "other_names": "[\"Amobarbital & noncontrolled active ingred.\", \"isoamylethylbarbituric acid\", \"5-ethyl-5-isoamylbarbituric acid\", \"Amytal\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710867927, \"_nanoseconds\": 518000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule II",
    "Name": "amphetamine",
    "guid": "1a9154be-1d17-4cd8-8cee-42b4a0bbe13a",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "amphetamine",
    "Reasons": "[{\"reason_code\": 6004, \"reason\": \"DEA Controlled Substance List: Schedule  II\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"207f9e17-8a22-4523-8dd6-24d9d39b4c45\", \"link_title\": \"DEA Controlled Substance List: Schedule  II\", \"updated\": {\"_seconds\": 1712942744, \"_nanoseconds\": 783000000}}]",
    "other_names": "[\"1-methyl-2-phenylethylamine\", \"Obetrol\", \"desoxynorephedrine\", \"alpha-methylphenethylamine\", \"Dexedrine\", \"Adderall\", \"1-phenylpropan-2-amine\", \"d-amphetamine\", \"amfetamine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715353859, \"_nanoseconds\": 249000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Anamorelin\", \"url\": \"https://drugs.ncats.io/drug/DD5RBA1NKF\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S2: Peptide Hormones, Growth Factors, etc.; Unapproved drug",
    "Name": "anamorelin",
    "guid": "8d0ef90e-13fb-41f4-8c21-252789962df4",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "anamorelin",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"3-piperidinecarboxylic acid, 1-(2-methylalanyl-D-tryptophyl)-3-(phenylmethyl)-, trimethylhydrazide, (3R)-\", \"RC-1291\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710867084, \"_nanoseconds\": 613000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Anastrozole\", \"url\": \"https://drugs.ncats.io/drug/2Z07MYW1AZ\"}, {\"title\": \"National Drug Code Directory: Anastrozole\", \"url\": \"https://www.accessdata.fda.gov/scripts/cder/ndc/index.cfm\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S4: Hormone and Metabolic Modulators; Prescription drug",
    "Name": "anastrozole",
    "guid": "33b112d1-d4df-45f7-bb59-9c5c155618d1",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "anastrozole",
    "Reasons": "[{\"reason_code\": 6012, \"reason\": \"WADA S4: Hormone and Metabolic Modulators\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"ac1ba347-6d44-4a17-829d-e589bf33bbdb\", \"link_title\": \"WADA Prohibited List S4: Hormone and Metabolic Modulators\", \"updated\": {\"_seconds\": 1703682875, \"_nanoseconds\": 162000000}}, {\"reason_code\": 6016, \"reason\": \"Prescription drug\", \"link\": null, \"guid\": \"becae72e-580f-4d8d-8665-c0c4b1dc1381\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683249, \"_nanoseconds\": 70000000}}]",
    "other_names": "[\"Arimidex\", \"2-[3-(2-Vyanopropan-2-yl)-5-(1,2,4-triazol-1- ylmethyl)phenyl]-2-methylpropanenitrile\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738871121, \"_nanoseconds\": 512000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Andarine\", \"url\": \"https://drugs.ncats.io/drug/7UT2HAH49H\"}, {\"title\": \"FDA warns against using SARMs in body-building products\", \"url\": \"https://www.fda.gov/news-events/fda-brief/fda-brief-fda-warns-against-using-sarms-body-building-products\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S1: Anabolic Agents; Unapproved drug; FDA statement: SARMs",
    "Name": "andarine",
    "guid": "532d1956-a8aa-4481-bbfd-06e3a8a6b292",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "andarine",
    "Reasons": "[{\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}, {\"reason_code\": 6018, \"reason\": \"FDA Statement\", \"link\": \"\", \"guid\": \"3cd17124-6ebc-4828-9edb-c20a81755502\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1711715334, \"_nanoseconds\": 457000000}}]",
    "other_names": "[\"(2S)-3-(4-acetamidophenoxy)-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide\", \"SARM S-4\", \"S-4 cpd\", \"S4\", \"propanamide, 3-(4-(acetylamino)phenoxy)-2-hydroxy-2-methyl-N-(4-nitro-3-(trifluoromethyl)phenyl)-, (2S)-\", \"3-(4-acetylaminophenoxy)-2-hydroxy-2-methyl-N-(4-nitro-3-trifluoromethylphenyl)-propionamide\", \"S-4\", \"S-3-(4-acetylaminophenoxy)-2-hydroxy-2-methyl-N-(4-nitro-3-trifluoromethylpheanyl)propionamide\", \"GTX-007\", \"androxolutamide\", \"GTx 007\", \"3-(4-acetylamino-phenoxy)-2-hydroxy-2-methyl-N-(4-nitro-3-trifluoromethylphenyl)propionamide\", \"acetamidoxolutamide\", \"tetrathietane\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738871209, \"_nanoseconds\": 825000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Androsta-3,5-diene-7,17-dione\", \"url\": \"https://drugs.ncats.io/drug/77P0LYX19T\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S4: Hormone and Metabolic Modulators",
    "Name": "androsta-3,5-diene-7,17-dione",
    "guid": "72211f8b-d72f-4ae2-b44d-ee819580a9cf",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "androsta-3,5-diene-7,17-dione",
    "Reasons": "[{\"reason_code\": 6012, \"reason\": \"WADA S4: Hormone and Metabolic Modulators\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"ac1ba347-6d44-4a17-829d-e589bf33bbdb\", \"link_title\": \"WADA Prohibited List S4: Hormone and Metabolic Modulators\", \"updated\": {\"_seconds\": 1703682875, \"_nanoseconds\": 162000000}}]",
    "other_names": "[\"arimistane\", \"3-deoxy-7-oxo-DHEA\", \"androst 3,5-dien-7, 17-dione (Arimistane\u2122)\", \"3,5-androstadiene-7,17-dione\", \"androst-3,5-dien-7,17-dione\", \"androst-3,5-diene-7,17-dione\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738871616, \"_nanoseconds\": 647000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S1: Anabolic Agents",
    "Name": "androstadienone",
    "guid": "eb9d709f-3703-4df8-a8e3-52ff284a91db",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "androstadienone",
    "Reasons": "[{\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"4,16-androstadien-3-one\", \"androsta-4,16-dien-3-one\", \"\u03944,16-androstadien-3-one\", \"delta4,16-androstadien-3-one\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738871721, \"_nanoseconds\": 939000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "androstanediol",
    "guid": "6d8a49ca-61d7-425d-bf82-5124fa1937e6",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "androstanediol",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}]",
    "other_names": "[\"3\u03b1,17\u03b2-dihydroxy-5\u03b1-androstane\", \"3alpha-androstanediol\", \"3alpha,17beta-dihydroxy-5alpha-androstane\", \"5-\u03b1-androstan-3-\u03b1,17-\u03b2-diol\", \"3\u03b1-androstanediol\", \"5-alpha-androstan-3-alpha,17-beta-diol\", \"3beta,17beta-dihydroxy-5alpha-androstane\", \"3\u03b2,17\u03b2-dihydroxy-5\u03b1-androstane\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1711997548, \"_nanoseconds\": 691000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "androstanedione",
    "guid": "3e4d9530-eaa2-43c4-b8b1-f7b765c118f3",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "androstanedione",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}]",
    "other_names": "[\"5\u03b1-androstan-3,17-dione\", \"5\u03b1-androstane-3,17-dione\", \"5alpha-androstane-3,17-dione\", \"5alpha-androstan-3,17-dione\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710865110, \"_nanoseconds\": 177000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "androstanolone",
    "guid": "a7aaedb7-af9a-46eb-9e37-ce1f46a7cb32",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "androstanolone",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}, {\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"dihydrotestosterone\", \"stanolone\", \"5\u03b1-dihydrotestosterone\", \"Pesomax\", \"17\u03b2-hydroxy-androstan-3-one\", \"Andractim\", \"4-dihydrotestosterone\", \"Anabolex\", \"5alpha-dihydrotestosterone\", \"17beta-hydroxy-5alpha-androstan-3-one\", \"17\u03b2-hydroxy-5\u03b1-androstan-3-one\", \"17beta-hydroxy-androstan-3-one\", \"DHT\", \"5\u03b1-DHT\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1721055113, \"_nanoseconds\": 514000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Androsta-1,4,6-triene-3,17-dione\", \"url\": \"https://drugs.ncats.io/drug/217A6T1V8N\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S4: Hormone and Metabolic Modulators",
    "Name": "androstatrienedione",
    "guid": "2fe5604e-fbe8-4b7a-9983-39e242a84a46",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "androstatrienedione",
    "Reasons": "[{\"reason_code\": 6012, \"reason\": \"WADA S4: Hormone and Metabolic Modulators\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"ac1ba347-6d44-4a17-829d-e589bf33bbdb\", \"link_title\": \"WADA Prohibited List S4: Hormone and Metabolic Modulators\", \"updated\": {\"_seconds\": 1703682875, \"_nanoseconds\": 162000000}}]",
    "other_names": "[\"ATD\", \"androst-1,4,6-triene-3,17-dione\", \"1,4,6-etioallochan-dione\", \"androsta-1,4,6-triene-3,17-dione\", \"3,17-keto-etiocholetriene\", \"1,4,6-androstatriene-3,17-dione\", \"androsta 1,4,6 triene 3,17 dione\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738871787, \"_nanoseconds\": 134000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "androstenediol",
    "guid": "fb235258-dc93-45b9-b0f1-c57fe1ccae50",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "androstenediol",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}, {\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"3beta,17beta-dihydroxy-androst-5-ene\", \"5-androstene-3\u03b2-17\u03b2-diol\", \"Adiol\", \"androst-5-ene-3,17-diol\", \"androst-5-ene-3\u03b2,17\u03b2-diol\", \"5-androstenediol\", \"3\u03b2,17\u03b2-dihydroxy-androst-5-ene\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1716920375, \"_nanoseconds\": 559000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "androstenedione",
    "guid": "73a653ea-1bff-4094-a4cc-9a502a68d4f8",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "androstenedione",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}, {\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"androst-4-en-3,17-dione\", \"17-ketotestosterone\", \"4-androstene-3,17-dione\", \"4-androstenedione\", \"androst-4-ene-3,17-dione\", \"Adione\", \"\u03944-androstenedione\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1716921022, \"_nanoseconds\": 249000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Androsterone\", \"url\": \"https://drugs.ncats.io/drug/C24W7J5D5R\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S1: Anabolic Agents; Unapproved drug",
    "Name": "androsterone",
    "guid": "a4abd2c6-eca7-49da-ae6c-fbda8b38c7d7",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "androsterone",
    "Reasons": "[{\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"3a-hydroxy-5a-androstan-17-one\", \"3\u03b1-hydroxyetioallocholan-17-one\", \"5\u03b1-androstane-3\u03b1-ol-17-one\", \"5\u03b1-androsterone\", \"3alpha-hydroxyetioallocholan-17-one\", \"3\u03b1-hydroxy-5\u03b1-androstan-17-one\", \"5\u03b1-androstan-3\u03b1-ol-17-one\", \"5alpha-androsterone\", \"3-epihydroxyetiollocholan-17-one\", \"3alpha-hydroxy-5alpha-androstan-17-one\", \"5alpha-androstane-3alpha-ol-17-one\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738871932, \"_nanoseconds\": 872000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule II",
    "Name": "anileridine",
    "guid": "b025129b-1193-4418-b68d-8cd404f228de",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "anileridine",
    "Reasons": "[{\"reason_code\": 6004, \"reason\": \"DEA Controlled Substance List: Schedule  II\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"207f9e17-8a22-4523-8dd6-24d9d39b4c45\", \"link_title\": \"DEA Controlled Substance List: Schedule  II\", \"updated\": {\"_seconds\": 1712942744, \"_nanoseconds\": 783000000}}]",
    "other_names": "[\"Leritine\", \"Alidine\", \"Nipecotan\", \"Adopol\", \"ethyl 1-[2-(4-aminophenyl)ethyl]-4-phenylpiperidine-4-carboxylate\", \"N-beta-(p-aminophenyl)ethylnormeperidine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710783878, \"_nanoseconds\": 323000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Aniracetam\", \"url\": \"https://drugs.ncats.io/drug/5L16LKN964\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Unapproved drug",
    "Name": "aniracetam",
    "guid": "9702d60f-c112-4ff8-8090-23b01231ffdd",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "aniracetam",
    "Reasons": "[{\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"Draganon\", \"1-(4-methoxybenzoyl)-2-pyrrolidinone\", \"Sarpul\", \"1-anisoyl-2-pyrrolidinone\", \"1-P-anisoyl-2-pyrrolidinone\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710783792, \"_nanoseconds\": 274000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Apitegromab\", \"url\": \"https://drugs.ncats.io/drug/UZ54216N0Y\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S4: Hormone and Metabolic Modulators",
    "Name": "apitegromab",
    "guid": "8f40f152-fd6b-4fa7-aee5-b7bfbcb5ee2f",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "apitegromab",
    "Reasons": "[{\"reason_code\": 6012, \"reason\": \"WADA S4: Hormone and Metabolic Modulators\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"ac1ba347-6d44-4a17-829d-e589bf33bbdb\", \"link_title\": \"WADA Prohibited List S4: Hormone and Metabolic Modulators\", \"updated\": {\"_seconds\": 1703682875, \"_nanoseconds\": 162000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710783572, \"_nanoseconds\": 978000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "aprobarbital",
    "guid": "7a5286b9-5785-472e-bd36-303729399321",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "aprobarbital",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}]",
    "other_names": "[\"Alurate\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710783364, \"_nanoseconds\": 617000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Arformoterol\", \"url\": \"https://drugs.ncats.io/drug/F91H02EBWT\"}, {\"title\": \"National Drug Code Directory: Arformoterol\", \"url\": \"https://www.accessdata.fda.gov/scripts/cder/ndc/index.cfm\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S3: Beta-2 Agonists; Prescription drug",
    "Name": "arformoterol",
    "guid": "20fdc71c-ab89-4d80-9866-9fc983263727",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "arformoterol",
    "Reasons": "[{\"reason_code\": 6011, \"reason\": \"WADA S3: Beta-2 Agonists\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"aecafa3b-c7ad-413c-bc5f-be7ed5b2f69d\", \"link_title\": \"WADA Prohibited List S3: Beta-2 Agonists\", \"updated\": {\"_seconds\": 1703682857, \"_nanoseconds\": 73000000}}, {\"reason_code\": 6016, \"reason\": \"Prescription drug\", \"link\": null, \"guid\": \"becae72e-580f-4d8d-8665-c0c4b1dc1381\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683249, \"_nanoseconds\": 70000000}}]",
    "other_names": "[\"formoterol R,R-form\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710783218, \"_nanoseconds\": 881000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S2: Peptide Hormones, Growth Factors, etc.",
    "Name": "asialo EPO",
    "guid": "3fdac671-8df1-4bdf-8963-11c519d54f87",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "asialo epo",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}]",
    "other_names": "[\"asialo-erythropoietin\", \"ASIALO-EPO\", \"asialo erythropoietin\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710783164, \"_nanoseconds\": 818000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "barbital",
    "guid": "c7c3eb60-6c60-4806-b81f-a56b57e0523c",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "barbital",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"Plexonal\", \"barbitone\", \"Veronal\", \"5,5-diethylbarbituric acid\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710782260, \"_nanoseconds\": 786000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "barbituric acid",
    "guid": "4e20f6b8-98bc-47f9-baa5-fc2823f7e2cd",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "barbituric acid",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}]",
    "other_names": "[\"Malonylurea\", \"barbituric acid derivative\", \"6-hydroxyuracil\", \"barbiturates not specifically listed\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710782210, \"_nanoseconds\": 33000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Bazedoxifene\", \"url\": \"https://drugs.ncats.io/drug/Q16TT9C5BK\"}, {\"title\": \"National Drug Code Directory: Bazedoxifene\", \"url\": \"https://www.accessdata.fda.gov/scripts/cder/ndc/index.cfm\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S4: Hormone and Metabolic ModulatorsPrescription drug",
    "Name": "bazedoxifene",
    "guid": "7f7c6fb1-6d26-4ca8-9bc8-4a4a693da0f1",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "bazedoxifene",
    "Reasons": "[{\"reason_code\": 6012, \"reason\": \"WADA S4: Hormone and Metabolic Modulators\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"ac1ba347-6d44-4a17-829d-e589bf33bbdb\", \"link_title\": \"WADA Prohibited List S4: Hormone and Metabolic Modulators\", \"updated\": {\"_seconds\": 1703682875, \"_nanoseconds\": 162000000}}, {\"reason_code\": 6016, \"reason\": \"Prescription drug\", \"link\": null, \"guid\": \"becae72e-580f-4d8d-8665-c0c4b1dc1381\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683249, \"_nanoseconds\": 70000000}}]",
    "other_names": "[\"WAY 140424\", \"TSE424\", \"bazedoxifene acetate\", \"Conbriza\", \"WAY140424\", \"1-((4-(2-Hexahydro-1H-azepin-1-yl)ethoxy)phenyl)methyl)-2-(4-hydroxyphenyl)-3-methyl-1H-indol-5-ol\", \"TSE 424\", \"Viviant\", \"WAY-140424\", \"Bazedoxifeno\", \"TSE-424\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738872869, \"_nanoseconds\": 647000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Bendroflumethiazide\", \"url\": \"https://drugs.ncats.io/drug/5Q52X6ICJI\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S5: Diuretics and Masking AgentsUnapproved drug",
    "Name": "bendroflumethiazide",
    "guid": "07b30360-0049-4e72-9922-b1c3ba1cfc91",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "bendroflumethiazide",
    "Reasons": "[{\"reason_code\": 6013, \"reason\": \"WADA S5: Diuretics and Masking Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b1ad44e4-cef0-4ae2-99fb-19e28540f282\", \"link_title\": \"WADA Prohibited List S5: Diuretics and Masking Agents\", \"updated\": {\"_seconds\": 1703682941, \"_nanoseconds\": 864000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"Aprinox\", \"bendrofluazide\", \"Naturetin\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738873031, \"_nanoseconds\": 851000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Benfluorex\", \"url\": \"https://drugs.ncats.io/drug/403FO0NQG3\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Unapproved drug",
    "Name": "benfluorex",
    "guid": "192684f8-3506-443f-aa39-70eb2500aa8b",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "benfluorex",
    "Reasons": "[{\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"benfluramate\", \"Mediator\", \"benfluorex hydrochloride\", \"1-(2-trifluoromethylphenyl)-2-(benzoyloxyethyl)aminopropane HCl\", \"Minolip\", \"benfluorexum\", \"benfluorex maleate\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715354278, \"_nanoseconds\": 617000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "benzethidine",
    "guid": "5642f4fc-2581-4811-98a8-732c5a6d35cc",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "benzethidine",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"ethyl 1-(2-benzyloxyethyl)-4-phenylpiperidine-4-carboxylate\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710781780, \"_nanoseconds\": 372000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Use or misuse prohibited under DoDI 1010.16 (synthetic cannabinoids)",
    "Name": "benzimidazole",
    "guid": "6788034d-3892-487f-a11a-535ca0f7e638",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "benzimidazole",
    "Reasons": "[{\"reason_code\": 6014, \"reason\": \"DoDI 1010.16\", \"link\": \"https://www.esd.whs.mil/directives/issuances/dodi\", \"guid\": \"b757aa46-4729-4d4a-a32e-25ef0b04e5c3\", \"link_title\": \"Use or misuse prohibited under DoDI 1010.16\", \"updated\": {\"_seconds\": 1703683049, \"_nanoseconds\": 190000000}}]",
    "other_names": "[\"1,3-benzodiazole\", \"1H-benzimidazole\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710781724, \"_nanoseconds\": 545000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Use or misuse prohibited under DoDI 1010.16 (cocaine metabolites)",
    "Name": "benzoylecgonine",
    "guid": "a887f9ae-3863-4aff-b2d0-aaa88b76853b",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "benzoylecgonine",
    "Reasons": "[{\"reason_code\": 6014, \"reason\": \"DoDI 1010.16\", \"link\": \"https://www.esd.whs.mil/directives/issuances/dodi\", \"guid\": \"b757aa46-4729-4d4a-a32e-25ef0b04e5c3\", \"link_title\": \"Use or misuse prohibited under DoDI 1010.16\", \"updated\": {\"_seconds\": 1703683049, \"_nanoseconds\": 190000000}}]",
    "other_names": "[\"3-(benzoyloxy)-8-methyl-8-azabicyclo(3.2.1)octane-2-carboxylic acid\", \"ecgonine benzoate\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710781646, \"_nanoseconds\": 705000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "benzphetamine",
    "guid": "4b8f165a-5911-4c09-8572-37a5b9e0f8a4",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "benzphetamine",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}]",
    "other_names": "[\"Didrex\", \"benzfetamine\", \"(R,S)-N-benzyl-alpha,N-dimethylphenethylamin\", \"d-benzphetamine\", \"Inapetyl\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715357789, \"_nanoseconds\": 636000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "benzylmorphine",
    "guid": "205139d8-2009-41f7-b2ac-3d788aa64594",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "benzylmorphine",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"3-benzyloxy-4,5alpha-epoxy-17-methyl-7-morphinen-6alpha-ol\", \"O3-benzylmorphine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710781338, \"_nanoseconds\": 1000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "beta'-phenyl fentanyl",
    "guid": "b35b2b90-cdb3-4e42-966f-26a86c7a2fc4",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "beta'-phenyl fentanyl",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"\u03b2\u2032-phenyl fentanyl\", \"beta'-phenyl fentanyl\", \"N-(1-phenethylpiperidin-4-yl)-N,3-diphenylpropanamide\", \"3-phenylpropanoyl fentanyl\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738937039, \"_nanoseconds\": 890000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "beta-hydroxy-3-methylfentanyl",
    "guid": "a13fd99d-6a80-4a42-870d-59ee394371bf",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "beta-hydroxy-3-methylfentanyl",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"N-[1-(2-hydroxy-2-phenylethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710781193, \"_nanoseconds\": 482000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "beta-hydroxyfentanyl",
    "guid": "771bc936-16e5-4c6a-879d-b119d71af328",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "beta-hydroxyfentanyl",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N-phenylpropanamide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710781141, \"_nanoseconds\": 410000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "beta-hydroxythiofentanyl",
    "guid": "2551d998-052a-4d31-9fe8-afa7418086b3",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "beta-hydroxythiofentanyl",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpropionamide\", \"N-[1-[2-hydroxy-2-(2-thienyl)ethyl]-4-piperidinyl]-N-phenylpropanamide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710781071, \"_nanoseconds\": 905000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "beta-methyl fentanyl",
    "guid": "c95a1d05-5730-4ca6-af20-441d2aae72bd",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "beta-methyl fentanyl",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"\u03b2-methyl fentanyl \", \"N-phenyl-N-(1-(2-phenylpropyl)piperidin-4-yl)propionamide \"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738936817, \"_nanoseconds\": 733000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "betacetylmethadol",
    "guid": "6ae15183-dc3f-43ca-a22d-872cbb404884",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "betacetylmethadol",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"(3S,6R)-3-acetoxy-6-dimethylamino-4,4-diphenylheptane\", \"beta-1-ethyl-4-dimethylamino-2,2-diphenylpentyl acetat\", \"betacemethadon\", \"beta-3-acetoxy-6-dimethylamino-4,4-diphenylheptane\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710780790, \"_nanoseconds\": 649000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "betameprodine",
    "guid": "f13d8e0e-1222-4400-a1ab-610227bb0da5",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "betameprodine",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"NU-1932\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1711996437, \"_nanoseconds\": 914000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "betamethadol",
    "guid": "e47c49dc-9d63-4ba7-8667-9ca4cccce940",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "betamethadol",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710780212, \"_nanoseconds\": 553000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "betaprodine",
    "guid": "0fe397d6-015f-44ce-aec0-c46c9465ce3c",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "betaprodine",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"beta-1,3-dimethyl-4-phenyl-4-propionyloxypiperidine\", \"beta-prodine\", \"[(3R,4R)-1,3-dimethyl-4-phenylpiperidin-4-yl] propanoate\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710780176, \"_nanoseconds\": 480000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule II",
    "Name": "bezitramide",
    "guid": "7bf2a94e-5617-4416-b66e-0137c465ece8",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "bezitramide",
    "Reasons": "[{\"reason_code\": 6004, \"reason\": \"DEA Controlled Substance List: Schedule  II\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"207f9e17-8a22-4523-8dd6-24d9d39b4c45\", \"link_title\": \"DEA Controlled Substance List: Schedule  II\", \"updated\": {\"_seconds\": 1712942744, \"_nanoseconds\": 783000000}}]",
    "other_names": "[\"Burgodin\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710780128, \"_nanoseconds\": 249000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Bimagrumab\", \"url\": \"https://drugs.ncats.io/drug/N15SW1DIV8\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S4: Hormone and Metabolic ModulatorsUnapproved drug",
    "Name": "bimagrumab",
    "guid": "7050408a-4069-4939-b8da-291d8daf3ed0",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "bimagrumab",
    "Reasons": "[{\"reason_code\": 6012, \"reason\": \"WADA S4: Hormone and Metabolic Modulators\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"ac1ba347-6d44-4a17-829d-e589bf33bbdb\", \"link_title\": \"WADA Prohibited List S4: Hormone and Metabolic Modulators\", \"updated\": {\"_seconds\": 1703682875, \"_nanoseconds\": 162000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"human anti-ACTRIIB monoclonal antibody\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738938533, \"_nanoseconds\": 144000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Bismuth nitrate\", \"url\": \"https://drugs.ncats.io/drug/4R459R54N0\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "OTC drug",
    "Name": "bismuth nitrate",
    "guid": "d23cd009-59d0-4cfd-b697-4b05298777b7",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "bismuth nitrate",
    "Reasons": "[{\"reason_code\": 6015, \"reason\": \"OTC drug\", \"link\": \"\", \"guid\": \"2a6a7454-fb0d-4d0b-9a4c-99ea7f0d386b\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703683233, \"_nanoseconds\": 942000000}}]",
    "other_names": "[\"bismuth(III) nitrate pentahydrate\", \"bismuth trinitrate pentahydrate\", \"nitric acid, bismuth(3+) salt\", \"bismuth trinitrate\", \"bismuth(III) nitrate\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1759155155, \"_nanoseconds\": 449000000}",
    "label_terms": "[]",
    "linked_ingredients": "[]",
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "bolasterone",
    "guid": "37b68d92-31be-488c-9d0d-d61abc03e734",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "bolasterone",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}, {\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"7\u03b1,17\u03b1-dimethyltestosterone\", \"7\u03b1,17\u03b1-dimethyl-17\u03b2-hydroxyandrost-4-en-3-one\", \"7alpha,17alpha-dimethyltestosterone\", \"7alpha,17alpha-dimethyl-17betahydroxyandrost-4-en-3-one\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1716921270, \"_nanoseconds\": 368000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "boldenone",
    "guid": "b9ad4d9b-7f3d-48de-80ce-dba4c0ff876c",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "boldenone",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}, {\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"1,4-androstadiene-17-beta-ol-3-one\", \"Equigan\", \"Ultragan\", \"dehydrotestosterone\", \"Ganabol\", \"1,4-androstadiene-3-one-17beta-ol\", \"boldenone undecylenate\", \"1,4-androstadiene-3-one-17\u03b2-ol\", \"Vebonol\", \"boldenone acetate\", \"1-dehydrotestosterone\", \"17beta-hydroxyandrost-1,4-diene-3-one\", \"Equipoise\", \"boldenone cypionate\", \"17\u03b2-hydroxyandrost-1,4,-diene-3-one\", \"Parenabol\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1716921397, \"_nanoseconds\": 81000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "boldione",
    "guid": "6418095e-8272-4873-ac45-cb8101f4fe8b",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "boldione",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}, {\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"androsta-1,4-diene-3,17-dione\", \"androstadienedione\", \"1,4-AD\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1716921443, \"_nanoseconds\": 81000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "brexanolone",
    "guid": "b3e36bf6-936e-4f63-b9c9-a2323c664015",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "brexanolone",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"allopregnan-3alpha-ol-20-one\", \"allopregnanolone\", \"3\u03b1-hydroxy-5\u03b1-pregnan-20-one\", \"allotetrahydroprogesterone\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710508138, \"_nanoseconds\": 234000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule V",
    "Name": "brivaracetam",
    "guid": "fa07f92f-327e-4cbc-8c44-12b94b86f064",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "brivaracetam",
    "Reasons": "[{\"reason_code\": 6007, \"reason\": \"DEA Controlled Substance List: Schedule V\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"d5b1da64-60db-4afa-af32-8491827c3497\", \"link_title\": \"DEA Controlled Substance List: Schedule V\", \"updated\": {\"_seconds\": 1712942766, \"_nanoseconds\": 551000000}}]",
    "other_names": "[\"UCB-34714\", \"BRV\", \"Briviact\", \"(2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl] butanamide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710508062, \"_nanoseconds\": 850000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "brolamfetamine",
    "guid": "ea57ed68-8152-464c-a804-0afdc4b88e90",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "brolamfetamine",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"4-bromo-2,5-DMA\", \"4-bromo-2,5-dimethoxy-amphetamine\", \"4-bromo-2,5-dimethoxy-\u03b1-methylphenethylamine\", \"4-bromo-DMA\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1711995771, \"_nanoseconds\": 482000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Bromantane\", \"url\": \"https://drugs.ncats.io/drug/N1ILS53XWK\"}, {\"title\": \"MeSH: Bromantane\", \"url\": \"https://meshb.nlm.nih.gov/record/ui?ui=C085955\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Unapproved drug",
    "Name": "bromantan",
    "guid": "b39cbe4a-da75-417a-a9ff-fce8920d7581",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "bromantan",
    "Reasons": "[{\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"N-(2-adamantyl)-N-(4-bromophenyl)amine\", \"bromontan\", \"bromantane\", \"N-(4-bromophenyl)adamantan-2-amine\", \"Ladasten\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1762180070, \"_nanoseconds\": 618000000}",
    "label_terms": "[]",
    "linked_ingredients": "[]",
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "bromazepam",
    "guid": "2c04a64c-ad2e-4f8e-81e9-da8e3a938b38",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "bromazepam",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"7-bromo-5-(2-pyridyl)-3H-1,4-benzodiazepin-2(1H)-one\", \"Lexotanil\", \"Lexatin\", \"Durazanil\", \"Compedium\", \"Lexotan\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710507693, \"_nanoseconds\": 330000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "brorphine",
    "guid": "6c311738-2137-497c-8945-3cf94a40276e",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "brorphine",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazol-2-one\", \"1-[1-[1-(4-bromophenyl)ethyl]-4-piperidinyl]-1,3-dihydro-2H-benzimidazol-2-one\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710507630, \"_nanoseconds\": 393000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "bufotenine",
    "guid": "1d9da8a0-e89f-412f-98cd-09ce9f0f9f32",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "bufotenine",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"3-(2-dimethylaminoethyl)-5-indolol\", \"N, N-dimethylserotonin\", \"mappine\", \"3-(\u03b2-Dimethylaminoethyl)-5-hydroxyindole\", \"5-hydroxy-N,N-dimethyltryptamine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710507556, \"_nanoseconds\": 656000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Bumetanide\", \"url\": \"https://drugs.ncats.io/drug/0Y2S3XUQ5H\"}, {\"title\": \"National Drug Code Directory: Bumetanide\", \"url\": \"https://www.accessdata.fda.gov/scripts/cder/ndc/index.cfm\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S5: Diuretics and Masking AgentsPrescription drug",
    "Name": "bumetanide",
    "guid": "236a120c-d140-43bb-95ff-00e9114153c8",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "bumetanide",
    "Reasons": "[{\"reason_code\": 6013, \"reason\": \"WADA S5: Diuretics and Masking Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b1ad44e4-cef0-4ae2-99fb-19e28540f282\", \"link_title\": \"WADA Prohibited List S5: Diuretics and Masking Agents\", \"updated\": {\"_seconds\": 1703682941, \"_nanoseconds\": 864000000}}, {\"reason_code\": 6016, \"reason\": \"Prescription drug\", \"link\": null, \"guid\": \"becae72e-580f-4d8d-8665-c0c4b1dc1381\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683249, \"_nanoseconds\": 70000000}}]",
    "other_names": "[\"Bumex\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738940608, \"_nanoseconds\": 573000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "buprenorphine",
    "guid": "9ea57a6c-e9f3-4e35-a7eb-aaee6550f4ee",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "buprenorphine",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}]",
    "other_names": "[\"Buprenex\", \"Temgesic\", \"Subutex\", \"Suboxone\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710507428, \"_nanoseconds\": 424000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Buserelin\", \"url\": \"https://drugs.ncats.io/drug/PXW8U3YXDV\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S2: Peptide Hormones, Growth Factors, etc.Unapproved drug",
    "Name": "buserelin",
    "guid": "c1cfc5aa-4624-47f5-b877-0c45bebb557a",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "buserelin",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"tiloryth\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710507264, \"_nanoseconds\": 696000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "butabarbital",
    "guid": "f361109d-619b-4b69-9a39-410a7ea19d90",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "butabarbital",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}]",
    "other_names": "[\"Butisol\", \"secbutabarbital\", \"Butibel\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710507202, \"_nanoseconds\": 672000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "butalbital",
    "guid": "6afe8f25-1d2e-482e-871c-577b7283e95e",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "butalbital",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}]",
    "other_names": "[\"Fiorinal\", \"butalbital with aspirin\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710507166, \"_nanoseconds\": 104000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "butobarbital",
    "guid": "f908ceb8-5ad8-4eb8-8d12-66362625f0bd",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "butobarbital",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}]",
    "other_names": "[\"Soneryl\", \"butethal\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710507130, \"_nanoseconds\": 561000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "butonitazene",
    "guid": "c2ca9c5e-13bb-4106-8c29-6bc1f8d4d5b1",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "butonitazene",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"(2-(2-(4-butoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1- amine)\", \"1H-benzimidazole-1-ethanamine, 2-((4-butoxyphenyl)methyl)-N,N-diethyl-5-nitro-\", \"2-[(4-butoxyphenyl)methyl]-N,N-diethyl-5-nitro-1H-benzimidazole-1-ethanamine\", \"2-[2-[(4-butoxyphenyl)methyl]-5-nitrobenzimidazol-1-yl]-N,N-diethylethanamine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710507103, \"_nanoseconds\": 41000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "butorphanol",
    "guid": "b8687f8f-add1-4093-b773-13de33d0bc6d",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "butorphanol",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"(-)-17-(cyclobutylmethyl)morphinan-3,14-diol\", \"Stadol\", \"Torbugesic\", \"Torbutrol\", \"Stadol NS\", \"butorfanol\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710507023, \"_nanoseconds\": 481000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "butylone",
    "guid": "4edd88c1-8cad-4a1e-a0e0-194c88e7bd48",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "butylone",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"MDDMC\", \"bk-MDDMA\", \"N,N-dimethyl-3,4-methylenedioxycathinone\", \"1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one)\", \"1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one\", \"bk-MBDB\", \"dimethylone\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710506954, \"_nanoseconds\": 74000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "butyryl fentanyl",
    "guid": "b9eb5352-ec13-4efa-bfa6-7924095fe9ee",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "butyryl fentanyl",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide\", \"N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710450098, \"_nanoseconds\": 620000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "calusterone",
    "guid": "e8ac3d06-3c2b-439e-b7cc-c25c09cf90af",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "calusterone",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}, {\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"Mesosarb\", \"7beta,17alpha-dimethyl-17betahydroxyandrost-4-en-3-one\", \"7\u03b2,17\u03b1-dimethyltestosterone\", \"7\u03b2,17\u03b1-dimethyl-17\u03b2-hydroxyandrost-4-en-3-one\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1716921541, \"_nanoseconds\": 617000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "camazepam",
    "guid": "af981463-dabe-4cce-86e7-539c9173d587",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "camazepam",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"Limpidon\", \"Paxor\", \"Albego\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710449683, \"_nanoseconds\": 108000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"Hemp and DoD policy\", \"url\": \"https://www.opss.org/article/hemp-and-dod-policy\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Military policy",
    "Name": "cannabidiol",
    "guid": "7ea194d1-01a2-4021-ae4f-216c6082f7d3",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "cannabidiol",
    "Reasons": "[{\"reason_code\": 6017, \"reason\": \"Military policy\", \"link\": null, \"guid\": \"96435789-439c-44d4-83cf-1d10a25ab7b5\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683268, \"_nanoseconds\": 216000000}}]",
    "other_names": "[\"CBD\", \"Epidiolex\", \"1,3-benzenediol, 2-(3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl)-5-pentyl-, (1R-trans)-\", \"delta1(2)-trans-cannabidiol\", \"trans-cannabidiol\", \"trans-2-p-mentha-1,8-dien-3-yl-5-pentylresorcinol\", \"\u03941(2)-trans-cannabidiol\", \"2-[(1R,6R)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl]-5-pentylbenzene-1,3-diol\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710449589, \"_nanoseconds\": 965000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Use or misuse prohibited under DoDI 1010.16 (cannabinoids)",
    "Name": "cannabigerol",
    "guid": "f7122236-e2a0-488d-a632-c19473ec029a",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "cannabigerol",
    "Reasons": "[{\"reason_code\": 6014, \"reason\": \"DoDI 1010.16\", \"link\": \"https://www.esd.whs.mil/directives/issuances/dodi\", \"guid\": \"b757aa46-4729-4d4a-a32e-25ef0b04e5c3\", \"link_title\": \"Use or misuse prohibited under DoDI 1010.16\", \"updated\": {\"_seconds\": 1703683049, \"_nanoseconds\": 190000000}}]",
    "other_names": "[\"cannabigerol (CBG)\", \"Cannabis Extract 5% CBG\", \"CBG\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738943606, \"_nanoseconds\": 848000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "cannabis",
    "guid": "a14fb5af-f365-404f-8d0f-641a639620b3",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "cannabis",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"Cannabis sativa L.\", \"Cannabis sativa\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710449428, \"_nanoseconds\": 485000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Canrenone\", \"url\": \"https://drugs.ncats.io/drug/78O20X9J0U\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S5: Diuretics and Masking Agents; Unapproved drug",
    "Name": "canrenone",
    "guid": "1fe06e94-9eb7-450a-8b3d-e032649bec39",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "canrenone",
    "Reasons": "[{\"reason_code\": 6013, \"reason\": \"WADA S5: Diuretics and Masking Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b1ad44e4-cef0-4ae2-99fb-19e28540f282\", \"link_title\": \"WADA Prohibited List S5: Diuretics and Masking Agents\", \"updated\": {\"_seconds\": 1703682941, \"_nanoseconds\": 864000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"Aldadiene\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738943990, \"_nanoseconds\": 306000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Capromorelin\", \"url\": \"https://drugs.ncats.io/drug/0MQ44VUN84\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "capromorelin",
    "guid": "9433b9d3-0558-4d93-b75f-da32bc98b116",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "capromorelin",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"CP-424,391\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709048873, \"_nanoseconds\": 164000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S2: Peptide Hormones, Growth Factors, etc.",
    "Name": "carbamylated EPO",
    "guid": "470d1159-a989-4304-9e82-d36c77e0dd98",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "carbamylated epo",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}]",
    "other_names": "[\"cEPO\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710449307, \"_nanoseconds\": 909000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Use or misuse prohibited under DoDI 1010.16 (synthetic cannabinoids)",
    "Name": "carbazole",
    "guid": "85378085-1395-467d-b634-6d1883df5683",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "carbazole",
    "Reasons": "[{\"reason_code\": 6014, \"reason\": \"DoDI 1010.16\", \"link\": \"https://www.esd.whs.mil/directives/issuances/dodi\", \"guid\": \"b757aa46-4729-4d4a-a32e-25ef0b04e5c3\", \"link_title\": \"Use or misuse prohibited under DoDI 1010.16\", \"updated\": {\"_seconds\": 1703683049, \"_nanoseconds\": 190000000}}]",
    "other_names": "[\"dibenzopyrrole\", \"9h-carbazole\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710449210, \"_nanoseconds\": 638000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "carfentanil",
    "guid": "a2074f3b-6686-4eeb-bc7b-3015f069b77b",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "carfentanil",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}]",
    "other_names": "[\"Wildnil\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710448953, \"_nanoseconds\": 326000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "carisoprodol",
    "guid": "80d1dde0-ff1d-4ea4-a640-3c7aed5d99ed",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "carisoprodol",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"Soma\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710448902, \"_nanoseconds\": 510000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedules III and IV",
    "Name": "cathine",
    "guid": "b2d9a08e-155d-40b7-b50f-c3db61ddfec9",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "cathine",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"d-norpseudoephedrine\", \"Fasupond\", \"norpseudoephedrine\", \"(+)-norpseudoephedrine\", \"Exponcit\", \"pseudonorephedrine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715361246, \"_nanoseconds\": 324000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "cathinone",
    "guid": "99066ef9-1476-44dc-9a43-415f0bffb2bb",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "cathinone",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"alpha-aminopropiophenone\", \"2-aminopropiophenone\", \"2-amino-1-phenyl-1-propanone\", \"norephedrone\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1762178149, \"_nanoseconds\": 182000000}",
    "label_terms": "[]",
    "linked_ingredients": "[]",
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule V",
    "Name": "cenobamate",
    "guid": "7ae3b2c4-325a-4ad1-9cb5-59e35bde6627",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "cenobamate",
    "Reasons": "[{\"reason_code\": 6007, \"reason\": \"DEA Controlled Substance List: Schedule V\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"d5b1da64-60db-4afa-af32-8491827c3497\", \"link_title\": \"DEA Controlled Substance List: Schedule V\", \"updated\": {\"_seconds\": 1712942766, \"_nanoseconds\": 551000000}}]",
    "other_names": "[\"carbamic acid (R)-(+)-1-(2-chlorophenyl)-2-(2H-tetrazol-2-yl)ethyl ester)\", \"2H-tetrazole-2-ethanol, alpha-(2-chlorophenyl)-, carbamate (ester), (alphaR)-\", \"[(1R)-1-(2-chlorophenyl)-2-(tetrazol-2-yl)ethyl] carbamate\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710448562, \"_nanoseconds\": 786000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"FDA: Cesium Chloride in Dietary Supplements\", \"url\": \"https://www.fda.gov/food/dietary-supplement-products-ingredients/cesium-chloride-dietary-supplements\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "FDA statement: New dietary ingredient lacking evidence for safe use",
    "Name": "cesium chloride",
    "guid": "42f239ad-845a-4177-8e93-5e67ba84710c",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "cesium chloride",
    "Reasons": "[{\"reason_code\": 6018, \"reason\": \"FDA Statement\", \"link\": \"\", \"guid\": \"3cd17124-6ebc-4828-9edb-c20a81755502\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1711715334, \"_nanoseconds\": 457000000}}]",
    "other_names": "[\"cesium salt\", \"CsCl\", \"caesium chloride\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710448454, \"_nanoseconds\": 206000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "chloral betaine",
    "guid": "2decbb47-8940-404d-8675-078b43f32218",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "chloral betaine",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"Beta Chlor\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710448361, \"_nanoseconds\": 302000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "chloral hydrate",
    "guid": "75ab3a48-b9aa-40a2-ad61-2ddc18342b8d",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "chloral hydrate",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"Noctec\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710448288, \"_nanoseconds\": 336000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "chlordiazepoxide",
    "guid": "efcd0df0-3eab-4113-b1ec-c2019bfc4ded",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "chlordiazepoxide",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"Libritabs\", \"Librium\", \"SK-Lygen\", \"Limbitrol\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710448242, \"_nanoseconds\": 703000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "chlorhexadol",
    "guid": "503b856c-93bd-4f7b-9e80-985f21e9046a",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "chlorhexadol",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}]",
    "other_names": "[\"Medodorm\", \"Mecoral\", \"Mechloral\", \"Chloralodol\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710448195, \"_nanoseconds\": 991000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "chlorodehydromethylandrostenediol",
    "guid": "ad35192b-5fa2-49f8-8094-b41bf2af05c2",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "chlorodehydromethylandrostenediol",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}, {\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"(3beta,17beta)-4-chloro-17-methyl-androsta-1,4-diene-3,17-diol\", \"Halovar\", \"4-chloro-17alpha-methyl-androst-1,4-diene-3beta,17beta-diol\", \"halodrol 50\", \"halodrol\", \"H-DROL\", \"CDMA\", \"4-chloro-17alpha-methyl-androsta-1,4-diene-3,17beta-diol\", \"4-chloro-17\u03b1-methyl-androsta-1,4-diene-3,17\u03b2-diol\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1716925975, \"_nanoseconds\": 37000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "chloromethylandrostenediol",
    "guid": "9f6c91ea-ac9b-4525-8ed0-2a0fa14c5f81",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "chloromethylandrostenediol",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}, {\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"4-chloro-17-methyl-androst-4-ene-3,17-diol\", \"Promagnon\", \"P-mag\", \"CMA\", \"4-chloro-17alpha-methyl-androst-4-ene-3beta,17beta-diol\", \"methyl-clostediol\", \"4-chloro-17\u03b1-methyl-androst-4-ene-3\u03b2,17\u03b2-diol\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1716928634, \"_nanoseconds\": 835000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Chlorothiazide\", \"url\": \"https://drugs.ncats.io/drug/77W477J15H\"}, {\"title\": \"National Drug Code Directory: Chlorothiazide\", \"url\": \"https://www.accessdata.fda.gov/scripts/cder/ndc/index.cfm\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S5: Diuretics and Masking Agents; Prescription drug",
    "Name": "chlorothiazide",
    "guid": "02c4c556-cf83-4ff7-8602-ade0e0fd79c5",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "chlorothiazide",
    "Reasons": "[{\"reason_code\": 6013, \"reason\": \"WADA S5: Diuretics and Masking Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b1ad44e4-cef0-4ae2-99fb-19e28540f282\", \"link_title\": \"WADA Prohibited List S5: Diuretics and Masking Agents\", \"updated\": {\"_seconds\": 1703682941, \"_nanoseconds\": 864000000}}, {\"reason_code\": 6016, \"reason\": \"Prescription drug\", \"link\": null, \"guid\": \"becae72e-580f-4d8d-8665-c0c4b1dc1381\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683249, \"_nanoseconds\": 70000000}}]",
    "other_names": "[\"Diuril\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738944818, \"_nanoseconds\": 563000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "chlorphentermine",
    "guid": "a9e0d9cb-28a4-4f37-a043-6fe8f2190556",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "chlorphentermine",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}]",
    "other_names": "[\"Desopimon\", \"Apsedon\", \"Pre-Sate\", \"Lucofen\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710447390, \"_nanoseconds\": 766000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Chlorthalidone\", \"url\": \"https://drugs.ncats.io/drug/Q0MQD1073Q\"}, {\"title\": \"National Drug Code Directory: Chlorthalidone\", \"url\": \"https://www.accessdata.fda.gov/scripts/cder/ndc/index.cfm\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S5: Diuretics and Masking Agents; Prescription drug",
    "Name": "chlorthalidone",
    "guid": "80764310-59f4-474b-88f3-749a2c70ab19",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "chlorthalidone",
    "Reasons": "[{\"reason_code\": 6013, \"reason\": \"WADA S5: Diuretics and Masking Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b1ad44e4-cef0-4ae2-99fb-19e28540f282\", \"link_title\": \"WADA Prohibited List S5: Diuretics and Masking Agents\", \"updated\": {\"_seconds\": 1703682941, \"_nanoseconds\": 864000000}}, {\"reason_code\": 6016, \"reason\": \"Prescription drug\", \"link\": null, \"guid\": \"becae72e-580f-4d8d-8665-c0c4b1dc1381\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683249, \"_nanoseconds\": 70000000}}]",
    "other_names": "[\"chlortalidone\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1761920514, \"_nanoseconds\": 218000000}",
    "label_terms": "[]",
    "linked_ingredients": "[]",
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Clenbuterol\", \"url\": \"https://drugs.ncats.io/drug/XTZ6AXU7KN\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S1: Anabolic Agents; Unapproved drug",
    "Name": "clenbuterol",
    "guid": "0237a9b6-5d42-4648-bb5b-23edf28c71fd",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "clenbuterol",
    "Reasons": "[{\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"Clen\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710446802, \"_nanoseconds\": 810000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "clobazam",
    "guid": "ffff36fc-936a-4ed4-94b0-9f7c9cc811b9",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "clobazam",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"Urbanyl\", \"Urbadan\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710445748, \"_nanoseconds\": 178000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Clobenzorex\", \"url\": \"https://drugs.ncats.io/drug/4A5352XI2A\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Use or misuse prohibited under DoDI 1010.16 (amphetamines)",
    "Name": "clobenzorex",
    "guid": "0b204d29-faec-407d-9dd8-8f3dec15d816",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "clobenzorex",
    "Reasons": "[{\"reason_code\": 6014, \"reason\": \"DoDI 1010.16\", \"link\": \"https://www.esd.whs.mil/directives/issuances/dodi\", \"guid\": \"b757aa46-4729-4d4a-a32e-25ef0b04e5c3\", \"link_title\": \"Use or misuse prohibited under DoDI 1010.16\", \"updated\": {\"_seconds\": 1703683049, \"_nanoseconds\": 190000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"benzeneethanamine, N-((2-chlorophenyl)methyl)-\u03b1-methyl-, (S)-\", \"(+)-N-(O-chlorobenzyl)-alpha-methylphenethylamine\", \"benzeneethanamine, N-((2-chlorophenyl)methyl)-alpha-methyl-, (S)-\", \"(+)-N-(O-chlorobenzyl)-\u03b1-methylphenethylamine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715354512, \"_nanoseconds\": 702000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Clomiphene\", \"url\": \"https://drugs.ncats.io/drug/1HRS458QU2\"}, {\"title\": \"National Drug Code Directory: Chlomiphene\", \"url\": \"https://www.accessdata.fda.gov/scripts/cder/ndc/index.cfm\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S4: Hormone and Metabolic Modulators; Prescription drug",
    "Name": "clomifene",
    "guid": "0c681947-0dcd-4c76-8e9e-0b9d5e5f5e8a",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "clomifene",
    "Reasons": "[{\"reason_code\": 6012, \"reason\": \"WADA S4: Hormone and Metabolic Modulators\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"ac1ba347-6d44-4a17-829d-e589bf33bbdb\", \"link_title\": \"WADA Prohibited List S4: Hormone and Metabolic Modulators\", \"updated\": {\"_seconds\": 1703682875, \"_nanoseconds\": 162000000}}, {\"reason_code\": 6016, \"reason\": \"Prescription drug\", \"link\": null, \"guid\": \"becae72e-580f-4d8d-8665-c0c4b1dc1381\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683249, \"_nanoseconds\": 70000000}}]",
    "other_names": "[\"clomid\", \"clomifen\", \"clomiphene citrate\", \"chloramiphene\", \"Serophene\", \"hydrochloride, clomiphene\", \"2-(4-(2-chloro-1,2-diphenylethenyl)phenoxy)-N,N-diethylethanamine\", \"HSDB 3039\", \"clostilbegit\", \"ethanamine, 2-(4-(2-chloro-1,2-diphenylethenyl)phenoxy)-N,N-diethyl-\", \"clomifenum\", \"citrate, clomiphene\", \"2-(p-(2-chloro-1,2-diphenylvinyl)phenoxy)triethylamine\", \"-(p-(\u03b2-diethylaminoethoxy)-phenyl)-1,2-diphenylchloroethylene\", \"Enclomiphene\", \"clomiphene B\", \"2-(p-(beta-chloro-alpha-phenylstyryl)phenoxy)-triethylamine\", \"clomiphene hydrochloride\", \"-(p-(beta-diethylaminoethoxy)-phenyl)-1,2-diphenylchloroethylene\", \"2-(p-(\u03b2-chloro-\u03b1-phenylstyryl)phenoxy)-triethylamine\", \"triethylamine, 2-(p-(2-chloro-1,2-diphenylvinyl)phenoxy)-\", \"clomide\", \"clomiphene\", \"Klostilbegit\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1761850807, \"_nanoseconds\": 912000000}",
    "label_terms": "[]",
    "linked_ingredients": "[]",
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "clonazepam",
    "guid": "885c0502-05c1-4abc-87f8-3e5c43fb8fc2",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "clonazepam",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"klonopin\", \"clonopin\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710443959, \"_nanoseconds\": 847000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "clonitazene",
    "guid": "b518083a-d507-4cf8-beed-3508830505df",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "clonitazene",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"benzimidazole, 2-(p-chlorobenzyl)-1-(2-(diethylamino)ethyl)-5-nitro-\", \"clobedolum\", \"2-(p-chlorobenzyl)-1-(2-diethylaminoethyl)-5-nitrobenzimidazole\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710443890, \"_nanoseconds\": 847000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "clorazepate",
    "guid": "e5203fda-9ce2-41b5-9f50-8b64b68fa04d",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "clorazepate",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"Tranxene\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710443814, \"_nanoseconds\": 502000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "clortermine",
    "guid": "74691276-4b78-40f9-8c81-359c97ffa68e",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "clortermine",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}]",
    "other_names": "[\"Voranil\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710443761, \"_nanoseconds\": 653000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "clostebol",
    "guid": "68f48613-9da8-480b-aea0-92880d88e1d6",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "clostebol",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}, {\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"clostebol acetate\", \"4-chloro-delta-4-androstene-3alpha-ol-17-one\", \"4-chloro-17beta-hydroxyandrost-4-en-3-one\", \"4-chloro-\u03944-androstene-3\u03b1-ol-17-one\", \"Alfa-Trofodermin\", \"Clostene\", \"4-chlorotestosterone\", \"4-chloro-17\u03b2-hydroxyandrost-4-en-3-one\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1716921952, \"_nanoseconds\": 738000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "clotiazepam",
    "guid": "a07d26e9-c53b-42d5-afa9-929661be0dea",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "clotiazepam",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"Trecalmo\", \"Rize\", \"Veratran\", \"Clozan\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710443539, \"_nanoseconds\": 235000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "cloxazolam",
    "guid": "5a148f2d-660c-4622-be7c-c82067be302d",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "cloxazolam",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"Akton\", \"Olcadil\", \"Luballix\", \"Sepazon\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710443485, \"_nanoseconds\": 213000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "cobalt",
    "guid": "212f32a1-7ec0-46ff-b84f-d3fede112f82",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "cobalt",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}]",
    "other_names": "[\"cobalt chloride\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1735580295, \"_nanoseconds\": 300000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule II",
    "Name": "cocaine",
    "guid": "7239f2ca-5079-43e6-a06c-197d1b350fa5",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "cocaine",
    "Reasons": "[{\"reason_code\": 6004, \"reason\": \"DEA Controlled Substance List: Schedule  II\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"207f9e17-8a22-4523-8dd6-24d9d39b4c45\", \"link_title\": \"DEA Controlled Substance List: Schedule  II\", \"updated\": {\"_seconds\": 1712942744, \"_nanoseconds\": 783000000}}]",
    "other_names": "[\"coca leaves\", \"methyl benzoylecgonine\", \"Crack\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715354628, \"_nanoseconds\": 937000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Use or misuse prohibited under DoDI 1010.16 (cocaine metabolites)",
    "Name": "cocaine metabolites",
    "guid": "71ffb204-7484-4919-9e4d-7a6cfc178445",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "cocaine metabolites",
    "Reasons": "[{\"reason_code\": 6014, \"reason\": \"DoDI 1010.16\", \"link\": \"https://www.esd.whs.mil/directives/issuances/dodi\", \"guid\": \"b757aa46-4729-4d4a-a32e-25ef0b04e5c3\", \"link_title\": \"Use or misuse prohibited under DoDI 1010.16\", \"updated\": {\"_seconds\": 1703683049, \"_nanoseconds\": 190000000}}]",
    "other_names": "[]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710442915, \"_nanoseconds\": 81000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule II",
    "Name": "codeine",
    "guid": "29bb0603-d4c9-4a94-928f-e0d19bebb442",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "codeine",
    "Reasons": "[{\"reason_code\": 6004, \"reason\": \"DEA Controlled Substance List: Schedule  II\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"207f9e17-8a22-4523-8dd6-24d9d39b4c45\", \"link_title\": \"DEA Controlled Substance List: Schedule  II\", \"updated\": {\"_seconds\": 1712942744, \"_nanoseconds\": 783000000}}]",
    "other_names": "[\"morphine methyl ester\", \"methyl morphine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710442172, \"_nanoseconds\": 17000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "codeine methylbromide",
    "guid": "4a846c0f-a07a-47fc-8a58-fb8b364b1fe0",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "codeine methylbromide",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"codeine bromomethylate\", \"Eucodin\", \"codeine methyl bromide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710442112, \"_nanoseconds\": 65000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "codeine-N-oxide",
    "guid": "a6ef48b9-202f-4e52-974d-f0a18a7afac1",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "codeine-n-oxide",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"codeine N-oxide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710441848, \"_nanoseconds\": 267000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Coluracetam\", \"url\": \"https://drugs.ncats.io/drug/V6FL6O5GR7\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Unapproved drug",
    "Name": "coluracetam",
    "guid": "0c13c2fd-add4-4186-81d0-f21fe6141d78",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "coluracetam",
    "Reasons": "[{\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"N-(2,3-dimethyl-5,6,7,8-tetrahydrofuro(2,3-B)quinolin-4-YL)-2-(2-oxopyrrolidin-1-YL)acetamide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710441787, \"_nanoseconds\": 715000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Conivaptan\", \"url\": \"https://drugs.ncats.io/drug/0NJ98Y462X\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "conivaptan",
    "guid": "29a728cd-a290-4180-a10e-5d3677937682",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "conivaptan",
    "Reasons": "[{\"reason_code\": 6013, \"reason\": \"WADA S5: Diuretics and Masking Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b1ad44e4-cef0-4ae2-99fb-19e28540f282\", \"link_title\": \"WADA Prohibited List S5: Diuretics and Masking Agents\", \"updated\": {\"_seconds\": 1703682941, \"_nanoseconds\": 864000000}}, {\"reason_code\": 6016, \"reason\": \"Prescription drug\", \"link\": null, \"guid\": \"becae72e-580f-4d8d-8665-c0c4b1dc1381\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683249, \"_nanoseconds\": 70000000}}]",
    "other_names": "[]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709048963, \"_nanoseconds\": 516000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Corticorelin\", \"url\": \"https://drugs.ncats.io/drug/305OE8862Y\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S2: Peptide Hormones, Growth Factors, etc.; Unapproved drug",
    "Name": "corticorelin",
    "guid": "8fd33bca-b449-47fa-a80e-1029799524ce",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "corticorelin",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"corticorelin acetate\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710441582, \"_nanoseconds\": 44000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Cropropamide\", \"url\": \"https://drugs.ncats.io/drug/W8TYE9V9BX\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Unapproved drug",
    "Name": "cropropamide",
    "guid": "d1ad3e82-3bc6-470f-970c-c8060e94dd95",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "cropropamide",
    "Reasons": "[{\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"2-[[(E)-but-2-enoyl]-propylamino]-N,N-dimethylbutanamide\", \"cropropamida\", \"cropropamidum\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715354696, \"_nanoseconds\": 745000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Crotetamide\", \"url\": \"https://drugs.ncats.io/drug/642I97LB5B\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Unapproved drug",
    "Name": "crotetamide",
    "guid": "4d185966-de6c-4b98-aff3-eb3e2e7d26fb",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "crotetamide",
    "Reasons": "[{\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"crotetamida\", \"crotetamidum\", \"crotethamide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715354723, \"_nanoseconds\": 201000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "crotonyl fentanyl",
    "guid": "d716fe3c-54de-475c-9792-31f9834e4e8c",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "crotonyl fentanyl",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"(E)-N-(1-phenethylpiperidin-4-yl)-N-phenylbut-2-enamide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710440983, \"_nanoseconds\": 437000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S1: Anabolic Agents",
    "Name": "cyanostane",
    "guid": "415201ae-c3d7-4475-9cee-03d2abd30a1c",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "cyanostane",
    "Reasons": "[{\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"2-cyano-17a-methyl-17b-hydroxy-androstan-3-one\", \"2-cyano-17a-methyl-17b-hydroxy androst-3-one\", \"2-cyano-17a-methyl-17b-hydroxy-5a-androst-3-one\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738947191, \"_nanoseconds\": 889000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Cyclofenil\", \"url\": \"https://drugs.ncats.io/drug/J468V64WZ1\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S4: Hormone and Metabolic Modulators; Unapproved drug",
    "Name": "cyclofenil",
    "guid": "e86f7c15-3078-4518-898a-d31426e5d556",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "cyclofenil",
    "Reasons": "[{\"reason_code\": 6012, \"reason\": \"WADA S4: Hormone and Metabolic Modulators\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"ac1ba347-6d44-4a17-829d-e589bf33bbdb\", \"link_title\": \"WADA Prohibited List S4: Hormone and Metabolic Modulators\", \"updated\": {\"_seconds\": 1703682875, \"_nanoseconds\": 162000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"4,4'-(cyclohexylidenmethylen)diphenyl diacetat\", \"Rehibin\", \"cyclofenilum\", \"Fertodur\", \"Sanocrisin\", \"NSC 86464\", \"ciclofenilo\", \"cyclophenil\", \"cyclopenil\", \"ICI 48213\", \"H 3452\", \"Sexovar\", \"4-((4-(Acetyloxy)phenyl)cyclohexylidenemethyl)phenol acetate\", \"cyclofenyl\", \"F 6066\", \"Sexovid\", \"bis(p-hydroxyphenyl)cyclohexyldienemethane diacetate\", \"4,4'-(cyclohexylidenemethylene)diphenol diacetate ester\", \"Oginex\", \"F-6066\", \"Neoclym\", \"F6066\", \"BRN 2014687\", \"cyclophenyl\", \"Ondonid\", \"Ondogyne\", \"bis-(p-hydroxyphenyl)-cyclohexylidenemethane diacetate\", \"Sexadieno\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738947273, \"_nanoseconds\": 803000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "cyclopentyl fentanyl",
    "guid": "fac04897-46f3-4ef9-9850-8b5531403b9b",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "cyclopentyl fentanyl",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710440271, \"_nanoseconds\": 288000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "cyclopropyl fentanyl",
    "guid": "293ec151-22ba-4562-b8ec-d74a2f7de18a",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "cyclopropyl fentanyl",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710440206, \"_nanoseconds\": 80000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "cyprenorphine",
    "guid": "234be5d1-18ac-490f-aed4-f6ada26973a6",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "cyprenorphine",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"N-Cyclopropylmethyl-6,14-endoetheno-7alpha-(1-hydroxy-1-methylethyl)-6,7,8,14-tetrahydronororipavine\", \"6,14-endo-Ethenotetrahydrooripavine, 21-cyclopropyl-7alpha-(1-hydroxy-1-methylethyl)-\", \"2-(N-cyclopropylmethyl-4,5-epoxy-6-methoxy-6,14-endo-morphinan-7alpha-yl)-2-propanol\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710440131, \"_nanoseconds\": 303000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Cyproheptadine\", \"url\": \"https://drugs.ncats.io/drug/2YHB6175DO\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Prescription drug",
    "Name": "cyproheptadine",
    "guid": "3bb6ce8b-0b07-499a-80ac-0a0571facb83",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "cyproheptadine",
    "Reasons": "[{\"reason_code\": 6016, \"reason\": \"Prescription drug\", \"link\": null, \"guid\": \"becae72e-580f-4d8d-8665-c0c4b1dc1381\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683249, \"_nanoseconds\": 70000000}}]",
    "other_names": "[\"Piperidine, 4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-methyl-\", \"1-Methyl-4-(dibenzo[a,e]cycloheptatrien-5-ylidene)piperidine\", \"4-(5H-dibenzo[a,d][7]annulen-5-ylidene)-1-methylpiperidine\", \"Periactinol\", \"Periactin\", \"Cyproheptadine hydrochloride\", \"1-Methyl-4-(5H-dibenzo[a,d]cycloheptenylidene)piperidine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1761849490, \"_nanoseconds\": 429000000}",
    "label_terms": "[]",
    "linked_ingredients": "[]",
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Danazol\", \"url\": \"https://drugs.ncats.io/drug/N29QWW3BUO\"}, {\"title\": \"National Drug Code Directory: Danazol\", \"url\": \"https://www.accessdata.fda.gov/scripts/cder/ndc/index.cfm\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S1: Anabolic Agents; Prescription drug",
    "Name": "danazol",
    "guid": "b2b21e63-11be-43e7-bbc3-723fe538df18",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "danazol",
    "Reasons": "[{\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}, {\"reason_code\": 6016, \"reason\": \"Prescription drug\", \"link\": null, \"guid\": \"becae72e-580f-4d8d-8665-c0c4b1dc1381\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683249, \"_nanoseconds\": 70000000}}]",
    "other_names": "[\"Danocrine\", \"[1,2]oxazolo[4',5':2,3]pregna-4-en-20-yn-17\u03b1-ol\", \"Danol\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710439241, \"_nanoseconds\": 46000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Daprodustat\", \"url\": \"https://drugs.ncats.io/drug/JVR38ZM64B\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S2: Peptide Hormones, Growth Factors, etc.; Unapproved drug",
    "Name": "daprodustat",
    "guid": "1493b94e-fae9-4420-9b5b-5e552224ae5a",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "daprodustat",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"GSK1278863\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710439020, \"_nanoseconds\": 411000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry Darbepoetin alfa\", \"url\": \"https://drugs.ncats.io/drug/15UQ94PT4P\"}, {\"title\": \"National Drug Code Directory: Darbepoetin alfa\", \"url\": \"https://www.accessdata.fda.gov/scripts/cder/ndc/index.cfm\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S2: Peptide Hormones, Growth Factors, etc.; Prescription drug",
    "Name": "darbepoetin alfa",
    "guid": "8f93419d-5b67-4b53-94cc-6baf965acfec",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "darbepoetin alfa",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}, {\"reason_code\": 6016, \"reason\": \"Prescription drug\", \"link\": null, \"guid\": \"becae72e-580f-4d8d-8665-c0c4b1dc1381\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683249, \"_nanoseconds\": 70000000}}]",
    "other_names": "[\"Aranesp\", \"darbepoetin\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1761923106, \"_nanoseconds\": 47000000}",
    "label_terms": "[]",
    "linked_ingredients": "[]",
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "daridorexant",
    "guid": "fe371546-eacc-4c28-a7ef-66ee1880180e",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "daridorexant",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"methanone, ((2S)-2-(6-chloro-7-methyl-1H-benzimidazol-2-yl)-2-methyl-1-pyrrolidinyl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)-\", \"Nemorexant\", \"Quviviq\", \"[(2S)-2-(5-chloro-4-methyl-1H-benzimidazol-2-yl)-2-methylpyrrolidin-1-yl]-[5-methoxy-2-(triazol-2-yl)phenyl]methanone\", \"[(2~{S})-2-(6-chloranyl-7-methyl-1~{H}-benzimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-methoxy-2-(1,2,3-triazol-2-yl)phenyl]methanone\", \"[(2S)-2-(5-chloro-4-methyl-1H-benzimidazol-2-yl)-2-methylpyrrolidin-1-yl][5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone\", \"[(S)-2-(5-chloro-4-methyl-1Hbenzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl](5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone\", \"[(S)-2-(5-chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methoxy-2-[1,2,3]triazol-2-yl-phenyl)-methanone\", \"QUIVIVIQ\", \"(s)-(2-(5-chloro-4-methyl-1h-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5 methoxy-2-(2h-1,2,3-triazol-2-yl)phenyl)methanone\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710438778, \"_nanoseconds\": 232000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "dehydrochlormethyltestosterone",
    "guid": "eed342da-b8b6-4207-b945-68062cc6cf86",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "dehydrochlormethyltestosterone",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}, {\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"4-chloro-17beta\u00adhydroxy-17alpha-methylandrost-1,4-dien-3-one\", \"4-chloro-17\u03b2-hydroxy-17\u03b1-methylandrosta-1,4-dien-3-one\", \"oral turinabol\", \"turinabol-oral\", \"oral-turinabol\", \"4-chloro-17\u03b2-hydroxy-17\u03b1-methyl-androst-1,4-dien-3-one\", \"dehydrochloromethyltestosterone\", \"turinabol-oral\", \"DHCMT\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1721055197, \"_nanoseconds\": 538000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"DoDI 6130.06 Use of Dietary Supplements in the DoD\", \"url\": \"https://www.esd.whs.mil/Directives/issuances/dodi\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "dehydroepiandrosterone",
    "guid": "6bf6dec6-5cfe-4584-9424-31196088ded5",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "dehydroepiandrosterone",
    "Reasons": "[{\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}, {\"reason_code\": 6017, \"reason\": \"Military policy\", \"link\": null, \"guid\": \"96435789-439c-44d4-83cf-1d10a25ab7b5\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683268, \"_nanoseconds\": 216000000}}]",
    "other_names": "[\"Psicosterone\", \"androstenolone\", \"GL-701\", \"3\u03b2-hydroxyandrost-5-en-17-one\", \"DHEA\", \"3beta-hydroxyandrost-5-en-17-one\", \"Prasterone\", \"3\u03b2-hydroxyandrost-5-en-17-one\", \"5-androsten-3-ol-17-one\", \"5-dehydroepiandrosterone\", \"Diandron\", \"3beta-hydroxy-androst-5-ene-17-one\", \"3b-hydroxy-androst-5-ene-17-one\", \"Prasterone, 3 alpha Isomer\", \"trans-dehydroandrosterone\", \"androstenolone (DHEA)\", \"5-androsten-3-beta-hydroxy-17-one\", \"5 androsten 3 beta hydroxy 17 one\", \"DHEA (Dehydroepiandrosterone)\", \"5 androsten 3 ol 17 one\", \"dehydroisoandrosterone\", \"5-DHEA\", \"Prasterone, 3 alpha-Isomer\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1716923802, \"_nanoseconds\": 381000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "delorazepam",
    "guid": "ec7cfb0d-8e0f-489a-b32d-17b4fd12a127",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "delorazepam",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"chlordesmethyldiazepam\", \"nordiclazepam\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710438360, \"_nanoseconds\": 682000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Demelverine\", \"url\": \"https://drugs.ncats.io/substance/MX0B07OP8M\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Unapproved drug",
    "Name": "demelverine",
    "guid": "1cdc5c1a-d5a5-45ac-9c38-37d2fcee1e93",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "demelverine",
    "Reasons": "[{\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"N-methyl-\u03b2,\u03b2\u2032-diphenyldiethylamine\", \"methphenethamine\", \"N-methyl-N-phenethyl-2-phenylethanamine\", \"N-methyl-beta,beta-diphenyldiethylamine\", \"N-methylbis(2-phenylethyl)amine\", \"benzeneethanamine, N-methyl-N-(2-phenylethyl)-\", \"N-methyl-N,N-diphenethylamine\", \"demelverin\", \"N-methyl-beta,beta-diphenyldiethylamine\", \"N-methyldiphenethylamine\", \"diphenethylamine, N-methyl-\", \"N-methyl-N-(2-phenylethyl)benzeneethanamine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738948098, \"_nanoseconds\": 668000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "des(1-3)IGF-1",
    "guid": "d0b2dce0-290d-4a85-a47c-f27f5e8ca079",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "des(1-3)igf-1",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}, {\"reason_code\": 6014, \"reason\": \"DoDI 1010.16\", \"link\": \"https://www.esd.whs.mil/directives/issuances/dodi\", \"guid\": \"b757aa46-4729-4d4a-a32e-25ef0b04e5c3\", \"link_title\": \"Use or misuse prohibited under DoDI 1010.16\", \"updated\": {\"_seconds\": 1703683049, \"_nanoseconds\": 190000000}}]",
    "other_names": "[]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1722279632, \"_nanoseconds\": 896000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Deslorelin\", \"url\": \"https://drugs.ncats.io/drug/TKG3I66TVE\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S2: Peptide Hormones, Growth Factors, etc.; Unapproved drug",
    "Name": "deslorelin",
    "guid": "4e117cad-6a0e-4144-beb4-e86146b6e815",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "deslorelin",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"D-TRP-LHRH-PEA\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710437906, \"_nanoseconds\": 284000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Desmopressin\", \"url\": \"https://drugs.ncats.io/drug/ENR1LLB0FP\"}, {\"title\": \"National Drug Code Directory: Desmopressin\", \"url\": \"https://www.accessdata.fda.gov/scripts/cder/ndc/index.cfm\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S5: Diuretics and Masking Agents; Prescription drug",
    "Name": "desmopressin",
    "guid": "899a67bc-73cd-4c2d-93f7-ea873c88f555",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "desmopressin",
    "Reasons": "[{\"reason_code\": 6013, \"reason\": \"WADA S5: Diuretics and Masking Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b1ad44e4-cef0-4ae2-99fb-19e28540f282\", \"link_title\": \"WADA Prohibited List S5: Diuretics and Masking Agents\", \"updated\": {\"_seconds\": 1703682941, \"_nanoseconds\": 864000000}}, {\"reason_code\": 6016, \"reason\": \"Prescription drug\", \"link\": null, \"guid\": \"becae72e-580f-4d8d-8665-c0c4b1dc1381\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683249, \"_nanoseconds\": 70000000}}]",
    "other_names": "[\"Stimate\", \"Nocdurna\", \"DDAVP\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738948271, \"_nanoseconds\": 604000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "desomorphine",
    "guid": "55c92c48-7d48-48d4-96bd-5315446a9f78",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "desomorphine",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"6-deoxy-7,8-dihydromorphine\", \"dihydrodesoxymorphine-D\", \"4,5-epoxy-3-hydroxy-N-methylmorphinan\", \"Permonid\", \"crocodile\", \"desmorfin\", \"dihydrodeoxymorphine\", \"krokodil\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710432142, \"_nanoseconds\": 901000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "desoxymethyltestosterone",
    "guid": "3290e749-b35e-45d4-af1d-2c56d27d6aab",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "desoxymethyltestosterone",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}, {\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"17alpha-methyl-5alpha-androst-2-en-17beta-ol\", \"madol\", \"17alpha-methyl-5alpha-androst-3-en-17beta-ol\", \"17\u03b1-methyl-5\u03b1-androst-2-en-17\u03b2-ol\", \"17\u03b1-methyl-5\u03b1-androst-3-en-17\u03b2-ol\", \"Pheraplex\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1721138790, \"_nanoseconds\": 592000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "desoxytestosterone",
    "guid": "4dcd4910-d6d9-44ff-8b76-bac2e1055d0e",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "desoxytestosterone",
    "Reasons": "[{\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}, {\"reason_code\": 6014, \"reason\": \"DoDI 1010.16\", \"link\": \"https://www.esd.whs.mil/directives/issuances/dodi\", \"guid\": \"b757aa46-4729-4d4a-a32e-25ef0b04e5c3\", \"link_title\": \"Use or misuse prohibited under DoDI 1010.16\", \"updated\": {\"_seconds\": 1703683049, \"_nanoseconds\": 190000000}}]",
    "other_names": "[\"5\u03b1-androst-2-en-17\u03b2-ol\", \"5\u03b1-androst-3-en-17\u03b2-ol\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1722279512, \"_nanoseconds\": 63000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Dexfenfluramine hydrochloride\", \"url\": \"https://drugs.ncats.io/drug/PM28L0FHNP\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "dexfenfluramine",
    "guid": "e8ba5b98-1ab2-4880-b8e3-de1af6728af5",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "dexfenfluramine",
    "Reasons": "[{\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"Redux\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710431590, \"_nanoseconds\": 583000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "dextromoramide",
    "guid": "abd89b36-4329-4bfc-bd36-b321d2814784",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "dextromoramide",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"Jetrium\", \"Palfium\", \"Narcolo\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710431239, \"_nanoseconds\": 918000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV in dosage forms; sched II in bulk",
    "Name": "dextropropoxyphene",
    "guid": "c85840b9-12ea-4929-bf72-90f2aa664525",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "dextropropoxyphene",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}, {\"reason_code\": 6004, \"reason\": \"DEA Controlled Substance List: Schedule  II\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"207f9e17-8a22-4523-8dd6-24d9d39b4c45\", \"link_title\": \"DEA Controlled Substance List: Schedule  II\", \"updated\": {\"_seconds\": 1712942744, \"_nanoseconds\": 783000000}}]",
    "other_names": "[\"propoxyphene\", \"Darvon\", \"alpha-(+)-4-dimethylamino-1,2-diphenyl-3-methyl-2-propionoxybutane\", \"Darvocet\", \"Propacet\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710431186, \"_nanoseconds\": 247000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "diampromide",
    "guid": "3f4eb7c1-e0ca-48d1-af6e-5b77279ad27b",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "diampromide",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"N-[2-(methylphenethylamino)propyl]propionanilide\", \"propionanilide, N-(2-(methylphenethylamino)propyl)-\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710431074, \"_nanoseconds\": 830000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "diazepam",
    "guid": "69a9339b-8e9d-4eed-b046-da7176617121",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "diazepam",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"Valium\", \"Diastat\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710431034, \"_nanoseconds\": 463000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "dichloralphenazone",
    "guid": "fdf905b4-ed46-4a49-a99d-0be232c8b0b7",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "dichloralphenazone",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"dichloralantipyrine\", \"Midrin\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710431000, \"_nanoseconds\": 414000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S1: Anabolic Agents",
    "Name": "dienolone",
    "guid": "90becc57-4440-4789-b876-2235622cfd5b",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "dienolone",
    "Reasons": "[{\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"estra-4,9-dien-17b-ol-3-one\", \"17\u03b2-Hydroxy-estra-4,9-dien-3-one\", \"3-oxo-4,9-estradien-17beta-ol\", \"dienalone\", \"RU-3118\", \"9,10-dehydro-19-nortestosterone\", \"3-oxo-4,9-estradien-17\u03b2-ol\", \"RU 3118\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738948581, \"_nanoseconds\": 288000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "diethylpropion",
    "guid": "4d9d8366-abd2-4362-a1a4-04e651fdb32b",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "diethylpropion",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"diethylpropione\", \"Danylen\", \"amfepramon\", \"amphepramone\", \"Derfon\", \"Phepranon\", \"diethylpropion hydrochloride\", \"amphepramon\", \"Maruate\", \"Dobesin\", \"amfepramone\", \"Cegramine\", \"alpha-diethylaminopropiophenone\", \"amfepramonum\", \"Tepanil\", \"Frekentine\", \"Tenuate\", \"Neobes\", \"Regenon\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715353726, \"_nanoseconds\": 953000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "diethylthiambutene",
    "guid": "bf6bd6af-2fe8-42ff-a1ec-b4c19f04468b",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "diethylthiambutene",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710430395, \"_nanoseconds\": 651000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "diethyltryptamine",
    "guid": "8a1a56ff-c5cf-4bd7-af1a-064211c69891",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "diethyltryptamine",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"DET\", \"MiPT\", \"N,N-diethyltryptamine\", \"N-methyl-N-isopropyltryptamine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710429679, \"_nanoseconds\": 898000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "difenoxin",
    "guid": "fa816723-2d90-4c9c-bcf9-bb7aebf92669",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "difenoxin",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"Lyspafen\", \"Motofen\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710429639, \"_nanoseconds\": 267000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"FDA: Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks\", \"url\": \"https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Unapproved drug",
    "Name": "dihexa",
    "guid": "a8d20d41-6f5b-4b81-9c6c-47dcb1a2a447",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "dihexa",
    "Reasons": "[{\"reason_code\": 6018, \"reason\": \"FDA Statement\", \"link\": \"\", \"guid\": \"3cd17124-6ebc-4828-9edb-c20a81755502\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1711715334, \"_nanoseconds\": 457000000}}]",
    "other_names": "[\"PNB-0408\", \"N-hexanoic-Tyr-Ile-(6) aminohexanoic amide\", \"L-Isoleucinamide, N-(1-oxohexyl)-L-tyrosyl-N-(6-amino-6-oxohexyl)-\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1764088794, \"_nanoseconds\": 407000000}",
    "label_terms": "[]",
    "linked_ingredients": "[]",
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule II",
    "Name": "dihydrocodeine",
    "guid": "e3c493b0-8502-4ba9-8227-e41324c48af3",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "dihydrocodeine",
    "Reasons": "[{\"reason_code\": 6004, \"reason\": \"DEA Controlled Substance List: Schedule  II\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"207f9e17-8a22-4523-8dd6-24d9d39b4c45\", \"link_title\": \"DEA Controlled Substance List: Schedule  II\", \"updated\": {\"_seconds\": 1712942744, \"_nanoseconds\": 783000000}}]",
    "other_names": "[\"Parzone\", \"Didrate\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710429584, \"_nanoseconds\": 627000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule II",
    "Name": "dihydroetorphine",
    "guid": "4fb15b74-9db2-4e42-b06d-42193603a511",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "dihydroetorphine",
    "Reasons": "[{\"reason_code\": 6004, \"reason\": \"DEA Controlled Substance List: Schedule  II\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"207f9e17-8a22-4523-8dd6-24d9d39b4c45\", \"link_title\": \"DEA Controlled Substance List: Schedule  II\", \"updated\": {\"_seconds\": 1712942744, \"_nanoseconds\": 783000000}}]",
    "other_names": "[\"tetrahydro-7alpha-(1-hydroxy-1-methylbutyl)-6,14-endo-ethanooripavine\", \"DHE\", \"7,8-dihydro-7alpha-(1-(R)-hydroxy-1-methylbutyl)-6,14-endo-ethanotetrahydrooripavine\", \"18,19-dihydroetorphine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710429547, \"_nanoseconds\": 227000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "dihydromorphine",
    "guid": "4a6390ff-9c9e-4193-88db-a3e4f57165a2",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "dihydromorphine",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"7,8 dihydromorphine\", \"Paramorphan\", \"6-alpha-hydromorphol\", \"hydromorphine\", \"7,8-dihydromorphine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710429348, \"_nanoseconds\": 508000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "dimenoxadol",
    "guid": "9dc1a191-4908-4a3a-a9d9-d438eb0471bb",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "dimenoxadol",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"Lokarin\", \"2-(dimethylamino)ethyl ethoxydiphenylacetate\", \"dimenoxadole\", \"2-(dimethylamino)ethyl 2-ethoxy-2,2-diphenylacetate\", \"Estocine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710429288, \"_nanoseconds\": 884000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "dimepheptanol",
    "guid": "d92a4bd6-3f26-4a28-bd31-1359f48541a4",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "dimepheptanol",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"methadol\", \"racemethadol\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710429241, \"_nanoseconds\": 140000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "dimethandrolone",
    "guid": "e63a1cab-d687-40f3-9853-b39351f9a584",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "dimethandrolone",
    "Reasons": "[{\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"7alpha,11beta-dimethyl-19-nortestosterone\", \"7\u03b1,11\u03b2-dimethyl-19-nortestosterone\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709048986, \"_nanoseconds\": 196000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Use or misuse prohibited under DoDI 1010.16 (designer amphetamines)",
    "Name": "dimethoxymethamphetamine",
    "guid": "4b5d4297-ed53-48be-91e4-7f01ec9fadc9",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "dimethoxymethamphetamine",
    "Reasons": "[{\"reason_code\": 6014, \"reason\": \"DoDI 1010.16\", \"link\": \"https://www.esd.whs.mil/directives/issuances/dodi\", \"guid\": \"b757aa46-4729-4d4a-a32e-25ef0b04e5c3\", \"link_title\": \"Use or misuse prohibited under DoDI 1010.16\", \"updated\": {\"_seconds\": 1703683049, \"_nanoseconds\": 190000000}}]",
    "other_names": "[\"3,4-dimethoxymethamphetamine\", \"DMMA\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1711991670, \"_nanoseconds\": 191000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "dimethylthiambutene",
    "guid": "5529bbd4-b118-4f7b-99f6-7c9226b298f3",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "dimethylthiambutene",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"dimethibutin\", \"aminobutene\", \"3-dimethylamino-1,1-bis(2-thienyl)-1-butene\", \"N,N,1-trimethyl-3,3-di-2-thienylallylamine\", \"Ohton\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710428805, \"_nanoseconds\": 829000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "dimethyltrienolone",
    "guid": "5822d406-8e05-49af-914c-e8e87fe52fe6",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "dimethyltrienolone",
    "Reasons": "[{\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}, {\"reason_code\": 6014, \"reason\": \"DoDI 1010.16\", \"link\": \"https://www.esd.whs.mil/directives/issuances/dodi\", \"guid\": \"b757aa46-4729-4d4a-a32e-25ef0b04e5c3\", \"link_title\": \"Use or misuse prohibited under DoDI 1010.16\", \"updated\": {\"_seconds\": 1703683049, \"_nanoseconds\": 190000000}}]",
    "other_names": "[\"17\u03b2-Hydroxy-7\u03b1,17\u03b1-dimethyl-estra-4,9,11-trien-3-one\", \"RU-2420\", \"17beta-hydroxy-7alpha,17alpha-dimethyl-estra-4,9,11-trien-3-one\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1722279677, \"_nanoseconds\": 589000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "dimethyltryptamine",
    "guid": "0e202e71-8294-4bff-ae7a-259dbce4ca44",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "dimethyltryptamine",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"DMT\", \"N,N-dimethyltryptamine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1717527074, \"_nanoseconds\": 519000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: 2,4-dinotrophenol\", \"url\": \"https://drugs.ncats.io/drug/Q13SKS21MN\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S0: Non-approved Substances; Unapproved drug",
    "Name": "dinitrophenol",
    "guid": "a79374a6-54b0-4595-a9ea-efbc7757b23a",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "dinitrophenol",
    "Reasons": "[{\"reason_code\": 6008, \"reason\": \"WADA S0: Non-approved Substances\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"f321f8bd-47c9-42f3-bea6-f36eafa02ecf\", \"link_title\": \"WADA Prohibited List S0: Non-approved Substances\", \"updated\": {\"_seconds\": 1703682727, \"_nanoseconds\": 352000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"2.4-dinitrophenol\", \"2,4-dinitrophenol\", \"2,4-DNP\", \"Nitrophen\", \"Dnoc\", \"DNP\", \"Aldifen\", \"Dinosan\", \"Chemox\", \"Mitcal\", \"Metcal\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738949329, \"_nanoseconds\": 888000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "dioxaphetyl butyrate",
    "guid": "4da3d599-b81f-4fe8-a597-1240af973dcf",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "dioxaphetyl butyrate",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"ethyl 4-morpholino-2,2-diphenylbutyrate\", \"4-morpholinebutanoic acid, alpha,alpha-diphenyl-, ethyl ester\", \"Amidalgon\", \"Spasmoxal\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710428070, \"_nanoseconds\": 604000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule II",
    "Name": "diphenoxylate",
    "guid": "207dc094-e157-4666-b154-974f66a66fb2",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "diphenoxylate",
    "Reasons": "[{\"reason_code\": 6004, \"reason\": \"DEA Controlled Substance List: Schedule  II\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"207f9e17-8a22-4523-8dd6-24d9d39b4c45\", \"link_title\": \"DEA Controlled Substance List: Schedule  II\", \"updated\": {\"_seconds\": 1712942744, \"_nanoseconds\": 783000000}}]",
    "other_names": "[]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710428020, \"_nanoseconds\": 340000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "dipipanone",
    "guid": "689521ab-c712-43ee-803c-89cf28d9ec19",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "dipipanone",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"phenylpiperone HCl\", \"Wellconal\", \"Dipipan\", \"Diconal\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710427993, \"_nanoseconds\": 317000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Domagrozumab\", \"url\": \"https://drugs.ncats.io/drug/516MD5WQ24\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S4: Hormone and Metabolic Modulators; Unapproved drug",
    "Name": "domagrozumab",
    "guid": "86e65d6a-8044-4831-b9df-30743b434dcc",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "domagrozumab",
    "Reasons": "[{\"reason_code\": 6012, \"reason\": \"WADA S4: Hormone and Metabolic Modulators\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"ac1ba347-6d44-4a17-829d-e589bf33bbdb\", \"link_title\": \"WADA Prohibited List S4: Hormone and Metabolic Modulators\", \"updated\": {\"_seconds\": 1703682875, \"_nanoseconds\": 162000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"PF-06252616\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738949944, \"_nanoseconds\": 421000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule II",
    "Name": "dronabinol",
    "guid": "bda0df02-0dc7-454d-9631-0f14a7461467",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "dronabinol",
    "Reasons": "[{\"reason_code\": 6004, \"reason\": \"DEA Controlled Substance List: Schedule  II\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"207f9e17-8a22-4523-8dd6-24d9d39b4c45\", \"link_title\": \"DEA Controlled Substance List: Schedule  II\", \"updated\": {\"_seconds\": 1712942744, \"_nanoseconds\": 783000000}}]",
    "other_names": "[\"(6aR-trans)-6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo [b,d]pyran-1-ol\", \"(-)-delta-9-(trans)-tetrahydrocannabinol\", \"Syndros\", \"Marinol\", \"(-)-delta-9-trans\u00a0tetrahydrocannabinol\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1712170461, \"_nanoseconds\": 265000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "drostanolone",
    "guid": "1378b4d0-32b3-44d9-b47b-345f8940dede",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "drostanolone",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}, {\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"2(\u03b1)-methyldihydrotestosterone\", \"Masterone\", \"Drolban\", \"17\u03b2-hydroxy-2\u03b1-methyl-5\u03b1-androstan-3-one\", \"drostanolone enanthate\", \"Permastril\", \"Masterid\", \"Masteril\", \"Masteron\", \"drostanolone propionate\", \"17beta-hydroxy-2alpha-methyl-5alphaandrostan-3-one\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1716924674, \"_nanoseconds\": 205000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "drotebanol",
    "guid": "ec19be6f-2f15-4f69-bab6-8bf436696569",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "drotebanol",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"oxymethebanol\", \"Metabanyl\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710353493, \"_nanoseconds\": 795000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule II",
    "Name": "ecgonine",
    "guid": "b676dcdb-653a-4158-9c79-8bdecbb9b257",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "ecgonine",
    "Reasons": "[{\"reason_code\": 6004, \"reason\": \"DEA Controlled Substance List: Schedule  II\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"207f9e17-8a22-4523-8dd6-24d9d39b4c45\", \"link_title\": \"DEA Controlled Substance List: Schedule  II\", \"updated\": {\"_seconds\": 1712942744, \"_nanoseconds\": 783000000}}]",
    "other_names": "[\"cocaine precursor\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710353461, \"_nanoseconds\": 274000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Use or misuse prohibited under DoDI 1010.16 (cocaine metabolites)",
    "Name": "ecgonine methyl ester",
    "guid": "0df47b67-682e-44d8-ad3e-07baf6559346",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "ecgonine methyl ester",
    "Reasons": "[{\"reason_code\": 6014, \"reason\": \"DoDI 1010.16\", \"link\": \"https://www.esd.whs.mil/directives/issuances/dodi\", \"guid\": \"b757aa46-4729-4d4a-a32e-25ef0b04e5c3\", \"link_title\": \"Use or misuse prohibited under DoDI 1010.16\", \"updated\": {\"_seconds\": 1703683049, \"_nanoseconds\": 190000000}}]",
    "other_names": "[\"EME\", \"methylecgonine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710353347, \"_nanoseconds\": 826000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "elacestrant",
    "guid": "0fbb8dbd-5eaf-468b-9fc6-a905ad5223c0",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "elacestrant",
    "Reasons": "[{\"reason_code\": 6012, \"reason\": \"WADA S4: Hormone and Metabolic Modulators\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"ac1ba347-6d44-4a17-829d-e589bf33bbdb\", \"link_title\": \"WADA Prohibited List S4: Hormone and Metabolic Modulators\", \"updated\": {\"_seconds\": 1703682875, \"_nanoseconds\": 162000000}}]",
    "other_names": "[]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1735580270, \"_nanoseconds\": 58000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "eluxadoline",
    "guid": "9d6ad8fd-7302-4545-8178-8603ad071f9b",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "eluxadoline",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"VIBERZI\", \"5-[[[(2S)-2-amino-3-[4-aminocarbonyl)-2,6-dimethylphenyl]-1-oxopropyl][(1S)-1-(4-phenyl-1H-imidazol-2-yl)ethyl]amino]methyl]-2-methoxybenzoic acid\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710353277, \"_nanoseconds\": 100000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "embutramide",
    "guid": "5cf2f429-8e90-410c-852d-99bc82de2493",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "embutramide",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}]",
    "other_names": "[\"Tributane\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710352731, \"_nanoseconds\": 308000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Enobosarm\", \"url\": \"https://drugs.ncats.io/drug/O3571H3R8N\"}, {\"title\": \"FDA warns against using SARMs in body-building products\", \"url\": \"https://www.fda.gov/news-events/fda-brief/fda-brief-fda-warns-against-using-sarms-body-building-products\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S1: Anabolic Agents; Unapproved drug; FDA statement: SARMs",
    "Name": "enobosarm",
    "guid": "86d79e58-87cc-4a94-81a3-516b69d8c421",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "enobosarm",
    "Reasons": "[{\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}, {\"reason_code\": 6018, \"reason\": \"FDA Statement\", \"link\": \"\", \"guid\": \"3cd17124-6ebc-4828-9edb-c20a81755502\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1711715334, \"_nanoseconds\": 457000000}}]",
    "other_names": "[\"GTx 024\", \"MK-2866 ester\", \"MK-2866\", \"MK2866 acetate\", \"MK2866 acetate ester\", \"SARM S-22\", \"Ostarine acetic acid ester\", \"2-[[2-(diethylamino)acetyl]amino]-4-methyl-5-(2-methylsulfanylethyl)-1H-pyrrole-3- carboxamide\", \"Ostarinyl acetate\", \"Ostarine-O-Acetate\", \"MK2866\", \"GTx-024\", \"(S)-Ostarine\", \"Ostarine\", \"Ostarine acetate ester\", \"GTx024\", \"(2S)-3-(4-Cyanophenoxy)-N-(4-cyano-3-(trifluoromethyl)phenyl)-2-hydroxy-2-methylpropanamide\", \"MK2866 acetic acid ester\", \"S22\", \"propanamide, 3-(4-cyanophenoxy)-N-(4-cyano-3-(trifluoromethyl)phenyl)-2-hydroxy-2-methyl-, (2S)-\", \"S-22\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1744128270, \"_nanoseconds\": 242000000}",
    "label_terms": "[\"(2S)-3-(4-cyanophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide\"]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"url\": \"https://www.fda.gov/regulatory-information/search-fda-guidance-documents/small-entity-compliance-guide-final-rule-declaring-dietary-supplements-containing-ephedrine\", \"title\": \"Final Rule Declaring Dietary Supplements Containing Ephedrine Alkaloids Adulterated Because They Present an Unreasonable Risk\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Federal regulation passed specifically to ban ephedra due to unreasonable risk of illness or injury",
    "Name": "ephedra",
    "guid": "eeee07b1-b2ab-4c12-8d8f-bb937a61f9f9",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "ephedra",
    "Reasons": "[{\"reason_code\": 6021, \"reason\": \"Other reason\", \"link\": null, \"guid\": \"9bdb33d0-1759-4198-8056-bc40e52a3afd\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683326, \"_nanoseconds\": 656000000}}]",
    "other_names": "[\"epitonin\", \"Sida cordifolia Linn\", \"Ephedra intermedia\", \"heart-leaf sida\", \"Pinellia ternata\", \"Ephedra distachya\", \"country mallow\", \"Ma huang\", \"Ephedra sinica\", \"Ephedra equisentina\", \"Chinese ephedra\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1729699990, \"_nanoseconds\": 675000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"Final Rule Declaring Dietary Supplements Containing Ephedrine Alkaloids Adulterated Because They Present an Unreasonable Risk\", \"url\": \"https://www.federalregister.gov/documents/2004/02/11/04-2912/final-rule-declaring-dietary-supplements-containing-ephedrine-alkaloids-adulterated-because-they\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Federal regulation passed specifically to ban ephedra due to unreasonable risk of illness or injury",
    "Name": "ephedrine alkaloids",
    "guid": "eaddaa9e-ff30-4ce2-8419-794b481a8267",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "ephedrine alkaloids",
    "Reasons": "[{\"reason_code\": 6021, \"reason\": \"Other reason\", \"link\": null, \"guid\": \"9bdb33d0-1759-4198-8056-bc40e52a3afd\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683326, \"_nanoseconds\": 656000000}}]",
    "other_names": "[\"norephedrine\", \"ephedrine\", \"ephedra alkaloids\", \"N-pseudoephedrine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715362341, \"_nanoseconds\": 185000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S1: Anabolic Agents",
    "Name": "epi-dihydrotestosterone",
    "guid": "64001c67-d524-45ee-814a-d22289b090f0",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "epi-dihydrotestosterone",
    "Reasons": "[{\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"5\u03b2-DHT\", \"17-hydroxyandrostan-3-one\", \"epi-DHT\", \"5beta-DHT\", \"5\u03b2-dihydrotestosterone\", \"17\u03b2-hydroxyetiocholan-3-one\", \"17beta-hydroxyetiocholan-3-one\", \"etiocholan-17\u03b2-ol-3-on\", \"17\u03b2-hydroxy-5\u03b2-androstan-3-one\", \"17beta-hydroxy-5beta-androstan-3-one\", \"etiocholan-17beta-ol-3-on\", \"5beta-dihydrotestosterone\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738950685, \"_nanoseconds\": 991000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S1: Anabolic Agents",
    "Name": "epiandrosterone",
    "guid": "319f9e5d-8ccc-4afd-9a36-72d0d6b9adbb",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "epiandrosterone",
    "Reasons": "[{\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"5\u03b1-androstan-3\u03b2-ol-17-one\", \"isoandrosterone\", \"epiandrosterone (from pine pollen)\", \"3b-androsterone\", \"epiandrostenolone\", \"3\u03b2-hydroxy-5alpha-androstan-17-one\", \"3-hydroxy-androstane-17-one\", \"5alpha-androstan-3beta-ol-17-one\", \"3beta-hydroxy-5alpha-androstan-17-one azine\", \"3a-androsterone\", \"3\u03b2-androsterone\", \"3beta-hydroxy-5alpha-androstan-17-one\", \"trans-androsterone\", \"3beta-hydroxyetioallocholan-17-one\", \"epi-andro\", \"3\u03b2-hydroxyetioallocholan-5-ene-17-one\", \"3b-hydroxy-5a-androstan-17-one\", \"3\u03b2-hydroxy-5\u03b1-androstan-17-one\", \"3-epiandrosterone\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738950901, \"_nanoseconds\": 433000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "epistane",
    "guid": "ecc91182-b8b9-42a2-adea-c9232a6e2375",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "epistane",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}, {\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"hemapolin\", \"havoc\", \"2alpha,3alpha-epithio-17alpha-methyl-5alpha-androstan-17beta-ol\", \"17\u0251-Methylepithiostanol\", \"methylepitiostanol\", \"epi plex\", \"2,3-thioepoxy madol\", \"17\u03b1-Methylepithiostanol\", \"epitiostanol\", \"2\u03b1,3\u03b1-epithio-17\u03b1-methyl-5\u03b1-androstan-17\u03b2-ol\", \"2,3a-epithio-17a-methyletioallo cholan-17b-ol\", \"2\u03b1,3\u03b1-Epithio-5\u03b1-androstan-17\u03b1-methyl-17\u03b2-ol\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1721919575, \"_nanoseconds\": 620000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"FDA: Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks\", \"url\": \"https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "epitalon",
    "guid": "909d736c-4474-4463-ba87-afbdab914bd5",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "epitalon",
    "Reasons": "[{\"reason_code\": 6018, \"reason\": \"FDA Statement\", \"link\": \"\", \"guid\": \"3cd17124-6ebc-4828-9edb-c20a81755502\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1711715334, \"_nanoseconds\": 457000000}}]",
    "other_names": "[]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1764088596, \"_nanoseconds\": 191000000}",
    "label_terms": "[]",
    "linked_ingredients": "[]",
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Epitestosterone\", \"url\": \"https://drugs.ncats.io/drug/48L726977Z\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S1: Anabolic AgentsUnapproved drug",
    "Name": "epitestosterone",
    "guid": "3d4cf5e8-d31a-48a8-b1d4-9666751592f5",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "epitestosterone",
    "Reasons": "[{\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"cis-testosterone\", \"17-epitestosterone\", \"17alpha-testosterone\", \"17\u03b1-testosterone\", \"17alpha-hydroxyandrost-4-en-3-one\", \"androst-4-en-17\u03b1-ol-3-one\", \"isotestosterone\", \"epi-testosterone\", \"androst-4-en-17alpha-ol-3-one\", \"17\u03b1-hydroxyandrost-4-en-3-one\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738950999, \"_nanoseconds\": 69000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: 17.alpha.-trenbolone\", \"url\": \"https://drugs.ncats.io/drug/K7IGB634GT\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S1: Anabolic AgentsUnapproved drug",
    "Name": "epitrenbolone",
    "guid": "2e66ed91-9520-4394-aa0e-e35b61cdd142",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "epitrenbolone",
    "Reasons": "[{\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"alpha-trenbolone\", \"estra-4,9,11-trien-3-one, 17-hydroxy-, (17-alpha)-\", \"Epi-Tren\", \"17alpha-hydroxytrenbolone\", \"17\u03b1-trenbolone\", \"17-epitrenbolone\", \"\u03b1-trenbolone\", \"17alpha-trenbolone\", \"17\u03b1-hydroxytrenbolone\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738951130, \"_nanoseconds\": 789000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "epthiostane",
    "guid": "5a77bc26-03ca-45e4-b525-74cf0b167502",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "epthiostane",
    "Reasons": "[{\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}, {\"reason_code\": 6014, \"reason\": \"DoDI 1010.16\", \"link\": \"https://www.esd.whs.mil/directives/issuances/dodi\", \"guid\": \"b757aa46-4729-4d4a-a32e-25ef0b04e5c3\", \"link_title\": \"Use or misuse prohibited under DoDI 1010.16\", \"updated\": {\"_seconds\": 1703683049, \"_nanoseconds\": 190000000}}]",
    "other_names": "[\"17\u03b2-hydroxy-2\u03b1,3\u03b1-epithio-5\u03b1-androstane\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1722279478, \"_nanoseconds\": 977000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Erythropoietin\", \"url\": \"https://drugs.ncats.io/drug/64FS3BFH5W\"}, {\"title\": \"National Drug Code Directory: Erythropoietin\", \"url\": \"https://www.accessdata.fda.gov/scripts/cder/ndc/index.cfm\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S2: Peptide Hormones, Growth Factors, etc.; Prescription drug",
    "Name": "erythropoietin",
    "guid": "00f094f8-d7f5-4bf4-b792-00c859e960a1",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "erythropoietin",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}, {\"reason_code\": 6016, \"reason\": \"Prescription drug\", \"link\": null, \"guid\": \"becae72e-580f-4d8d-8665-c0c4b1dc1381\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683249, \"_nanoseconds\": 70000000}}]",
    "other_names": "[\"human erythropoietin\", \"Epogen\", \"epoetin theta\", \"epoetin epsilon\", \"epoetin kappa\", \"recombinant human erythropoietin\", \"epoetin zeta\", \"epoetin omega\", \"EPO\", \"epoetin alfa\", \"epoetin beta\", \"rEPO\", \"epoetin gamma\", \"EPOrh\", \"erythropoietin human recombinant\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1761914533, \"_nanoseconds\": 968000000}",
    "label_terms": "[]",
    "linked_ingredients": "[]",
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "erythropoietin Fc",
    "guid": "f236c464-d18b-4f9a-9a02-0d4c550d26fa",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "erythropoietin fc",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}]",
    "other_names": "[\"EPO-Fc\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709049037, \"_nanoseconds\": 651000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "estazolam",
    "guid": "634c5b70-b198-43e4-9c8e-c5904cec8536",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "estazolam",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"Eurodin\", \"Domnamid\", \"Nuctalon\", \"ProSom\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710254216, \"_nanoseconds\": 23000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "estra-4,9,11-triene-3,17-dione",
    "guid": "fecc5f92-5ee8-495e-8678-e631a4fabfcb",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "estra-4,9,11-triene-3,17-dione",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}, {\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"trendione\", \"trenavar\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1720803717, \"_nanoseconds\": 903000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Ethamivan\", \"url\": \"https://drugs.ncats.io/drug/M44O63YPV9\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Unapproved drug",
    "Name": "etamivan",
    "guid": "4629d3c9-8e16-4e63-a293-56993d640d80",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "etamivan",
    "Reasons": "[{\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"Cardiovanil\", \"Corivanil\", \"Sevanil\", \"Diethamivan\", \"Emivan\", \"Diethylvanillamide\", \"etamivanum\", \"vanillic acid diethylamide\", \"Vandid\", \"ethamivan\", \"Analepticon\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715362555, \"_nanoseconds\": 554000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Ethacrynic acid\", \"url\": \"https://drugs.ncats.io/drug/M5DP350VZV\"}, {\"title\": \"National Drug Code Directory: Ethacrynic acid\", \"url\": \"https://www.accessdata.fda.gov/scripts/cder/ndc/index.cfm\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S5: Diuretics and Masking Agents; Prescription drug",
    "Name": "ethacrynic acid",
    "guid": "fb7296c8-2135-4ef4-8650-3a63b7c7d558",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "ethacrynic acid",
    "Reasons": "[{\"reason_code\": 6013, \"reason\": \"WADA S5: Diuretics and Masking Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b1ad44e4-cef0-4ae2-99fb-19e28540f282\", \"link_title\": \"WADA Prohibited List S5: Diuretics and Masking Agents\", \"updated\": {\"_seconds\": 1703682941, \"_nanoseconds\": 864000000}}, {\"reason_code\": 6016, \"reason\": \"Prescription drug\", \"link\": null, \"guid\": \"becae72e-580f-4d8d-8665-c0c4b1dc1381\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683249, \"_nanoseconds\": 70000000}}]",
    "other_names": "[\"etacrynic acid\", \"sodium ethacrynate\", \"ethacrinic acid\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738951760, \"_nanoseconds\": 106000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "ethchlorvynol",
    "guid": "bb6fcada-864e-4786-af22-dec5f48a576b",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "ethchlorvynol",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"Placidyl\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710253247, \"_nanoseconds\": 840000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "ethinamate",
    "guid": "26bb7ed0-ba74-4f50-95aa-5dd274f72647",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "ethinamate",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"Valmid\", \"Valamin\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710253218, \"_nanoseconds\": 328000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "ethyl loflazepate",
    "guid": "e1994b07-b18d-463e-aa1b-e9007cb22075",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "ethyl loflazepate",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"Meilax\", \"Ronlax\", \"Victan\", \"ethyl 7-chloro-2,3-dihydro-5-(2-fluorophenyl)-2-OXO-1H-1,4-benzodiazepine-3-carboxylate\", \"CM 6912\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710179765, \"_nanoseconds\": 587000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "ethylestrenol",
    "guid": "2efb2842-e5e6-4dfb-80b2-4e9a67120b02",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "ethylestrenol",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}, {\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"Maxibolin\", \"Orabolin\", \"17alpha-ethyl-17beta-hydroxyestr-4-ene\", \"17\u03b1-ethyl-17\u03b2-hydroxyestr-4-ene\", \"Duraboral\", \"Durabolin-O\", \"19-norpregna-4-en-17\u03b1-ol\", \"19-norpregna-4-en-17\u0251-ol\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1727714368, \"_nanoseconds\": 976000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "ethylmethylthiambutene",
    "guid": "9ba9e998-aa56-4bbb-bb8d-3482a4f40d18",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "ethylmethylthiambutene",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710179398, \"_nanoseconds\": 259000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule II",
    "Name": "ethylmorphine",
    "guid": "99900bae-aa1e-46fa-b9da-eac1bdf98abd",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "ethylmorphine",
    "Reasons": "[{\"reason_code\": 6004, \"reason\": \"DEA Controlled Substance List: Schedule  II\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"207f9e17-8a22-4523-8dd6-24d9d39b4c45\", \"link_title\": \"DEA Controlled Substance List: Schedule  II\", \"updated\": {\"_seconds\": 1712942744, \"_nanoseconds\": 783000000}}]",
    "other_names": "[\"Dionin\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710179372, \"_nanoseconds\": 45000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "ethylone",
    "guid": "1df02693-5830-4934-8422-e54d339405bc",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "ethylone",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"MDEC\", \"3,4-methylenedioxy-N-ethylcathinone\", \"bk-MDEA\", \"\u03b2k-MDEA\", \"1-(1,3-benzodioxol-5-yl)-2-(ethylamino)propan-1-one\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710178851, \"_nanoseconds\": 714000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Ethylphenidate, threo-\", \"url\": \"https://drugs.ncats.io/drug/984DG861KD\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Unapproved drug",
    "Name": "ethylphenidate",
    "guid": "857187e4-5f5c-4316-aca9-4b45343c5b59",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "ethylphenidate",
    "Reasons": "[{\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"EPH\", \"ethylphenidate, threo-\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1751288429, \"_nanoseconds\": 356000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Etilefrine\", \"url\": \"https://drugs.ncats.io/drug/ZB6F8MY53V\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Unapproved drug",
    "Name": "etilefrine",
    "guid": "9326b9d0-1a7e-406a-a36f-4e89452984f9",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "etilefrine",
    "Reasons": "[{\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"etilefrina\", \"Eti-Puren\", \"Effortil\", \"etilefrin\", \"ethyl Adrianol\", \"Efortil\", \"ethylnorphenylephrine\", \"Bioflutin\", \"ethylephrine\", \"Circupon\", \"ethyladrianol\", \"etilefrine pivalate hydrochloride\", \"ethyladrianol\", \"Eti Puren\", \"etilephrine\", \"etilefrine hydrochloride\", \"etilefrinum\", \"ethylphenylephrine\", \"Cardanat\", \"Thomasin\", \"ethyl noradrianol\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715363442, \"_nanoseconds\": 507000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "etiocholanolone",
    "guid": "0324cc50-3176-41cf-81be-9600b3d24850",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "etiocholanolone",
    "Reasons": "[{\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}, {\"reason_code\": 6014, \"reason\": \"DoDI 1010.16\", \"link\": \"https://www.esd.whs.mil/directives/issuances/dodi\", \"guid\": \"b757aa46-4729-4d4a-a32e-25ef0b04e5c3\", \"link_title\": \"Use or misuse prohibited under DoDI 1010.16\", \"updated\": {\"_seconds\": 1703683049, \"_nanoseconds\": 190000000}}]",
    "other_names": "[\"5-isoandrosterone\", \"3alpha-hydroxy-5beta-androstan-17-one\", \"3\u03b1-hydroxy-5\u03b2-androstan-17-one\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1722279463, \"_nanoseconds\": 425000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "etodesnitazene",
    "guid": "71f05dfd-4532-4812-9f81-b4bf6b4b363e",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "etodesnitazene",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"Etazone\", \"benzimidazole, 1-(2-(diethylamino)ethyl)-2-(p-ethoxybenzyl)-\", \"1H-benzimidazole-1-ethanamine, 2-((4-ethoxyphenyl)methyl)-N,N-diethyl-\", \"2-(2-(4-ethoxybenzyl)-1Hbenzimadazol-1-yl)-N,N-diethylethan-1-amine\", \"2-((4-ethoxyphenyl)methyl)-N,N-diethyl-1H-benzimidazole-1-ethanamine\", \"(2-(2-(4-ethoxybenzyl)-1H-benzimidazol-1-yl)-N,N-diethylethan-1- amine)\", \"Desnitroetonitazene\", \"Etazen\", \"Etazene\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1711987719, \"_nanoseconds\": 244000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "etonitazene",
    "guid": "b5e799a8-bc27-4d1b-9308-364c8721f8fc",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "etonitazene",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"Chinese Dwarf\", \"1-(2-(diethylamino)ethyl)-2-(p-ethoxybenzyl)-5-nitrobenzimidazole\", \"etonitazine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710178249, \"_nanoseconds\": 410000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "etorphine",
    "guid": "d20a7092-5fca-4623-9256-dd586b4e88c2",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "etorphine",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710178062, \"_nanoseconds\": 979000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule II",
    "Name": "etorphine hydrochloride",
    "guid": "121a71f6-6c3c-46ee-b08a-42deb7fe44be",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "etorphine hydrochloride",
    "Reasons": "[{\"reason_code\": 6004, \"reason\": \"DEA Controlled Substance List: Schedule  II\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"207f9e17-8a22-4523-8dd6-24d9d39b4c45\", \"link_title\": \"DEA Controlled Substance List: Schedule  II\", \"updated\": {\"_seconds\": 1712942744, \"_nanoseconds\": 783000000}}]",
    "other_names": "[\"M 99\", \"etorphine HCl\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710178040, \"_nanoseconds\": 538000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "etoxeridine",
    "guid": "e15837fc-46f0-462f-a519-5b591844f6d6",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "etoxeridine",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"Wy-2039\", \"Carbetidine\", \"Atenos\", \"isonipecotic acid, 1-(2-(2-hydroxyethoxy)ethyl)-4-phenyl-, ethyl ester\", \"ethyl 1-[2-(2-hydroxyethoxy)ethyl]-4-phenylpiperidine-4-carboxylate\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710177993, \"_nanoseconds\": 91000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "eutylone",
    "guid": "b942b9fe-3592-438f-b25a-6ae8a2e11d5f",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "eutylone",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"1-(1,3-benzodioxol-5-yl)-2(ethylamino)butan-1-one\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710177854, \"_nanoseconds\": 786000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Examorelin\", \"url\": \"https://drugs.ncats.io/drug/09QF37C617\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S2: HormonesUnapproved drug",
    "Name": "examorelin",
    "guid": "3078c159-5e07-4857-8e6d-c0fd392123e9",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "examorelin",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"hexarelin\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710177802, \"_nanoseconds\": 802000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Exemestane\", \"url\": \"https://drugs.ncats.io/drug/NY22HMQ4BX\"}, {\"title\": \"National Drug Code Directory: Exemestane\", \"url\": \"https://www.accessdata.fda.gov/scripts/cder/ndc/index.cfm\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S4: Hormone and Metabolic ModulatorsPrescription drug",
    "Name": "exemestane",
    "guid": "b799d5f9-729c-43fa-b8ae-a06f777c308f",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "exemestane",
    "Reasons": "[{\"reason_code\": 6012, \"reason\": \"WADA S4: Hormone and Metabolic Modulators\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"ac1ba347-6d44-4a17-829d-e589bf33bbdb\", \"link_title\": \"WADA Prohibited List S4: Hormone and Metabolic Modulators\", \"updated\": {\"_seconds\": 1703682875, \"_nanoseconds\": 162000000}}, {\"reason_code\": 6016, \"reason\": \"Prescription drug\", \"link\": null, \"guid\": \"becae72e-580f-4d8d-8665-c0c4b1dc1381\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683249, \"_nanoseconds\": 70000000}}]",
    "other_names": "[\"androsta-1,4-diene-3,17-dione, 6-methylene-\", \"PNU 155971\", \"6-methylene-androsta-1,4-diene-3,17-dione\", \"PNU-155971\", \"CCRIS 9351\", \"Aromasin\", \"6-methyleneandrosta-1,4-diene-3,17-dione\", \"FCE 24304\", \"FCE-24304\", \"HSDB 7463\", \"Aromasine\", \"6-methylenandrosta-1,4-diene-3,17-dione\", \"examestane\", \"Aromasil\", \"exemestano\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1761914142, \"_nanoseconds\": 839000000}",
    "label_terms": "[]",
    "linked_ingredients": "[]",
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule V",
    "Name": "ezogabine",
    "guid": "4d2f19fa-595b-4724-99a3-6e59e3088c9f",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "ezogabine",
    "Reasons": "[{\"reason_code\": 6007, \"reason\": \"DEA Controlled Substance List: Schedule V\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"d5b1da64-60db-4afa-af32-8491827c3497\", \"link_title\": \"DEA Controlled Substance List: Schedule V\", \"updated\": {\"_seconds\": 1712942766, \"_nanoseconds\": 551000000}}]",
    "other_names": "[\"Potiga\", \"N-[2-amino-4-(4-fluorobenzylamino)-phenyl]-carbamic acid ethyl ester\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710177467, \"_nanoseconds\": 3000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Famprofazone\", \"url\": \"https://drugs.ncats.io/drug/HN0NCX453C\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Unapproved drug",
    "Name": "famprofazone",
    "guid": "354e05e1-0052-432e-bd24-629b838336f5",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "famprofazone",
    "Reasons": "[{\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"famprofazone hydrochloride\", \"4-isopropyl-2-methyl-3-(N-methyl-N-(\u03b1-methylphenylethyl)aminomethyl)-1-phenyl-3-pyrazolin-5-one\", \"famprofazon\", \"4-isopropyl-2-methyl-3-(N-methyl-N-(alpha-methylphenylethyl)aminomethyl)-1-phenyl-3-pyrazolin-5-one\", \"famprofazonum\", \"Geodowin\", \"famprofazona\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715367321, \"_nanoseconds\": 556000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Fenbutrazate\", \"url\": \"https://drugs.ncats.io/drug/BKY8H56395\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Unapproved drug",
    "Name": "fenbutrazate",
    "guid": "df68edf0-8e70-4d43-a43a-8de86b6eee2f",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "fenbutrazate",
    "Reasons": "[{\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"phenbutrazate\", \"fenbutrazatum\", \"phenbutrazatum\", \"fenbutrazato\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715367474, \"_nanoseconds\": 226000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "fencamfamin",
    "guid": "c2f1dd12-4a3a-43c2-9628-4bd1a5ac329e",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "fencamfamin",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"Reactivan\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715367526, \"_nanoseconds\": 674000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Use or misuse prohibited under DoDI 1010.16 (amphetamines)",
    "Name": "fencamine",
    "guid": "6ec06801-00bb-414c-9927-7ea1381e6763",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "fencamine",
    "Reasons": "[{\"reason_code\": 6014, \"reason\": \"DoDI 1010.16\", \"link\": \"https://www.esd.whs.mil/directives/issuances/dodi\", \"guid\": \"b757aa46-4729-4d4a-a32e-25ef0b04e5c3\", \"link_title\": \"Use or misuse prohibited under DoDI 1010.16\", \"updated\": {\"_seconds\": 1703683049, \"_nanoseconds\": 190000000}}]",
    "other_names": "[\"Sicoclor\", \"1,3,7-trimethyl-8-[2-[methyl(1-phenylpropan-2-yl)amino]ethylamino]purine-2,6-dione\", \"Altimina\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715354766, \"_nanoseconds\": 9000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "fenethylline",
    "guid": "02bb35fd-b030-4aee-a645-11ae194a56ce",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "fenethylline",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"amfetyline\", \"ethyltheophylline amphetamine\", \"fenetylline\", \"Captagon\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715355015, \"_nanoseconds\": 617000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Fenoterol\", \"url\": \"https://drugs.ncats.io/drug/22M9P70OQ9\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S3: Beta-2 AgonistsUnapproved drug",
    "Name": "fenoterol",
    "guid": "26a44e95-3618-435b-a816-81d03349e032",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "fenoterol",
    "Reasons": "[{\"reason_code\": 6011, \"reason\": \"WADA S3: Beta-2 Agonists\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"aecafa3b-c7ad-413c-bc5f-be7ed5b2f69d\", \"link_title\": \"WADA Prohibited List S3: Beta-2 Agonists\", \"updated\": {\"_seconds\": 1703682857, \"_nanoseconds\": 73000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"(1RS)-1-(3,5-dihydroxyphenyl)-2-(((1RS)-2-(4-hydroxyphenyl)-1-methylethyl)amino)ethanol\", \"3,5-dihydroxy-alpha-(((P-hydroxy-alpha-methylphenethyl)amino)methyl)benzyl alcohol\", \"3,5-dihydroxy-\u03b1-(((P-hydroxy-\u03b1-methylphenethyl)amino)methyl)benzyl alcohol\", \"1,3-benzenediol, 5-(1-hydroxy-2-((2-(4-hydroxyphenyl)-1-methylethyl)amino)ethyl)-\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710176827, \"_nanoseconds\": 561000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "fenproporex",
    "guid": "094e1961-0884-47ce-b8fe-ba56323ce2ff",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "fenproporex",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"Solvolip\", \"Gacilin\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715355118, \"_nanoseconds\": 969000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule II",
    "Name": "fentanyl",
    "guid": "f9689e4f-e1c7-4d02-9550-f526c4eaf113",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "fentanyl",
    "Reasons": "[{\"reason_code\": 6004, \"reason\": \"DEA Controlled Substance List: Schedule  II\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"207f9e17-8a22-4523-8dd6-24d9d39b4c45\", \"link_title\": \"DEA Controlled Substance List: Schedule  II\", \"updated\": {\"_seconds\": 1712942744, \"_nanoseconds\": 783000000}}]",
    "other_names": "[\"Actiq\", \"Innovar\", \"Duragesic\", \"Oralet\", \"Sublimaze\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710176681, \"_nanoseconds\": 417000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "fentanyl carbamate",
    "guid": "915cbd27-8d44-45ac-89ce-dc0bf46f2e2a",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "fentanyl carbamate",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"ethyl (1-phenethylpiperidin-4-yl)(phenyl)carbamate\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738952895, \"_nanoseconds\": 258000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "fludiazepam",
    "guid": "003b675b-fa8a-41cb-a820-487c6985726b",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "fludiazepam",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710176603, \"_nanoseconds\": 809000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "flunitazene",
    "guid": "eb1e9c54-e06b-4717-82ab-eb2710217c75",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "flunitazene",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"1H-benzimidazole-1-ethanamine, N,N-diethyl-2-((4-fluorophenyl)methyl)-5-nitro-\", \"benzimidazole, 1-(2-(diethylamino)ethyl)-2-(p-fluorobenzyl)-5-nitro-\", \"N,N-diethyl-2-((4-fluorophenyl)methyl)-5-nitro-1H-benzimidazole-1-ethanamine\", \"N,N-diethyl-2-(2-(4-fluorobenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710176569, \"_nanoseconds\": 187000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "flunitrazepam",
    "guid": "5c8eac88-5a61-4503-b47c-f794045298d0",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "flunitrazepam",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"Roipnol\", \"Rohypnol\", \"Narcozep\", \"Darkene\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710176422, \"_nanoseconds\": 561000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "fluoxymesterone",
    "guid": "72f88d26-203e-48b8-b346-8c761f66ed57",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "fluoxymesterone",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}, {\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"Ora-Testryl\", \"Halotestin\", \"Stenox\", \"Android-F\", \"Androxy\", \"9-fluoro-17\u03b1-methyl-11\u03b2,17\u03b2-dihydroxyandrost-4-en-3-one\", \"9\u03b1-Fluoro-11\u03b2,17\u03b2-dihydroxy-17\u03b1-methylandrost-4-en-3-one\", \"9-fluoro-17alpha-methyl-11beta,17beta-dihydroxyandrost-4-en-3-one\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1721225116, \"_nanoseconds\": 926000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "flurazepam",
    "guid": "9848ab06-9acc-43b9-bab5-8002eb3085dc",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "flurazepam",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"Dalmane\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710175829, \"_nanoseconds\": 938000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Follistatin\", \"url\": \"https://drugs.ncats.io/drug/506IY26H2I\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S4: Hormone and Metabolic Modulators",
    "Name": "follistatin",
    "guid": "c7544716-a80e-4308-9afe-b90e22706d11",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "follistatin",
    "Reasons": "[{\"reason_code\": 6012, \"reason\": \"WADA S4: Hormone and Metabolic Modulators\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"ac1ba347-6d44-4a17-829d-e589bf33bbdb\", \"link_title\": \"WADA Prohibited List S4: Hormone and Metabolic Modulators\", \"updated\": {\"_seconds\": 1703682875, \"_nanoseconds\": 162000000}}]",
    "other_names": "[\"activin-binding protein\", \"FST\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738953293, \"_nanoseconds\": 113000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Fonturacetam\", \"url\": \"https://drugs.ncats.io/drug/99QW5JU66Y\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Unapproved drug",
    "Name": "fonturacetam",
    "guid": "e9740c63-ae79-4828-bb65-0afc8f663ee6",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "fonturacetam",
    "Reasons": "[{\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"phenotropil\", \"Carphedone\", \"phenylpiracetam\", \"carphedon\", \"4-phenylpiracetam\", \"Karfedon\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715355160, \"_nanoseconds\": 273000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "formebolone",
    "guid": "155b7f74-46e1-4f39-8179-c59cc736a7ce",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "formebolone",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}, {\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"2-formyl-17alpha-methyl-11alpha,17beta-dihydroxyandrost-1,4-dien-3-one\", \"Hubernol\", \"Esiclene\", \"2-formyl-17\u03b1-methyl-11\u03b1,17\u03b2-dihydroxyandrost-1,4-dien-3-one\", \"2-Formyl-17\u03b1-methyl-1,4-androsta-1,4-dien-11\u03b1,17\u03b2-diol-3- one\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1722271584, \"_nanoseconds\": 960000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Formestane\", \"url\": \"https://drugs.ncats.io/drug/PUB9T8T355\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III; WADA S4: Hormone and Metabolic ModulatorsUnapproved drug",
    "Name": "formestane",
    "guid": "3f512445-4025-4845-b757-a7b429df845b",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "formestane",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}, {\"reason_code\": 6012, \"reason\": \"WADA S4: Hormone and Metabolic Modulators\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"ac1ba347-6d44-4a17-829d-e589bf33bbdb\", \"link_title\": \"WADA Prohibited List S4: Hormone and Metabolic Modulators\", \"updated\": {\"_seconds\": 1703682875, \"_nanoseconds\": 162000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"4-hydroxy-androst-4-ene-3,17-dione[3,2-c]pyrazole-5\u03b1-androstan-17\u03b2-ol\", \"4-hydroxy-androst-4-ene-3,17-dione\", \"4-hydroxy-androst-4-ene-3,17-dione[3,2-c]pyrazole-5alpha-androstan-17beta-ol\", \"4-hydroxy-\u0394(sub 4)-androstenedione\", \"4-hydroxyandrost-4-ene-3,17-dione\", \"4-OH-A\", \"CGP 32 349\", \"4-OHA\", \"4-hydroxyandrostenedione\", \"4-hydroxy-4-androstene-3,17-dione\", \"Lentaron\", \"CGP-32349\", \"NSC 282175\", \"CGP 32349\", \"CCRIS 7483\", \"4-hydroxyandrostene-3,17-dione\", \"4-hydroxy-delta(sub 4)-androstenedione\", \"BRN 1889793\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738953485, \"_nanoseconds\": 550000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Formoterol\", \"url\": \"https://drugs.ncats.io/drug/5ZZ84GCW8B\"}, {\"title\": \"National Drug Code Directory: Formoterol\", \"url\": \"https://www.accessdata.fda.gov/scripts/cder/ndc/index.cfm\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S3: Beta-2 AgonistsPrescription drug",
    "Name": "formoterol",
    "guid": "a4a8520a-b19d-4daf-b2fa-712fe5e8d822",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "formoterol",
    "Reasons": "[{\"reason_code\": 6011, \"reason\": \"WADA S3: Beta-2 Agonists\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"aecafa3b-c7ad-413c-bc5f-be7ed5b2f69d\", \"link_title\": \"WADA Prohibited List S3: Beta-2 Agonists\", \"updated\": {\"_seconds\": 1703682857, \"_nanoseconds\": 73000000}}, {\"reason_code\": 6016, \"reason\": \"Prescription drug\", \"link\": null, \"guid\": \"becae72e-580f-4d8d-8665-c0c4b1dc1381\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683249, \"_nanoseconds\": 70000000}}]",
    "other_names": "[\"eformoterol\", \"formamide, N-(2-hydroxy-5-(1-hydroxy-2-((2-(4-methoxyphenyl)-1-methylethyl)amino)ethyl)phenyl)-\", \"Oxis\u00ae Turbuhaler\u00ae \"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1761926083, \"_nanoseconds\": 657000000}",
    "label_terms": "[]",
    "linked_ingredients": "[]",
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "fospropofol",
    "guid": "430a18e1-a130-41f4-947d-ed9e1990a055",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "fospropofol",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"Lusedra\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710175208, \"_nanoseconds\": 528000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Fulvestrant\", \"url\": \"https://drugs.ncats.io/drug/22X328QOC4\"}, {\"title\": \"National Drug Code Directory: Fulvestrant\", \"url\": \"https://www.accessdata.fda.gov/scripts/cder/ndc/index.cfm\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S4: Hormone and Metabolic ModulatorsPrescription drug",
    "Name": "fulvestrant",
    "guid": "36b59d76-1fa1-424b-b547-07f5f7335961",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "fulvestrant",
    "Reasons": "[{\"reason_code\": 6012, \"reason\": \"WADA S4: Hormone and Metabolic Modulators\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"ac1ba347-6d44-4a17-829d-e589bf33bbdb\", \"link_title\": \"WADA Prohibited List S4: Hormone and Metabolic Modulators\", \"updated\": {\"_seconds\": 1703682875, \"_nanoseconds\": 162000000}}, {\"reason_code\": 6016, \"reason\": \"Prescription drug\", \"link\": null, \"guid\": \"becae72e-580f-4d8d-8665-c0c4b1dc1381\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683249, \"_nanoseconds\": 70000000}}]",
    "other_names": "[\"ZM182780\", \"ICI 182,780\", \"ICI-182780\", \"ICI 182780\", \"7-(9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl)estra-1,3,5(10)-triene-3,17-diol\", \"ZM 182780\", \"ICI182780\", \"ZM-182780\", \"Faslodex\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738953849, \"_nanoseconds\": 697000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "furanyl fentanyl",
    "guid": "e13e57f7-9abe-4253-862c-a198188a8fe3",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "furanyl fentanyl",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710174841, \"_nanoseconds\": 257000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "furazabol",
    "guid": "8e0d7e70-4ada-4c84-8942-564b1994653e",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "furazabol",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}, {\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"furazabolum\", \"17alpha-methyl-17beta\u00ad-hydroxyandrostano[2,3-c]-furazan\", \"Furuza\", \"17\u03b1-methyl [1,2,5]oxadiazolo[3',4':2,3]-5\u03b1-androstan-17\u03b2-ol\", \"Frazalon\", \"androfurazanol\", \"Qu Zhi Shu\", \"Miotolon\", \"17\u03b1-methyl-17\u03b2-hydroxyandrostano[2,3-c]-furazan\", \"17\u0251-methyl [1,2,5] oxadiazolo[3\u2019,4\u2019:2,3]-5\u0251-androstan-17\u00df-ol\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1727714541, \"_nanoseconds\": 525000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "furethidine",
    "guid": "aed25ff3-fb25-4528-8a0a-18eeaacd553c",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "furethidine",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"1-(2-tetrahydrofurfuryloxyethyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester\", \"ethyl 4-phenyl-1-(2-tetrahydrofurfuryloxyethyl)piperidine-4-carboxylate\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710174370, \"_nanoseconds\": 450000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Furfenorex\", \"url\": \"https://drugs.ncats.io/drug/X83CZ0Y5TF\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Use or misuse prohibited under DoDI 1010.16 (amphetamines)",
    "Name": "furfenorex",
    "guid": "34b0ab49-6928-4edc-bdef-accc13ef501e",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "furfenorex",
    "Reasons": "[{\"reason_code\": 6014, \"reason\": \"DoDI 1010.16\", \"link\": \"https://www.esd.whs.mil/directives/issuances/dodi\", \"guid\": \"b757aa46-4729-4d4a-a32e-25ef0b04e5c3\", \"link_title\": \"Use or misuse prohibited under DoDI 1010.16\", \"updated\": {\"_seconds\": 1703683049, \"_nanoseconds\": 190000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"furfurylmethylamphetamine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715355203, \"_nanoseconds\": 425000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Furosemide\", \"url\": \"https://drugs.ncats.io/drug/7LXU5N7ZO5\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S5: Diuretics and Masking AgentsPrescription drug",
    "Name": "furosemide",
    "guid": "4b65c6cf-e552-4799-b621-893f5ce8ccd3",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "furosemide",
    "Reasons": "[{\"reason_code\": 6013, \"reason\": \"WADA S5: Diuretics and Masking Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b1ad44e4-cef0-4ae2-99fb-19e28540f282\", \"link_title\": \"WADA Prohibited List S5: Diuretics and Masking Agents\", \"updated\": {\"_seconds\": 1703682941, \"_nanoseconds\": 864000000}}, {\"reason_code\": 6016, \"reason\": \"Prescription drug\", \"link\": null, \"guid\": \"becae72e-580f-4d8d-8665-c0c4b1dc1381\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683249, \"_nanoseconds\": 70000000}}]",
    "other_names": "[\"Lasix\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738954240, \"_nanoseconds\": 115000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"FDA Warning Letter\", \"url\": \"https://web.archive.org/web/20041108022715/http:/www.fda.gov/foi/warning_letters/g3741d.htm\"}, {\"title\": \"NIH NCATS Inxight Drugs entry: Galantamine\", \"url\": \"https://drugs.ncats.io/drug/0D3Q044KCA\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "galantamine",
    "guid": "3d13af47-278b-4e02-a602-9e1874e8d3df",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "galantamine",
    "Reasons": "[{\"reason_code\": 6019, \"reason\": \"FDA Warning Letter\", \"link\": null, \"guid\": \"1cd0ab89-14ce-43c2-a804-e4b29b8780fe\", \"link_title\": null, \"updated\": {\"_seconds\": 1711571477, \"_nanoseconds\": 43000000}}, {\"reason_code\": 6016, \"reason\": \"Prescription drug\", \"link\": null, \"guid\": \"becae72e-580f-4d8d-8665-c0c4b1dc1381\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683249, \"_nanoseconds\": 70000000}}]",
    "other_names": "[\"Razadyne ER\", \"Razadyne\", \"Galantamine HBr\", \"Galantamine hydrobromide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1751040535, \"_nanoseconds\": 842000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "gamma hydroxybutyric acid",
    "guid": "3db41ab3-74e7-42fc-856d-9fb36385233c",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "gamma hydroxybutyric acid",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"Anetamin\", \"4-hydroxybutanoic acid\", \"gamma-hydroxybutyric acid\", \"GHB\", \"4-hydroxybutyrate\", \"4-hydroxybutyric acid\", \"Xyrem\", \"sodium oxybutyrate\", \"sodium oxybate\", \"gamma-hydroxybutyrate\", \"gamma hydroxybutyrate\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710174187, \"_nanoseconds\": 961000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "gamma-butyrolactone",
    "guid": "2d9b3183-bf72-41b6-9c9e-e305e2b45026",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "gamma-butyrolactone",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"gamma butyrolactone\", \"GBL\", \"4-butyrolactone \"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1711994276, \"_nanoseconds\": 848000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule V",
    "Name": "ganaxolone",
    "guid": "e38c2a73-0d19-466e-b098-b1fd068f1e02",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "ganaxolone",
    "Reasons": "[{\"reason_code\": 6007, \"reason\": \"DEA Controlled Substance List: Schedule V\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"d5b1da64-60db-4afa-af32-8491827c3497\", \"link_title\": \"DEA Controlled Substance List: Schedule V\", \"updated\": {\"_seconds\": 1712942766, \"_nanoseconds\": 551000000}}]",
    "other_names": "[\"1-((3R,5S,8R,9S,10S,13S,14S,17S)-3-hydroxy-3,10,13-trimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)ethan-1-one\", \"1-((3R,5S,8R,9S,10S,13S,14S,17S)-3-Hydroxy-3,10,13-trimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)ethanone\", \"1-[(3R,5S,8R,9S,10S,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone\", \"3alpha-hydroxy-3beta-methyl-5alpha-pregnan-20-one\", \"(3alpha,5alpha)-3-Hydroxy-3-methylpregnan-20-one\", \"3\u03b1-hydroxy-3\u03b2-methyl-5\u03b1-pregnan-20-one\", \"pregnan-20-one, 3-hydroxy-3-methyl-, (3a,5a)-\", \"Ztalmy \"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710173731, \"_nanoseconds\": 890000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Gestrinone\", \"url\": \"https://drugs.ncats.io/drug/1421533RCM\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S1: Anabolic AgentsUnapproved drug",
    "Name": "gestrinone",
    "guid": "3e6a6819-5188-4726-b625-60de2474f10b",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "gestrinone",
    "Reasons": "[{\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"(17alpha)-13-ethyl-17-hydroxy-18,19-dinorpregna-4,9,11-trien-20-yn-3-one\", \"13\u03b2-Ethyl-17\u03b2-hydroxy-18,19-dinor-17\u03b1-pregna-4,9,11-trien- 20-yn-3-one\", \"13-Ethyl-17a-ethynyl-17b-hydroxygona-4,9,11-trien-3-one\", \"ethylnorgestrienone\", \"nemestran\", \"(17\u03b1)-13-ethyl-17-hydroxy-18,19-dinorpregna-4,9,11-trien-20-yn-3-one\", \"tridomose\", \"dimetriose\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738954420, \"_nanoseconds\": 683000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule II",
    "Name": "glutethimide",
    "guid": "949eab88-846a-4967-9e03-8b13102abfff",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "glutethimide",
    "Reasons": "[{\"reason_code\": 6004, \"reason\": \"DEA Controlled Substance List: Schedule  II\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"207f9e17-8a22-4523-8dd6-24d9d39b4c45\", \"link_title\": \"DEA Controlled Substance List: Schedule  II\", \"updated\": {\"_seconds\": 1712942744, \"_nanoseconds\": 783000000}}]",
    "other_names": "[\"Doriden\", \"Dorimide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710173163, \"_nanoseconds\": 985000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Gonadorelin\", \"url\": \"https://drugs.ncats.io/drug/9O7312W37G\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S2: Peptide Hormones, Growth Factors, etc.Unapproved drug",
    "Name": "gonadorelin",
    "guid": "d4f71cd2-4441-4a7f-9c3b-fdebf9afffb3",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "gonadorelin",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"GNRH\", \"LHRH\", \"luteinizing hormone-releasing factor\", \"gonadotropin-releasing hormone\", \"gonadorelin decapeptide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710173129, \"_nanoseconds\": 769000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: goralatide\", \"url\": \"https://drugs.ncats.io/drug/H041538E9P\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S2: Peptide Hormones, Growth Factors, etc.; Unapproved drug",
    "Name": "goralatide",
    "guid": "f61f8423-cb3a-41a8-8b4a-5a80ab0100c7",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "goralatide",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"Seraspenide\", \"Ac-SDKP\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738954715, \"_nanoseconds\": 294000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Goserelin\", \"url\": \"https://drugs.ncats.io/drug/0F65R8P09N\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S2: Peptide Hormones, Growth Factors, etc.Prescription drug",
    "Name": "goserelin",
    "guid": "cdaef0a5-a1b3-4713-a0ba-b486be1025ed",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "goserelin",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}, {\"reason_code\": 6016, \"reason\": \"Prescription drug\", \"link\": null, \"guid\": \"becae72e-580f-4d8d-8665-c0c4b1dc1381\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683249, \"_nanoseconds\": 70000000}}]",
    "other_names": "[]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709916984, \"_nanoseconds\": 571000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S2: Peptide Hormones, Growth Factors, etc.",
    "Name": "growth hormone-releasing peptide",
    "guid": "840faf21-fa69-470e-ad38-c8e66541b6a0",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "growth hormone-releasing peptide",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}]",
    "other_names": "[\"GHRP-3\", \"GHRP-4\", \"GHRP-5\", \"GHRP\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1727719720, \"_nanoseconds\": 547000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "halazepam",
    "guid": "4311cdc1-be9a-4e2b-8889-e3fadb1dc76e",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "halazepam",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"Paxipam\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709915919, \"_nanoseconds\": 23000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "haloxazolam",
    "guid": "821f28c5-6893-4858-9342-a01a646cbde7",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "haloxazolam",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"Haloxazolamum\", \"Somelin\", \"10-bromo-11b-(2-fluorophenyl)-2,3,7,11b-tetrahydrooxazolo(3,2-d)(1,4)benzodiazepin-6(5H)-one\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709915899, \"_nanoseconds\": 398000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"26 February 2020 Memorandum from the Office of Under Secretary of Defense\", \"url\": \"https://www.opss.org/infographic/dod-memo-policy-hemp\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Military policy",
    "Name": "hemp",
    "guid": "082bdaa3-630e-4a58-8d0b-f597c2b1f211",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "hemp",
    "Reasons": "[{\"reason_code\": 6017, \"reason\": \"Military policy\", \"link\": null, \"guid\": \"96435789-439c-44d4-83cf-1d10a25ab7b5\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683268, \"_nanoseconds\": 216000000}}]",
    "other_names": "[\"hemp seed protein\", \"organic hemp protein concentrate\", \"hemp seed protein powder\", \"nextHEMP\", \"hemp protein (Cannabis sativum) powder (seed)\", \"hemp hearts\", \"hemp protein\", \"hemp seed\", \"organic hemp protein powder \"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1739977737, \"_nanoseconds\": 425000000}",
    "label_terms": "[\"Proprietary Protein Blend (Organic Pea Protein, Organic Hemp Protein, Organic Goji Berry)\", \"Orgain Organic Protein Blend\u2122 (Organic Brown Rice Protein, Organic Chia Seed, Organic Hemp Protein, Organic Pea Protein)\", \"Vega Protein Blend (Pea Protein, Saviseed\u2122 (Sacha Inchi) Protein, Hemp Seed Protein, Sprouted Whole Grain Brown Rice Protein)\"]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Heptaminol\", \"url\": \"https://drugs.ncats.io/drug/3DQS188SY5\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Unapproved drug",
    "Name": "heptaminol",
    "guid": "eabc4711-e321-41bd-abb5-5a7a40b1b038",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "heptaminol",
    "Reasons": "[{\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"heptaminol hydrochloride\", \"Corasore\", \"Ginkor Fort\", \"heptaminolum\", \"6-amino-2-methyl-2-heptanol\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715367610, \"_nanoseconds\": 74000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "heroin",
    "guid": "ff9b4226-d257-4707-aa04-214076ded40a",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "heroin",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"diacetylmorphine\", \"diamorphine hydrochloride\", \"diamorphine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709915436, \"_nanoseconds\": 582000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"FDA Warning Letter\", \"url\": \"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/big-dans-fitness-nutrition-llc-494626-05252017\"}, {\"title\": \"NIH NCATS Inxight Drugs entry: 4-androsten-6.beta.-chloro-17.beta.-ol-3-on3\", \"url\": \"https://drugs.ncats.io/drug/495G1O8XSK\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S1: AnabolicFDA warning letter: synthetic steroid that does not constitute a dietary ingredient",
    "Name": "hexadrone",
    "guid": "0ca27e0f-9a4a-4832-8533-a45211b4618c",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "hexadrone",
    "Reasons": "[{\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}, {\"reason_code\": 6019, \"reason\": \"FDA Warning Letter\", \"link\": null, \"guid\": \"1cd0ab89-14ce-43c2-a804-e4b29b8780fe\", \"link_title\": null, \"updated\": {\"_seconds\": 1711571477, \"_nanoseconds\": 43000000}}]",
    "other_names": "[\"6-chloro-androst-4-ene-3-one-17beta-ol\", \"6-chloro-androst-4-en-17b-ol-3-one\", \"6-chloro-androst-4-ene-3-one-17\u03b2-ol\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738956922, \"_nanoseconds\": 529000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Use or misuse prohibited under DoDI 1010.16 (cathinones)",
    "Name": "hexedrone",
    "guid": "1d3a8bfd-120e-48d1-aa12-83402fe27898",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "hexedrone",
    "Reasons": "[{\"reason_code\": 6014, \"reason\": \"DoDI 1010.16\", \"link\": \"https://www.esd.whs.mil/directives/issuances/dodi\", \"guid\": \"b757aa46-4729-4d4a-a32e-25ef0b04e5c3\", \"link_title\": \"Use or misuse prohibited under DoDI 1010.16\", \"updated\": {\"_seconds\": 1703683049, \"_nanoseconds\": 190000000}}]",
    "other_names": "[\"alpha-methylamino-caprophenone\", \"2-(methylamino)-1-phenyl-1-hexanone\", \"\u03b1-methylamino-caprophenone\", \"1-hexanone, 2-(methylamino)-1-phenyl-\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738957080, \"_nanoseconds\": 872000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"FDA Warning Letter\", \"url\": \"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/advanced-nutritional-supplements-llc-622055-05042022\"}, {\"title\": \"NIH NCATS Inxight Drugs entry: Higenamine\", \"url\": \"https://drugs.ncats.io/drug/TBV5O16GAP\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S3: Beta-2 AgonistsFDA warningUnapproved drug",
    "Name": "higenamine",
    "guid": "e0bbe070-5e64-4c65-826c-26551a22834c",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "higenamine",
    "Reasons": "[{\"reason_code\": 6011, \"reason\": \"WADA S3: Beta-2 Agonists\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"aecafa3b-c7ad-413c-bc5f-be7ed5b2f69d\", \"link_title\": \"WADA Prohibited List S3: Beta-2 Agonists\", \"updated\": {\"_seconds\": 1703682857, \"_nanoseconds\": 73000000}}, {\"reason_code\": 6019, \"reason\": \"FDA Warning Letter\", \"link\": null, \"guid\": \"1cd0ab89-14ce-43c2-a804-e4b29b8780fe\", \"link_title\": null, \"updated\": {\"_seconds\": 1711571477, \"_nanoseconds\": 43000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"(+-)-demethylcoclaurine\", \"Gnetum parvifolium\", \"Tinospora crispa\", \"higenamine tartrate\", \"6,7-dihydroxy-1-(4-hydroxybenzyl)-1,2,3,4-tetrahydroisoquinoline\", \"higenamine hydrobromide\", \"Galium divaricatum\", \"(+-)-norcoclaurine\", \"Nelumbo nucifera (standarized for higenamine)\", \"6,7-isoquinolinediol, 1,2,3,4-tetrahydro-1-((4-hydroxyphenyl)methyl)-, (+-)-\", \"6,7-dihydroxy-1-[(4-hydroxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinoline\", \"demethylcoclaurine\", \"norcoclaurine\", \"Magnolia salicifolia\", \"Argemone mexicana\", \"higenamine oxalate\", \"(+-)-1,2,3,4-tetrahydro-1-((4-hydroxyphenyl)methyl)-6,7-isoquinolinediol\", \"1-(p-hydroxybenzyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline\", \"(+-)-O-demethylcoclaurine\", \"Nelumbo nucifera\", \"(R)-higenamine\", \"higenamine hydrochloride\", \"DL-demethylcoclaurine\", \"1-[(4-hydroxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinoline-6,7-diol\", \"(R,S)-norcoclaurine\", \"DMC\", \"Annona squamosa\", \"1-(4-hydroxybenzyl)-1,2,3,4-tetrahydro-6,7-isoquinolinediol\", \"Coptis japonica\", \"isoquinolin-6,7-diol, 1,2,3,4-tetrahydro-1-[4-hydroxybenzyl]-\", \"Nandina domestica\", \"1-(4-hydroxybenzyl)-1,2,3,4-tetrahydroisoquinoline-6,7-diol\", \"Asarum hetertropoides\", \"higenamine HCl\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738957365, \"_nanoseconds\": 422000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Histrelin\", \"url\": \"https://drugs.ncats.io/drug/H50H3S3W74\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "histrelin",
    "guid": "a915d0a8-b843-4c6f-b861-c60a1313f0ff",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "histrelin",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}, {\"reason_code\": 6016, \"reason\": \"Prescription drug\", \"link\": null, \"guid\": \"becae72e-580f-4d8d-8665-c0c4b1dc1381\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683249, \"_nanoseconds\": 70000000}}]",
    "other_names": "[]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709049061, \"_nanoseconds\": 665000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"FDA warning letter\", \"url\": \"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/max-muscle-622401-05042022\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "FDA Warning Letter: Does not meet the definition of a dietary ingredient",
    "Name": "hordenine",
    "guid": "2f7ab47e-74b3-4892-8b97-2c4ee31e602d",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "hordenine",
    "Reasons": "[{\"reason_code\": 6019, \"reason\": \"FDA Warning Letter\", \"link\": null, \"guid\": \"1cd0ab89-14ce-43c2-a804-e4b29b8780fe\", \"link_title\": null, \"updated\": {\"_seconds\": 1711571477, \"_nanoseconds\": 43000000}}]",
    "other_names": "[\"anhaline\", \"p-hydroxy-N,N-dimethylphenethylamine\", \"eremursine\", \"ordenina\", \"peyocactine\", \"N,N-dimethyl-4-hydroxy-beta-phenethylamine\", \"N,N-dimethyltyramine\", \"cactine\", \"4-[2-(dimethylamino)ethyl]phenol\", \"hordenine HCl\", \"hordenine sulfate\", \"hordenine hydrochloride\", \"ordenine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738957871, \"_nanoseconds\": 26000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Hydrochlorothiazide\", \"url\": \"https://drugs.ncats.io/drug/0J48LPH2TH\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S5: Diuretics and Masking AgentsPrescription drug",
    "Name": "hydrochlorothiazide",
    "guid": "6333db22-14de-46a6-8562-b82c8d957361",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "hydrochlorothiazide",
    "Reasons": "[{\"reason_code\": 6013, \"reason\": \"WADA S5: Diuretics and Masking Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b1ad44e4-cef0-4ae2-99fb-19e28540f282\", \"link_title\": \"WADA Prohibited List S5: Diuretics and Masking Agents\", \"updated\": {\"_seconds\": 1703682941, \"_nanoseconds\": 864000000}}, {\"reason_code\": 6016, \"reason\": \"Prescription drug\", \"link\": null, \"guid\": \"becae72e-580f-4d8d-8665-c0c4b1dc1381\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683249, \"_nanoseconds\": 70000000}}]",
    "other_names": "[\"Microzide\", \"HCTZ\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709913280, \"_nanoseconds\": 877000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule II",
    "Name": "hydrocodone",
    "guid": "fe60f466-a726-4dd2-a8ae-d6a7eb78f609",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "hydrocodone",
    "Reasons": "[{\"reason_code\": 6004, \"reason\": \"DEA Controlled Substance List: Schedule  II\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"207f9e17-8a22-4523-8dd6-24d9d39b4c45\", \"link_title\": \"DEA Controlled Substance List: Schedule  II\", \"updated\": {\"_seconds\": 1712942744, \"_nanoseconds\": 783000000}}]",
    "other_names": "[\"dihydrocodeinone\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709913131, \"_nanoseconds\": 301000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "hydromorphinol",
    "guid": "ffe2111e-f056-4e0a-9dae-de2036041e93",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "hydromorphinol",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"14-hydroxydihydromorphine\", \"7,8-dihydro-14-hydroxymorphine\", \"RAM-320\", \"6alpha-Oxymorphol\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709913097, \"_nanoseconds\": 709000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule II",
    "Name": "hydromorphone",
    "guid": "562ec9de-b688-47dd-8d45-14cf012ad8c4",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "hydromorphone",
    "Reasons": "[{\"reason_code\": 6004, \"reason\": \"DEA Controlled Substance List: Schedule  II\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"207f9e17-8a22-4523-8dd6-24d9d39b4c45\", \"link_title\": \"DEA Controlled Substance List: Schedule  II\", \"updated\": {\"_seconds\": 1712942744, \"_nanoseconds\": 783000000}}]",
    "other_names": "[\"Dilaudid\", \"dihydromorphinone\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709912792, \"_nanoseconds\": 630000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Use or misuse prohibited under DoDI 1010.16 (amphetamines)",
    "Name": "hydroxyamphetamine",
    "guid": "8c017cbe-9a94-43cd-97f1-857b989de689",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "hydroxyamphetamine",
    "Reasons": "[{\"reason_code\": 6014, \"reason\": \"DoDI 1010.16\", \"link\": \"https://www.esd.whs.mil/directives/issuances/dodi\", \"guid\": \"b757aa46-4729-4d4a-a32e-25ef0b04e5c3\", \"link_title\": \"Use or misuse prohibited under DoDI 1010.16\", \"updated\": {\"_seconds\": 1703683049, \"_nanoseconds\": 190000000}}]",
    "other_names": "[\"hydroxyamfetamine\", \"parahydroxyamphetamine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715367811, \"_nanoseconds\": 639000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "hydroxypethidine",
    "guid": "cd18531d-fae7-4649-b586-aab6820a32d2",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "hydroxypethidine",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"Demidone\", \"Oxydolantin\", \"ethyl 4-(3-hydroxyphenyl)-1-methylpiperidine-4-carboxylate\", \"Oxipethidine\", \"Oxypetidin\", \"Win 771\", \"Bemidone\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709912501, \"_nanoseconds\": 229000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Hydroxypropyl betadex\", \"url\": \"https://drugs.ncats.io/drug/1I96OHX6EK\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Unapproved drug",
    "Name": "hydroxypropyl betadex",
    "guid": "3942d2ec-59fd-4c22-983b-2efd5478797c",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "hydroxypropyl betadex",
    "Reasons": "[{\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"hydroxypropyl BCD\", \"hydroxypropyl-\u03b2-cyclodextrin\", \"2-hydroxypropyl-beta-cyclodextrin\", \"hydroxypropyl-beta-cyclodextrin (HPBCD)\", \"HPbetaCD\", \"hydroxypropylbetadex\", \"beta-hydroxypropylcyclodextrin\", \"HP-\u03b2-CD\", \"2 hydroxypropyl beta cyclodextrin\", \"hydroxypropyl beta cyclodextrin\", \"2-hydroxypropyl-\u03b2-cyclodextrin\", \"hydroxypropyl-B-cyclodextrin\", \"VTS-270\", \"hydroxypropyl-beta-cyclodextrin\", \"HP-beta-CD\", \"adrabetadex\", \"betadex, hydroxypropyl\", \"beta hydroxypropylcyclodextrin\", \"HPBCD\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1738958549, \"_nanoseconds\": 755000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "ibogaine",
    "guid": "280f0d29-2f13-4c79-a629-f993d88c90e7",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "ibogaine",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"7-Ethyl-6,6\u03b2,7,8,9,10,12,13-octahydro-2-methoxy-6,9-methano-5H-pyrido [1', 2':1,2] azepino [5,4-b] indole\", \"Tabernanthe iboga\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709912097, \"_nanoseconds\": 862000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Indicaterol\", \"url\": \"https://drugs.ncats.io/drug/8OR09251MQ\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S3: Beta-2 AgonistsPrescription drug",
    "Name": "indacaterol",
    "guid": "0ddb2c30-ee2c-4552-80ee-58b555f54f9d",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "indacaterol",
    "Reasons": "[{\"reason_code\": 6011, \"reason\": \"WADA S3: Beta-2 Agonists\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"aecafa3b-c7ad-413c-bc5f-be7ed5b2f69d\", \"link_title\": \"WADA Prohibited List S3: Beta-2 Agonists\", \"updated\": {\"_seconds\": 1703682857, \"_nanoseconds\": 73000000}}, {\"reason_code\": 6022, \"reason\": \"Discontinued drug\", \"link\": \"\", \"guid\": \"69df11c9-4b6c-4a02-9903-d201a6e29544\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1713452078, \"_nanoseconds\": 467000000}}]",
    "other_names": "[\"QAB-149\", \"Onbrez\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1713452213, \"_nanoseconds\": 628000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Indapamide\", \"url\": \"https://drugs.ncats.io/drug/F089I0511L\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S5: Diuretics and Masking AgentsPrescription drug",
    "Name": "indapamide",
    "guid": "0c1cf038-a0d3-4a61-b64e-c502b49cc53a",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "indapamide",
    "Reasons": "[{\"reason_code\": 6013, \"reason\": \"WADA S5: Diuretics and Masking Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b1ad44e4-cef0-4ae2-99fb-19e28540f282\", \"link_title\": \"WADA Prohibited List S5: Diuretics and Masking Agents\", \"updated\": {\"_seconds\": 1703682941, \"_nanoseconds\": 864000000}}, {\"reason_code\": 6016, \"reason\": \"Prescription drug\", \"link\": null, \"guid\": \"becae72e-580f-4d8d-8665-c0c4b1dc1381\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683249, \"_nanoseconds\": 70000000}}]",
    "other_names": "[\"Lozol\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709911305, \"_nanoseconds\": 254000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Use or misuse prohibited under DoDI 1010.16 (synthetic cannabinoids)",
    "Name": "indene",
    "guid": "7c9fbb1c-c36d-44b8-be62-43929f385f1a",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "indene",
    "Reasons": "[{\"reason_code\": 6014, \"reason\": \"DoDI 1010.16\", \"link\": \"https://www.esd.whs.mil/directives/issuances/dodi\", \"guid\": \"b757aa46-4729-4d4a-a32e-25ef0b04e5c3\", \"link_title\": \"Use or misuse prohibited under DoDI 1010.16\", \"updated\": {\"_seconds\": 1703683049, \"_nanoseconds\": 190000000}}]",
    "other_names": "[\"1H-indene\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709911151, \"_nanoseconds\": 958000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Ipamorelin\", \"url\": \"https://drugs.ncats.io/drug/Y9M3S784Z6\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S2: Peptide Hormones, Growth Factors, etc.Unapproved drug",
    "Name": "ipamorelin",
    "guid": "b8280a07-cf4a-43a2-839f-5eac23f7e694",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "ipamorelin",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709910450, \"_nanoseconds\": 592000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "isobutyryl fentanyl",
    "guid": "2edf042e-3a18-4f11-a2dd-85caea71a3c8",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "isobutyryl fentanyl",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709910389, \"_nanoseconds\": 711000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule II",
    "Name": "isomethadone",
    "guid": "253594ee-b7d3-471c-949d-b46476da08c3",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "isomethadone",
    "Reasons": "[{\"reason_code\": 6014, \"reason\": \"DoDI 1010.16\", \"link\": \"https://www.esd.whs.mil/directives/issuances/dodi\", \"guid\": \"b757aa46-4729-4d4a-a32e-25ef0b04e5c3\", \"link_title\": \"Use or misuse prohibited under DoDI 1010.16\", \"updated\": {\"_seconds\": 1703683049, \"_nanoseconds\": 190000000}}, {\"reason_code\": 6004, \"reason\": \"DEA Controlled Substance List: Schedule  II\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"207f9e17-8a22-4523-8dd6-24d9d39b4c45\", \"link_title\": \"DEA Controlled Substance List: Schedule  II\", \"updated\": {\"_seconds\": 1712942744, \"_nanoseconds\": 783000000}}]",
    "other_names": "[\"isomethadone II\", \"Win 1783\", \"1,1-diphenyl-1-(dimethylaminoisopropyl)butanone-2\", \"isoamidone\", \"isoamidone II\", \"6-dimethylamino-5-methyl-4,4-diphenyl-3-hexanone\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709841907, \"_nanoseconds\": 502000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Isometheptene\", \"url\": \"https://drugs.ncats.io/drug/Y7L24THH6T\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Unapproved drug",
    "Name": "isometheptene",
    "guid": "becbd388-ff50-4198-b204-41e52cc24353",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "isometheptene",
    "Reasons": "[{\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"5-hepten-2-amine, N,6-dimethyl-\", \"isonyl\", \"octinum\", \"octanil\", \"octin\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715367871, \"_nanoseconds\": 658000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"FDA: New dietary ingredient response letter\", \"url\": \"https://www.regulations.gov/document/FDA-2005-S-0518-0010\"}, {\"title\": \"NIH NCATS Inxight Drugs entry: Deterenol\", \"url\": \"https://drugs.ncats.io/drug/BR971OUC9M\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "FDA statement: Synthetic substance that currently does not meet the definition of a dietary ingredientUnapproved drug",
    "Name": "isopropylnorsynephrine",
    "guid": "14d91c66-dd59-44a9-a4f0-ba07ab9cb091",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "isopropylnorsynephrine",
    "Reasons": "[{\"reason_code\": 6018, \"reason\": \"FDA Statement\", \"link\": \"\", \"guid\": \"3cd17124-6ebc-4828-9edb-c20a81755502\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1711715334, \"_nanoseconds\": 457000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"Deterenol\", \"isopropyloctopamine\", \"N-isopropyloctopamine\", \"Betaphrine\", \"N-isopropylnorsynephrine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709841618, \"_nanoseconds\": 141000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "isotonitazene",
    "guid": "becd89d2-f01e-4722-ab53-c1a99b15f604",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "isotonitazene",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"N,N-diethyl-2-(2-(4 isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine\", \"N,N-diethyl-2-[[4-(1-methylethoxy)phenyl]methyl]-5-nitro-1H-benzimidazole-1-ethanamine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709841385, \"_nanoseconds\": 4000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "isovaleryl fentanyl",
    "guid": "df173691-db1a-4d15-93af-eba517aae175",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "isovaleryl fentanyl",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"Isovalerylfentanyl\", \"3-methyl-N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide\", \"isovalery fentanyl\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1711033260, \"_nanoseconds\": 780000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "ketamine",
    "guid": "85ce9a94-8082-44dd-a17e-135c4a26cec9",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "ketamine",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}]",
    "other_names": "[\"Ketaset\", \"Special K\", \"Ketalar\", \"K\", \"(\u00b1)-2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709840749, \"_nanoseconds\": 609000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "ketazolam",
    "guid": "500a6d4d-eba5-4db5-bab5-180a5df23c72",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "ketazolam",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"Contamex\", \"Loftran\", \"Solatran\", \"Anxon\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709840644, \"_nanoseconds\": 153000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "ketobemidone",
    "guid": "0900a5dc-1a6a-4d9a-a7d5-0d56b318a32a",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "ketobemidone",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"Cliradon\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709840600, \"_nanoseconds\": 1000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "kisspeptin",
    "guid": "a32959af-89df-4e1d-a774-f45deb5ccb72",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "kisspeptin",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}]",
    "other_names": "[]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709049084, \"_nanoseconds\": 153000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"FDA and Kratom\", \"url\": \"https://www.fda.gov/news-events/public-health-focus/fda-and-kratom\"}, {\"title\": \"FDA Warning Letter\", \"url\": \"https://www.fda.gov/news-events/press-announcements/fda-issues-warning-letters-firms-marketing-products-containing-7-hydroxymitragynine?utm_medium=email&utm_source=govdelivery\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "FDA statement: New dietary ingredient lacking evidence for safe use; deadly risks associated with its use",
    "Name": "kratom",
    "guid": "ede48b4f-c1c8-41c3-a5be-c57ee077b5f4",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "kratom",
    "Reasons": "[{\"reason_code\": 6018, \"reason\": \"FDA Statement\", \"link\": \"\", \"guid\": \"3cd17124-6ebc-4828-9edb-c20a81755502\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1711715334, \"_nanoseconds\": 457000000}}]",
    "other_names": "[\"ketum\", \"gratom\", \"kratum\", \"Maeng Da Leaf\", \"drathom\", \"mambog\", \"mitragynine\", \"mitraciliatine\", \"cratom\", \"7-hydroxymitragynine\", \"Maeng Da\", \"kedemba\", \"Mitragyna speciose\", \"mitragynine extract\", \"biak\", \"ithang\", \"kraton\", \"katawn\", \"thom\", \"Mitragyna speciosa\", \"7-OH-mitragynine\", \"madat\", \"speciogynine\", \"7-hydroxy-mitragynine\", \"7-OH\", \"biak-biak\", \"thang\", \"7-hydroxy mitragynine\", \"speciociliatine\", \"kakuam\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1759415380, \"_nanoseconds\": 817000000}",
    "label_terms": "[]",
    "linked_ingredients": "[]",
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule V",
    "Name": "lacosamide",
    "guid": "4e59ab30-9ebb-4d36-a954-87acb8d87f22",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "lacosamide",
    "Reasons": "[{\"reason_code\": 6007, \"reason\": \"DEA Controlled Substance List: Schedule V\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"d5b1da64-60db-4afa-af32-8491827c3497\", \"link_title\": \"DEA Controlled Substance List: Schedule V\", \"updated\": {\"_seconds\": 1712942766, \"_nanoseconds\": 551000000}}]",
    "other_names": "[\"(R)-2-acetoamido-N-benzyl-3-methoxy-propionamide\", \"Vimpat\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709840057, \"_nanoseconds\": 274000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Landogrozumab\", \"url\": \"https://drugs.ncats.io/drug/B1792M902R\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S4: Hormone and Metabolic ModulatorsUnapproved drug",
    "Name": "landogrozumab",
    "guid": "b5172d28-2262-48e5-a7a4-890b4f0b5fbf",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "landogrozumab",
    "Reasons": "[{\"reason_code\": 6012, \"reason\": \"WADA S4: Hormone and Metabolic Modulators\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"ac1ba347-6d44-4a17-829d-e589bf33bbdb\", \"link_title\": \"WADA Prohibited List S4: Hormone and Metabolic Modulators\", \"updated\": {\"_seconds\": 1703682875, \"_nanoseconds\": 162000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"anti-myostatin antibody\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709840013, \"_nanoseconds\": 690000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule V",
    "Name": "lasmiditan",
    "guid": "1c718b82-16fa-47cf-a1e7-47eb62ddde8c",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "lasmiditan",
    "Reasons": "[{\"reason_code\": 6007, \"reason\": \"DEA Controlled Substance List: Schedule V\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"d5b1da64-60db-4afa-af32-8491827c3497\", \"link_title\": \"DEA Controlled Substance List: Schedule V\", \"updated\": {\"_seconds\": 1712942766, \"_nanoseconds\": 551000000}}]",
    "other_names": "[\"Reyvow\", \"2,4,6-trifluoro-N-(6-(1-methylpiperidine-4-carbonyl)pyridine-2-yl-benzamide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709839903, \"_nanoseconds\": 937000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "lefetamine",
    "guid": "7993137a-94ec-4c2d-b1db-517f8b0c884f",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "lefetamine",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"(-)-1-dimethylamino-1,2-diphenylethane\", \"SPA\", \"1-dimethylamino-1,2-diphenylethane\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709839862, \"_nanoseconds\": 266000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "lemborexant",
    "guid": "99c5799e-16af-4924-b6c1-dd324a89d128",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "lemborexant",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"(1R,2S)-2-[(2,4-dimethylpyrimidin-5-yl)oxymethyl]-2-(3-fluorophenyl)-N-(5-fluoropyridin-2-yl)cyclopropane-1-carboxamide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709839726, \"_nanoseconds\": 922000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Lenomorelin\", \"url\": \"https://drugs.ncats.io/drug/UXG268Q86R\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S2: Peptide Hormones, Growth Factors, etc.Unapproved drug",
    "Name": "lenomorelin",
    "guid": "10566c11-d335-46e2-9c06-d15325367826",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "lenomorelin",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"ghrelin human\", \"ghrelin\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709839647, \"_nanoseconds\": 523000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Letrozole\", \"url\": \"https://drugs.ncats.io/drug/7LKK855W8I\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S4: Hormone and Metabolic ModulatorsPrescription drug",
    "Name": "letrozole",
    "guid": "0f6166e9-eb19-41e8-840a-c322aac64b13",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "letrozole",
    "Reasons": "[{\"reason_code\": 6012, \"reason\": \"WADA S4: Hormone and Metabolic Modulators\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"ac1ba347-6d44-4a17-829d-e589bf33bbdb\", \"link_title\": \"WADA Prohibited List S4: Hormone and Metabolic Modulators\", \"updated\": {\"_seconds\": 1703682875, \"_nanoseconds\": 162000000}}, {\"reason_code\": 6016, \"reason\": \"Prescription drug\", \"link\": null, \"guid\": \"becae72e-580f-4d8d-8665-c0c4b1dc1381\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683249, \"_nanoseconds\": 70000000}}]",
    "other_names": "[\"CGS20267\", \"CGS-20267\", \"Femara\", \"F\u00e9mara\", \"HSDB 7461\", \"Letoval\", \"4,4'-(1H-1,2,4-triazol-1-yl-methylene)-bis(benzonitrile)\", \"CCRIS 8822\", \"CGS 20267\", \"4-[(4-Cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzonitrile\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1722279321, \"_nanoseconds\": 792000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Leuprolide\", \"url\": \"https://drugs.ncats.io/drug/EFY6W0M8TG\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S2: Peptide Hormones, Growth Factors, etc.Prescription drug",
    "Name": "leuprorelin",
    "guid": "d3e1bd9a-617e-4aea-83ca-998df83457bd",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "leuprorelin",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}, {\"reason_code\": 6016, \"reason\": \"Prescription drug\", \"link\": null, \"guid\": \"becae72e-580f-4d8d-8665-c0c4b1dc1381\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683249, \"_nanoseconds\": 70000000}}]",
    "other_names": "[\"leuprolide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709839299, \"_nanoseconds\": 18000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule II",
    "Name": "levo-alphacetylmethadol",
    "guid": "aad48205-5d3b-4695-8f02-69e1820ba3e7",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "levo-alphacetylmethadol",
    "Reasons": "[{\"reason_code\": 6004, \"reason\": \"DEA Controlled Substance List: Schedule  II\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"207f9e17-8a22-4523-8dd6-24d9d39b4c45\", \"link_title\": \"DEA Controlled Substance List: Schedule  II\", \"updated\": {\"_seconds\": 1712942744, \"_nanoseconds\": 783000000}}]",
    "other_names": "[\"LAAM\", \"levo-alpha-acetylmethadol\", \"levomethadyl acetate\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709839227, \"_nanoseconds\": 258000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Levmetamfetamine\", \"url\": \"https://drugs.ncats.io/drug/Y24T9BT2Q2\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Use or misuse prohibited under DoDI 1010.16 (amphetamines)OTC drug",
    "Name": "levomethamphetamine",
    "guid": "0138dd6b-bbf7-42cf-b6f0-24fa8a51ab6a",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "levomethamphetamine",
    "Reasons": "[{\"reason_code\": 6014, \"reason\": \"DoDI 1010.16\", \"link\": \"https://www.esd.whs.mil/directives/issuances/dodi\", \"guid\": \"b757aa46-4729-4d4a-a32e-25ef0b04e5c3\", \"link_title\": \"Use or misuse prohibited under DoDI 1010.16\", \"updated\": {\"_seconds\": 1703683049, \"_nanoseconds\": 190000000}}, {\"reason_code\": 6015, \"reason\": \"OTC drug\", \"link\": \"\", \"guid\": \"2a6a7454-fb0d-4d0b-9a4c-99ea7f0d386b\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703683233, \"_nanoseconds\": 942000000}}]",
    "other_names": "[\"levmetamfetamine\", \"l-methamphetamine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1761745106, \"_nanoseconds\": 729000000}",
    "label_terms": "[]",
    "linked_ingredients": "[]",
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule II",
    "Name": "levomethorphan",
    "guid": "3066643d-bee1-41e4-84de-5654706e6667",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "levomethorphan",
    "Reasons": "[{\"reason_code\": 6004, \"reason\": \"DEA Controlled Substance List: Schedule  II\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"207f9e17-8a22-4523-8dd6-24d9d39b4c45\", \"link_title\": \"DEA Controlled Substance List: Schedule  II\", \"updated\": {\"_seconds\": 1712942744, \"_nanoseconds\": 783000000}}]",
    "other_names": "[\"methorphan\", \"l-methorphan\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1712069995, \"_nanoseconds\": 92000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "levomoramide",
    "guid": "c7b2bfea-86be-45fa-92bd-530e87987260",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "levomoramide",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"levoramide\", \"(3R)-3-methyl-4-morpholin-4-yl-2,2-diphenyl-1-pyrrolidin-1-ylbutan-1-one\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709838506, \"_nanoseconds\": 937000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "levophenacylmorphan",
    "guid": "bdf96d4a-d5e8-47c3-a545-db6f34e879c4",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "levophenacylmorphan",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"(-)-3-hydroxy-N-phenacylmorphinan\", \"benzorphanol\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709838469, \"_nanoseconds\": 874000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule II",
    "Name": "levorphanol",
    "guid": "b99c38e2-f6eb-4f3e-8a80-d2a8b7f67fd0",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "levorphanol",
    "Reasons": "[{\"reason_code\": 6004, \"reason\": \"DEA Controlled Substance List: Schedule  II\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"207f9e17-8a22-4523-8dd6-24d9d39b4c45\", \"link_title\": \"DEA Controlled Substance List: Schedule  II\", \"updated\": {\"_seconds\": 1712942744, \"_nanoseconds\": 783000000}}]",
    "other_names": "[\"Levo-Dromoran\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709838437, \"_nanoseconds\": 34000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Levalbuterol\", \"url\": \"https://drugs.ncats.io/drug/EDN2NBH5SS\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S3: Beta-2 AgonistsPrescription drug",
    "Name": "levosalbutamol",
    "guid": "7c917b1b-cc4d-45ce-b896-b1589f1159db",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "levosalbutamol",
    "Reasons": "[{\"reason_code\": 6011, \"reason\": \"WADA S3: Beta-2 Agonists\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"aecafa3b-c7ad-413c-bc5f-be7ed5b2f69d\", \"link_title\": \"WADA Prohibited List S3: Beta-2 Agonists\", \"updated\": {\"_seconds\": 1703682857, \"_nanoseconds\": 73000000}}, {\"reason_code\": 6016, \"reason\": \"Prescription drug\", \"link\": null, \"guid\": \"becae72e-580f-4d8d-8665-c0c4b1dc1381\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683249, \"_nanoseconds\": 70000000}}]",
    "other_names": "[\"levalbuterol\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709838391, \"_nanoseconds\": 298000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule II",
    "Name": "lisdexamfetamine",
    "guid": "76df70bf-0804-4e67-906e-ee556673e94d",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "lisdexamfetamine",
    "Reasons": "[{\"reason_code\": 6004, \"reason\": \"DEA Controlled Substance List: Schedule  II\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"207f9e17-8a22-4523-8dd6-24d9d39b4c45\", \"link_title\": \"DEA Controlled Substance List: Schedule  II\", \"updated\": {\"_seconds\": 1712942744, \"_nanoseconds\": 783000000}}]",
    "other_names": "[\"Vyvanse\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715355243, \"_nanoseconds\": 689000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Lonapegsomatropin\", \"url\": \"https://drugs.ncats.io/drug/OP35X9610Y\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S2: Peptide Hormones, Growth Factors, etc.Prescription drug",
    "Name": "lonapegsomatropin",
    "guid": "6facf0a0-e542-48d6-af35-262cdfff369a",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "lonapegsomatropin",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}, {\"reason_code\": 6016, \"reason\": \"Prescription drug\", \"link\": null, \"guid\": \"becae72e-580f-4d8d-8665-c0c4b1dc1381\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683249, \"_nanoseconds\": 70000000}}]",
    "other_names": "[\"Skytrofa\", \"lonapegsomatropin-tcgd\", \"TRANSCONPEG HGH\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1761927580, \"_nanoseconds\": 252000000}",
    "label_terms": "[]",
    "linked_ingredients": "[]",
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "long R3-IGF-1",
    "guid": "340f5a97-4df2-4f10-9012-0fbf30d9988a",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "long r3-igf-1",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}, {\"reason_code\": 6014, \"reason\": \"DoDI 1010.16\", \"link\": \"https://www.esd.whs.mil/directives/issuances/dodi\", \"guid\": \"b757aa46-4729-4d4a-a32e-25ef0b04e5c3\", \"link_title\": \"Use or misuse prohibited under DoDI 1010.16\", \"updated\": {\"_seconds\": 1703683049, \"_nanoseconds\": 190000000}}]",
    "other_names": "[]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1722279636, \"_nanoseconds\": 848000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "loprazolam",
    "guid": "801beef3-7a25-426f-a75b-8e1aa0185006",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "loprazolam",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709836650, \"_nanoseconds\": 356000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "lorazepam",
    "guid": "45e51355-a645-4262-b0ee-ff212e927cdf",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "lorazepam",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"Ativan\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709836578, \"_nanoseconds\": 572000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "lorcaserin",
    "guid": "644da77d-4a9e-47f8-b2e9-3fd4b03e4b2a",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "lorcaserin",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"Belviq\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709836326, \"_nanoseconds\": 933000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "lormetazepam",
    "guid": "b52e8b52-4de6-4e2b-95d2-b632a8a89bb5",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "lormetazepam",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"Noctamid\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709836068, \"_nanoseconds\": 876000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Luspatercept\", \"url\": \"https://drugs.ncats.io/drug/AQK7UBA1LS\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S2: Peptide Hormones, Growth Factors, etc.Prescription drug",
    "Name": "luspatercept",
    "guid": "bc712174-ec84-431d-b3b3-f3e9daa92c64",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "luspatercept",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}, {\"reason_code\": 6016, \"reason\": \"Prescription drug\", \"link\": null, \"guid\": \"becae72e-580f-4d8d-8665-c0c4b1dc1381\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683249, \"_nanoseconds\": 70000000}}]",
    "other_names": "[\"Reblozyl\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709836012, \"_nanoseconds\": 803000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "luteinizing hormone",
    "guid": "22823b8f-4ffb-419b-8682-8b3d95a48bfd",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "luteinizing hormone",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}]",
    "other_names": "[\"LH\", \"luteinising hormone\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1735580306, \"_nanoseconds\": 79000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "lysergic acid",
    "guid": "724cd8b1-3eb0-430c-849d-40eeab7db6f3",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "lysergic acid",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}]",
    "other_names": "[\"D-lysergic acid\", \"(8R)-9,10-didehydro-6-methylergoline-8-carboxylic acid\", \"ergoline acid\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709835920, \"_nanoseconds\": 12000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "lysergic acid amide",
    "guid": "dfa3dcf9-4ed5-45a4-8a5b-ba1ba5b413bb",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "lysergic acid amide",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}]",
    "other_names": "[\"D-lysergic acid amide\", \"lysergamide\", \"ergine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709835780, \"_nanoseconds\": 292000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "lysergic acid diethylamide",
    "guid": "6428409a-d12f-49bd-bfe0-d7d5b406e1e2",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "lysergic acid diethylamide",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"lysergide\", \"LSD\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709835711, \"_nanoseconds\": 85000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Use or misuse prohibited under DoDI 1010.16 (cocaine metabolites)",
    "Name": "m-hydroxybenzoylecgonine",
    "guid": "08ccc303-9ae3-4bd7-b348-c26e73a26571",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "m-hydroxybenzoylecgonine",
    "Reasons": "[{\"reason_code\": 6014, \"reason\": \"DoDI 1010.16\", \"link\": \"https://www.esd.whs.mil/directives/issuances/dodi\", \"guid\": \"b757aa46-4729-4d4a-a32e-25ef0b04e5c3\", \"link_title\": \"Use or misuse prohibited under DoDI 1010.16\", \"updated\": {\"_seconds\": 1703683049, \"_nanoseconds\": 190000000}}]",
    "other_names": "[\"mOHBE\", \"3-hydroxybenzoylecgonine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709834956, \"_nanoseconds\": 149000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Use or misuse prohibited under DoDI 1010.16 (cocaine metabolites)",
    "Name": "m-hydroxycocaine",
    "guid": "cd378f67-07d2-4685-b796-b9bfcb961ca5",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "m-hydroxycocaine",
    "Reasons": "[{\"reason_code\": 6014, \"reason\": \"DoDI 1010.16\", \"link\": \"https://www.esd.whs.mil/directives/issuances/dodi\", \"guid\": \"b757aa46-4729-4d4a-a32e-25ef0b04e5c3\", \"link_title\": \"Use or misuse prohibited under DoDI 1010.16\", \"updated\": {\"_seconds\": 1703683049, \"_nanoseconds\": 190000000}}]",
    "other_names": "[\"3'-hydroxybenzoylecgonine methyl ester\", \"3'-hydroxycocaine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709834777, \"_nanoseconds\": 114000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Macimorelin\", \"url\": \"https://drugs.ncats.io/drug/8680B21W73\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S2: Peptide Hormones, Growth Factors, etc.Prescription drug",
    "Name": "macimorelin",
    "guid": "b503d58b-2855-4bcc-8ea6-b7b0e1288eaf",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "macimorelin",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}, {\"reason_code\": 6016, \"reason\": \"Prescription drug\", \"link\": null, \"guid\": \"becae72e-580f-4d8d-8665-c0c4b1dc1381\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683249, \"_nanoseconds\": 70000000}}]",
    "other_names": "[]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709834575, \"_nanoseconds\": 269000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "marihuana",
    "guid": "f11a3b72-81d8-4539-8fee-da45cb929612",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "marihuana",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"weed\", \"marijuana\", \"marihuana extract\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709834496, \"_nanoseconds\": 525000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "mazindol",
    "guid": "6349d9db-5014-4e37-8ce1-85de44e7ca40",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "mazindol",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"Mazanor\", \"Sanorex\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709834425, \"_nanoseconds\": 10000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Mebolazine\", \"url\": \"https://drugs.ncats.io/drug/69C642I19V\"}, {\"title\": \"FDA Warning Letter\", \"url\": \"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/hardcore-formulations-522783-06052017\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Unapproved drug, FDA warning letter: synthetic steroid that does not constitute a dietary ingredient",
    "Name": "mebolazine",
    "guid": "6f5f6523-8760-434c-a645-702ac4f8b01d",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "mebolazine",
    "Reasons": "[{\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}, {\"reason_code\": 6019, \"reason\": \"FDA Warning Letter\", \"link\": null, \"guid\": \"1cd0ab89-14ce-43c2-a804-e4b29b8780fe\", \"link_title\": null, \"updated\": {\"_seconds\": 1711571477, \"_nanoseconds\": 43000000}}, {\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"17-beta-hydroxy-2alpha,17-dimethyl-5-alpha-androstan-3-one azine\", \"17\u03b2-hydroxy-2\u03b1,17-dimethyl-5\u03b1-androstan-3-one azine\", \"di(methasterone) azine\", \"2\u03b1,17\u03b1-dimethyl-5\u03b1-androstan-17\u03b2-ol-3-one azine\", \"mebolazina\", \"mebolazinum\", \"Dostalon\", \"17-beta-hydroxy-2-alpha,17-dimethyl-5-alpha-androstan-3-one azine\", \"dymethazine\", \"17-\u03b2-hydroxy-2-\u03b1,17-dimethyl-5-\u03b1-androstan-3-one azine\", \"dimetazin\", \"mebulazina\", \"Roxilon\", \"dimethazine\", \"DMZ\", \"2alpha,17alpha-dimethyl-5alpha-androstan-17beta-ol-3-one azine\", \"17-\u03b2-hydroxy-2\u03b1,17-dimethyl-5-\u03b1-androstan-3-one azine\", \"17\u03b2-hydroxy-2\u03b1,17\u03b1-dimethyl-5\u03b1-androstan-3-one azine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1721921336, \"_nanoseconds\": 150000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "mebutamate",
    "guid": "e241777f-2dc2-4a2c-92fb-8a36f3f842b2",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "mebutamate",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"Capla\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709821259, \"_nanoseconds\": 843000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Meclofenoxate\", \"url\": \"https://drugs.ncats.io/drug/C76QQ2I0RG\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Unapproved drug",
    "Name": "meclofenoxate",
    "guid": "0595a1bc-8730-436c-bb4c-8bcdaacf64b9",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "meclofenoxate",
    "Reasons": "[{\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"meclophenoxate\", \"centrophenoxine\", \"Analux\", \"dimethylaminoethyl P-chlorophenoxyacetate\", \"2-(dimethylamino)ethyl(P-chlorphenoxy)acetate\", \"Cetrexin\", \"Proseryl\", \"Lucidril\", \"(4-chlorophenoxy)acetic acid 2-(dimethylamino)ethyl ester\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715367978, \"_nanoseconds\": 803000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "mecloqualone",
    "guid": "bef09448-7296-4011-bbc0-b6ce7ca7ac7b",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "mecloqualone",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"Nubarene\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709820750, \"_nanoseconds\": 263000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "medazepam",
    "guid": "f95c76ad-ea77-413f-b67b-07bac005db77",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "medazepam",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"Nobrium\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709820700, \"_nanoseconds\": 903000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "mefenorex",
    "guid": "d8707d2d-74f6-41cd-8852-1671eae8ccb2",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "mefenorex",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"Doracil\", \"Amexate\", \"Anorexic\", \"Pondinil\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715355292, \"_nanoseconds\": 353000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Meldonium\", \"url\": \"https://drugs.ncats.io/drug/73H7UDN6EC\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S4: Hormone and Metabolic ModulatorsUnapproved drug",
    "Name": "meldonium",
    "guid": "04479001-0266-4c3c-8078-e622cdac7cb6",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "meldonium",
    "Reasons": "[{\"reason_code\": 6012, \"reason\": \"WADA S4: Hormone and Metabolic Modulators\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"ac1ba347-6d44-4a17-829d-e589bf33bbdb\", \"link_title\": \"WADA Prohibited List S4: Hormone and Metabolic Modulators\", \"updated\": {\"_seconds\": 1703682875, \"_nanoseconds\": 162000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"Kvaterin\", \"Quaterin\", \"Q-4224-IOS\", \"mindronate\", \"mildronat\", \"mildronate\", \"3-TMHP\", \"trimethylhydraziniumpropionate\", \"2-(2-carboxyethyl)-1,1,1-trimethyl hydrazinium hydroxide inner salt\", \"N-trimethylhydrazine-3-propionate\", \"CCRIS 8536\", \"3-(2,2,2-trimethylhydrazine)propionate\", \"MET-88\", \"2-(2-carboxyethyl)-1,1,1-trimethylhydrazinium hydroxide inner salt\", \"Vasonat\", \"3-(2,2,2-trimethylhydrazinium)propionate\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709819209, \"_nanoseconds\": 524000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"FDA Warning Letter\", \"url\": \"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/big-dans-fitness-nutrition-llc-494626-05252017\"}, {\"title\": \"NIH NCATS Inxight Drugs entry: 7.alpha.-methylestr-4-ene-3,17-dione\", \"url\": \"https://drugs.ncats.io/drug/25W4OLA785\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "FDA warning letter: synthetic steroid that does not constitute a dietary ingredientUnapproved drug",
    "Name": "mentabolan",
    "guid": "f64888bd-ecaf-4752-9efc-c7d0c2b018be",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "mentabolan",
    "Reasons": "[{\"reason_code\": 6019, \"reason\": \"FDA Warning Letter\", \"link\": null, \"guid\": \"1cd0ab89-14ce-43c2-a804-e4b29b8780fe\", \"link_title\": null, \"updated\": {\"_seconds\": 1711571477, \"_nanoseconds\": 43000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"SR 16278\", \"estr-4-ene-3,17-dione, 7alpha-methyl-\", \"MENT dione\", \"7alpha-methyl-estra-4-en-3,17-dione\", \"trestione\", \"(7\u03b1,14\u03b2)-7-methylestra-4-ene-3,17-dione\", \"7\u03b1-methyl-estra-4-en-3,17-dione\", \"7\u03b1-methyl-19-norandrostenedione\", \"estr-4-ene-3,17-dione, 7-methyl-, (7alpha)-\", \"7alpha-methyl-19-norandrostenedione\", \"SR-16278\", \"7alpha-methylestr-4-ene-3,17-dione\", \"7a-methyl-estra-4-en-3,17-dione\", \"estr-4-ene-3,17-dione, 7-methyl-, (7\u03b1)-\", \"estr-4-ene-3,17-dione, 7\u03b1-methyl-\", \"(7alpha,14beta)-7-methylestra-4-ene-3,17-dione\", \"7\u03b1-methylestr-4-ene-3,17-dione\", \"(7alpha)-7-methylestr-4-ene-3,17-dione\", \"(7\u03b1)-7-methylestr-4-ene-3,17-dione\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710347572, \"_nanoseconds\": 930000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "mephedrone",
    "guid": "bb8f1aee-c2e7-448a-9c1b-f9d32de49a60",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "mephedrone",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"Mcat\", \"buphedrone\", \"N,N-dimethyl-cathinone\", \"3-methyl-methcathinone\", \"4-methylmethcathinone\", \"ethcathinone\", \"4-methyl-N-methylcathinone\", \"4-MMC\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715361483, \"_nanoseconds\": 205000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Mephentermine\", \"url\": \"https://drugs.ncats.io/drug/TEZ91L71V4\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Unapproved drug",
    "Name": "mephentermine",
    "guid": "386227b2-b573-4d13-a774-ba535eca413f",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "mephentermine",
    "Reasons": "[{\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"mephenterdrinum\", \"mephentermine sulfate\", \"mefentermina\", \"mefenterdrin\", \"Wyfentermina\", \"Wyamine\", \"mefentermin\", \"mephenterdrine\", \"mephenterminum\", \"mephetedrine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709749599, \"_nanoseconds\": 844000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "meprobamate",
    "guid": "18a80211-0a06-41a2-acf1-cd2a23070857",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "meprobamate",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"Meprospan\", \"Miltown\", \"Micrainin\", \"Equanil\", \"Equagesic\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709749430, \"_nanoseconds\": 964000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "mescaline",
    "guid": "ade5be4f-8b84-4b7b-8dda-1aaa22ff3472",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "mescaline",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"3,4,5-trimethoxyphenethylamine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709749379, \"_nanoseconds\": 484000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "mesocarb",
    "guid": "6656dea5-a837-41f5-a551-0dc249c0c814",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "mesocarb",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"N-phenyl-N'-(3-(1-phenylpropan-2-yl)-1,2,3-oxadiazol-3-ium-5-yl)carbamimidate\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715355340, \"_nanoseconds\": 106000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "mestanolone",
    "guid": "6d0f855d-0dcc-4680-9cd2-aaaa4390cd17",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "mestanolone",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}, {\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"17alpha-methyl-17beta-hydroxy-5alpha-androstan-3-one\", \"17\u03b1-methyl-17\u03b2-hydroxy-5\u03b1-androstan-3-one\", \"Tantarone\", \"Ermalone\", \"Assimil\", \"Methybol\", \"17a-methyl-d1-dihydrotestosterone\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1716926084, \"_nanoseconds\": 511000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "mesterolone",
    "guid": "390353f0-7001-4bf7-b56e-f519221e6f33",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "mesterolone",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}, {\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"1\u03b1-methyl-17\u03b2-hydroxy-[5\u03b1]-androstan-3-one\", \"restore\", \"visimon\", \"Proviron\", \"Androviron\", \"infelon\", \"andarion\", \"1alpha-methyl-17beta-hydroxy-5alphaandrostan-3-one\", \"Testiwop\", \"17\u03b2-hydroxy-1\u03b1-methyl-5\u03b1-androstan-3-one\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1721225613, \"_nanoseconds\": 724000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "meta-fluorofentanyl",
    "guid": "23e77748-1d6d-41c9-92b3-84668baa521b",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "meta-fluorofentanyl",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"N-(3-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709046212, \"_nanoseconds\": 111000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "meta-fluoroisobutyryl fentanyl",
    "guid": "23300045-9882-4128-8e60-0568f1026d38",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "meta-fluoroisobutyryl fentanyl",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"N-(3-fluorophenyl)-N-(1-phenylpiperidin-4-yl)isobutyramide\", \"meta-fluoroisobutylryl fentanyl\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709044334, \"_nanoseconds\": 698000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule II",
    "Name": "metazocine",
    "guid": "4d0c4511-b76b-4137-9aba-625f9b990be4",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "metazocine",
    "Reasons": "[{\"reason_code\": 6004, \"reason\": \"DEA Controlled Substance List: Schedule  II\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"207f9e17-8a22-4523-8dd6-24d9d39b4c45\", \"link_title\": \"DEA Controlled Substance List: Schedule  II\", \"updated\": {\"_seconds\": 1712942744, \"_nanoseconds\": 783000000}}]",
    "other_names": "[\"2,6-methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-3,6,11-trimethyl-\", \"methobenzmorphan\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709748405, \"_nanoseconds\": 848000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule II",
    "Name": "methadone",
    "guid": "7e28f60e-7fd6-4c34-a282-bc57a47b845c",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "methadone",
    "Reasons": "[{\"reason_code\": 6004, \"reason\": \"DEA Controlled Substance List: Schedule  II\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"207f9e17-8a22-4523-8dd6-24d9d39b4c45\", \"link_title\": \"DEA Controlled Substance List: Schedule  II\", \"updated\": {\"_seconds\": 1712942744, \"_nanoseconds\": 783000000}}]",
    "other_names": "[\"Methadose\", \"Amidone\", \"Dolophine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709748301, \"_nanoseconds\": 864000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule II",
    "Name": "methadone-intermediate",
    "guid": "05a6b93a-547a-40c8-bc2c-2714c34a78b2",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "methadone-intermediate",
    "Reasons": "[{\"reason_code\": 6004, \"reason\": \"DEA Controlled Substance List: Schedule  II\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"207f9e17-8a22-4523-8dd6-24d9d39b4c45\", \"link_title\": \"DEA Controlled Substance List: Schedule  II\", \"updated\": {\"_seconds\": 1712942744, \"_nanoseconds\": 783000000}}]",
    "other_names": "[\"4-cyano-2-dimethylamino-4,4-diphenyl butane\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709748272, \"_nanoseconds\": 658000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule II",
    "Name": "methamphetamine",
    "guid": "d4bed760-8679-4628-86a6-c0df8d0a10c2",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "methamphetamine",
    "Reasons": "[{\"reason_code\": 6004, \"reason\": \"DEA Controlled Substance List: Schedule  II\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"207f9e17-8a22-4523-8dd6-24d9d39b4c45\", \"link_title\": \"DEA Controlled Substance List: Schedule  II\", \"updated\": {\"_seconds\": 1712942744, \"_nanoseconds\": 783000000}}]",
    "other_names": "[\"metamfetamine(d-)\", \"ICE\", \"Desoxyn\", \"Speed\", \"d-methamphetamine\", \"Crank\", \"D-desoxyephedrine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715355362, \"_nanoseconds\": 249000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "methandienone",
    "guid": "a2c373db-02c9-4a48-85dc-a9c071df60b3",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "methandienone",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}, {\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"metaboline\", \"metabolina\", \"17\u03b1-methyl-17\u03b2-hydroxyandrost-1,4-dien-3-one\", \"Metaboline\", \"17alpha-methyl-17beta\u00ad-hydroxyandrost-1,4-dien-3-one\", \"17beta-methyl-17alpha-\u00adhydroxyandrost-1,4-dien-3-one\", \"metandienone\", \"methandrostenolone\", \"dianabol\", \"17\u03b2-hydroxy-17\u03b1-methylandrosta-1,4-dien-3-one\", \"Nerobol\", \"Perbolin\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1716926427, \"_nanoseconds\": 789000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "methandriol",
    "guid": "55a603af-1f15-462c-8a61-b9b65e65c59a",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "methandriol",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}, {\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"androdiol\", \"madiol\", \"17alpha-methyl-3beta,17beta-dihydroxyandrost-5-ene\", \"cenabolic\", \"Sinesex\", \"methylandrostenediol\", \"mestenediol\", \"Stenediol\", \"17\u03b1-methyl-3\u03b2,17\u03b2-dihydroxyandrost-5-ene\", \"Troformone\", \"17\u03b1-methylandrost-5-ene-3\u03b2,17\u03b2-diol\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1721225860, \"_nanoseconds\": 926000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "methaqualone",
    "guid": "17a77174-baa5-432f-abe0-ebccc58e9728",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "methaqualone",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"Quaalude\", \"Somnafac\", \"Parest\", \"Mandrax\", \"Opitimil\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709747199, \"_nanoseconds\": 288000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "methasterone",
    "guid": "242bd831-0e57-4182-aae0-14b9240acdc2",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "methasterone",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}, {\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"17\u03b2-hydroxy-2\u03b1,17\u03b1-dimethyl-5\u03b1-androstan-3-one\", \"superdrol\", \"methyldrostanolone\", \"2\u03b1,17\u03b1-dimethyl-5\u03b1-androstan-17\u03b2-ol-3-one\", \"2alpha,17alpha-dimethyl-5alphaandrostan-17beta-ol-3-one\", \"2alpha,17alpha-dimethyl-17beta-hydroxy-5alpha-androstan-3-one\", \"17beta-hydroxy-2alpha,17alpha-dimethyl-5alpha-androstan-3-one\", \"2\u03b1,17\u03b1-dimethyl-17\u03b2-hydroxy-5\u03b1-androstan-3-one\", \"17a-methyl-drostanolone\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1716926757, \"_nanoseconds\": 765000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "methcathinone",
    "guid": "3f87bb15-f234-4c64-8620-237546ea2160",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "methcathinone",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"monomethylpropion\", \"2-(methylamino)-propiophenone\", \"AL-463\", \"AL-464\", \"methylcathinone\", \"cat\", \"ephedrone\", \"UR1432\", \"AL-422\", \"2-(methylamino)-1-phenylpropan-1-one\", \"alpha-(methylamino)propiophenone\", \"alpha-N-methylaminopropiophenone\", \"N-methylcathinone\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709746714, \"_nanoseconds\": 360000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "methenolone",
    "guid": "b67c03ee-ced1-47db-b954-4dac13b4a6cc",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "methenolone",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}, {\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"1-methyl-17\u03b2-hydroxy-5\u03b1-androst-1-en-3-one\", \"Primobolan\", \"1-methyl-17beta-hydroxy-5alpha-androst-1-en-3-one\", \"(5\u03b1,17\u03b2)-17-hydroxy-1-methylandrost-1-en-3-one\", \"(5alpha,17beta)-17-hydroxy-1-methylandrost-1-en-3-one\", \"Primobolan S\", \"Primobolan Depot\", \"metenolone\", \"17\u03b2-hydroxy-1-methyl-5\u03b1-androst-1-en-3-one\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1721225748, \"_nanoseconds\": 133000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "methiopropamine",
    "guid": "22c9575a-7232-4667-8e6f-d1c3090a23eb",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "methiopropamine",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"N-methyl-1-(thiophen-2-yl)propane-2-amine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709746043, \"_nanoseconds\": 712000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "methohexital",
    "guid": "ca2fd8b9-3d10-4da1-9538-cfd7c5c7a1a7",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "methohexital",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"Brevital\", \"methohexitone\", \"methohexitone sodium\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710263401, \"_nanoseconds\": 836000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Methoxy polyethylene glycol-epoetin beta\", \"url\": \"https://drugs.ncats.io/drug/LR3UXN0193\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "methoxy polyethylene glycol-epoetin beta",
    "guid": "5d8dd5ae-baa2-4757-b8a4-16cd83336dff",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "methoxy polyethylene glycol-epoetin beta",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}, {\"reason_code\": 6016, \"reason\": \"Prescription drug\", \"link\": null, \"guid\": \"becae72e-580f-4d8d-8665-c0c4b1dc1381\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683249, \"_nanoseconds\": 70000000}}]",
    "other_names": "[\"MIRCERA\u00ae\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1761922774, \"_nanoseconds\": 588000000}",
    "label_terms": "[]",
    "linked_ingredients": "[]",
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "methoxyacetyl fentanyl",
    "guid": "590b0fd0-2bc4-4f5c-81b8-26a3e0de5b07",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "methoxyacetyl fentanyl",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709745773, \"_nanoseconds\": 592000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Methoxygonadiene\", \"url\": \"https://drugs.ncats.io/drug/12AU99WIMP\"}, {\"title\": \"FDA warning letter\", \"url\": \"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/big-dans-fitness-nutrition-llc-494626-05252017\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S1: Anabolic Agents",
    "Name": "methoxydienone",
    "guid": "a2c18354-2aab-4918-b0eb-30e201309219",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "methoxydienone",
    "Reasons": "[{\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}, {\"reason_code\": 6019, \"reason\": \"FDA Warning Letter\", \"link\": null, \"guid\": \"1cd0ab89-14ce-43c2-a804-e4b29b8780fe\", \"link_title\": null, \"updated\": {\"_seconds\": 1711571477, \"_nanoseconds\": 43000000}}]",
    "other_names": "[\"methoxygonadiene\", \"MAX-LMG\", \"Max LMG\", \"13-beta-Ethyl-3-methoxy-gona-2,5(10)-dien-17-one\", \"13-ethyl-3-methoxy-gona-2,5(10)-diene-17-one\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710263330, \"_nanoseconds\": 340000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: methoxyphedrine\", \"url\": \"https://drugs.ncats.io/drug/L7HY239I58\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "methoxyphedrine",
    "guid": "e52c055d-2d99-4fb6-8a8c-d38636e32141",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "methoxyphedrine",
    "Reasons": "[{\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"4-methoxymethcathinone\", \"methedrone\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715361624, \"_nanoseconds\": 88000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "methyl-1-testosterone",
    "guid": "b7ce694b-73cc-4592-aad2-4e2a6be2bbbf",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "methyl-1-testosterone",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}, {\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"17-\u03b1-methyl-1-testosterone\", \"17beta-hydroxy-17alpha-methyl-5alpha-androst-1-en-3-one\", \"17\u03b2-hydroxy-17\u03b1-methyl-5\u03b1-androst-1-en-3-one\", \"17\u03b1-methyl-\u03941-dihydrotestosterone\", \"17alpha-methyl-delta1-dihydrotestosterone\", \"17-alpha-methyl-1-testosterone\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1716927057, \"_nanoseconds\": 933000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "methylclostebol",
    "guid": "28fdbfaf-961a-4080-8510-14f05956f9fe",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "methylclostebol",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}, {\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"4-chloro-17alpha-methyl-17beta-hydroxy-androst-4-en-3-one\", \"4-chloro-17\u03b1-methyl-17\u03b2-hydroxy-androst-4-en-3-one\", \"4-Chloro-17\u03b2-hydroxy-17\u03b1-methylandrost-4-en-3-one\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1722272484, \"_nanoseconds\": 990000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "methyldesorphine",
    "guid": "7d97cf7b-59a2-44ea-b499-a4a6075e6c0c",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "methyldesorphine",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"MK 57\", \"3-hydroxy-6,N-dimethyl-4,5-epoxymorphin-6-en\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709575623, \"_nanoseconds\": 380000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "methyldienolone",
    "guid": "65dd1e73-4024-45ef-96ed-313b3b7f3f50",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "methyldienolone",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}, {\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"17\u03b1-methyl-17\u03b2-hydroxyestra-4,9(10)-dien-3-one\", \"17beta-hydroxy-17alpha-methylestra-4,9-dien-3-one\", \"17\u03b2-hydroxy-17\u03b1-methylestra-4,9-dien-3-one\", \"17alpha-methyl-17beta-hydroxyestra4,9(10)-dien-3-one\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1716926925, \"_nanoseconds\": 797000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "methyldihydromorphine",
    "guid": "c94c7523-70f1-4b63-affa-88a13f342df2",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "methyldihydromorphine",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"methyl dihydromorphine\", \"morphine, methyldihydro-\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709575426, \"_nanoseconds\": 724000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"Final Rule Declaring Dietary Supplements Containing Ephedrine Alkaloids Adulterated Because They Present an Unreasonable Risk\", \"url\": \"https://www.federalregister.gov/documents/2004/02/11/04-2912/final-rule-declaring-dietary-supplements-containing-ephedrine-alkaloids-adulterated-because-they\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Federal regulation passed specifically to ban ephedra due to unreasonable risk of illness or injury",
    "Name": "methylephedrine",
    "guid": "a1a6a735-4ac7-4474-9b28-dad87100277e",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "methylephedrine",
    "Reasons": "[{\"reason_code\": 6021, \"reason\": \"Other reason\", \"link\": null, \"guid\": \"9bdb33d0-1759-4198-8056-bc40e52a3afd\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683326, \"_nanoseconds\": 656000000}}]",
    "other_names": "[\"N-methylephedrine hydrochloride\", \"methylpseudoephedrine\", \"Tybraine\", \"N-methylephedrine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715368158, \"_nanoseconds\": 290000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Methylnaphthidate\", \"url\": \"https://drugs.ncats.io/drug/T52Y9T2U0W\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Unapproved drug",
    "Name": "methylnaphthidate",
    "guid": "1c79b46c-3b30-4a00-b4a6-c4d055d6e361",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "methylnaphthidate",
    "Reasons": "[{\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"2-piperidineacetic acid, \u03b1-2-naphthalenyl-, methyl ester\", \"HDMP-28\", \"methyl 2-(naphthalen-2-yl)-2-(piperidin-2-yl)acetate\", \"2-piperidineacetic acid, alpha-2-naphthalenyl-, methyl ester\", \"DL-threo-methylnaphthidate\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715368197, \"_nanoseconds\": 770000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "methylone",
    "guid": "ebcf08b6-70dd-4a18-bf2a-d1af279be0ad",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "methylone",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"2,3-methylenedioxymethcathinone\", \"1-(benzo[d][1,3]dioxol-4-yl)-2-(methylamino)propan-1-one)\", \"2,3-MDMC\", \"3,4-methylenedioxy-N-methylcathinone\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709574724, \"_nanoseconds\": 196000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule II",
    "Name": "methylphenidate",
    "guid": "1b145377-45d4-4417-8cda-780c932d9c10",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "methylphenidate",
    "Reasons": "[{\"reason_code\": 6004, \"reason\": \"DEA Controlled Substance List: Schedule  II\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"207f9e17-8a22-4523-8dd6-24d9d39b4c45\", \"link_title\": \"DEA Controlled Substance List: Schedule  II\", \"updated\": {\"_seconds\": 1712942744, \"_nanoseconds\": 783000000}}]",
    "other_names": "[\"Tsentedrin\", \"Concerta\u00ae\", \"Ritalin\u00aeSR\", \"Cotempla\u00aeXR-ODT\", \"Aptensio XR\u00ae\", \"Methylin\u00ae\", \"Methylin\u00aeER\", \"Metadate\u00aeER\", \"Centedrin\", \"methylphenidatum\", \"Ritalin\u00ae\", \"Plimasine\", \"methyl phenidate\", \"Quillichew\u00aeER\", \"methylphenidylacetate hydrochloride\", \"methylfenidan\", \"Ritalin\u00aeLA\", \"Metadate\u00aeCD\", \"methylphenidan\", \"Adhansia XR\u00ae\", \"Equasym\", \"Daytrana\", \"Quillivant\u00aeXR\", \"Jornay PM\u00ae\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715368264, \"_nanoseconds\": 50000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "methylphenobarbital",
    "guid": "67cb4af2-1055-43c9-9473-8f439d2fce74",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "methylphenobarbital",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"mephobarbital\", \"Mebaral\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709574492, \"_nanoseconds\": 620000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"FDA Warning Letter\", \"url\": \"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/hardcore-formulations-522783-06052017\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S1: Anabolic AgentsFDA warning letter: synthetic steroid that does not constitute a dietary ingredient",
    "Name": "methylstenbolone",
    "guid": "a85eda48-6a96-435c-b8c4-4ff0348155ce",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "methylstenbolone",
    "Reasons": "[{\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}, {\"reason_code\": 6019, \"reason\": \"FDA Warning Letter\", \"link\": null, \"guid\": \"1cd0ab89-14ce-43c2-a804-e4b29b8780fe\", \"link_title\": null, \"updated\": {\"_seconds\": 1711571477, \"_nanoseconds\": 43000000}}]",
    "other_names": "[\"2,17a-dimethyl-17b-hydroxy-5a-androst-1-en-3-one\", \"Ultradrol\", \"M-Sten\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709574401, \"_nanoseconds\": 236000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"FDA: Methylsynephrine in Dietary Supplements\", \"url\": \"https://www.fda.gov/food/dietary-supplement-products-ingredients/methylsynephrine-dietary-supplements\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "FDA statement: Synthetic substance that currently does not meet the definition of a dietary ingredient",
    "Name": "methylsynephrine",
    "guid": "00f977b3-763d-4823-8912-fa56a7c72b66",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "methylsynephrine",
    "Reasons": "[{\"reason_code\": 6018, \"reason\": \"FDA Statement\", \"link\": \"\", \"guid\": \"3cd17124-6ebc-4828-9edb-c20a81755502\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1711715334, \"_nanoseconds\": 457000000}}]",
    "other_names": "[\"1-(4-hydroxyphenyl)-2-methylaminopropanol\", \"Oxyephedrin\", \"4\u2010[1\u2010hydroxy\u20102\u2010(methylamino)propyl]phenol\", \"Suprifene\", \"Supriphen\", \"1-(4'-hydroxyphenyl)-2-methylaminopropanol\", \"4-HMP\", \"Oxyephedrine\", \"Suprifen\", \"oxilofrine\", \"oxilofrin\", \"oxilofrine hydrochloride\", \"Methyl synephrin\", \"p-Oxy-ephedrin\", \"erythro-p-Hydroxy-alpha-(1-(methylamino)ethyl)benzyl alcohol\", \"oxilofrinum\", \"4-hydroxyephedrine\", \"p-hydroxyephedrine\", \"Hydroxyephedrine\", \"Methyl synephrine\", \"Methylsynephrin\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715368730, \"_nanoseconds\": 975000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "methyltestosterone",
    "guid": "591d3440-edfe-4c01-8ae3-2e037a223962",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "methyltestosterone",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}, {\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"17alpha-methyl-17beta-\u00adhydroxyandrost-4-en-3-one\", \"Android\", \"Oreton\", \"Testred\", \"17\u03b1-methyl-17\u03b2-hydroxyandrost-4-en-3-one\", \"17a-methyltestosterone\", \"Virilon\", \"17\u03b2-hydroxy-17\u03b1-methylandrost-4-en-3-one\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1721226330, \"_nanoseconds\": 389000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Methylene blue\", \"url\": \"https://drugs.ncats.io/drug/8NAP7826UB\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Prescription drug",
    "Name": "methylthioninium chloride",
    "guid": "14905f91-5d22-417a-aedf-45d95b486096",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "methylthioninium chloride",
    "Reasons": "[{\"reason_code\": 6016, \"reason\": \"Prescription drug\", \"link\": null, \"guid\": \"becae72e-580f-4d8d-8665-c0c4b1dc1381\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683249, \"_nanoseconds\": 70000000}}]",
    "other_names": "[\"methylene blue anhydrous\", \"methylene blue\", \"methylene blue\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1759160424, \"_nanoseconds\": 253000000}",
    "label_terms": "[]",
    "linked_ingredients": "[]",
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "methyltrienolone",
    "guid": "49b91acb-727b-4377-b4e0-7b2838fa54ef",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "methyltrienolone",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}, {\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"17alpha-methyltrienolone\", \"17beta-hydroxy-17alpha-methylestra-4,9,11-trien-3-one\", \"metribolone\", \"17\u03b1-methyl-17\u03b2-hydroxyestra-4,9-11-trien-3-one\", \"17\u03b2-hydroxy-17\u03b1-methylestra-4,9,11-trien-3-one\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1716927485, \"_nanoseconds\": 4000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "methyprylon",
    "guid": "eeab04a0-f218-49db-8da8-7a51e74e0af1",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "methyprylon",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}]",
    "other_names": "[\"Noludar\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709573277, \"_nanoseconds\": 92000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "metodesnitazene",
    "guid": "319f731e-3c72-41c3-b8c9-05f6ab0891b4",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "metodesnitazene",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"N,N-diethyl-2-(2-(4-methoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine\", \"2-(2-(4-methoxybenzyl)-1H-benzo[d]imidazol-1-yl)-N,N-diethylethanamine\", \"N,N-diethyl-N-(2-(2-(4-methoxybenzyl)-1H-benzimidazol-1-yl)ethyl)amine\", \"benzimidazole, 1-(2-(diethylamino)ethyl)-2-(p-methoxybenzyl)-\", \"N,N-diethyl-2-(2-(4-methoxybenzyl)-1H-benzimidazol-1-yl)ethanamine\", \"1-(2-diethylaminoethyl)-2-(p-methoxybenzyl)benzimidazole\", \"N,N-diethyl-2-[2-[(4-methoxyphenyl)methyl]benzimidazol-1-yl]ethanamine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715278322, \"_nanoseconds\": 90000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Metolazone\", \"url\": \"https://drugs.ncats.io/drug/TZ7V40X7VX\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S5: Diuretics and Masking AgentsPrescription drug",
    "Name": "metolazone",
    "guid": "17495751-9cfb-44b4-9494-276c621d11f0",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "metolazone",
    "Reasons": "[{\"reason_code\": 6013, \"reason\": \"WADA S5: Diuretics and Masking Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b1ad44e4-cef0-4ae2-99fb-19e28540f282\", \"link_title\": \"WADA Prohibited List S5: Diuretics and Masking Agents\", \"updated\": {\"_seconds\": 1703682941, \"_nanoseconds\": 864000000}}, {\"reason_code\": 6016, \"reason\": \"Prescription drug\", \"link\": null, \"guid\": \"becae72e-580f-4d8d-8665-c0c4b1dc1381\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683249, \"_nanoseconds\": 70000000}}]",
    "other_names": "[\"Mykrox\u00ae\", \"Zaroxolyn\u00ae\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709572805, \"_nanoseconds\": 572000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "metonitazene",
    "guid": "4f743905-311f-4946-9b57-b33279bfc839",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "metonitazene",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"N,N-diethyl-2-[(4-methoxyphenyl)methyl]-5-nitro-1H-benzimidazole-1-ethanamine\", \"benzimidazole, 1-(2-(diethylamino)ethyl)-2-(p-methoxybenzyl)-5-nitro-\", \"N,N-diethyl-2-[2-[(4-methoxyphenyl)methyl]-5-nitrobenzimidazol-1-yl]ethanamine\", \"1H-benzimidazole-1-ethanamine, N,N-diethyl-2-((4-methoxyphenyl)methyl)-5-nitro-\", \"N,N-diethyl-2-((4-methoxyphenyl)methyl)-5-nitro-1H-benzimidazole-1-ethanamine\", \"N,N-diethyl-2-(2-(4- methoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine\", \"1-(2-diethylaminoethyl)-2-(p-methoxybenzyl)-5-nitro-1H-benzimidazole\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709572752, \"_nanoseconds\": 346000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule II",
    "Name": "metopon",
    "guid": "7b447610-4d7b-43e2-ab31-2c010d31fce0",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "metopon",
    "Reasons": "[{\"reason_code\": 6004, \"reason\": \"DEA Controlled Substance List: Schedule  II\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"207f9e17-8a22-4523-8dd6-24d9d39b4c45\", \"link_title\": \"DEA Controlled Substance List: Schedule  II\", \"updated\": {\"_seconds\": 1712942744, \"_nanoseconds\": 783000000}}]",
    "other_names": "[\"dihydro-6-methylmorphinone\", \"methyldihydromorphinone\", \"5-methyldihydromorphinone\", \"5-methylhydromorphone\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709572136, \"_nanoseconds\": 8000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "mibolerone",
    "guid": "34a90fb9-4832-4f7e-8cbc-45714b3771e5",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "mibolerone",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}, {\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"7alpha,17alpha-dimethyl-17beta-\u00adhydroxyestr-4-en-3-one\", \"Cheque\", \"Matenon\", \"Cheque drops\", \"7\u03b1,17\u03b1-dimethyl-17\u03b2-hydroxyestr-4-en-3-one\", \"17\u03b2-Hydroxy-7\u03b1,17\u03b1-dimethylestr-4-en-3-one\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1722272534, \"_nanoseconds\": 368000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "midazolam",
    "guid": "ecd6e114-1c75-4107-aac9-4f4b605de535",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "midazolam",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"Versed\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709571616, \"_nanoseconds\": 208000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "mitochondrial open reading frame of the 12S rRNA-c",
    "guid": "785b334d-de32-4669-bf8f-569d29b98320",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "mitochondrial open reading frame of the 12s rrna-c",
    "Reasons": "[{\"reason_code\": 6012, \"reason\": \"WADA S4: Hormone and Metabolic Modulators\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"ac1ba347-6d44-4a17-829d-e589bf33bbdb\", \"link_title\": \"WADA Prohibited List S4: Hormone and Metabolic Modulators\", \"updated\": {\"_seconds\": 1703682875, \"_nanoseconds\": 162000000}}]",
    "other_names": "[\"MOTS-c\", \"mitochondrial open reading frame of the 12S rRNA-c (MOTS-c)\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1748883067, \"_nanoseconds\": 60000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "modafinil",
    "guid": "a6bc9149-6f14-4568-8ed7-99c335be0406",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "modafinil",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"benzhydrylsulfinylacetamide\", \"Sparlon\", \"modafinilum\", \"Provigil\", \"modafinilo\", \"2-((diphenylmethyl)sulfinyl)acetamide\", \"Modiodal\", \"Pulmicort\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715355488, \"_nanoseconds\": 186000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Molidustat\", \"url\": \"https://drugs.ncats.io/drug/9JH486CZ13\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S2: Peptide Hormones, Growth Factors, etc.Unapproved drug",
    "Name": "molidustat",
    "guid": "8d1936d2-b532-43ac-a653-c8bf2d4a40f1",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "molidustat",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"BAY 85-3934\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709315439, \"_nanoseconds\": 229000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule II",
    "Name": "moramide-intermediate",
    "guid": "994cb79a-af0d-45ec-afa5-11c48d7f081a",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "moramide-intermediate",
    "Reasons": "[{\"reason_code\": 6004, \"reason\": \"DEA Controlled Substance List: Schedule  II\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"207f9e17-8a22-4523-8dd6-24d9d39b4c45\", \"link_title\": \"DEA Controlled Substance List: Schedule  II\", \"updated\": {\"_seconds\": 1712942744, \"_nanoseconds\": 783000000}}]",
    "other_names": "[\"2-methyl-3-morpholino-1,1-diphenylpropane-carboxylic acid\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709315384, \"_nanoseconds\": 978000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "morpheridine",
    "guid": "a102b1e5-1218-4a8c-8ee7-9e1dd7f4f12e",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "morpheridine",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"TA 1\", \"ethyl 1-(2-morpholin-4-ylethyl)-4-phenylpiperidine-4-carboxylate\", \"morpholinoethyl-norpethidine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709315284, \"_nanoseconds\": 173000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule II",
    "Name": "morphine",
    "guid": "88d701b4-2005-431d-ab10-da505b2c8fab",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "morphine",
    "Reasons": "[{\"reason_code\": 6004, \"reason\": \"DEA Controlled Substance List: Schedule  II\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"207f9e17-8a22-4523-8dd6-24d9d39b4c45\", \"link_title\": \"DEA Controlled Substance List: Schedule  II\", \"updated\": {\"_seconds\": 1712942744, \"_nanoseconds\": 783000000}}]",
    "other_names": "[\"morphine methylsulfonate\", \"morphine methylbromide\", \"Roxanol\", \"Oramorph\", \"MSIR\", \"MS Contin\", \"RMS\", \"morphine-N-oxide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709314975, \"_nanoseconds\": 390000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Mozavaptan\", \"url\": \"https://drugs.ncats.io/drug/17OJ42922Y\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "mozavaptan",
    "guid": "b51244b8-b08c-4aa6-aa48-5331c8342355",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "mozavaptan",
    "Reasons": "[{\"reason_code\": 6013, \"reason\": \"WADA S5: Diuretics and Masking Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b1ad44e4-cef0-4ae2-99fb-19e28540f282\", \"link_title\": \"WADA Prohibited List S5: Diuretics and Masking Agents\", \"updated\": {\"_seconds\": 1703682941, \"_nanoseconds\": 864000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709049124, \"_nanoseconds\": 936000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Myo-inositol trispyrophosphate\", \"url\": \"https://drugs.ncats.io/drug/116EYZ0PPX\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "myo-inositol trispyrophosphate ",
    "guid": "94d25bc3-1962-4cca-a2b8-c15476ae5f93",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "myo-inositol trispyrophosphate ",
    "Reasons": "[{\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"OXY111A\", \"inositol trispyrophosphate\", \"ITPP cpd\", \"ITPP\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1760025614, \"_nanoseconds\": 909000000}",
    "label_terms": "[]",
    "linked_ingredients": "[]",
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "myostatin propeptide",
    "guid": "9be6782c-4b3d-4d86-8e9d-ef02c79a28f8",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "myostatin propeptide",
    "Reasons": "[{\"reason_code\": 6012, \"reason\": \"WADA S4: Hormone and Metabolic Modulators\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"ac1ba347-6d44-4a17-829d-e589bf33bbdb\", \"link_title\": \"WADA Prohibited List S4: Hormone and Metabolic Modulators\", \"updated\": {\"_seconds\": 1703682875, \"_nanoseconds\": 162000000}}]",
    "other_names": "[]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1735580240, \"_nanoseconds\": 592000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "myrophine",
    "guid": "aa82883d-d033-4b81-9176-0f8188810b43",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "myrophine",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"benzylmorphinyl myristate\", \"myrophinium\", \"myristylbenzylmorphine\", \"3-benzylmorphine 6-myristate\", \"3-benzyloxy-6-myristoyloxymorphine\", \"myrocodine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709314806, \"_nanoseconds\": 581000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule II",
    "Name": "nabilone",
    "guid": "554b6dec-4778-4a3a-8ed3-db874e8c0460",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "nabilone",
    "Reasons": "[{\"reason_code\": 6004, \"reason\": \"DEA Controlled Substance List: Schedule  II\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"207f9e17-8a22-4523-8dd6-24d9d39b4c45\", \"link_title\": \"DEA Controlled Substance List: Schedule  II\", \"updated\": {\"_seconds\": 1712942744, \"_nanoseconds\": 783000000}}]",
    "other_names": "[\"Cesamet\", \"(+)-trans-3-(1,1-dimethylheptyl)-6, 6a, 7, 8, 10, 10a-hexahydro-1-hydroxy-6, 6-dimethyl-9H-dibenzo[b,d]pyran-9-one\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709312625, \"_nanoseconds\": 503000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Nafarelin\", \"url\": \"https://drugs.ncats.io/drug/1X0094V6JV\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S2: Peptide Hormones, Growth Factors, etc.Prescription drug",
    "Name": "nafarelin",
    "guid": "ad4f710d-29a2-40f7-b584-8121796338c5",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "nafarelin",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}, {\"reason_code\": 6016, \"reason\": \"Prescription drug\", \"link\": null, \"guid\": \"becae72e-580f-4d8d-8665-c0c4b1dc1381\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683249, \"_nanoseconds\": 70000000}}]",
    "other_names": "[\"LHRH, 6(D-NAL(2))\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709312322, \"_nanoseconds\": 94000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "nalorphine",
    "guid": "8e9766f1-0e56-4f04-9842-4a0001b06a71",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "nalorphine",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}]",
    "other_names": "[\"Nalline\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709312170, \"_nanoseconds\": 205000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "nandrolone",
    "guid": "93509201-9243-4125-ab18-9f8e9b5589a5",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "nandrolone",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}, {\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"17beta-hydroxyestr-4-en-3-one\", \"19-nortestosterone\", \"durabolin-50\", \"nandrolone decanoate\", \"nandrolone phenylpropionate\", \"17\u03b2-hydroxyestr-4-en-3-one\", \"17\u03b2-hydroxy-estr-4-en-3-one\", \"duraboin\", \"deca-durabolin\", \"nandrolone enanthate\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1727716080, \"_nanoseconds\": 185000000}",
    "label_terms": "[\"19-norandrost-4-ene-3b-ol, 17-one decanoate\", \"19-norandrost-4-ene-3b-ol, 17-one enanthate\"]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Use or misuse prohibited under DoDI 1010.16 (synthetic cannabinoids)",
    "Name": "naphthalene",
    "guid": "c9490902-af3f-49fe-9d21-ec7a71903c7a",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "naphthalene",
    "Reasons": "[{\"reason_code\": 6014, \"reason\": \"DoDI 1010.16\", \"link\": \"https://www.esd.whs.mil/directives/issuances/dodi\", \"guid\": \"b757aa46-4729-4d4a-a32e-25ef0b04e5c3\", \"link_title\": \"Use or misuse prohibited under DoDI 1010.16\", \"updated\": {\"_seconds\": 1703683049, \"_nanoseconds\": 190000000}}]",
    "other_names": "[\"albocarbon\", \"dezodorator\", \"tar camphor\", \"white tar\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709312101, \"_nanoseconds\": 588000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "naphyrone",
    "guid": "3afac356-d83b-410b-bb6a-7ca74af5d10e",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "naphyrone",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"\u03b1-naphyrone\", \"1-(naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one\", \"naphthylpyrovalerone\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709311997, \"_nanoseconds\": 157000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Nefiracetam\", \"url\": \"https://drugs.ncats.io/drug/1JK12GX30N\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Unapproved drug",
    "Name": "nefiracetam",
    "guid": "655eaea6-262b-4eb4-8b21-5e2281fd83ec",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "nefiracetam",
    "Reasons": "[{\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"N-(2,6-dimethylphenyl)-2-(2-oxo-1-pyrrolidinyl)acetamide\", \"N-(2,6-dimethylphenyl)-2-(2-oxo-1-pyrrolidinyl) acetamide\", \"2-oxo-1-pyrrolidineaceto-2',6'-xylidide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1751986401, \"_nanoseconds\": 696000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "nicocodeine",
    "guid": "0e46541c-696d-4506-b53b-8fd814116076",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "nicocodeine",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"nicocodine\", \"6-nicotinoylcodeine\", \"lyopect\", \"nicotinic acid, ester with codeine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709311900, \"_nanoseconds\": 730000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "nicomorphine",
    "guid": "220001c4-0f60-462b-a926-1e0fbbf0cc1b",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "nicomorphine",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"Vilan\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709311854, \"_nanoseconds\": 859000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Carditonic\", \"url\": \"https://drugs.ncats.io/drug/368IVD6M32\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Unapproved drug",
    "Name": "nikethamide",
    "guid": "81565b91-86bc-4fa4-8d06-5140c00b5d2a",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "nikethamide",
    "Reasons": "[{\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"Anacardone\", \"nicethamide\", \"nicotinic acid diethylamide\", \"N,N-diethylnicotinamide\", \"Coramin\", \"nizethamid\", \"Coramine\", \"Corethamid\", \"nicetamida\", \"nicethamidum\", \"Cordiamine\", \"carditonic\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715368364, \"_nanoseconds\": 114000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "nimetazepam",
    "guid": "4d7104bc-5665-4f65-a226-8832f0f56df0",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "nimetazepam",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"methylnitrazepam\", \"1,3-dihydro-1-methyl-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one\", \"Elimin\", \"Erimin\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709311703, \"_nanoseconds\": 900000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "nitrazepam",
    "guid": "0ed7a204-064f-422c-907a-10b63788e836",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "nitrazepam",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"Mogadon\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709311661, \"_nanoseconds\": 539000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: nor-NOHA\", \"url\": \"https://drugs.ncats.io/drug/U0F1149OFR\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Unapproved drug",
    "Name": "nor-NOHA",
    "guid": "d76a0407-67ae-4a41-8343-a0f8226342b4",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "nor-noha",
    "Reasons": "[{\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"(2S)-2-amino-4-(((hydroxyamino)iminomethyl)amino)butanoic acid\", \"N-omega-hydroxy-L-norarginine\", \"(2S)-2-amino-4-[[amino-(hydroxyamino)methylidene]amino]butanoic acid\", \"N-hydroxy-nor-arginine\", \"butanoic acid, 2-amino-4-(((hydroxyamino)iminomethyl)amino)-, (S)-\", \"Nomega-hydroxy-nor-L-arginine\", \"nor-N-omega-hydroxy-L-arginine\", \"(2S)-4-[[amino-(hydroxyamino)methylidene]amino]-2-azaniumylbutanoate\", \"N-hydroxy-nor-L-arginine\", \"N-omega-hydroxynor-L-arginine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709311580, \"_nanoseconds\": 547000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "noracymethadol",
    "guid": "a755e584-a209-44a0-b4fa-483a4f17bfab",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "noracymethadol",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"[6-(methylamino)-4,4-diphenylheptan-3-yl] acetate\", \"paracymethadol\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709224127, \"_nanoseconds\": 673000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "norandrostenediol",
    "guid": "3421da38-5373-43ff-bd17-db96b1a7f2aa",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "norandrostenediol",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}, {\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"3\u03b1, 17\u03b2-dihydroxyestr-4-ene\", \"3alpha,17beta-dihydroxyestr-4-ene\", \"3beta,17beta-dihydroxyestr-4ene\", \"3\u03b2-dihydronandrolone\", \"19-nor-4-androstenediol\", \"estr-4-ene-3,17-diol\", \"bolandiol\", \"3beta-dihydronandrolone\", \"3\u03b2, 17\u03b2-dihydroxyestr-4-ene\", \"19-norandrostenediol\", \"19-nor-androstenediol\", \"estr-4-ene-3\u03b2,17\u03b2-diol\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1716913403, \"_nanoseconds\": 753000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "norandrostenedione",
    "guid": "887270c0-0997-4cda-a677-1846a277c8ba",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "norandrostenedione",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}, {\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"estr-4-en-3,17-dione\", \"estr-4-ene-3,17-dione\", \"Nordione\", \"19-norandrostenedione\", \"bolandione\", \"19-nor-4-androstenedione\", \"19-nor-androstenedione\", \"19-norandrost-4-en-3,17-dione\", \"19-norandrost-4-ene-3,17-dione\", \"estr-4-ene-3\u03b2,17-dione\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1721919621, \"_nanoseconds\": 772000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Use or misuse prohibited under DoDI 1010.16 (cocaine metabolites)",
    "Name": "norbenzoylecgonine",
    "guid": "56165f5e-1f9b-4f73-98e6-445ee854879c",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "norbenzoylecgonine",
    "Reasons": "[{\"reason_code\": 6014, \"reason\": \"DoDI 1010.16\", \"link\": \"https://www.esd.whs.mil/directives/issuances/dodi\", \"guid\": \"b757aa46-4729-4d4a-a32e-25ef0b04e5c3\", \"link_title\": \"Use or misuse prohibited under DoDI 1010.16\", \"updated\": {\"_seconds\": 1703683049, \"_nanoseconds\": 190000000}}]",
    "other_names": "[\"NBE\", \"benzoylnorecgonine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710260833, \"_nanoseconds\": 365000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "norbolethone",
    "guid": "719eaf1d-2f56-4331-b48e-da06ae0edcb0",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "norbolethone",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}, {\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"13beta,17alpha-diethyl-17beta-\u00adhydroxygon-4-en-3-one\", \"norboletone\", \"Genabol\", \"13\u03b2,17\u03b1-diethyl-17\u03b2-hydroxygon-4-en-3-one\", \"17\u03b1-Ethyl-17\u03b2-hydroxy-18-methylestr-4-en-3-one\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1722272630, \"_nanoseconds\": 536000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "norclostebol",
    "guid": "37bbb286-f053-4f81-a8a7-04a35750461f",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "norclostebol",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}, {\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"4-chloro-17beta-ol-estr-4-en-3-one\", \"4-chloro-17\u03b2-ol-estr-4-en-3-one\", \"4-chloro-17beta-hydroxyestr-4-en-3-one\", \"Lentabol\", \"4-chloro-17\u03b2-hydroxyestr-4-en-3-one\", \"Anabol-4-19\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1716927926, \"_nanoseconds\": 245000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Use or misuse prohibited under DoDI 1010.16 (cocaine metabolites)",
    "Name": "norcocaine",
    "guid": "88ab383f-f21c-49c8-963e-8abd7ecb4c85",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "norcocaine",
    "Reasons": "[{\"reason_code\": 6014, \"reason\": \"DoDI 1010.16\", \"link\": \"https://www.esd.whs.mil/directives/issuances/dodi\", \"guid\": \"b757aa46-4729-4d4a-a32e-25ef0b04e5c3\", \"link_title\": \"Use or misuse prohibited under DoDI 1010.16\", \"updated\": {\"_seconds\": 1703683049, \"_nanoseconds\": 190000000}}]",
    "other_names": "[\"n-demethylcocaine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709223064, \"_nanoseconds\": 441000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "nordiazepam",
    "guid": "9d5f41fb-fdb9-4d84-be43-d7c940caef48",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "nordiazepam",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"nordazepam\", \"dealkylprazepam\", \"Madar\", \"desmethyldiazepam\", \"norprazepam\", \"Demadar\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709223030, \"_nanoseconds\": 328000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "norethandrolone",
    "guid": "7a90d173-2da2-4347-9937-ef030889ad84",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "norethandrolone",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}, {\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"17\u03b1-ethyl-17\u03b2-hydroxyestr-4-en-3-one\", \"Pronabol\", \"Solevar\", \"Nilevar\", \"17alpha-ethyl-17beta-hydroxyestr-4en-3-one\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1716928025, \"_nanoseconds\": 629000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Norfenefrine\", \"url\": \"https://drugs.ncats.io/drug/D2P3M6SRN5\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Unapproved drug",
    "Name": "norfenefrine",
    "guid": "37a6d1d6-64a1-49a1-a17f-ffbf61b5bd34",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "norfenefrine",
    "Reasons": "[{\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"norphenephrine\", \"Novadral\", \"norfenefrine hydrochloride\", \"Metacardiol\", \"Normetol\", \"norfenefrine sulfate\", \"3,\u03b2-dihydroxyphenethylamine\", \"Norenol\", \"norfenefrine citrate\", \"norfenefrina\", \"3,beta-dihydroxyphenethylamine\", \"norfenefrinum\", \"m-octopamine\", \"3-octopamine\", \"meta-octopamine\", \"norfenefrin ziethen\", \"norphenylephrine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1762180182, \"_nanoseconds\": 303000000}",
    "label_terms": "[]",
    "linked_ingredients": "[]",
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Use or misuse prohibited under DoDI 1010.16 (cocaine metabolites)",
    "Name": "norfenfluramine",
    "guid": "6643dc6b-bdcc-48a2-a4a1-7082878b8928",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "norfenfluramine",
    "Reasons": "[{\"reason_code\": 6014, \"reason\": \"DoDI 1010.16\", \"link\": \"https://www.esd.whs.mil/directives/issuances/dodi\", \"guid\": \"b757aa46-4729-4d4a-a32e-25ef0b04e5c3\", \"link_title\": \"Use or misuse prohibited under DoDI 1010.16\", \"updated\": {\"_seconds\": 1703683049, \"_nanoseconds\": 190000000}}]",
    "other_names": "[]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715355533, \"_nanoseconds\": 298000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule II",
    "Name": "norfentanyl",
    "guid": "a761e4e6-f640-4e4c-8ab5-abe6a80022d8",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "norfentanyl",
    "Reasons": "[{\"reason_code\": 6004, \"reason\": \"DEA Controlled Substance List: Schedule  II\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"207f9e17-8a22-4523-8dd6-24d9d39b4c45\", \"link_title\": \"DEA Controlled Substance List: Schedule  II\", \"updated\": {\"_seconds\": 1712942744, \"_nanoseconds\": 783000000}}]",
    "other_names": "[\"N-phenyl-N-(piperidin-4-yl)propionamide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709222491, \"_nanoseconds\": 144000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "norlevorphanol",
    "guid": "1bd2165b-1105-4190-900c-b10bdd96d74d",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "norlevorphanol",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"3-hydroxymorphinan\", \"morphinan-3-ol\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709222456, \"_nanoseconds\": 864000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "normethadone",
    "guid": "3f82d4bc-ee98-420e-a1ee-bfdc33cbba4e",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "normethadone",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"phenyldimazone\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709222410, \"_nanoseconds\": 760000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "normethandrolone",
    "guid": "409b7aae-517f-4ee3-9fd6-56c6e2bb4588",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "normethandrolone",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}, {\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"17\u03b1-methyl-19-nortestosterone\", \"Matronal\", \"methylestrenolone\", \"Lutenin\", \"17\u03b2-hydroxy-17\u03b1-methylestr-4-en-3-one\", \"17\u03b1-methyl-17\u03b2-hydroxyestr-4-en-3-one\", \"methylnortestosterone\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1727715811, \"_nanoseconds\": 301000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "normorphine",
    "guid": "946806b1-8721-4eb0-ba86-56ca6dac2fee",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "normorphine",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709222182, \"_nanoseconds\": 15000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule II",
    "Name": "noroxymorphone",
    "guid": "f13b1f9c-c96a-4073-8e87-2e3ffe247605",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "noroxymorphone",
    "Reasons": "[{\"reason_code\": 6004, \"reason\": \"DEA Controlled Substance List: Schedule  II\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"207f9e17-8a22-4523-8dd6-24d9d39b4c45\", \"link_title\": \"DEA Controlled Substance List: Schedule  II\", \"updated\": {\"_seconds\": 1712942744, \"_nanoseconds\": 783000000}}]",
    "other_names": "[\"7,8-dihydro-14-hydroxynormorphinone\", \"(5alpha)-4,5-Epoxy-3,14-dihydroxymorphinan-6-one\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709222147, \"_nanoseconds\": 240000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "norpipanone",
    "guid": "f8b50107-3762-4603-9208-21f86166ac4e",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "norpipanone",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"Hoechst 10495\", \"Orfenso\", \"3-hexanone, 4,4-diphenyl-6-(1-piperidinyl)-\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709222111, \"_nanoseconds\": 175000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"FDA Warning Letter\", \"url\": \"https://www.fda.gov/drugs/medication-health-fraud/public-notification-best-candy-contains-hidden-drug-ingredient\"}, {\"title\": \"NIH NCATS Inxight Drugs entry: nortadalafil\", \"url\": \"https://drugs.ncats.io/drug/5W59DMB3LD\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "nortadalafil",
    "guid": "330008eb-b1f1-4a3d-87f5-832c804e5868",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "nortadalafil",
    "Reasons": "[{\"reason_code\": 6019, \"reason\": \"FDA Warning Letter\", \"link\": null, \"guid\": \"1cd0ab89-14ce-43c2-a804-e4b29b8780fe\", \"link_title\": null, \"updated\": {\"_seconds\": 1711571477, \"_nanoseconds\": 43000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715869230, \"_nanoseconds\": 580000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "ocfentanil",
    "guid": "82771cc8-a3de-4433-8a96-988ca4095c0e",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "ocfentanil",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)acetamide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709221997, \"_nanoseconds\": 48000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"FDA Warning Letter\", \"url\": \"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/nutritional-sales-and-customer-service-llc-622403-05042022\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "FDA Warning Letter: New dietary ingredient lacking evidence for safe use",
    "Name": "octopamine",
    "guid": "8852cc67-a94a-4c78-b20a-3fb974bb55a4",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "octopamine",
    "Reasons": "[{\"reason_code\": 6019, \"reason\": \"FDA Warning Letter\", \"link\": null, \"guid\": \"1cd0ab89-14ce-43c2-a804-e4b29b8780fe\", \"link_title\": null, \"updated\": {\"_seconds\": 1711571477, \"_nanoseconds\": 43000000}}]",
    "other_names": "[\"4-(2-amino-1-hydroxyethyl)phenol\", \"Norden\", \"1-(p-hydroxyphenyl)-2-aminoethanol\", \"alpha-aminoethyl-4-hydroxybenzylalkohol\", \"Norphen\", \"p-hydroxyphenylethanolamine\", \"norsynephrine\", \"paraoxyphenyl aminoethanol\", \"p-octopamine\", \"Analet\", \"Norsympatol\", \"octopaminum\", \"alpha-(aminoethyl)-p-hydroxybenzyl alcohol\", \"Benzenemethanol, alpha-(aminomethyl)-4-hydroxy-\", \"p-norsynephrin\", \"alpha-(aminoethyl)-4-hydroxybenzenemethanol\", \"Norsympathol\", \"octopamine HCl\", \"norfen\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715368684, \"_nanoseconds\": 618000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule II",
    "Name": "oliceridine",
    "guid": "a18d2322-defe-4019-a344-a32ed0cb421d",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "oliceridine",
    "Reasons": "[{\"reason_code\": 6004, \"reason\": \"DEA Controlled Substance List: Schedule  II\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"207f9e17-8a22-4523-8dd6-24d9d39b4c45\", \"link_title\": \"DEA Controlled Substance List: Schedule  II\", \"updated\": {\"_seconds\": 1712942744, \"_nanoseconds\": 783000000}}]",
    "other_names": "[\"N-[(3-methoxythiophen-2-yl)methyl] ({2-[(9R)-9-(pyridin-2-yl)-6-oxaspiro [4.5]decan-9-yl]ethyl})amine fumarate\", \"N-[(3-methoxythiophen-2-yl)methyl] ({2-[(9R)-9-(pyridin-2-yl)-6-oxaspiro [4.5]decan-9-yl]ethyl{time} )amine fumarate\", \"N-[(3-Methoxythiophen-2-yl)methyl]-2-[(9R)-9-(pyridin-2-yl)-6-oxaspiro[4.5]decan-9-yl]ethanamine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709221638, \"_nanoseconds\": 399000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Olodaterol\", \"url\": \"https://drugs.ncats.io/drug/VD2YSN1AFD\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S3: Beta-2 AgonistsPrescription drug",
    "Name": "olodaterol",
    "guid": "952cab28-aea7-4c59-ae99-672c6e167e2e",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "olodaterol",
    "Reasons": "[{\"reason_code\": 6011, \"reason\": \"WADA S3: Beta-2 Agonists\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"aecafa3b-c7ad-413c-bc5f-be7ed5b2f69d\", \"link_title\": \"WADA Prohibited List S3: Beta-2 Agonists\", \"updated\": {\"_seconds\": 1703682857, \"_nanoseconds\": 73000000}}, {\"reason_code\": 6016, \"reason\": \"Prescription drug\", \"link\": null, \"guid\": \"becae72e-580f-4d8d-8665-c0c4b1dc1381\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683249, \"_nanoseconds\": 70000000}}]",
    "other_names": "[]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709221042, \"_nanoseconds\": 391000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Omberacetam\", \"url\": \"https://drugs.ncats.io/drug/4QBJ98683M\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Unapproved drug",
    "Name": "omberacetam",
    "guid": "2de9f953-ffa0-419b-a218-b7275a9ab2f6",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "omberacetam",
    "Reasons": "[{\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"GVS-111\", \"ethyl phenylacetyl-pro-gly\", \"N-phenylacetyl-L-prolylglycine ethyl ester\", \"GVS 111\", \"Noopept\", \"noopept (N-phenylacetyl-L-prolyglycine ethyl ester)\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709220997, \"_nanoseconds\": 0}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule II",
    "Name": "opium",
    "guid": "6172e896-9203-44cb-a673-d4b1545cf732",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "opium",
    "Reasons": "[{\"reason_code\": 6004, \"reason\": \"DEA Controlled Substance List: Schedule  II\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"207f9e17-8a22-4523-8dd6-24d9d39b4c45\", \"link_title\": \"DEA Controlled Substance List: Schedule  II\", \"updated\": {\"_seconds\": 1712942744, \"_nanoseconds\": 783000000}}]",
    "other_names": "[\"paregoric\", \"opium, raw\", \"opium fluid extract\", \"powdered opium\", \"gum opium\", \"Papaver somniferum\", \"opium, powdered\", \"granulated opium\", \"opium poppy\", \"laudunum\", \"opium tincture\", \"opium extract\", \"tincture of opium\", \"raw opium\", \"opium, granulated\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710260481, \"_nanoseconds\": 965000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule II",
    "Name": "oripavine",
    "guid": "b27100a5-11bb-43d1-9256-0c810a1e3d86",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "oripavine",
    "Reasons": "[{\"reason_code\": 6004, \"reason\": \"DEA Controlled Substance List: Schedule  II\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"207f9e17-8a22-4523-8dd6-24d9d39b4c45\", \"link_title\": \"DEA Controlled Substance List: Schedule  II\", \"updated\": {\"_seconds\": 1712942744, \"_nanoseconds\": 783000000}}]",
    "other_names": "[]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709220690, \"_nanoseconds\": 855000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "ortho-fluoroacryl fentanyl",
    "guid": "392b6628-2823-483f-a945-4c4bf8384673",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "ortho-fluoroacryl fentanyl",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)acrylamide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709220651, \"_nanoseconds\": 407000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "ortho-fluorobutyryl fentanyl",
    "guid": "20353dcd-9ab6-469c-ba80-ea7412432534",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "ortho-fluorobutyryl fentanyl",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide\", \"2-fluorobutyryl fentanyl\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709220621, \"_nanoseconds\": 360000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "ortho-fluorofentanyl",
    "guid": "13417d75-83a9-41fc-ab15-94fe7a285a82",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "ortho-fluorofentanyl",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide\", \"2-fluorofentanyl\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709220585, \"_nanoseconds\": 800000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "ortho-fluorofuranyl fentanyl",
    "guid": "3cd9a1cb-2480-4ba4-b8b1-1bea4c5ba890",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "ortho-fluorofuranyl fentanyl",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709046749, \"_nanoseconds\": 533000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "ortho-fluoroisobutyryl fentanyl",
    "guid": "0ba8a1d6-6809-44d2-9386-bab0a70edcdb",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "ortho-fluoroisobutyryl fentanyl",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709220438, \"_nanoseconds\": 662000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "ortho-methyl acetylfentanyl",
    "guid": "b1f59a3e-a96c-4e0b-aa29-975584a35950",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "ortho-methyl acetylfentanyl",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"2-methylacetylfentanyl\", \"N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709220330, \"_nanoseconds\": 446000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "ortho-methyl methoxyacetylfentanyl",
    "guid": "1271651c-c33a-4e28-9745-172fae40f42d",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "ortho-methyl methoxyacetylfentanyl",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"2-methyl methoxyacetyl fentanyl\", \"2-methoxy-N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709220268, \"_nanoseconds\": 66000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Osilodrostat\", \"url\": \"https://drugs.ncats.io/drug/5YL4IQ1078\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S1: Anabolic AgentsPrescription drug",
    "Name": "osilodrostat",
    "guid": "e018b2b2-e91d-4008-86ed-bec2f9784519",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "osilodrostat",
    "Reasons": "[{\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}, {\"reason_code\": 6016, \"reason\": \"Prescription drug\", \"link\": null, \"guid\": \"becae72e-580f-4d8d-8665-c0c4b1dc1381\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683249, \"_nanoseconds\": 70000000}}]",
    "other_names": "[\"Isturisa\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709220190, \"_nanoseconds\": 823000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Ospemifene\", \"url\": \"https://drugs.ncats.io/drug/B0P231ILBK\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S4: Hormone and Metabolic ModulatorsPrescription drug",
    "Name": "ospemifene",
    "guid": "cda4d0b2-bbed-45ca-8e31-55cf43b3ae22",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "ospemifene",
    "Reasons": "[{\"reason_code\": 6012, \"reason\": \"WADA S4: Hormone and Metabolic Modulators\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"ac1ba347-6d44-4a17-829d-e589bf33bbdb\", \"link_title\": \"WADA Prohibited List S4: Hormone and Metabolic Modulators\", \"updated\": {\"_seconds\": 1703682875, \"_nanoseconds\": 162000000}}, {\"reason_code\": 6016, \"reason\": \"Prescription drug\", \"link\": null, \"guid\": \"becae72e-580f-4d8d-8665-c0c4b1dc1381\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683249, \"_nanoseconds\": 70000000}}]",
    "other_names": "[\"FC-1271a\", \"CCRIS 9205\", \"2-(p-((Z)-4-chloro-1,2-diphenyl-1-butenyl)phenoxy)ethanol\", \"Fc-1271\", \"Z-2-(4-(4-chloro-1,2-diphenyl-but-1-enyl)phenoxy)ethanol\", \"HSDB 8281\", \"2-(4-(4-chloro-1,2-diphenyl-but-1-enyl)phenoxy)ethanol\", \"Senshio\", \"(deaminohydroxy)toremifene\", \"Osphena\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1761928041, \"_nanoseconds\": 411000000}",
    "label_terms": "[]",
    "linked_ingredients": "[]",
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "oxabolone",
    "guid": "b7b256ef-de12-492f-86e2-87ce4e4c520c",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "oxabolone",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}, {\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"4,17beta-dihydroxyestr-4-en-3-one\", \"4,17\u03b2-dihydroxy-estr-4-en-3-one\", \"19-norandrost-4-ene-4,17\u03b2-diol-3-one\", \"4-hydroxy-19-nortestosterone\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1716928126, \"_nanoseconds\": 16000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "oxandrolone",
    "guid": "85c1ad0b-2606-4b60-9403-e7a205962b8e",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "oxandrolone",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}, {\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"17\u03b1-methyl-17\u03b2-hydroxy-2-oxa-[5\u03b1]-androstan-3-one\", \"2-Oxa-5alpha-androstan-3-one, 17beta-hydroxy-17-methyl-\", \"Vasorome\", \"SC 11585\", \"2-Oxaandrostan-3-one, 17-hydroxy-17-methyl-, (5alpha,17beta)-\", \"Protivar\", \"17beta-Hydroxy-17-methyl-2-oxa-5alpha-androstan-3-one\", \"Ossandrolone\", \"SC11585\", \"Oxandrolonum\", \"Lonavar\", \"Dodecahydro-3-hydroxy-6-(hydroxy-methyl)-3,3a,6-trimethyl-1H-benz(e)indene-7-acetic acid delta-lactone\", \"SC-11585\", \"Anavar\", \"Oxandrin\", \"17alpha-methyl-17beta-hydroxy-2-oxa5alpha-androstan-3-one\", \"Provitar\", \"Oxandrolona\", \"17\u03b2-hydroxy-17\u03b1-methyl-2-oxa-5\u03b1-androstan-3-one\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1721226922, \"_nanoseconds\": 299000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "oxazepam",
    "guid": "a98ea1eb-cc37-487c-9f76-76d5ddaa41db",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "oxazepam",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"Serenid-D\", \"Serax\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709144741, \"_nanoseconds\": 137000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "oxazolam",
    "guid": "72d60706-001d-4236-a8f1-fe2676490559",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "oxazolam",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"Convertal\", \"Serenal\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709144701, \"_nanoseconds\": 154000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Oxiracetam\", \"url\": \"https://drugs.ncats.io/drug/P7U817352G\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Unapproved drug",
    "Name": "oxiracetam",
    "guid": "09f3c4d5-2fb4-4d89-a272-9d0c8c21845e",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "oxiracetam",
    "Reasons": "[{\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"4-hydroxy-2-oxo-pyrrolidinacetamide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709144667, \"_nanoseconds\": 981000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule II",
    "Name": "oxycodone",
    "guid": "7e2a40a2-2cbe-47e2-8ad7-8de28532f295",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "oxycodone",
    "Reasons": "[{\"reason_code\": 6004, \"reason\": \"DEA Controlled Substance List: Schedule  II\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"207f9e17-8a22-4523-8dd6-24d9d39b4c45\", \"link_title\": \"DEA Controlled Substance List: Schedule  II\", \"updated\": {\"_seconds\": 1712942744, \"_nanoseconds\": 783000000}}]",
    "other_names": "[\"OxyContin\", \"Roxicodone\", \"Endocet\", \"Percocet\", \"Roxicet\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709144520, \"_nanoseconds\": 11000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "oxyguno",
    "guid": "cf04514d-595b-485f-a5a0-c846ce58956a",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "oxyguno",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}]",
    "other_names": "[\"4-chloro-17alpha-methyl-17beta-hydroxy-androst-4-ene-3,11-dione\", \"4-chloro-17\u03b1-methyl-17\u03b2-hydroxy-androst-4-ene-3,11-dione\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709144483, \"_nanoseconds\": 430000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "oxymesterone",
    "guid": "cd25ded9-c1e1-47fc-b4b6-b56db6c2e7e9",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "oxymesterone",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}, {\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"17alpha-methyl-4,17beta-dihydroxyandrost-4-en-3-one\", \"Balnimax\", \"17\u03b1-methyl-4,17\u03b2-dihydroxyandrost-4-en-3-one\", \"Anamidol\", \"Oranabol\", \"Oranabol 10\", \"Aranabol\", \"4,17\u03b2-dihydroxy-17\u03b1-methylandrost-4-en-3-one\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1721227021, \"_nanoseconds\": 715000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "oxymetholone",
    "guid": "53b915f1-80d0-4bb0-81c5-3806342cfe23",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "oxymetholone",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}, {\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"Anadrol-50\", \"17\u03b2-Hydroxy-2-hydroxymethylidene-17\u03b1-methyl-3-androstanone\", \"17alpha-methyl-2-hydroxymethylene\u00ad-17beta-hydroxy-5alpha-androstan-3-one\", \"anasterone\", \"Anadrol\", \"17\u03b1-methyl-2-hydroxymethylene-17\u03b2-hydroxy-[5\u03b1]-androstan-3-one\", \"Anapolon\", \"5a-androstan-2-hydroxymethylene-17a-methyl-17b-ol-3-one\", \"Anasteron\", \"Adroyd\", \"Pardroyd\", \"17\u03b2-hydroxy-2-hydroxymethylene-17\u03b1-methyl-5\u03b1-androstan- 3-one\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1721227176, \"_nanoseconds\": 893000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule II",
    "Name": "oxymorphone",
    "guid": "b3572130-0088-448f-820d-183e81b7926e",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "oxymorphone",
    "Reasons": "[{\"reason_code\": 6004, \"reason\": \"DEA Controlled Substance List: Schedule  II\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"207f9e17-8a22-4523-8dd6-24d9d39b4c45\", \"link_title\": \"DEA Controlled Substance List: Schedule  II\", \"updated\": {\"_seconds\": 1712942744, \"_nanoseconds\": 783000000}}]",
    "other_names": "[\"Numorphan\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709143845, \"_nanoseconds\": 594000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Use or misuse prohibited under DoDI 1010.16 (cocaine metabolites)",
    "Name": "p-hydroxybenzoylecgonine",
    "guid": "ff02e80e-bc96-4c51-bd12-65a9500a661f",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "p-hydroxybenzoylecgonine",
    "Reasons": "[{\"reason_code\": 6014, \"reason\": \"DoDI 1010.16\", \"link\": \"https://www.esd.whs.mil/directives/issuances/dodi\", \"guid\": \"b757aa46-4729-4d4a-a32e-25ef0b04e5c3\", \"link_title\": \"Use or misuse prohibited under DoDI 1010.16\", \"updated\": {\"_seconds\": 1703683049, \"_nanoseconds\": 190000000}}]",
    "other_names": "[\"pOHBE\", \"4-hydroxybenzoylecgonine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709143824, \"_nanoseconds\": 66000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Use or misuse prohibited under DoDI 1010.16 (cocaine metabolites)",
    "Name": "p-hydroxycocaine",
    "guid": "4e086a0b-d7ee-4bc9-a13f-b45eb3261210",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "p-hydroxycocaine",
    "Reasons": "[{\"reason_code\": 6014, \"reason\": \"DoDI 1010.16\", \"link\": \"https://www.esd.whs.mil/directives/issuances/dodi\", \"guid\": \"b757aa46-4729-4d4a-a32e-25ef0b04e5c3\", \"link_title\": \"Use or misuse prohibited under DoDI 1010.16\", \"updated\": {\"_seconds\": 1703683049, \"_nanoseconds\": 190000000}}]",
    "other_names": "[\"4'-hydroxybenzoylecgonine methyl ester\", \"4'-hydroxycocaine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709143662, \"_nanoseconds\": 890000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "para-chloroisobutyryl fentanyl",
    "guid": "64392669-7022-4221-b953-f5670111dcb9",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "para-chloroisobutyryl fentanyl",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709143532, \"_nanoseconds\": 74000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "para-fluoro furanyl fentanyl",
    "guid": "4cd9887c-248b-41e6-9a27-0e72a3ddd05b",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "para-fluoro furanyl fentanyl",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709143499, \"_nanoseconds\": 57000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "para-fluorobutyryl fentanyl",
    "guid": "b6e05ac7-81aa-409d-a5be-f4b354b801dc",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "para-fluorobutyryl fentanyl",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709143435, \"_nanoseconds\": 291000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "para-fluorofentanyl",
    "guid": "cd329784-a417-4d7a-a830-766f9954cb67",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "para-fluorofentanyl",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"N-(4-fluorophenyl)-N-[1-(2-phenylethyl)-4-piperidinyl]propanamide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709143318, \"_nanoseconds\": 809000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "para-methoxybutyryl fentanyl",
    "guid": "3c408a81-18c5-41c6-82eb-505a0459dfb6",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "para-methoxybutyryl fentanyl",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)butyramide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709143119, \"_nanoseconds\": 115000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "para-methoxyfuranyl fentanyl",
    "guid": "0198c166-e8ca-4d53-976e-eb3df367a10e",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "para-methoxyfuranyl fentanyl",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709046774, \"_nanoseconds\": 748000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "para-methoxymethamphetamine",
    "guid": "a22d7112-c9f8-4669-8397-63378eb26601",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "para-methoxymethamphetamine",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"PMMA\", \"1-(4-methoxyphenyl)-N-methylpropan-2-amine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709143020, \"_nanoseconds\": 730000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "para-methylcyclopropyl fentanyl",
    "guid": "78eede51-fdbc-4ee2-8356-57db48c1e43d",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "para-methylcyclopropyl fentanyl",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"N-(4-methylphenyl)-N-(1-phenylpiperidin-4-yl)cyclopropanecarboxamide\", \"para-methylcyclopropylfentanyl\", \"N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl)cyclopropanecarboxamide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709046987, \"_nanoseconds\": 189000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "para-methylfentanyl",
    "guid": "c630f4b2-981a-4e17-a688-a1f8cb0bf9f7",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "para-methylfentanyl",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"4-methylfentanyl\", \"N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl)propionamide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709143080, \"_nanoseconds\": 634000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "parahexyl",
    "guid": "adf4e21f-ee3d-434b-8c82-246c3c727113",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "parahexyl",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"Synhexyl\", \"3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709142942, \"_nanoseconds\": 82000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "paraldehyde",
    "guid": "28b388b1-5d36-4ed2-949d-d20a5603d058",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "paraldehyde",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"Paral\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709142892, \"_nanoseconds\": 250000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Peginesatide\", \"url\": \"https://drugs.ncats.io/drug/JX56W9N61Q\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S2: Peptide Hormones, Growth Factors, etc.Unapproved drug",
    "Name": "peginesatide",
    "guid": "e5339579-b5f5-4643-9311-6fee86568853",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "peginesatide",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"hematide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709142806, \"_nanoseconds\": 978000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "pemoline",
    "guid": "82ad2e02-97df-435c-87cc-c3db5c751ac1",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "pemoline",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"Cylert\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715368844, \"_nanoseconds\": 976000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "pentazocine",
    "guid": "c9f24629-d8fb-4b36-8f53-c108afb7c4d5",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "pentazocine",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"Talacen\", \"Talwin NX\", \"Talwin Compound\", \"Talwin\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709142676, \"_nanoseconds\": 586000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "pentedrone",
    "guid": "4b9077fd-559c-48d3-ad25-291eaa7ca9a4",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "pentedrone",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"4-methylbuphedrone\", \"2-(methylamino)-1-phenylpentan-1-one\", \"\u03b1-methylaminovalerophenone\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709142633, \"_nanoseconds\": 130000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Pentetrazol\", \"url\": \"https://drugs.ncats.io/drug/WM5Z385K7T\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Unapproved drug",
    "Name": "pentetrazol",
    "guid": "f3b42619-b812-40db-bbc6-73fe2b818c8a",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "pentetrazol",
    "Reasons": "[{\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"leptazole\", \"metrazole\", \"PTZ\", \"Corazol\", \"Korazole\", \"Korazol\", \"Cardiazol\", \"pentetrazolum\", \"metrazole\", \"metrazol\", \"pentetrazole\", \"pentylenetetrazol\", \"Corazole\", \"Deumacard\", \"pentazol\", \"pentylenetetrazole\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1762180148, \"_nanoseconds\": 531000000}",
    "label_terms": "[]",
    "linked_ingredients": "[]",
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule II",
    "Name": "pentobarbital",
    "guid": "5e2c8b25-0630-4555-90bd-8dcf79515590",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "pentobarbital",
    "Reasons": "[{\"reason_code\": 6004, \"reason\": \"DEA Controlled Substance List: Schedule  II\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"207f9e17-8a22-4523-8dd6-24d9d39b4c45\", \"link_title\": \"DEA Controlled Substance List: Schedule  II\", \"updated\": {\"_seconds\": 1712942744, \"_nanoseconds\": 783000000}}]",
    "other_names": "[\"Nembutal\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709142327, \"_nanoseconds\": 670000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "pentylone",
    "guid": "1dbeb008-1544-48f4-9f26-b70dfcbd66e5",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "pentylone",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"propylone\", \"bk-DMBDB\", \"1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1- one\", \"bk-MBDP\", \"3',4'-methylenedioxy-N-propylaminocathinone\", \"dibutylone\", \"1-(benzo[d][1,3]dioxol-5-yl)-2-(propylamino)propan-1-one)\", \"bk-EBDB\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709141952, \"_nanoseconds\": 258000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "perampanel",
    "guid": "50a1b012-9554-44d5-86c9-e4f36280635e",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "perampanel",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}]",
    "other_names": "[\"Fycompa\", \"2-(2-oxo-l-phenyl-5-pyridin-2-yl-l,2-dihydropyridin-3-yl) benzonitrile\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709141711, \"_nanoseconds\": 926000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule II",
    "Name": "pethidine",
    "guid": "6073e3dd-37e1-479f-9142-28eec3e29b5b",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "pethidine",
    "Reasons": "[{\"reason_code\": 6004, \"reason\": \"DEA Controlled Substance List: Schedule  II\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"207f9e17-8a22-4523-8dd6-24d9d39b4c45\", \"link_title\": \"DEA Controlled Substance List: Schedule  II\", \"updated\": {\"_seconds\": 1712942744, \"_nanoseconds\": 783000000}}]",
    "other_names": "[\"meperidine\", \"Demerol\", \"Mepergan\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709141559, \"_nanoseconds\": 1000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule II",
    "Name": "pethidine-intermediate-A",
    "guid": "f942e493-cb40-40cd-9c50-c3b3f8fe4626",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "pethidine-intermediate-a",
    "Reasons": "[{\"reason_code\": 6004, \"reason\": \"DEA Controlled Substance List: Schedule  II\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"207f9e17-8a22-4523-8dd6-24d9d39b4c45\", \"link_title\": \"DEA Controlled Substance List: Schedule  II\", \"updated\": {\"_seconds\": 1712942744, \"_nanoseconds\": 783000000}}]",
    "other_names": "[\"4-cyano-1-methyl-4-phenylpiperidine\", \"meperedine intermediate-A\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709141529, \"_nanoseconds\": 146000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule II",
    "Name": "pethidine-intermediate-B",
    "guid": "11d105ba-7ad4-4533-9bca-811242317a8b",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "pethidine-intermediate-b",
    "Reasons": "[{\"reason_code\": 6004, \"reason\": \"DEA Controlled Substance List: Schedule  II\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"207f9e17-8a22-4523-8dd6-24d9d39b4c45\", \"link_title\": \"DEA Controlled Substance List: Schedule  II\", \"updated\": {\"_seconds\": 1712942744, \"_nanoseconds\": 783000000}}]",
    "other_names": "[\"ethyl-4-phenylpiperidine-4-carboxylate\", \"normeperidine\", \"meperedine intermediate-B\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709141497, \"_nanoseconds\": 490000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule II",
    "Name": "pethidine-intermediate-C",
    "guid": "e7979772-9dbf-4552-9bf8-3997b1dc2629",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "pethidine-intermediate-c",
    "Reasons": "[{\"reason_code\": 6004, \"reason\": \"DEA Controlled Substance List: Schedule  II\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"207f9e17-8a22-4523-8dd6-24d9d39b4c45\", \"link_title\": \"DEA Controlled Substance List: Schedule  II\", \"updated\": {\"_seconds\": 1712942744, \"_nanoseconds\": 783000000}}]",
    "other_names": "[\"1-methyl-4-phenylpiperidine-4-carboxylic acid\", \"meperedine intermediate-C\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709141429, \"_nanoseconds\": 314000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "petrichloral",
    "guid": "0dff54db-6abf-4a7d-a942-4aa40933bc47",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "petrichloral",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"Pentaerythritol chloral\", \"Periclor\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709141155, \"_nanoseconds\": 584000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "peyote",
    "guid": "68fe8eef-6e66-40eb-9afe-ad077df3455a",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "peyote",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"Lophophora williamsii Lemaire\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709141115, \"_nanoseconds\": 165000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "phenadoxone",
    "guid": "a2ecd03c-6ac5-488d-9a8b-12fca340c765",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "phenadoxone",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"6-morpholino-4,4-diphenyl-3-heptanone\", \"4,4-diphenyl-6-morpholino-3-heptanone\", \"phenodoxone\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709140684, \"_nanoseconds\": 251000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "phenampromide",
    "guid": "0e27169b-70ed-4586-b9e9-deb2ce6c82cb",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "phenampromide",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"N-(1-methyl-2-piperidinoethyl)propionanilide\", \"fenampromide\", \"phenampromid\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709140634, \"_nanoseconds\": 34000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule II",
    "Name": "phenazocine",
    "guid": "06079c30-7786-4e48-92c4-cfe39a7c1a44",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "phenazocine",
    "Reasons": "[{\"reason_code\": 6004, \"reason\": \"DEA Controlled Substance List: Schedule  II\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"207f9e17-8a22-4523-8dd6-24d9d39b4c45\", \"link_title\": \"DEA Controlled Substance List: Schedule  II\", \"updated\": {\"_seconds\": 1712942744, \"_nanoseconds\": 783000000}}]",
    "other_names": "[\"Prinadol\", \"Narphen\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709140590, \"_nanoseconds\": 385000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule II",
    "Name": "phencyclidine",
    "guid": "62fcac77-3b81-461e-8654-5a43e46eb755",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "phencyclidine",
    "Reasons": "[{\"reason_code\": 6004, \"reason\": \"DEA Controlled Substance List: Schedule  II\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"207f9e17-8a22-4523-8dd6-24d9d39b4c45\", \"link_title\": \"DEA Controlled Substance List: Schedule  II\", \"updated\": {\"_seconds\": 1712942744, \"_nanoseconds\": 783000000}}]",
    "other_names": "[\"Semylan\", \"1-(1-phenylcyclohexyl)piperidine\", \"PCP\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709140550, \"_nanoseconds\": 49000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "phendimetrazine",
    "guid": "cfe4ba7c-314a-4d09-ad98-61127d2c1963",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "phendimetrazine",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}]",
    "other_names": "[\"Prelu-2\", \"Statobex\", \"Melfiat\", \"Bontril\", \"Plegine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715355570, \"_nanoseconds\": 441000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"FDA: Phenibut in Dietary Supplements\", \"url\": \"https://www.fda.gov/food/dietary-supplement-products-ingredients/phenibut-dietary-supplements\"}, {\"title\": \"NIH NCATS Inxight Drugs entry: 4-amino-3-phenylbutyric acid\", \"url\": \"https://drugs.ncats.io/drug/T2M58D6LA8\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "FDA statement: Synthetic substance that currently does not meet the definition of a dietary ingredientUnapproved drug",
    "Name": "phenibut",
    "guid": "925e051c-b2af-49f9-b0be-d1f8c789fbd1",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "phenibut",
    "Reasons": "[{\"reason_code\": 6018, \"reason\": \"FDA Statement\", \"link\": \"\", \"guid\": \"3cd17124-6ebc-4828-9edb-c20a81755502\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1711715334, \"_nanoseconds\": 457000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"4-amino-3-phenylbutyric acid hydrochloride\", \"phenigam\", \"phenylgam\", \"beta-phenyl-gamma-aminobutyric acid\", \"4-amino-3-phenylbutanoic acid\", \"phenygam\", \"\u03b2-phenyl-\u03b3-aminobutyric acid\", \"\u03b2-phenyl-GABA\", \"phenybut\", \"beta-(Aminomethyl)hydrocinnamic acid\", \"fenibut\", \"phenigama\", \"phenigamma\", \"phenyl-GABA\", \"aminophenylbutyric acid\", \"\u03b2-(aminomethyl)benzenepropanoic acid\", \"fenigama\", \"Anvifen\", \"fenibut citrate\", \"phenylgamma\", \"noophen\", \"4-amino-3-phenylbutyric acid\", \"fenigam\", \"PhGaba\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709140444, \"_nanoseconds\": 297000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule II",
    "Name": "phenmetrazine",
    "guid": "2d3db1ed-68dc-4ec6-8bf5-e0203bc63baa",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "phenmetrazine",
    "Reasons": "[{\"reason_code\": 6004, \"reason\": \"DEA Controlled Substance List: Schedule  II\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"207f9e17-8a22-4523-8dd6-24d9d39b4c45\", \"link_title\": \"DEA Controlled Substance List: Schedule  II\", \"updated\": {\"_seconds\": 1712942744, \"_nanoseconds\": 783000000}}]",
    "other_names": "[\"Preludin\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715369838, \"_nanoseconds\": 474000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "phenobarbital",
    "guid": "3c284ab4-2fdf-4498-af1c-93b70ebab02b",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "phenobarbital",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"Bellergal-S\", \"Luminal\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709139925, \"_nanoseconds\": 577000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "phenomorphan",
    "guid": "52ac06f4-ce07-40b0-8f17-78630da39673",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "phenomorphan",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709139889, \"_nanoseconds\": 433000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "phenoperidine",
    "guid": "ddb8ae87-f03d-4e51-bb0f-e052c4ff06be",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "phenoperidine",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"Operidine\", \"Lealgin\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709058564, \"_nanoseconds\": 913000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Phenpromethamine\", \"url\": \"https://drugs.ncats.io/drug/7D4542I59V\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Unapproved drug",
    "Name": "phenpromethamine",
    "guid": "81d89115-5474-4b1c-bf2b-163a28d554f5",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "phenpromethamine",
    "Reasons": "[{\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"1-methylamino-2-phenylpropane\", \"N,\u03b2-dimethylphenethylamine\", \"1-methylamino-2-methyl-2-phenylethane\", \"phenpromethaminum\", \"Vonedrine\", \"N,beta-dimethylphenethylamine\", \"phenpromethadrinum\", \"phenylpropylmethylamine\", \"N-methyl-2-phenylpropylamine\", \"fenprometamina\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1751996542, \"_nanoseconds\": 516000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "phentermine",
    "guid": "ec76d9e1-34b4-4922-98bf-86e9bccdfe45",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "phentermine",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"Phentrol\", \"Lonamin\", \"Fastin\", \"normephentermine\", \"phentermine hydrochloride\", \"Zantryl\", \"Adipex-P\", \"Obermine\", \"Omnibex\", \"Mirapront\", \"Adipex P\", \"Ionamine\", \"phenterminum\", \"phentermine HCl\", \"Suprenza\", \"AdipexP\", \"Obe-Nix\", \"Duromine\", \"Lomaira\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1748887878, \"_nanoseconds\": 284000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "phenyl fentanyl",
    "guid": "814f8f7a-0ab6-4663-ae47-e3b3ec4a561e",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "phenyl fentanyl",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"benzoyl fentanyl\", \"N-(1-phenethylpiperidin-4-yl)-N-phenylbenzamide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709057631, \"_nanoseconds\": 496000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule II",
    "Name": "phenylacetone",
    "guid": "e839afb9-49cf-469f-873c-252e234a4bdf",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "phenylacetone",
    "Reasons": "[{\"reason_code\": 6004, \"reason\": \"DEA Controlled Substance List: Schedule  II\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"207f9e17-8a22-4523-8dd6-24d9d39b4c45\", \"link_title\": \"DEA Controlled Substance List: Schedule  II\", \"updated\": {\"_seconds\": 1712942744, \"_nanoseconds\": 783000000}}]",
    "other_names": "[\"P2P\", \"benzyl methyl ketone\", \"methyl benzyl ketone\", \"phenyl-2-propanone\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709057487, \"_nanoseconds\": 271000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "pholcodine",
    "guid": "f1d327d4-7eff-4fad-b3cb-78dbb6958766",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "pholcodine",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"Lantuss\", \"Pholcolin\", \"Adaphol\", \"Codisol\", \"Copholco\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709057443, \"_nanoseconds\": 385000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"FDA: Picamilon in Dietary Supplements\", \"url\": \"https://www.fda.gov/food/dietary-supplement-products-ingredients/picamilon-dietary-supplements\"}, {\"title\": \"NIH NCATS Inxight Drugs entry: Picamilon\", \"url\": \"https://drugs.ncats.io/drug/0S5N9SEK4N\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "FDA statement: Synthetic substance that currently does not meet the definition of a dietary ingredientUnapproved drug",
    "Name": "picamilon",
    "guid": "793727c5-dfb8-4900-a6d2-4714d279a618",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "picamilon",
    "Reasons": "[{\"reason_code\": 6018, \"reason\": \"FDA Statement\", \"link\": \"\", \"guid\": \"3cd17124-6ebc-4828-9edb-c20a81755502\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1711715334, \"_nanoseconds\": 457000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"4-(pyridine-3-carbonylamino) butanoic acid\", \"pikamilon\", \"monosodium 4-((3-pyridinylcarbonyl)amino)butanoate\", \"pikatropin\", \"N-nicotinoyl-gamma-aminobutyric acid sodium salt\", \"nicotinyl-gamma-aminobutyric acid\", \"nicotinyl-GABA\", \"nicotinoyl-GABA\", \"sodium;4-(pyridine-3-carbonylamino)butanoate\", \"GABA-NG\", \"nicotinoyl-GABA sodium salt\", \"N-(3-pyridylcarbonyl)-4-aminobutyric acid sodium salt\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709057380, \"_nanoseconds\": 801000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule II",
    "Name": "piminodine",
    "guid": "938a3448-8e7a-44dd-9e28-504bf2691986",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "piminodine",
    "Reasons": "[{\"reason_code\": 6004, \"reason\": \"DEA Controlled Substance List: Schedule  II\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"207f9e17-8a22-4523-8dd6-24d9d39b4c45\", \"link_title\": \"DEA Controlled Substance List: Schedule  II\", \"updated\": {\"_seconds\": 1712942744, \"_nanoseconds\": 783000000}}]",
    "other_names": "[]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709056966, \"_nanoseconds\": 152000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "pinazepam",
    "guid": "d284b3fb-7eb1-406c-984e-b60560fcdc67",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "pinazepam",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"Domar\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709056934, \"_nanoseconds\": 387000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "pipradrol",
    "guid": "49ebef6f-1cce-4feb-be58-4dad67219406",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "pipradrol",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"Stimolag Fortis\", \"Detaril\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709056904, \"_nanoseconds\": 593000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Piracetam\", \"url\": \"https://drugs.ncats.io/drug/ZH516LNZ10\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Unapproved drug",
    "Name": "piracetam",
    "guid": "a713fd40-415f-4994-90cf-04191939fec9",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "piracetam",
    "Reasons": "[{\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"2-oxo-pyrrolidin-1-ylacetamide\", \"2-pyrrolidone-N-acetamide\", \"Axonyl\", \"Cuxabrain\", \"Nootropyl\", \"Piracetam-RPh\", \"Piracebral\", \"Pirroxil\", \"Pirazetam\", \"Gabacet\", \"Avigilen\", \"Euvifor\", \"2-ketopyrrolidine-1-ylacetamide\", \"Genogris\", \"2-oxo-pyrrolidine acetamide\", \"Piracetrop\", \"Normabrain\", \"Ciclofalina\", \"Cerepar N\", \"Dinagen\", \"1-acetamido-2-pyrrolidinone\", \"2-pyrrolidoneacetamide\", \"Breinox\", \"2-oxo-pyrrolidone\", \"Pyramem\", \"Nootron\", \"Geram\", \"Nootropil\", \"Naofukang\", \"Nootrop\", \"Pyracetam\", \"2-pyrrolidinoneacetamide\", \"Piracetam RPh\", \"2-oxo-1-pyrrolidineacetamide\", \"Piracetam AbZ\", \"2-oxo-1-pyrrolidine acetamide\", \"Cerebroforte\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1762183727, \"_nanoseconds\": 455000000}",
    "label_terms": "[]",
    "linked_ingredients": "[]",
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "piritramide",
    "guid": "d0ba37cd-bac1-4d3c-92d3-93f7564528d0",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "piritramide",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"Piridolan\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709056566, \"_nanoseconds\": 160000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule II",
    "Name": "poppy straw",
    "guid": "e4125c9c-21ae-401e-bf6e-97c022d35836",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "poppy straw",
    "Reasons": "[{\"reason_code\": 6004, \"reason\": \"DEA Controlled Substance List: Schedule  II\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"207f9e17-8a22-4523-8dd6-24d9d39b4c45\", \"link_title\": \"DEA Controlled Substance List: Schedule  II\", \"updated\": {\"_seconds\": 1712942744, \"_nanoseconds\": 783000000}}]",
    "other_names": "[\"concentrate of poppy straw\", \"CPS\", \"poppy heads\", \"opium poppy capsules\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709056515, \"_nanoseconds\": 72000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Pralmorelin\", \"url\": \"https://drugs.ncats.io/drug/E6S6E1F19M\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S2: HormonesUnapproved drug",
    "Name": "pralmorelin",
    "guid": "80b4a3ba-fa87-43af-9024-0d779ce1f428",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "pralmorelin",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"GHRP-2\", \"growth hormone-releasing peptide-2\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709056409, \"_nanoseconds\": 447000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Pramiracetam\", \"url\": \"https://drugs.ncats.io/drug/4449F8I3LE\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Unapproved drug",
    "Name": "pramiracetam",
    "guid": "f490796a-ebfb-4668-90d7-909eb9298485",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "pramiracetam",
    "Reasons": "[{\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"1-pyrrolidineacetamide, N-(2-(bis(1-methylethyl)amino)ethyl)-2-oxo-\", \"CI-879 free base\", \"N-(2-(diisopropylamino)ethyl)-2-oxo-1-pyrrolidineacetamide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709056307, \"_nanoseconds\": 384000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "prazepam",
    "guid": "871f749b-73af-4d3a-aaf5-932f84d503d6",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "prazepam",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"Centrax\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709742666, \"_nanoseconds\": 794000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule V",
    "Name": "pregabalin",
    "guid": "e10ee4cc-4cab-4627-a7bc-7e66ac24758e",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "pregabalin",
    "Reasons": "[{\"reason_code\": 6007, \"reason\": \"DEA Controlled Substance List: Schedule V\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"d5b1da64-60db-4afa-af32-8491827c3497\", \"link_title\": \"DEA Controlled Substance List: Schedule V\", \"updated\": {\"_seconds\": 1712942766, \"_nanoseconds\": 551000000}}]",
    "other_names": "[\"(S)-3-(aminomethyl)-5-methylhexanoic acid\", \"Lyrica\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709742629, \"_nanoseconds\": 185000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: pregnenolone\", \"url\": \"https://drugs.ncats.io/drug/73R90F7MQ8\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Unapproved drug",
    "Name": "pregnenolone",
    "guid": "27aec876-a349-4b89-942b-e371fa50510c",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "pregnenolone",
    "Reasons": "[{\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"Pregnetan\", \"5-pregnen-3\u03b2-ol-20-one\", \"5 pregnen 3 beta ol 20 one\", \"pregneninolone\", \"Natolone\", \"5-pregnen-3-\u03b2-ol-20-one\", \"pregnenolonum\", \"pregn-5-en-20-one, 3-hydroxy-, (3-beta)-\", \"3\u03b2-hydroxypregn-5-en-20-one\", \"Prenolon\", \"3-\u03b2-hydroxypregn-5-en-20-one\", \"Regnosone\", \"Enelone\", \"Pregneton\", \"Pregnolon\", \"delta5-pregnenolone\", \"pregnenolona\", \"3beta-hydroxypregn-5-en-20-one\", \"6 pregnen 3 \u03b2 ol 20 one\", \"5-pregnen-3beta-ol-20-one\", \"Arthenolone\", \"Skinostelon\", \"5-pregnen-3-beta-ol-20-one\", \"3-beta-hydroxypregn-5-en-20-one\", \"\u03945-pregnenolone\", \"Bina-Skin\", \"pregn-5-en-20-one, 3-hydroxy-, (3-\u03b2)-\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709056015, \"_nanoseconds\": 983000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Prenylamine\", \"url\": \"https://drugs.ncats.io/drug/K2OH82Z000\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Unapproved drug",
    "Name": "prenylamine",
    "guid": "66f1482a-0f6d-48b3-bb69-7281f2309c04",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "prenylamine",
    "Reasons": "[{\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"Difril\", \"Falliocor\", \"Synadrin\", \"prenylaminum\", \"Valecor\", \"Hostaginan\", \"Segontin\", \"prenilamina\", \"Bismethin\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715355820, \"_nanoseconds\": 626000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Probenecid\", \"url\": \"https://drugs.ncats.io/drug/PO572Z7917\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S5: Diuretics and Masking AgentsPrescription drug",
    "Name": "probenecid",
    "guid": "01fd7c57-fcb4-4dc6-ad2c-48946ed6bb70",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "probenecid",
    "Reasons": "[{\"reason_code\": 6013, \"reason\": \"WADA S5: Diuretics and Masking Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b1ad44e4-cef0-4ae2-99fb-19e28540f282\", \"link_title\": \"WADA Prohibited List S5: Diuretics and Masking Agents\", \"updated\": {\"_seconds\": 1703682941, \"_nanoseconds\": 864000000}}, {\"reason_code\": 6016, \"reason\": \"Prescription drug\", \"link\": null, \"guid\": \"becae72e-580f-4d8d-8665-c0c4b1dc1381\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683249, \"_nanoseconds\": 70000000}}]",
    "other_names": "[\"Probalan\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709055283, \"_nanoseconds\": 750000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Procaterol\", \"url\": \"https://drugs.ncats.io/drug/X7I3EMM5K0\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S3: Beta-2 AgonistsUnapproved drug",
    "Name": "procaterol",
    "guid": "38c58d99-27c1-4a43-a90e-3de0c165dbad",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "procaterol",
    "Reasons": "[{\"reason_code\": 6011, \"reason\": \"WADA S3: Beta-2 Agonists\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"aecafa3b-c7ad-413c-bc5f-be7ed5b2f69d\", \"link_title\": \"WADA Prohibited List S3: Beta-2 Agonists\", \"updated\": {\"_seconds\": 1703682857, \"_nanoseconds\": 73000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"procaterol hydrochloride hydrate\", \"procaterol hydrochloride\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709055197, \"_nanoseconds\": 371000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "proheptazine",
    "guid": "8ea2fc08-b125-4083-ba2c-be44fa4f0b93",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "proheptazine",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"dimepheprimine\", \"1,3-dimethyl-4-phenyl-4-propionyloxyazacycloheptane\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709742589, \"_nanoseconds\": 506000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Prolintane\", \"url\": \"https://drugs.ncats.io/drug/EM4YZW677H\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Unapproved drug",
    "Name": "prolintane",
    "guid": "40728f90-0625-42ca-b74d-6c95bdad0fb1",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "prolintane",
    "Reasons": "[{\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"prolintano\", \"prolintan\", \"Promotil\", \"Villescon\", \"Catovit\", \"prolintane hydrochloride\", \"prolintanum\", \"Katovit\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715355869, \"_nanoseconds\": 978000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "properidine",
    "guid": "b93146d2-8696-4d2d-aa28-c22fb1b26b48",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "properidine",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"isopropyl 1-methyl-4-phenylisonipecotate\", \"gevelina\", \"ipropethidine\", \"isopedine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709054794, \"_nanoseconds\": 640000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "propiram",
    "guid": "ab110440-8abb-4660-879e-0ef056fe465c",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "propiram",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"Algeril\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709742559, \"_nanoseconds\": 738000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "prostanozol",
    "guid": "78c33d55-7b98-4291-878e-5f82c98979b5",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "prostanozol",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}, {\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"17\u03b2-hydroxy-5\u03b1-androstano[3,2-c]pyrazole\", \"17\u03b2-[(tetrahydropyran-2-yl)oxy]-1'H-pyrazolo[3,4:2,3]-5\u03b1-androstane\", \"[3,2-c]pyrazole-5alpha-androstan-17beta-ol\", \"17beta-[(tetrahydropyran-2-yl)oxy]-1'H-pyrazolo[3,4:2,3]-5alpha-androstane\", \"17beta-hydroxy-5alpha-androstano[3,2c]pyrazole\", \"[3,2-c]pyrazole-5\u03b1-androstan-17\u03b2-ol\", \"17\u03b2-[(Tetrahydro-2H-pyran-2-yl)oxy]-5\u03b1-androst-2-eno[3,2- c]pyrazole\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1722274024, \"_nanoseconds\": 731000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "protonitazene",
    "guid": "5d73c926-31fa-42ae-b3b9-3c1540759a30",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "protonitazene",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"N,N-diethyl-2-(5-nitro-2-(4-propoxybenzyl)-1H-benzimidazol-1- yl)ethan-1-amine\", \"N,N-diethyl-2-[5-nitro-2-[(4-propoxyphenyl)methyl]benzimidazol-1-yl]ethanamine\", \"propoxynitazene\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710259907, \"_nanoseconds\": 778000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"FDA: Legal Requirements for the Sale and Purchase of Drug Products Containing Pseudoephedrine\u2026\", \"url\": \"https://www.fda.gov/drugs/information-drug-class/legal-requirements-sale-and-purchase-drug-products-containing-pseudoephedrine-ephedrine-and\"}, {\"title\": \"NIH NCATS Inxight Drugs entry: Pseudoephedrine\", \"url\": \"https://drugs.ncats.io/drug/7CUC9DDI9F\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Over-the-counter (OTC) drug",
    "Name": "pseudoephedrine",
    "guid": "8ba99759-abea-4038-915d-71f3f38533be",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "pseudoephedrine",
    "Reasons": "[{\"reason_code\": 6015, \"reason\": \"OTC drug\", \"link\": \"\", \"guid\": \"2a6a7454-fb0d-4d0b-9a4c-99ea7f0d386b\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703683233, \"_nanoseconds\": 942000000}}]",
    "other_names": "[\"pseudoephedrine HCl\", \"(1S,2S)-2-(methylamino)-1-phenylpropan-1-ol\", \"pseudoephedrine hydrochloride\", \"Isoephedrine\", \"d-Isoephedrine\", \"d-pseudoephedrine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1761744568, \"_nanoseconds\": 552000000}",
    "label_terms": "[]",
    "linked_ingredients": "[]",
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "psilocybin",
    "guid": "30e897ba-a883-4165-822d-9423e070279a",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "psilocybin",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709053707, \"_nanoseconds\": 45000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "psilocyn",
    "guid": "66263de9-4247-4134-a36b-dd813a46ee48",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "psilocyn",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"psilocin\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1758720859, \"_nanoseconds\": 277000000}",
    "label_terms": "[]",
    "linked_ingredients": "[]",
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule V",
    "Name": "pyrovalerone",
    "guid": "76bfda40-0f56-4c26-a734-1a377a0e342e",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "pyrovalerone",
    "Reasons": "[{\"reason_code\": 6007, \"reason\": \"DEA Controlled Substance List: Schedule V\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"d5b1da64-60db-4afa-af32-8491827c3497\", \"link_title\": \"DEA Controlled Substance List: Schedule V\", \"updated\": {\"_seconds\": 1712942766, \"_nanoseconds\": 551000000}}]",
    "other_names": "[\"Centroton\", \"Thymergix\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709053561, \"_nanoseconds\": 679000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Use or misuse prohibited under DoDI 1010.16 (synthetic cannabinoids)",
    "Name": "pyrrole",
    "guid": "cfc3dfe2-009e-471d-ade5-b34d911892f7",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "pyrrole",
    "Reasons": "[{\"reason_code\": 6014, \"reason\": \"DoDI 1010.16\", \"link\": \"https://www.esd.whs.mil/directives/issuances/dodi\", \"guid\": \"b757aa46-4729-4d4a-a32e-25ef0b04e5c3\", \"link_title\": \"Use or misuse prohibited under DoDI 1010.16\", \"updated\": {\"_seconds\": 1703683049, \"_nanoseconds\": 190000000}}]",
    "other_names": "[\"1h-pyrrole\", \"imidole\", \"azole\", \"1-aza-2,4-cyclopentadiene\", \"divinylenimine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1708971453, \"_nanoseconds\": 631000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "quazepam",
    "guid": "11f82ae6-dc86-43f5-8794-0dacdc9ddd77",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "quazepam",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"Doral\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709742319, \"_nanoseconds\": 802000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Quinbolone\", \"url\": \"https://drugs.ncats.io/drug/W59598KWLX\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S1: Anabolic AgentsUnapproved drug",
    "Name": "quinbolone",
    "guid": "50d48b1c-9622-4755-a608-9310a60760e0",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "quinbolone",
    "Reasons": "[{\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"androsta-1,4-dien-3-one, 17-(1-cyclopenten-1-yloxy)-, (17\u03b2)\", \"17\u03b2-(1-cyclopentenyloxy)-1,4-androstadien-3-on\", \"quinbolona\", \"17beta-(1-cyclopenten-1-yloxy)androsta-1,4-dien-3-one\", \"17\u03b2-(1-cyclopenten-1-yloxy)androsta-1,4-dien-3-one\", \"quinbolonum\", \"17|A-(1-cyclopenten-1-yloxy)androsta-1,4-dien-3-one\", \"anabolicum vister\", \"17beta-(1-cyclopentenyloxy)-1,4-androstadien-3-one\", \"17beta-(1-cyclopentenyloxy)-1,4-androstadien-3-on\", \"androsta-1,4-dien-3-one, 17-(1-cyclopenten-1-yloxy)-, (17beta)\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1761935516, \"_nanoseconds\": 948000000}",
    "label_terms": "[]",
    "linked_ingredients": "[]",
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Quinethazone\", \"url\": \"https://drugs.ncats.io/drug/455E0S048W\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S5: Diuretics and Masking AgentsUnapproved drug",
    "Name": "quinethazone",
    "guid": "c355e706-f6f8-459f-bc9d-41cb9fbc0f74",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "quinethazone",
    "Reasons": "[{\"reason_code\": 6013, \"reason\": \"WADA S5: Diuretics and Masking Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b1ad44e4-cef0-4ae2-99fb-19e28540f282\", \"link_title\": \"WADA Prohibited List S5: Diuretics and Masking Agents\", \"updated\": {\"_seconds\": 1703682941, \"_nanoseconds\": 864000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"Hydromox\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1761935677, \"_nanoseconds\": 464000000}",
    "label_terms": "[]",
    "linked_ingredients": "[]",
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule II",
    "Name": "racemethorphan",
    "guid": "6f45a90d-fd29-4080-9ddc-a870437ddbd6",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "racemethorphan",
    "Reasons": "[{\"reason_code\": 6004, \"reason\": \"DEA Controlled Substance List: Schedule  II\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"207f9e17-8a22-4523-8dd6-24d9d39b4c45\", \"link_title\": \"DEA Controlled Substance List: Schedule  II\", \"updated\": {\"_seconds\": 1712942744, \"_nanoseconds\": 783000000}}]",
    "other_names": "[\"DL-methorphan\", \"3-methoxy-17-methylmorphinan\", \"racemethorphan hydrobromide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709041504, \"_nanoseconds\": 118000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "racemoramide",
    "guid": "db6b15cf-cfcc-4c98-a88a-eaafb51a84c3",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "racemoramide",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"dimorlin\", \"DL-moramide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709742297, \"_nanoseconds\": 418000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule II",
    "Name": "racemorphan",
    "guid": "194e98dc-4232-474a-8125-723648b7357f",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "racemorphan",
    "Reasons": "[{\"reason_code\": 6004, \"reason\": \"DEA Controlled Substance List: Schedule  II\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"207f9e17-8a22-4523-8dd6-24d9d39b4c45\", \"link_title\": \"DEA Controlled Substance List: Schedule  II\", \"updated\": {\"_seconds\": 1712942744, \"_nanoseconds\": 783000000}}]",
    "other_names": "[\"Dromoran\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709041570, \"_nanoseconds\": 603000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Ractopamine\", \"url\": \"https://drugs.ncats.io/drug/57370OZ3P1\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S1: Anabolic AgentsUnapproved drug",
    "Name": "ractopamine",
    "guid": "af9326ba-3be4-49fa-acac-9b4891849b1d",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "ractopamine",
    "Reasons": "[{\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709041592, \"_nanoseconds\": 43000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Raloxifene\", \"url\": \"https://drugs.ncats.io/drug/YX9162EO3I\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S4: Hormone and Metabolic ModulatorsPrescription drug",
    "Name": "raloxifene",
    "guid": "3c5f0589-7814-4eaa-9909-a141e24408c8",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "raloxifene",
    "Reasons": "[{\"reason_code\": 6012, \"reason\": \"WADA S4: Hormone and Metabolic Modulators\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"ac1ba347-6d44-4a17-829d-e589bf33bbdb\", \"link_title\": \"WADA Prohibited List S4: Hormone and Metabolic Modulators\", \"updated\": {\"_seconds\": 1703682875, \"_nanoseconds\": 162000000}}, {\"reason_code\": 6016, \"reason\": \"Prescription drug\", \"link\": null, \"guid\": \"becae72e-580f-4d8d-8665-c0c4b1dc1381\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683249, \"_nanoseconds\": 70000000}}]",
    "other_names": "[\"LY-139481\", \"LY 139481\", \"LY-156758\", \"(2-(4-Hydroxyphenyl)-6-hydroxybenzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone\", \"CCRIS 7129\", \"LY139481\", \"raloxifeno\", \"Evista\", \"LY156758\", \"LY 156758\", \"HSDB 7460\", \"raloxifene hydrochloride\", \"raloxifene HCl\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1761934423, \"_nanoseconds\": 367000000}",
    "label_terms": "[]",
    "linked_ingredients": "[]",
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Reldesemtiv\", \"url\": \"https://drugs.ncats.io/drug/4S0HBYW6QE\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "reldesemtiv",
    "guid": "fb5ae475-6eda-4e8f-b2ec-25f3633e8833",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "reldesemtiv",
    "Reasons": "[{\"reason_code\": 6008, \"reason\": \"WADA S0: Non-approved Substances\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"f321f8bd-47c9-42f3-bea6-f36eafa02ecf\", \"link_title\": \"WADA Prohibited List S0: Non-approved Substances\", \"updated\": {\"_seconds\": 1703682727, \"_nanoseconds\": 352000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"CK-2127107\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709041724, \"_nanoseconds\": 503000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule II",
    "Name": "remifentanil",
    "guid": "062f7d8d-7ec7-4409-8280-43429b79c1af",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "remifentanil",
    "Reasons": "[{\"reason_code\": 6004, \"reason\": \"DEA Controlled Substance List: Schedule  II\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"207f9e17-8a22-4523-8dd6-24d9d39b4c45\", \"link_title\": \"DEA Controlled Substance List: Schedule  II\", \"updated\": {\"_seconds\": 1712942744, \"_nanoseconds\": 783000000}}]",
    "other_names": "[\"Ultiva\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709742064, \"_nanoseconds\": 530000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: remimazolam\", \"url\": \"https://drugs.ncats.io/drug/7V4A8U16MB\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "remimazolam",
    "guid": "0100167e-5d66-4ef4-877f-2a4f7c94fe50",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "remimazolam",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}, {\"reason_code\": 6016, \"reason\": \"Prescription drug\", \"link\": null, \"guid\": \"becae72e-580f-4d8d-8665-c0c4b1dc1381\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683249, \"_nanoseconds\": 70000000}}]",
    "other_names": "[\"methyl 3-[(4S)-8-bromo-1-methyl-6-pyridin-2-yl-4H-imidazo[1,2-a][1,4]benzodiazepin-4yl]propanoate benzenesulfonic acid\", \"4H-imidazol[1,2-a][1,4]benzodiazepine-4-propionic acid\", \"8-bromo-1-methyl-6-(2-pyridinyl)-(4S)-methyl ester\", \"benzenesulfonate (1:1)\", \"byfavo\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709041787, \"_nanoseconds\": 343000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Reproterol\", \"url\": \"https://drugs.ncats.io/drug/11941YC6RN\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S3: Beta-2 AgonistsUnapproved drug",
    "Name": "reproterol",
    "guid": "75c6ac1e-6fc1-4af6-92d7-6b8ccac93dd3",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "reproterol",
    "Reasons": "[{\"reason_code\": 6011, \"reason\": \"WADA S3: Beta-2 Agonists\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"aecafa3b-c7ad-413c-bc5f-be7ed5b2f69d\", \"link_title\": \"WADA Prohibited List S3: Beta-2 Agonists\", \"updated\": {\"_seconds\": 1703682857, \"_nanoseconds\": 73000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"7-(3-((beta,3,5-trihydroxyphenethyl)amino)propyl)theophylline\", \"7-(3-((\u03b2,3,5-trihydroxyphenethyl)amino)propyl)theophylline\", \"1H-purine-2,6-dione, 7-(3-((2-(3,5-dihydroxyphenyl)-2-hydroxyethyl)amino)propyl)-3,7-dihydro-1,3-dimethyl-\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709041805, \"_nanoseconds\": 951000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "rismorelin",
    "guid": "9d3f59ff-4d39-483a-89ce-21aceec648d0",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "rismorelin",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}, {\"reason_code\": 6014, \"reason\": \"DoDI 1010.16\", \"link\": \"https://www.esd.whs.mil/directives/issuances/dodi\", \"guid\": \"b757aa46-4729-4d4a-a32e-25ef0b04e5c3\", \"link_title\": \"Use or misuse prohibited under DoDI 1010.16\", \"updated\": {\"_seconds\": 1703683049, \"_nanoseconds\": 190000000}}]",
    "other_names": "[]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1722279567, \"_nanoseconds\": 355000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Roxadustat\", \"url\": \"https://drugs.ncats.io/drug/X3O30D9YMX\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S2: Peptide Hormones, Growth Factors, etc.Unapproved drug",
    "Name": "roxadustat",
    "guid": "4b91df30-613c-48ee-9310-28642fcdca01",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "roxadustat",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"FG-4592\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709041832, \"_nanoseconds\": 319000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Albuterol\", \"url\": \"https://drugs.ncats.io/drug/QF8SVZ843E\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S3: Beta-2 AgonistsPrescription drug",
    "Name": "salbutamol",
    "guid": "668f4766-e36a-44ad-bbd1-751aee3d3f8c",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "salbutamol",
    "Reasons": "[{\"reason_code\": 6011, \"reason\": \"WADA S3: Beta-2 Agonists\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"aecafa3b-c7ad-413c-bc5f-be7ed5b2f69d\", \"link_title\": \"WADA Prohibited List S3: Beta-2 Agonists\", \"updated\": {\"_seconds\": 1703682857, \"_nanoseconds\": 73000000}}, {\"reason_code\": 6016, \"reason\": \"Prescription drug\", \"link\": null, \"guid\": \"becae72e-580f-4d8d-8665-c0c4b1dc1381\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683249, \"_nanoseconds\": 70000000}}]",
    "other_names": "[\"albuterol\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709041899, \"_nanoseconds\": 327000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Salmeterol\", \"url\": \"https://drugs.ncats.io/drug/2I4BC502BT\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S3: Beta-2 AgonistsPrescription drug",
    "Name": "salmeterol",
    "guid": "4e8aee6b-0546-4b44-9864-1369cc3be227",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "salmeterol",
    "Reasons": "[{\"reason_code\": 6011, \"reason\": \"WADA S3: Beta-2 Agonists\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"aecafa3b-c7ad-413c-bc5f-be7ed5b2f69d\", \"link_title\": \"WADA Prohibited List S3: Beta-2 Agonists\", \"updated\": {\"_seconds\": 1703682857, \"_nanoseconds\": 73000000}}, {\"reason_code\": 6016, \"reason\": \"Prescription drug\", \"link\": null, \"guid\": \"becae72e-580f-4d8d-8665-c0c4b1dc1381\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683249, \"_nanoseconds\": 70000000}}]",
    "other_names": "[\"Serevent\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709041913, \"_nanoseconds\": 536000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule II",
    "Name": "secobarbital",
    "guid": "0e7d2607-ab5f-4dfa-abd4-6f93f7fa8fc6",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "secobarbital",
    "Reasons": "[{\"reason_code\": 6004, \"reason\": \"DEA Controlled Substance List: Schedule  II\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"207f9e17-8a22-4523-8dd6-24d9d39b4c45\", \"link_title\": \"DEA Controlled Substance List: Schedule  II\", \"updated\": {\"_seconds\": 1712942744, \"_nanoseconds\": 783000000}}]",
    "other_names": "[\"Quinalbarbitone\", \"Tuinal\", \"Seconal\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709741797, \"_nanoseconds\": 281000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Semax\", \"url\": \"https://drugs.ncats.io/drug/I5FAL2585H\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S2: Peptide Hormones, Growth Factors, etc.Prescription drug",
    "Name": "semax",
    "guid": "a322623c-c41c-4077-903f-124a365ac114",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "semax",
    "Reasons": "[{\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1763404649, \"_nanoseconds\": 753000000}",
    "label_terms": "[]",
    "linked_ingredients": "[]",
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: serdexmethylphenidate\", \"url\": \"https://drugs.ncats.io/drug/0H8KZ470DW\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "serdexmethylphenidate",
    "guid": "b3c3f3ac-7e04-46d1-ac03-edcb6d07e15a",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "serdexmethylphenidate",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}, {\"reason_code\": 6016, \"reason\": \"Prescription drug\", \"link\": null, \"guid\": \"becae72e-580f-4d8d-8665-c0c4b1dc1381\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683249, \"_nanoseconds\": 70000000}}]",
    "other_names": "[\"3-[[[(1S)-1-carboxy-2-hydroxyethyl]-amino]carbonyl]-1-[[[[(2R)-2-[(1R)-2-methoxy-2-oxo-1-phenylethyl]-1-piperidinyl]carbonyl]oxy]methyl]pyridinium chloride\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1761934078, \"_nanoseconds\": 530000000}",
    "label_terms": "[]",
    "linked_ingredients": "[]",
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Sermorelin\", \"url\": \"https://drugs.ncats.io/drug/89243S03TE\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S2: Peptide Hormones, Growth Factors, etc.Unapproved drug",
    "Name": "sermorelin",
    "guid": "66439726-8a95-4660-a030-b5ce58db5d67",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "sermorelin",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}, {\"reason_code\": 6022, \"reason\": \"Discontinued drug\", \"link\": \"\", \"guid\": \"69df11c9-4b6c-4a02-9903-d201a6e29544\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1713452078, \"_nanoseconds\": 467000000}}]",
    "other_names": "[\"Geref\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1713452290, \"_nanoseconds\": 945000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"FDA Drug Safety Communication Recommends Against Use\", \"url\": \"https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-recommends-against-continued-use-meridia-sibutramine\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "sibutramine",
    "guid": "baa3a060-7a8b-4cff-b91b-45fcd6c56970",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "sibutramine",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"sibutraminum\", \"mono-desmethylsibutramine\", \"N-1-(1-(4-chlorophenyl)cyclobutyl)-3-methylbutyl-N,N-dimethylamine HCl\", \"sibutramine hydrochloride monohydrate\", \"BTS-54524\", \"sibutramine hydrochloride\", \"didesmethylsibutramine\", \"Meridia\", \"sibutramina\", \"di-desmethylsibutramine\", \"Reductil\", \"BTS 54 524\", \"BTS 54524\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715370524, \"_nanoseconds\": 204000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Sildenafil\", \"url\": \"https://drugs.ncats.io/drug/3M7OB98Y7H\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Prescription drug",
    "Name": "sildenafil",
    "guid": "deed484d-398d-44e6-9c87-688d46f762bc",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "sildenafil",
    "Reasons": "[{\"reason_code\": 6016, \"reason\": \"Prescription drug\", \"link\": null, \"guid\": \"becae72e-580f-4d8d-8665-c0c4b1dc1381\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683249, \"_nanoseconds\": 70000000}}]",
    "other_names": "[\"Viagra\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1751042839, \"_nanoseconds\": 249000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Sodium tetrachloroaurate\", \"url\": \"https://drugs.ncats.io/drug/7FT6QUT299\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Unapproved drug",
    "Name": "sodium tetrachloroaurate",
    "guid": "6d7b350b-5eed-4c14-bf57-454c01c7e443",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "sodium tetrachloroaurate",
    "Reasons": "[{\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"sodium tetrachloroaurate (3+)\", \"gold sodium chloride\", \"tetrachloroaurate (1-) sodium\", \"natrium tetrachloroauratum\", \"sodium gold chloride\", \"sodium tetrachloroaurate (1-)\", \"gold chloride sodium\", \"sodium chloroaurate\", \"hydrochloroauric acid, sodium salt\", \"tetrachloroauric (3+) acid, sodium salt\", \"sodium tetrachloroaurate (III)\", \"sodium gold(III) chloride\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709042218, \"_nanoseconds\": 696000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: solriamfetol\", \"url\": \"https://drugs.ncats.io/drug/939U7C91AI\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "solriamfetol",
    "guid": "031735df-2a5c-48f1-8f59-f0d173bfc5db",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "solriamfetol",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}, {\"reason_code\": 6016, \"reason\": \"Prescription drug\", \"link\": null, \"guid\": \"becae72e-580f-4d8d-8665-c0c4b1dc1381\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683249, \"_nanoseconds\": 70000000}}]",
    "other_names": "[\"benzenepropanol, beta-amino-, carbamate (ester)\", \"2-amino-3-phenylpropyl carbamate\", \"(2R)-2-amino-3-phenylpropyl carbamate\", \"Sunosi\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1715370547, \"_nanoseconds\": 715000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Somapacitan\", \"url\": \"https://drugs.ncats.io/drug/8FOJ430U94\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S2: Peptide Hormones, Growth Factors, etc.Prescription drug",
    "Name": "somapacitan",
    "guid": "8df0dc21-a02b-4697-8455-aeda880f3af5",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "somapacitan",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}, {\"reason_code\": 6016, \"reason\": \"Prescription drug\", \"link\": null, \"guid\": \"becae72e-580f-4d8d-8665-c0c4b1dc1381\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683249, \"_nanoseconds\": 70000000}}]",
    "other_names": "[\"somapacitan-geco\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709042312, \"_nanoseconds\": 576000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "somatorelin",
    "guid": "6876bd42-a1fd-43f4-8e2c-60191d5b9947",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "somatorelin",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}, {\"reason_code\": 6014, \"reason\": \"DoDI 1010.16\", \"link\": \"https://www.esd.whs.mil/directives/issuances/dodi\", \"guid\": \"b757aa46-4729-4d4a-a32e-25ef0b04e5c3\", \"link_title\": \"Use or misuse prohibited under DoDI 1010.16\", \"updated\": {\"_seconds\": 1703683049, \"_nanoseconds\": 190000000}}]",
    "other_names": "[]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1722279622, \"_nanoseconds\": 0}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Somatrogon\", \"url\": \"https://drugs.ncats.io/drug/6D848RA61B\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S2: Peptide Hormones, Growth Factors, etc.Unapproved drug",
    "Name": "somatrogon",
    "guid": "1d20422e-0017-4aff-9ee0-c8ba9cf9c45b",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "somatrogon",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"Ngenla\", \"NGENLA\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1762180939, \"_nanoseconds\": 20000000}",
    "label_terms": "[]",
    "linked_ingredients": "[]",
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Sotatercept\", \"url\": \"https://drugs.ncats.io/drug/0QI90BTJ37\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S2: Peptide Hormones, Growth Factors, etc.Unapproved drug",
    "Name": "sotatercept",
    "guid": "00cc31f7-746a-482b-841e-f37c95390479",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "sotatercept",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"ACE-011\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709042354, \"_nanoseconds\": 976000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Spironolactone\", \"url\": \"https://drugs.ncats.io/drug/27O7W4T232\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S5: Diuretics and Masking AgentsPrescription drug",
    "Name": "spironolactone",
    "guid": "3042aa67-2bfd-4473-94ae-ab2f5f0cf67c",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "spironolactone",
    "Reasons": "[{\"reason_code\": 6013, \"reason\": \"WADA S5: Diuretics and Masking Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b1ad44e4-cef0-4ae2-99fb-19e28540f282\", \"link_title\": \"WADA Prohibited List S5: Diuretics and Masking Agents\", \"updated\": {\"_seconds\": 1703682941, \"_nanoseconds\": 864000000}}, {\"reason_code\": 6016, \"reason\": \"Prescription drug\", \"link\": null, \"guid\": \"becae72e-580f-4d8d-8665-c0c4b1dc1381\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683249, \"_nanoseconds\": 70000000}}]",
    "other_names": "[\"Verospiron\", \"spiro(17H-cyclopenta(a)phenauthrene-17,2'-(3'H)-furan)\", \"CaroSpir\", \"Aldactone\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709042390, \"_nanoseconds\": 807000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Stamulumab\", \"url\": \"https://drugs.ncats.io/drug/V43X8G4797\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S4: Hormone and Metabolic ModulatorsUnapproved drug",
    "Name": "stamulumab",
    "guid": "8e032671-6a29-4271-b7e9-9f4f43130588",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "stamulumab",
    "Reasons": "[{\"reason_code\": 6012, \"reason\": \"WADA S4: Hormone and Metabolic Modulators\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"ac1ba347-6d44-4a17-829d-e589bf33bbdb\", \"link_title\": \"WADA Prohibited List S4: Hormone and Metabolic Modulators\", \"updated\": {\"_seconds\": 1703682875, \"_nanoseconds\": 162000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"Myo-29\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709042479, \"_nanoseconds\": 672000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "stanozolol",
    "guid": "97f9201e-51bd-4d5f-aea3-2350ba473522",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "stanozolol",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}, {\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"17-beta-hydroxy-17-alpha-methylandrostano(3,2-c)pyrazole\", \"Winstrol-V\", \"17alpha-methyl-17beta-hydroxy-5alphaandrost-2-eno[3,2-c]-pyrazole\", \"17\u03b1-methyl-17\u03b2-hydroxy-[5\u03b1]-androst-2-eno[3,2-c]-pyrazole\", \"androstanazole\", \"17\u03b2-hydroxy-17\u03b1-methylandrostano(3,2-c)pyrazole\", \"Winstrol\", \"androstanazol\", \"17\u03b1-Methylpyrazolo[4',3':2,3]-5\u03b1-androstan-17\u03b2-ol\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1722275417, \"_nanoseconds\": 191000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "stenbolone",
    "guid": "c960f2ee-9073-4c01-89c3-912374552f54",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "stenbolone",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}, {\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"17\u03b2-hydroxy-2-methyl-[5\u03b1]-androst-1-en-3-one\", \"17beta-hydroxy-2-methyl-5alpha-androst-1-en-3-one\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709042519, \"_nanoseconds\": 976000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Strychnine\", \"url\": \"https://drugs.ncats.io/drug/H9Y79VD43J\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Unapproved drug",
    "Name": "strychnine",
    "guid": "af2ee7fb-2147-4da7-9275-cb059542b565",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "strychnine",
    "Reasons": "[{\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"strychinos\", \"strychnine nitrate\", \"estricnina\", \"strychnidin-10-one\", \"stricnina\", \"Certox\", \"strychnin\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1751992849, \"_nanoseconds\": 650000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule II",
    "Name": "sufentanil",
    "guid": "d18b081d-5da0-4bac-ab5d-58ae6a143b06",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "sufentanil",
    "Reasons": "[{\"reason_code\": 6004, \"reason\": \"DEA Controlled Substance List: Schedule  II\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"207f9e17-8a22-4523-8dd6-24d9d39b4c45\", \"link_title\": \"DEA Controlled Substance List: Schedule  II\", \"updated\": {\"_seconds\": 1712942744, \"_nanoseconds\": 783000000}}]",
    "other_names": "[\"Sufenta\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709042675, \"_nanoseconds\": 752000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Sulbutiamine\", \"url\": \"https://drugs.ncats.io/drug/42NCM1BW43\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Unapproved drug",
    "Name": "sulbutiamine",
    "guid": "db63a6b8-9939-4cde-9d85-d60c0c20d2af",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "sulbutiamine",
    "Reasons": "[{\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"sulbutiaminum\", \"Bis(1-(4-amino-2-methyl-5-pyrimidinyl)-2-formyl-3,9-dimethyl-8-oxo-2-aza-7-oxa-3-decen-4-yl)disulfid\", \"UNII-42NCM1BW43\", \"Arcalion\", \"sulbutiamina\", \"O-isobutyroylthiamine disulfide\", \"N,N'-(dithiobis(2-(2-hydroxyethyl)-1-methylvinylene))bis(N-((4-amino-2-methyl-5-pyrimidinyl)methyl)formamide) diisobutyrate (ester)\", \"Vitaberin\", \"Bisibuthiamine\", \"BRN 0741531\", \"O,O'-diisobutyrylthiamine disulfide\", \"Bis(1-(2-isobutyryloxyethyl)-2-(N-((4-amino-2-methyl-5-pyrimidinyl)methyl)formamido)-1-propenyl)disulfid\", \"Bisibutiamin\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1761936829, \"_nanoseconds\": 365000000}",
    "label_terms": "[]",
    "linked_ingredients": "[]",
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "sulfondiethylmethane",
    "guid": "93ff2f5e-3568-48fc-a39a-4e1ee6f9569a",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "sulfondiethylmethane",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}]",
    "other_names": "[\"tetronal\", \"3,3-bis(ethylsulfonyl)pentane\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709042856, \"_nanoseconds\": 497000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "sulfonethylmethane",
    "guid": "153ba0fa-aa40-43a7-a5ed-1087a1846041",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "sulfonethylmethane",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}]",
    "other_names": "[]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709042999, \"_nanoseconds\": 937000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "sulfonmethane",
    "guid": "29e5cfcb-4b6e-4fbe-adf2-c7ee0edb7799",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "sulfonmethane",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}]",
    "other_names": "[\"trional\", \"methylsulfonal\", \"2,2-bis(ethylsulfonyl)butane\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709043015, \"_nanoseconds\": 97000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Sunifiram\", \"url\": \"https://drugs.ncats.io/drug/66924E735K\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S4: Hormone and Metabolic ModulatorsUnapproved drug",
    "Name": "sunifiram",
    "guid": "9c6363fa-6b24-4e13-a8bb-da06254138e6",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "sunifiram",
    "Reasons": "[{\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"1-benzoyl-4-propanoylpiperazine\", \"piperazine, 1-benzoyl-4-(1-oxopropyl)-\", \"DM-235\", \"1-benzyl-4-propanoylpiperazine\", \"1-propanone, 1-(4-benzoyl-1-piperazinyl)-\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1751295884, \"_nanoseconds\": 6000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "suvorexant",
    "guid": "5444b675-4a29-4e3e-ab2d-280b25d144d9",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "suvorexant",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"[(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone\", \"MK-4305\", \"Belsomra\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709043117, \"_nanoseconds\": 466000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Use or misuse prohibited under DoDI 1010.16 (synthetic cannabinoids)",
    "Name": "synthetic cannabinoids",
    "guid": "747dae96-6121-46bb-8ace-3ad40cf93bc3",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "synthetic cannabinoids",
    "Reasons": "[{\"reason_code\": 6014, \"reason\": \"DoDI 1010.16\", \"link\": \"https://www.esd.whs.mil/directives/issuances/dodi\", \"guid\": \"b757aa46-4729-4d4a-a32e-25ef0b04e5c3\", \"link_title\": \"Use or misuse prohibited under DoDI 1010.16\", \"updated\": {\"_seconds\": 1703683049, \"_nanoseconds\": 190000000}}]",
    "other_names": "[\"pyrrolo-benzoxazine\", \"cannabinoid derivative\", \"indazole carboxamide cannabinoid\", \"naphthoylindole cannabinoids\", \"indole carboxylate cannabinoid\", \"indole carboxamide cannabinoid\", \"alkoylindole cannabinoids\", \"azaindole\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709043149, \"_nanoseconds\": 194000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Tabimorelin\", \"url\": \"https://drugs.ncats.io/drug/L51CBE03KF\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S2: Peptide Hormones, Growth Factors, etc.Unapproved drug",
    "Name": "tabimorelin",
    "guid": "2685ce2b-12c6-42f9-9aab-54bc5220fe52",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "tabimorelin",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"D-phenylalaninamide, N-((2E)-5-amino-5-methyl-1-oxo-2-hexen-1-YL)-N-methyl-3-(2-naphthalenyl)-D-alanyl-N,N\u03b1-dimethyl-\", \"D-phenylalaninamide, N-((2E)-5-amino-5-methyl-1-oxo-2-hexen-1-YL)-N-methyl-3-(2-naphthalenyl)-D-alanyl-N,Nalpha-dimethyl-\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709043186, \"_nanoseconds\": 490000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Tadalafil\", \"url\": \"https://drugs.ncats.io/drug/742SXX0ICT\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Prescription drug",
    "Name": "tadalafil",
    "guid": "53d70482-8340-42d7-8252-389a8b4c8be1",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "tadalafil",
    "Reasons": "[{\"reason_code\": 6016, \"reason\": \"Prescription drug\", \"link\": null, \"guid\": \"becae72e-580f-4d8d-8665-c0c4b1dc1381\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683249, \"_nanoseconds\": 70000000}}]",
    "other_names": "[\"Cialis\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1751042812, \"_nanoseconds\": 881000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Talbutal\", \"url\": \"https://drugs.ncats.io/drug/4YIR8202AX\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Unapproved drug",
    "Name": "talbutal",
    "guid": "f875d2c0-022e-484a-b42d-277dbb55744c",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "talbutal",
    "Reasons": "[{\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"Lotusate\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709043296, \"_nanoseconds\": 611000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Tamoxifen\", \"url\": \"https://drugs.ncats.io/drug/094ZI81Y45\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S4: Hormone and Metabolic ModulatorsPrescription drug",
    "Name": "tamoxifen",
    "guid": "f3d72c85-deca-4be2-a8b6-10c09abad156",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "tamoxifen",
    "Reasons": "[{\"reason_code\": 6012, \"reason\": \"WADA S4: Hormone and Metabolic Modulators\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"ac1ba347-6d44-4a17-829d-e589bf33bbdb\", \"link_title\": \"WADA Prohibited List S4: Hormone and Metabolic Modulators\", \"updated\": {\"_seconds\": 1703682875, \"_nanoseconds\": 162000000}}, {\"reason_code\": 6016, \"reason\": \"Prescription drug\", \"link\": null, \"guid\": \"becae72e-580f-4d8d-8665-c0c4b1dc1381\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683249, \"_nanoseconds\": 70000000}}]",
    "other_names": "[\"ICI-47699\", \"ICI-46,474\", \"Crisafeno\", \"ICI 46,474\", \"HSDB 6782\", \"Novaldex\", \"ICI 46474\", \"Oncomox\", \"ICI47699\", \"CCRIS 3275\", \"(Z)-2-(4-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine\", \"ICI46,474\", \"tamoxifen citrate\", \"trans-tamoxifen\", \"Nolvadex\", \"1-para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene\", \"Valodex\", \"EC 234-118-0\", \"1-para-\u03b2-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene\", \"Zitazonium\", \"Tamoxen\", \"1-p-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene\", \"ICI 47699\", \"tamoxifene\", \"ICI46474\", \"tamoxifeno\", \"1-p-\u03b2-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene\", \"(Z)-2-(para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine\", \"Citofen\", \"NSC 180973\", \"Soltamox\", \"ICI-46474\", \"tamoxifenum\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1761933404, \"_nanoseconds\": 22000000}",
    "label_terms": "[]",
    "linked_ingredients": "[]",
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule II",
    "Name": "tapentadol",
    "guid": "fd693273-9ecd-4b51-a552-45e5eda7f892",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "tapentadol",
    "Reasons": "[{\"reason_code\": 6004, \"reason\": \"DEA Controlled Substance List: Schedule  II\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"207f9e17-8a22-4523-8dd6-24d9d39b4c45\", \"link_title\": \"DEA Controlled Substance List: Schedule  II\", \"updated\": {\"_seconds\": 1712942744, \"_nanoseconds\": 783000000}}]",
    "other_names": "[]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709043342, \"_nanoseconds\": 794000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: ursodoxicoltaurine\", \"url\": \"https://drugs.ncats.io/drug/60EUX8MN5X\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Unapproved drug",
    "Name": "tauroursodeoxycholic acid",
    "guid": "12763f29-e2a5-4209-bdb6-6daf5b128469",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "tauroursodeoxycholic acid",
    "Reasons": "[{\"reason_code\": 6022, \"reason\": \"Discontinued drug\", \"link\": \"\", \"guid\": \"69df11c9-4b6c-4a02-9903-d201a6e29544\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1713452078, \"_nanoseconds\": 467000000}}]",
    "other_names": "[\"TUDCA\", \"tauroursodeoxycholic acid (TUDCA)\", \"tuaroursodeoxycholic acid\", \"ursodoxicoltaurine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1754420281, \"_nanoseconds\": 242000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "temazepam",
    "guid": "c4140cd3-7fd0-4643-8025-38e3c7bfbc19",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "temazepam",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"Restoril\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709043415, \"_nanoseconds\": 794000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Terbutaline\", \"url\": \"https://drugs.ncats.io/drug/N8ONU3L3PG\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S3: Beta-2 AgonistsPrescription drug",
    "Name": "terbutaline",
    "guid": "baa78e37-311e-4c30-bcf6-f73943b1fbda",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "terbutaline",
    "Reasons": "[{\"reason_code\": 6011, \"reason\": \"WADA S3: Beta-2 Agonists\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"aecafa3b-c7ad-413c-bc5f-be7ed5b2f69d\", \"link_title\": \"WADA Prohibited List S3: Beta-2 Agonists\", \"updated\": {\"_seconds\": 1703682857, \"_nanoseconds\": 73000000}}, {\"reason_code\": 6016, \"reason\": \"Prescription drug\", \"link\": null, \"guid\": \"becae72e-580f-4d8d-8665-c0c4b1dc1381\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683249, \"_nanoseconds\": 70000000}}]",
    "other_names": "[\"terbutaline sulfate\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709043435, \"_nanoseconds\": 354000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Tesamorelin\", \"url\": \"https://drugs.ncats.io/drug/MQG94M5EEO\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S2: Peptide Hormones, Growth Factors, etc.Prescription drug",
    "Name": "tesamorelin",
    "guid": "0b241b8b-70d2-416e-9dce-41b43b39fa09",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "tesamorelin",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}, {\"reason_code\": 6016, \"reason\": \"Prescription drug\", \"link\": null, \"guid\": \"becae72e-580f-4d8d-8665-c0c4b1dc1381\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683249, \"_nanoseconds\": 70000000}}]",
    "other_names": "[\"egrifta\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709043458, \"_nanoseconds\": 786000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: tesofensine\", \"url\": \"https://drugs.ncats.io/drug/BLH9UKX9V1\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Unapproved drug",
    "Name": "tesofensine",
    "guid": "f454abc0-ca6d-4d7b-ba49-6ddd3750a322",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "tesofensine",
    "Reasons": "[{\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"NS-2330\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709043481, \"_nanoseconds\": 290000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "testolactone",
    "guid": "a628cb96-5495-4498-a5b8-a9e5b304b9b8",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "testolactone",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}, {\"reason_code\": 6012, \"reason\": \"WADA S4: Hormone and Metabolic Modulators\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"ac1ba347-6d44-4a17-829d-e589bf33bbdb\", \"link_title\": \"WADA Prohibited List S4: Hormone and Metabolic Modulators\", \"updated\": {\"_seconds\": 1703682875, \"_nanoseconds\": 162000000}}]",
    "other_names": "[\"13-hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17-oic acid lactone\", \"delta(1)-dehydrotestolactone\", \"testolacton\", \"NSC-12173\", \"testolactona\", \"HSDB 3255\", \"1-dehydrotestololactone\", \"testololactone, 1,2-didehydro-\", \"testololactone, 1-dehydro-\", \"1-dehydrotestolactone\", \"17alpha-oxo-D-homo-1,4-androstadiene-3,17-dione\", \"1 dehydrotestolactone\", \"1,2-didehydrotestololactone\", \"teslac\", \"d-homo-17a-oxaandrosta-1,4-diene-3,17-dione\", \"EINECS 213-534-6\", \"testolactonum\", \"13-hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17-oic acid delta-lactone\", \"NSC 23759\", \"teolit\", \"delta(1)-testololactone\", \"testolattone\", \"delta(1)-testolactone\", \"SQ 9538\", \"Fludestrin\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709043522, \"_nanoseconds\": 578000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "testosterone",
    "guid": "c03decd8-993a-45dc-a276-6d6a87cd5e3e",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "testosterone",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}, {\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"testosterone phenylpropionate\", \"testosterone acetate\", \"Android-T\", \"testosterone cypionate\", \"Androlan\", \"Depotest\", \"testosterone decanoate\", \"Andriol\", \"17b-hydroxy-androst-4-ene-3,11-dione\", \"testosterone enanthate\", \"testosterone undecanoate\", \"17\u03b2-hydroxyandrost-4-en-3-one\", \"17beta-hydroxyandrost-4-en-3-one\", \"testosterone propionate\", \"Sustanon\", \"Delatestryl\", \"testosterone isocaproate\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1716929248, \"_nanoseconds\": 902000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Cosyntropin\", \"url\": \"https://drugs.ncats.io/drug/72YY86EA29\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "tetracosactide",
    "guid": "936c86d6-4563-4b25-b625-5904eba99871",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "tetracosactide",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}, {\"reason_code\": 6016, \"reason\": \"Prescription drug\", \"link\": null, \"guid\": \"becae72e-580f-4d8d-8665-c0c4b1dc1381\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683249, \"_nanoseconds\": 70000000}}]",
    "other_names": "[\"cosyntropin\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1761930529, \"_nanoseconds\": 104000000}",
    "label_terms": "[]",
    "linked_ingredients": "[]",
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "tetrahydrocannabinols",
    "guid": "9d417205-bbe9-4a43-a322-de6810fd661c",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "tetrahydrocannabinols",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"delta-9-THC\", \"6 trans tetrahydrocannabinol\", \"delta 8\", \"HHC\", \"3, 4 trans tetrahydrocannabinol\", \"\u03948-THC\", \"1 cis tetrahydrocannabinol\", \"hexahydrocannabinol\", \"3, 4 cis tetrahydrocannabinol\", \"C(11)-Methyl-hhc\", \"1 trans tetrahydrocannabinol\", \"THC\", \"11-nor-\u03948-tetrahydrocannabinol-9-carboxylic acid\", \"6 cis tetrahydrocannabinol\", \"11-nor-\u03949-tetrahydrocannabinol-9-carboxylic acid\", \"6,6,9-trimethyl-3-pentyl-6a,7,8,9,10,10a-hexahydrobenzo[c]chromen-1-ol\", \"C(11)-Methyl-hexahydrocannabinol\", \"\u03949-THC\", \"delta-8-THC\", \"11-nor-delta8-tetrahydrocannabinol-9-carboxylic acid\", \"11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1710259582, \"_nanoseconds\": 247000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "tetrahydrofuranyl fentanyl",
    "guid": "ea0b1d18-eed6-4c25-8477-060af9a185cd",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "tetrahydrofuranyl fentanyl",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709043740, \"_nanoseconds\": 868000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "tetrahydrogestrinone",
    "guid": "203876f7-5e8a-4852-9cc4-30d976ff23d7",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "tetrahydrogestrinone",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}, {\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"17-hydroxy-18a-homo-19-nor-17\u03b1-pregna-4,9,11-trien-3-one\", \"THG\", \"13beta,17alpha-diethyl-17betahydroxygon-4,9,11-trien-3-one\", \"13\u03b2,17\u03b1-diethyl-17\u03b2-hydroxygon-4,9,11-trien-3-one\", \"17\u03b2-Hydroxy-18\u03b1-homo-19-nor-17\u03b1-pregna-4,9,11-trien-3- one\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1722275642, \"_nanoseconds\": 285000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "tetrazepam",
    "guid": "a3d16363-a238-4f16-8355-ff4db69ac545",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "tetrazepam",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"Myolastan\", \"Musaril\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709043826, \"_nanoseconds\": 611000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "thebacon",
    "guid": "f3293521-f970-4593-a310-f39e02153d08",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "thebacon",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"acetylhydrocodone\", \"Acedicon\", \"Thebacetyl\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709043857, \"_nanoseconds\": 227000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule II",
    "Name": "thebaine",
    "guid": "53ae51f2-0732-4473-b915-6a7733b23937",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "thebaine",
    "Reasons": "[{\"reason_code\": 6004, \"reason\": \"DEA Controlled Substance List: Schedule  II\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"207f9e17-8a22-4523-8dd6-24d9d39b4c45\", \"link_title\": \"DEA Controlled Substance List: Schedule  II\", \"updated\": {\"_seconds\": 1712942744, \"_nanoseconds\": 783000000}}]",
    "other_names": "[\"paramorphine\", \"codeine methyl enol ether\", \"3-O-methyl-oripavin\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709043869, \"_nanoseconds\": 355000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule II",
    "Name": "thiafentanil",
    "guid": "bbc1ab8f-cce8-452c-81af-bc81b9c02016",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "thiafentanil",
    "Reasons": "[{\"reason_code\": 6004, \"reason\": \"DEA Controlled Substance List: Schedule  II\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"207f9e17-8a22-4523-8dd6-24d9d39b4c45\", \"link_title\": \"DEA Controlled Substance List: Schedule  II\", \"updated\": {\"_seconds\": 1712942744, \"_nanoseconds\": 783000000}}]",
    "other_names": "[\"Thianil\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709043888, \"_nanoseconds\": 363000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "thiamylal",
    "guid": "487c3d17-6f97-4233-849a-04f4a86aec3e",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "thiamylal",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}]",
    "other_names": "[\"Surital\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709043918, \"_nanoseconds\": 842000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Use or misuse prohibited under DoDI 1010.16 (synthetic cannabinoids)",
    "Name": "thiazolidene",
    "guid": "bb86a4dd-03ee-47e1-8858-d9f313c1a787",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "thiazolidene",
    "Reasons": "[{\"reason_code\": 6014, \"reason\": \"DoDI 1010.16\", \"link\": \"https://www.esd.whs.mil/directives/issuances/dodi\", \"guid\": \"b757aa46-4729-4d4a-a32e-25ef0b04e5c3\", \"link_title\": \"Use or misuse prohibited under DoDI 1010.16\", \"updated\": {\"_seconds\": 1703683049, \"_nanoseconds\": 190000000}}]",
    "other_names": "[\"tetrahydrothiazole\", \"1,3-thiazolidine\", \"1-thia-3-azacyclopentane\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709043953, \"_nanoseconds\": 810000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "thiofentanyl",
    "guid": "050cea6c-d1fc-438d-abd2-b8008e82847a",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "thiofentanyl",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]propanamide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709043989, \"_nanoseconds\": 834000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "thiofuranyl fentanyl",
    "guid": "88774ffe-394a-4305-bbad-84905075c46b",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "thiofuranyl fentanyl",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"N-(1-phenethylpiperidin-4-yl)-Nphenylthiophene-2-carboxamide\", \"2-thiofuranyl fentanyl\", \"thiophene fentanyl\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709044004, \"_nanoseconds\": 274000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "thiomesterone",
    "guid": "25406f10-0ebe-4c5c-bfb1-c56f26ca042f",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "thiomesterone",
    "Reasons": "[{\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}, {\"reason_code\": 6014, \"reason\": \"DoDI 1010.16\", \"link\": \"https://www.esd.whs.mil/directives/issuances/dodi\", \"guid\": \"b757aa46-4729-4d4a-a32e-25ef0b04e5c3\", \"link_title\": \"Use or misuse prohibited under DoDI 1010.16\", \"updated\": {\"_seconds\": 1703683049, \"_nanoseconds\": 190000000}}]",
    "other_names": "[\"1,7-bis(acetylthio)-17\u03b2-hydroxy-17\u03b1-methyl-androst-4-en-3- one\", \"Emdabol\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1722279430, \"_nanoseconds\": 889000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "thiopental",
    "guid": "968ce3ce-8d34-428e-915d-1fc8707d6211",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "thiopental",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}]",
    "other_names": "[\"Pentothal\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709044026, \"_nanoseconds\": 778000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Thymosin .beta.-4\", \"url\": \"https://drugs.ncats.io/drug/549LM7U24W\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S2: Peptide Hormones, Growth Factors, etc.Unapproved drug",
    "Name": "thymosin beta 4",
    "guid": "f8fd3377-4d2e-4fe8-9556-cb98be324c7e",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "thymosin beta 4",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"thymosin-\u03b24\", \"Timbetasin\", \"T\u03b24\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709044073, \"_nanoseconds\": 802000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Tianeptine\", \"url\": \"https://drugs.ncats.io/drug/0T493YFU8O\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "FDA statement: Not a dietary ingredient; unsafe food additiveUnapproved drug",
    "Name": "tianeptine",
    "guid": "944b9be3-6334-416d-8fb5-00cf31925277",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "tianeptine",
    "Reasons": "[{\"reason_code\": 6018, \"reason\": \"FDA Statement\", \"link\": \"\", \"guid\": \"3cd17124-6ebc-4828-9edb-c20a81755502\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1711715334, \"_nanoseconds\": 457000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"Tianna White\", \"Tianna Red\", \"tianeptine sodium powder\", \"Tianaa\", \"tianeptina\", \"Tianna Green\", \"tianeptine sulfate\", \"tianeptine acid\", \"7-[(3-chloro-6-methyl-5,5-dioxo-11H-benzo[c][2,1]benzothiazepin-11-yl)amino]heptanoic acid\", \"Coaxil\", \"7-[(3-chloro-6-methyl-5,5-dioxo-11H-benzo[c][2,1]benzothiazepin-11-yl)amino] heptanoic acid\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1733494233, \"_nanoseconds\": 33000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Tibolone\", \"url\": \"https://drugs.ncats.io/drug/FF9X0205V2\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S1: Anabolic AgentsUnapproved drug",
    "Name": "tibolone",
    "guid": "64815e4e-8add-4ef6-88d4-5e946d7d3436",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "tibolone",
    "Reasons": "[{\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"17-hydroxy-7\u03b1-methyl-19-nor-17\u03b1-pregn-5(10)-en-20-yn-3-one\", \"17-hydroxy-7alpha-methyl-19-nor-17alpha-pregn-5(10)-en-20-yn-3-one\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709047171, \"_nanoseconds\": 164000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "tiletamine",
    "guid": "9a5b34bd-d24d-4e50-b54a-b1f73146d4f3",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "tiletamine",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}]",
    "other_names": "[\"Telazol\", \"2-(ethylamino)-2-(2-thienyl)-cyclohexanone\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709047194, \"_nanoseconds\": 484000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "tilidine",
    "guid": "4366d2aa-ec8f-4f64-92c3-46e6f0bf5ae1",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "tilidine",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"Lak\", \"Kitadol\", \"Tilsa\", \"Tilidate\", \"Valoron\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709047211, \"_nanoseconds\": 733000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Tirasemtiv\", \"url\": \"https://drugs.ncats.io/drug/G8WSM7R635\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "tirasemtiv",
    "guid": "a6de22c9-beec-46f9-a484-9aeab61375f0",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "tirasemtiv",
    "Reasons": "[{\"reason_code\": 6008, \"reason\": \"WADA S0: Non-approved Substances\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"f321f8bd-47c9-42f3-bea6-f36eafa02ecf\", \"link_title\": \"WADA Prohibited List S0: Non-approved Substances\", \"updated\": {\"_seconds\": 1703682727, \"_nanoseconds\": 352000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"CK-2017357\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709049172, \"_nanoseconds\": 815000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Tolvaptan\", \"url\": \"https://drugs.ncats.io/drug/21G72T1950\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S5: Diuretics and Masking AgentsPrescription drug",
    "Name": "tolvaptan",
    "guid": "be002dac-bf47-43a7-9d1b-e24cd929219e",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "tolvaptan",
    "Reasons": "[{\"reason_code\": 6013, \"reason\": \"WADA S5: Diuretics and Masking Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b1ad44e4-cef0-4ae2-99fb-19e28540f282\", \"link_title\": \"WADA Prohibited List S5: Diuretics and Masking Agents\", \"updated\": {\"_seconds\": 1703682941, \"_nanoseconds\": 864000000}}, {\"reason_code\": 6016, \"reason\": \"Prescription drug\", \"link\": null, \"guid\": \"becae72e-580f-4d8d-8665-c0c4b1dc1381\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683249, \"_nanoseconds\": 70000000}}]",
    "other_names": "[\"Jynarque\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709047484, \"_nanoseconds\": 444000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Torsemide\", \"url\": \"https://drugs.ncats.io/drug/W31X2H97FB\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S5: Diuretics and Masking Agents",
    "Name": "torasemide",
    "guid": "4a2c3397-7d34-4216-b898-8fb671e4ead8",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "torasemide",
    "Reasons": "[{\"reason_code\": 6013, \"reason\": \"WADA S5: Diuretics and Masking Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b1ad44e4-cef0-4ae2-99fb-19e28540f282\", \"link_title\": \"WADA Prohibited List S5: Diuretics and Masking Agents\", \"updated\": {\"_seconds\": 1703682941, \"_nanoseconds\": 864000000}}, {\"reason_code\": 6016, \"reason\": \"Prescription drug\", \"link\": null, \"guid\": \"becae72e-580f-4d8d-8665-c0c4b1dc1381\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683249, \"_nanoseconds\": 70000000}}]",
    "other_names": "[\"Demadex\", \"torsemide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709047521, \"_nanoseconds\": 780000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Toremifene\", \"url\": \"https://drugs.ncats.io/drug/7NFE54O27T\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S4: Hormone and Metabolic ModulatorsPrescription drug",
    "Name": "toremifene",
    "guid": "c24495ca-6529-4074-b267-4d717c4609a4",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "toremifene",
    "Reasons": "[{\"reason_code\": 6012, \"reason\": \"WADA S4: Hormone and Metabolic Modulators\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"ac1ba347-6d44-4a17-829d-e589bf33bbdb\", \"link_title\": \"WADA Prohibited List S4: Hormone and Metabolic Modulators\", \"updated\": {\"_seconds\": 1703682875, \"_nanoseconds\": 162000000}}, {\"reason_code\": 6016, \"reason\": \"Prescription drug\", \"link\": null, \"guid\": \"becae72e-580f-4d8d-8665-c0c4b1dc1381\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683249, \"_nanoseconds\": 70000000}}]",
    "other_names": "[\"Fareston\", \"GTx 006\", \"toremifeno\", \"NK 622\", \"toremifene citrate\", \"2-(para-((Z)-4-chloro-1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylethylamine\", \"CCRIS 8745\", \"FC1157a\", \"(Z)-2-(4-(4-Chloro-1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine\", \"Acapodene\", \"toremifenum\", \"FC-1157a\", \"FC 1157a\", \"Z-Toremifene\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1761929972, \"_nanoseconds\": 5000000}",
    "label_terms": "[]",
    "linked_ingredients": "[]",
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "tramadol",
    "guid": "4326e65e-0da8-4317-9407-542a10174376",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "tramadol",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol\", \"tramadol hydrochloride\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709047669, \"_nanoseconds\": 245000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "trenbolone",
    "guid": "2f627fdb-bca4-4a2a-a3c2-07b575fb3883",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "trenbolone",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}, {\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}]",
    "other_names": "[\"17 beta-acetoxyestra-4,9,11-trien-3-one\", \"trenbolone acetate\", \"17beta-trenbolone\", \"Finaplix-S\", \"17\u03b2-hydroxyestr-4,9,11-trien-3-one\", \"trenbolone hexahydrobenzylcarbonate\", \"Finajet\", \"17 beta-acetoxyestr-4,9,11-trien-3-one\", \"trenbolone cypionate\", \"Parabolan\", \"trienbolone\", \"trenbolone enanthate\", \"Tren\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1722275698, \"_nanoseconds\": 444000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Trestolone\", \"url\": \"https://drugs.ncats.io/drug/40P3287I94\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S1: Anabolic AgentsUnapproved drug",
    "Name": "trestolone",
    "guid": "e6a1f2cb-fccf-4f36-9dd0-90492c2baf6b",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "trestolone",
    "Reasons": "[{\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"19-nor-methyltestosterone\", \"MENT\", \"7\u03b1-methyl-19-nortestosterone\", \"7\u03b1-methylnandrolone\", \"7alpha-methyl-19-nortestosterone\", \"7alpha-methylnandrolone\", \"trestolone acetate\", \"trestolone acetate [7a-methyl-17\u00df-hydroxyestr-4-en-3-one acetate]\", \"trestolone decanoate\", \"trestolone phenylpropionate\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1711033194, \"_nanoseconds\": 498000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Tretoquinol\", \"url\": \"https://drugs.ncats.io/drug/JIO3275WGI\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S3: Beta-2 AgonistsUnapproved drug",
    "Name": "tretoquinol",
    "guid": "d13630c3-c95f-46f7-a2f1-25e1b25dbba8",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "tretoquinol",
    "Reasons": "[{\"reason_code\": 6011, \"reason\": \"WADA S3: Beta-2 Agonists\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"aecafa3b-c7ad-413c-bc5f-be7ed5b2f69d\", \"link_title\": \"WADA Prohibited List S3: Beta-2 Agonists\", \"updated\": {\"_seconds\": 1703682857, \"_nanoseconds\": 73000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"trimethoquinol\", \"trimetoquinol\", \"tretoquinol, (+)-\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709047821, \"_nanoseconds\": 717000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Uridine triacetate\", \"url\": \"https://drugs.ncats.io/drug/2WP61F175M\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Prescription drug",
    "Name": "triacetyluridine",
    "guid": "e0dfc830-8ebb-4ddf-8aac-6aaf0d3f924a",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "triacetyluridine",
    "Reasons": "[{\"reason_code\": 6016, \"reason\": \"Prescription drug\", \"link\": null, \"guid\": \"becae72e-580f-4d8d-8665-c0c4b1dc1381\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683249, \"_nanoseconds\": 70000000}}]",
    "other_names": "[\"uridine triacetate\", \"TAU\", \"Xuriden\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1751039442, \"_nanoseconds\": 279000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Triamterene\", \"url\": \"https://drugs.ncats.io/drug/WS821Z52LQ\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S5: Diuretics and Masking AgentsPrescription drug",
    "Name": "triamterene",
    "guid": "4f70c584-8252-4fdd-8711-1a10b78a061b",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "triamterene",
    "Reasons": "[{\"reason_code\": 6013, \"reason\": \"WADA S5: Diuretics and Masking Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b1ad44e4-cef0-4ae2-99fb-19e28540f282\", \"link_title\": \"WADA Prohibited List S5: Diuretics and Masking Agents\", \"updated\": {\"_seconds\": 1703682941, \"_nanoseconds\": 864000000}}, {\"reason_code\": 6016, \"reason\": \"Prescription drug\", \"link\": null, \"guid\": \"becae72e-580f-4d8d-8665-c0c4b1dc1381\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683249, \"_nanoseconds\": 70000000}}]",
    "other_names": "[\"2,4,7-triamino-6-phenylpteridine\", \"6-phenylpteridine-2,4,7-triamine\", \"Dyrenium\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709047972, \"_nanoseconds\": 395000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "triazolam",
    "guid": "4d45c725-4288-4ed7-a3ef-3bb99128fb3b",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "triazolam",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"Halcion\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709047996, \"_nanoseconds\": 461000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "trimeperidine",
    "guid": "d3516124-ca43-4955-aa21-a8d1ef0ead84",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "trimeperidine",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"Promedolum\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709048051, \"_nanoseconds\": 420000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Trimetazidine\", \"url\": \"https://drugs.ncats.io/drug/N9A0A0R9S8\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S4: Hormone and Metabolic ModulatorsUnapproved drug",
    "Name": "trimetazidine",
    "guid": "a20f391c-a9da-45fd-86db-f953b05ebf94",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "trimetazidine",
    "Reasons": "[{\"reason_code\": 6012, \"reason\": \"WADA S4: Hormone and Metabolic Modulators\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"ac1ba347-6d44-4a17-829d-e589bf33bbdb\", \"link_title\": \"WADA Prohibited List S4: Hormone and Metabolic Modulators\", \"updated\": {\"_seconds\": 1703682875, \"_nanoseconds\": 162000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"trimetazidine hydrochloride\", \"Idaptan\", \"Vasorel\", \"Preductal MB\", \"Vastarel\", \"4-(2,3,4-trimethoxybenzyl)piperazine\", \"trimetazidinum\", \"triametazidine\", \"trimetazidina\", \"dihydrochloride, trimetazidine\", \"Centroph\u00e8ne\", \"1-(2,3,4-trimethoxybenzyl)piperazine\", \"trimetazidine dihydrochloride\", \"trim\u00e9tazidine irex\", \"Vasartel\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1762173424, \"_nanoseconds\": 505000000}",
    "label_terms": "[]",
    "linked_ingredients": "[]",
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Triptorelin\", \"url\": \"https://drugs.ncats.io/drug/9081Y98W2V\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S2: Peptide Hormones, Growth Factors, etc.Prescription drug",
    "Name": "triptorelin",
    "guid": "48f1be78-fc3c-4699-ab2c-89c14d62ca90",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "triptorelin",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}, {\"reason_code\": 6016, \"reason\": \"Prescription drug\", \"link\": null, \"guid\": \"becae72e-580f-4d8d-8665-c0c4b1dc1381\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683249, \"_nanoseconds\": 70000000}}]",
    "other_names": "[\"Arvekap\", \"Triptodur\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1761928542, \"_nanoseconds\": 774000000}",
    "label_terms": "[]",
    "linked_ingredients": "[]",
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Tuaminoheptane\", \"url\": \"https://drugs.ncats.io/drug/Z0420GYD84\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Unapproved drug",
    "Name": "tuaminoheptane",
    "guid": "2efc646b-5d37-4384-8d79-fa58c9ad24ab",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "tuaminoheptane",
    "Reasons": "[{\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"tuaminoheptano\", \"2-aminoheptane\", \"Rineptyl\", \"heptin\", \"heptadrine\", \"Rineptil\", \"tuamine hydrochloride\", \"tuamine\", \"tuamine sulfate\", \"tuaminoheptanum\", \"heptedrine\", \"tuaminoheptane sulfate\", \"2-heptylamine\", \"2-heptanamine\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1751990106, \"_nanoseconds\": 81000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Tulobuterol\", \"url\": \"https://drugs.ncats.io/drug/591I9SU0F7\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S3: Beta-2 AgonistsUnapproved drug",
    "Name": "tulobuterol",
    "guid": "9fa6e06c-53cc-4f6c-b6c6-ed5d203f94d0",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "tulobuterol",
    "Reasons": "[{\"reason_code\": 6011, \"reason\": \"WADA S3: Beta-2 Agonists\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"aecafa3b-c7ad-413c-bc5f-be7ed5b2f69d\", \"link_title\": \"WADA Prohibited List S3: Beta-2 Agonists\", \"updated\": {\"_seconds\": 1703682857, \"_nanoseconds\": 73000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"alpha-((tert-butylamino)methyl)-O-chlorobenzyl alcohol\", \"\u03b1-((tert-butylamino)methyl)-O-chlorobenzyl alcohol\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709048183, \"_nanoseconds\": 196000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Unifiram\", \"url\": \"https://drugs.ncats.io/drug/N4024LN29G\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S4: Hormone and Metabolic ModulatorsUnapproved drug",
    "Name": "unifiram",
    "guid": "71103e3c-6c71-4df0-b2ce-13e454dee155",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "unifiram",
    "Reasons": "[{\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"DM-232\", \"pyrrolo(1,2-A)pyrazin-6(2H)-one, 2-((4-fluorophenyl)sulfonyl)hexahydro-\", \"2-((4-fluorophenyl)sulfonyl)hexahydropyrrolo(1,2-A)pyrazin-6(2H)-one\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1751294486, \"_nanoseconds\": 504000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Vadadustat\", \"url\": \"https://drugs.ncats.io/drug/I60W9520VV\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S2: Peptide Hormones, Growth Factors, etc.Prescription drug",
    "Name": "vadadustat",
    "guid": "487a4b02-2b14-4fd1-acc6-eb6a8b5ba19e",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "vadadustat",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"AKB-6548\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709048327, \"_nanoseconds\": 941000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "valeryl fentanyl",
    "guid": "473fadd9-6ca7-48cb-b24b-bfdd106a7466",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "valeryl fentanyl",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709048446, \"_nanoseconds\": 388000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Vilanterol\", \"url\": \"https://drugs.ncats.io/drug/028LZY775B\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S3: Beta-2 AgonistsPrescription drug",
    "Name": "vilanterol",
    "guid": "88f64735-beb0-43eb-a7fb-a8ad08afc039",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "vilanterol",
    "Reasons": "[{\"reason_code\": 6011, \"reason\": \"WADA S3: Beta-2 Agonists\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"aecafa3b-c7ad-413c-bc5f-be7ed5b2f69d\", \"link_title\": \"WADA Prohibited List S3: Beta-2 Agonists\", \"updated\": {\"_seconds\": 1703682857, \"_nanoseconds\": 73000000}}, {\"reason_code\": 6016, \"reason\": \"Prescription drug\", \"link\": null, \"guid\": \"becae72e-580f-4d8d-8665-c0c4b1dc1381\", \"link_title\": null, \"updated\": {\"_seconds\": 1703683249, \"_nanoseconds\": 70000000}}]",
    "other_names": "[\"GW-642444X\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709048474, \"_nanoseconds\": 789000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "vinbarbital",
    "guid": "ad8cd8cf-b146-4f3a-a775-a39e2a383ff7",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "vinbarbital",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}]",
    "other_names": "[\"Delvinal\", \"vinbarbitone\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709048488, \"_nanoseconds\": 645000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"FDA:\u00a0Vinpocetine in Dietary Supplements\", \"url\": \"https://www.fda.gov/food/dietary-supplement-products-ingredients/vinpocetine-dietary-supplements\"}, {\"title\": \"NIH NCATS Inxight Drugs entry: Vinpocetine\", \"url\": \"https://drugs.ncats.io/drug/543512OBTC\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "FDA statement: Synthetic substance that currently does not meet the definition of a dietary ingredientUnapproved drug",
    "Name": "vinpocetine",
    "guid": "19e65ba6-c949-4185-80a4-bb1ec3d1f374",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "vinpocetine",
    "Reasons": "[{\"reason_code\": 6018, \"reason\": \"FDA Statement\", \"link\": \"\", \"guid\": \"3cd17124-6ebc-4828-9edb-c20a81755502\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1711715334, \"_nanoseconds\": 457000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"Vinpocetine Oral Grade\", \"ethyl apovincamin-22-oate\", \"3-alpha,16-alpha-apovincaminic acid ethyl ester\", \"ethyl (3\u03b1,16\u03b1)-eburnamenine-14-carboxylate\", \"vinpocetinum\", \"ethyl apovincaminate\", \"apovincaminate d'ethyle\", \"3-\u03b1,16-\u03b1-apovincaminic acid ethyl ester\", \"apovincaminic acid ethyl ester\", \"Cavinton\", \"Ceractin\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1761938124, \"_nanoseconds\": 451000000}",
    "label_terms": "[]",
    "linked_ingredients": "[]",
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Vosilasarm\", \"url\": \"https://drugs.ncats.io/drug/4O87Q44KNC\"}, {\"title\": \"FDA warns against using SARMs in body-building products\", \"url\": \"https://www.fda.gov/news-events/fda-brief/fda-brief-fda-warns-against-using-sarms-body-building-products\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S1: Anabolic AgentsUnapproved drugFDA statement: SARMs",
    "Name": "vosilasarm",
    "guid": "383a7d15-b880-45bb-80a8-59f64546a243",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "vosilasarm",
    "Reasons": "[{\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}, {\"reason_code\": 6018, \"reason\": \"FDA Statement\", \"link\": \"\", \"guid\": \"3cd17124-6ebc-4828-9edb-c20a81755502\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1711715334, \"_nanoseconds\": 457000000}}]",
    "other_names": "[\"2-chloro-4-((1R,2S)-1-(5-(4-cyanophenyl)-1,3,4-oxadiazol-2-yl)-2-hydroxypropylamino)-3-methylbenzonitrile\", \"Radarine\", \"2-[4-chlorobutyl(methyl)amino]-N-(2,6-dimethylphenyl) acetamide\", \"Testolone\", \"RAD-140 testolone\", \"RAD140\", \"RAD-140\", \"2-chloro-4-[[(1R,2S)-1-[5-(4-cyanophenyl)-1,3,4-oxadiazol-2-yl]-2-hydroxypropyl]amino]-3-methylbenzonitrile\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1742485730, \"_nanoseconds\": 194000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "xenon",
    "guid": "5107954c-7ec7-465f-b2da-d08129e010d7",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "xenon",
    "Reasons": "[{\"reason_code\": 6010, \"reason\": \"WADA S2: Peptide Hormones, Growth Factors, etc.\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b49bc2e0-90e1-419e-b471-3d43d775d79b\", \"link_title\": \"WADA Prohibited List S2: Peptide Hormones, Growth Factors, etc.\", \"updated\": {\"_seconds\": 1703682804, \"_nanoseconds\": 164000000}}]",
    "other_names": "[]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1735580281, \"_nanoseconds\": 376000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "xipamide",
    "guid": "b6a2c9d3-b70c-4d23-9669-8a51ec4e421c",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "xipamide",
    "Reasons": "[{\"reason_code\": 6013, \"reason\": \"WADA S5: Diuretics and Masking Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"b1ad44e4-cef0-4ae2-99fb-19e28540f282\", \"link_title\": \"WADA Prohibited List S5: Diuretics and Masking Agents\", \"updated\": {\"_seconds\": 1703682941, \"_nanoseconds\": 864000000}}]",
    "other_names": "[]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1735929672, \"_nanoseconds\": 449000000}",
    "label_terms": "[]",
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "zaleplon",
    "guid": "6726e9a2-dda3-427d-858e-a0bcbd4ca05d",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "zaleplon",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"Sonata\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709048644, \"_nanoseconds\": 437000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Zeranol\", \"url\": \"https://drugs.ncats.io/drug/76LO2L2V39\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S1: Anabolic AgentsUnapproved drug",
    "Name": "zeranol",
    "guid": "a7b04e33-cd43-48b3-93dd-8c8ed48dc31f",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "zeranol",
    "Reasons": "[{\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"(3S,7R)-7,14,16-trihydroxy-3-methyl-3,4,5,6,7,8,9,10,11,12-decahydro-1H-2-benzoxacyclotetradecin-1-one\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709048662, \"_nanoseconds\": 397000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[{\"title\": \"NIH NCATS Inxight Drugs entry: Zilpaterol\", \"url\": \"https://drugs.ncats.io/drug/S384A1Y12J\"}]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "WADA S1: Anabolic AgentsUnapproved drug",
    "Name": "zilpaterol",
    "guid": "c937c061-89c2-47b6-b7d3-554bcfcf6567",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "zilpaterol",
    "Reasons": "[{\"reason_code\": 6009, \"reason\": \"WADA S1: Anabolic Agents\", \"link\": \"https://www.wada-ama.org/en/prohibited-list\", \"guid\": \"45aac7e6-3bec-4832-a1ad-6c18ed0cc070\", \"link_title\": \"WADA Prohibited List S1: Anabolic Agents\", \"updated\": {\"_seconds\": 1703682746, \"_nanoseconds\": 731000000}}, {\"reason_code\": 6002, \"reason\": \"Unapproved Drug\", \"link\": \"\", \"guid\": \"63770d11-b58d-40e1-8ecb-803201be48be\", \"link_title\": \"\", \"updated\": {\"_seconds\": 1703610861, \"_nanoseconds\": 641000000}}]",
    "other_names": "[\"imidazo(4,5,1-jk)(1)benzazepin-2(1H)-one, 4,5,6,7-tetrahydro-7-hydroxy-6-((1-methylethyl)amino)-, trans-(+-)-\", \"imidazo(4,5,1-jk)(1)benzazepin-2(1H)-one, 4,5,6,7-tetrahydro-7-hydroxy-6-((1-methylethyl)amino)-, (6R,7R)-rel-\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709048677, \"_nanoseconds\": 117000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule I",
    "Name": "zipeprol",
    "guid": "896f8a04-d200-46df-a7a9-f82e45c1767d",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "zipeprol",
    "Reasons": "[{\"reason_code\": 6003, \"reason\": \"DEA Controlled Substance List: Schedule I\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"3ca67615-fda5-4809-9ff4-0a2b121de966\", \"link_title\": \"DEA Controlled Substance List: Schedule I\", \"updated\": {\"_seconds\": 1712942737, \"_nanoseconds\": 951000000}}]",
    "other_names": "[\"1-methoxy-3[-4-(2-methoxy-2-phenylethyl)piperazin-1-yl]-1-phenylpropan-2-ol\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709048698, \"_nanoseconds\": 332000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule III",
    "Name": "zolazepam",
    "guid": "5aae6bcd-99f8-4c09-9312-38964dda35be",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "zolazepam",
    "Reasons": "[{\"reason_code\": 6005, \"reason\": \"DEA Controlled Substance List: Schedule III\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"1d38dd1b-7731-4cbc-aeb7-cd15d8c454fc\", \"link_title\": \"DEA Controlled Substance List: Schedule III\", \"updated\": {\"_seconds\": 1712942752, \"_nanoseconds\": 111000000}}]",
    "other_names": "[\"4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo-[3,4-e] [1,4]-diazepin-7(1H)-one\", \"flupyrazapon\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709048722, \"_nanoseconds\": 428000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "zolpidem",
    "guid": "31493ecc-a6b5-4755-abaa-47024052e821",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "zolpidem",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"Ambien\", \"Stilnoct\", \"Ivadal\", \"N,N-dimethyl-2-[6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]acetamid\", \"Stilnox\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709048743, \"_nanoseconds\": 204000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "Controlled substance: Schedule IV",
    "Name": "zopiclone",
    "guid": "e35c138c-6335-4bc5-bf6b-a548fee636fb",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "zopiclone",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"Lunesta\", \"Imovane\", \"Zimovane\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709049157, \"_nanoseconds\": 528000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  },
  {
    "References": "[]",
    "SourceOf": "",
    "More_info_URL": "",
    "Reason": "",
    "Name": "zuranolone",
    "guid": "b65caec0-0a5f-4867-b3e4-1f8ea88fd89d",
    "More_info": "",
    "Warnings": "",
    "searchable_name": "zuranolone",
    "Reasons": "[{\"reason_code\": 6006, \"reason\": \"DEA Controlled Substance List: Schedule IV\", \"link\": \"https://www.deadiversion.usdoj.gov/schedules/schedules.html\", \"guid\": \"757955e6-323c-42a9-b716-b56b260afbd9\", \"link_title\": \"DEA Controlled Substance List: Schedule IV\", \"updated\": {\"_seconds\": 1712942759, \"_nanoseconds\": 559000000}}]",
    "other_names": "[\"Zurzuvae\"]",
    "classifications": "[\"6000\"]",
    "updated": "{\"_seconds\": 1709049190, \"_nanoseconds\": 854000000}",
    "label_terms": null,
    "linked_ingredients": null,
    "added": "2025-12-30T21:42:08.769789+00:00"
  }
]